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001
Frameshift Mutation in the V2 Domain of Keratin 1 Causes the Striate Form of
Palmoplantar Keratoderma
N.V. Whittock, H. Wan,* F.J.D. Smith, F. Keane,* R. Mallipedi,* W.A.D.Grif®ths,* P.
Dopping-Hepenstal,* G.H.S. Ashton,* R.A.J. Eady,* W.H.I. McLean, and J.A. McGrath*
Epithelial Genetics Group, Human Genetics Unit, University of Dundee, Ninewells Hospital and Medical
School, Dundee, UK; *Department of Cellular and Molecular Pathology, St John's Institute of Dermatology,
The Guy's, King's College, and St Thomas' Hospitals' Medical School, London, UK
The striate form of palmoplantar keratoderma is a rare autosomal dominant disorder affecting palm
and sole skin. Genetic heterogeneity of SPPK has been demonstrated with mutations being
characterised in the desmosomal proteins, desmoplakin and desmoglein 1. We have studied a three
generation family of British descent with striate PPK in which assessment of affected palmar skin
shows a reduced expression of keratins K5/14 in the basal layer and K1/10 and K9 in the spinous
layer, as well as up regulation of K6/16/17 across the epidermis. Ultrastructural studies show that
desmosome numbers are normal, but their inner plaques and midline structures are attenuated.
Microsatellite markers were used to screen candidate loci including the epidermal differentiation
complex on 1q, the desmoplakin locus on 6p, the type I and II keratin gene clusters on
chromosomes 12q and 17q, and the desmosomal cadherin gene cluster on chromosome 18q.
Signi®cant genetic linkage to chromosome 12q was observed using marker D12S368, with a
maximum two-point lod score of 3.496 at a recombination fraction of 0. Direct sequencing of the
keratin 1 gene revealed a frameshift mutation in exon 9 that leads to the partial loss of the glycine
loop motif in the V2 domain and gain of a novel 70 amino acid residue peptide. Using expression
studies we show that the V2 domain is essential for the correct insertion of the keratin intermediate
®laments into the desmosomal plaque. In conclusion, the ultrastructural ®ndings described here are
unique in SPPK, and although the molecular defect is very similar to that recently reported in
ichthyosis hystrix the changes in the keratin intermediate ®laments are different.
002
E-Selectin Dependent In Vivo Migration of Atopic Dermatitis (AD) Derived Th2 Cells
Through Chemokine Receptor (CCR) 4 Ligation
T. Biedermann, C. SchwaÈrzler, J. Kund, G. Lametschwandtner, N. Carballido-Perrig, and J.
Carballido
Novartis Research Institute, Vienna, Austria
AD is the cutaneous manifestation of atopy and may be induced by allergen speci®c Th2 cells.
Previous data suggest that P- and E-Selectin mediate Th1, but not Th2 cell migration to the skin.
In contrast, Th2 cells expressing the E-Selectin ligand cutaneous leukocyte antigen (CLA)
dominate early AD lesions and can be isolated from AD skin. CCR3 was initially assigned to Th2
cells, but Th2 cells from AD were not speci®cally analyzed. In order to understand the multistep
process of Th2 cell migration, we investigated CCR expression and E-Selectin binding properties
relevant for skin homing of Th2 cells. Highly polarized Th2 clones, grown from AD skin, showed
strong CCR4, but no CCR3 or CCR8 expression as determined by real time PCR and FACS
analysis. Ca2+ ¯ux assays revealed a selective response to CCR4 ligands macrophage derived
chemokine (MDC) and thymus and activation regulated chemokine (TARC) binding, but not to
control chemokines such as CCR3 ligand eotaxin or CCR8 ligand I 309. Interestingly, only MDC
and not TARC induced complete receptor desensitization indicating also incomplete TARC
signaling. Consistently, pronounced expression of MDC was shown in AD skin by in situ RT-
PCR and superantigen stimulation induced MDC in Th2, but not in Th1 clones. To investigate
speci®c skin homing in a physiologic environment, we developed a SCID-hu mouse model.
Human skin was transplanted on SCID mice and AD derived Th2 cells were adoptively transferred
(i.p.). Th2 cells migrated exclusively to human skin grafts treated with CCR4 ligands, but
interestingly, homing was always more enhanced with MDC than with TARC. This skin homing
of human Th2 cells depended on CCR4 ligation, since blocking of G-coupled receptor signaling
in Th2 cells by pertussis toxin pretreatment inhibited Th2 cell migration. Also, a blocking E-
Selectin mAb strongly reduced Th2 homing, indicating a crucial role for E-Selectin. Our in vitro
and in vivo studies using a SCID-hu Th2 migration model, suggest that rolling on E-Selectin and
ligation of CCR4 are functionally relevant steps in Th2 cell skin homing. These data provide
insights into the pathogenesis of AD and indicate novel strategies and targets for therapeutic
interventions.
003
Platelet Activation in Psoriasis: A Possible Link to Skin In¯ammation?
R.J. Ludwig, J.E. Schulz, C. Weber, R. Kaufmann, M. Podda, and T.M. Zollner
Department of Dermatology, University of Frankfurt/Main, Germany
Circulating lymphocytes gain access to tissues due to their ability to roll along venules. It has been
shown that platelet-mediated lymphocyte rolling occurs in lymph nodes: Platelets bind
lymphocytes via P-Selectin and lymphocyte P-selectin glycoprotein ligand-1 (PSGL-1). The
platelet-lymphocyte-aggregate is then able to roll in a cart wheel-like fashion on the endothelium
via platelet P-Selectin and endothelial peripheral node addressin (PNAd). Additionally, in psoriasis
increased susceptibility to occlusive vascular disease has been linked to platelet activation. The
purpose of this study is to investigate whether platelets mediate lymphocyte homing to skin. If this
holds true platelets in psoriatics should express elevated levels of P-selectin and bind lymphocytes.
Furthermore, platelets and platelet-lymphocyte aggregates should roll on PNAd-expressing
endothelial cells, such as in psoriatic vessels. Platelet P-selectin expression was increased in patients
with psoriasis compared to controls (2.1 6 1.1 vs. 0.7 6 0.5%; n = 25 and 32, respectively) as shown
by ¯ow cytometry. In an in vitro binding assay, lymphocytes predominantly bound activated
platelets (2.4-fold; n = 6). Binding of activated platelets is mediated by P-selectin binding to
lymphocyte PSGL-1 as it was completely blocked by addition of speci®c mAbs (n = 6). As PNAd is
expressed in psoriatic lesions and also constitutively in murine skin (n = 3) we observed platelet±
endothelial interactions in murine skin vessels using intravital microscopy. For this purpose human
platelets were ¯uorescently labeled, activated, and infused into the carotid artery of anesthetized
mice. Fluorescent platelets in downstream microvessels of the ear were visualized by epi-
illumination. In vivo, rolling of activated platelets along endothelium is signi®cantly increased
compared to resting platelets (14.8 6 11.1 vs. 4.0 6 5.3%; p < 0.001). The increased rolling of
activated platelets is abolished by addition of WAPS12.2 (anti human P-selectin mAb) or MECA-
79 (anti PNAd mAb) indicating that rolling of activated platelets is mediated via P-selectin±PNAd
interaction. We conclude that activated platelets interact with PNAd-expressing skin vessels. This
interaction may facilitate rolling of platelet±lymphocyte aggregates as shown by our binding assays.
Therefore, platelet activation in psoriasis is hypothesized to aggravate skin in¯ammatory processes.
004
The G2/M Regulator 14±3-3 s Prevents the Progression of Apoptosis by Associating
with Bax
T. Samuel, H.O. Weber, P. Rauch, J.-T. Eppel, B. Verdoodt, A. McShea,² H. Hermeking,* and
J.O. Funk
Erlangen and *Martinsried, Germany; ²Seattle
Although the requirement of the p53 tumor suppressor to mediate either cell cycle arrest or
apoptosis has been shown, the molecular mechanism by which p53 mediates the balance of either
outcome is unclear. 14±3-3 s (HME1, strati®n) was recently cloned by serial analysis of gene
expression as a p53-regulated inhibitor of G2/M. 14±3-3 s, which is expressed exclusively in
epithelial cells, thereby acts as a central regulator of DNA damage-triggered G2 arrest.
Overexpression of 14±3-3 s leads to a block of cytokinesis, probably by inhibiting the activation
network of the G2/M cyclin-dependent kinase (CDK) 1, followed by apoptosis. We show that,
surprisingly, 14±3-3 s plays a crucial role in the protection of cells from apoptosis by associating
with the pro-apoptotic protein Bax and preventing its translocation from the cytoplasm to
membraneous organelles. This quality of 14±3-3 s is not shared by other 14-3-3 isotypes.
Consequently, upon DNA damage parental 14±3-3 s+/+ carcinoma cells sustain G1 and G2 cell
cycle arrest. In contrast, in 14±3-3 s±/± cells DNA damage leads to a dramatic translocation of Bax
and distinct concentration of mitochondria and Bax around the centrosome, preceeding activation
of caspase-3, and ultimately apoptosis, as judged by sub-G1 peak, DNA laddering, and annexin V
stain. This scenario is further accompanied by caspase-dependent cleavage of the CDK inhibitor
p21CIP1, resulting in its functional inactivation through cytoplasmic translocation, unavailability for
G1 arrest, and lack of CDK2 inactivation. In conclusion, 14±3-3 s not only enforces the p53-
dependent G2 arrest but also delays the apoptotic signal transduction by associating with Bax.
Therefore, strategies to target 14±3-3 s during chemotherapy might contribute to the therapeutic
ef®ciency.
005
A Novel Approach to Characterise the BP180 Epitope Pattern Recognised by IgG
Autoantibodies of Bullous Pemphigoid (BP) Patient Sera
G. Di Zenzo, F. Grosso, F. Mariotti, M. Terracina, A. Frezzolini, A. Mastrogiacomo, K. Owaribe,
and G. Zambruno
IDI-IRCCS, Rome, Italy and Nagoya, Japan
The BP180 antigen, a glycoprotein transmembrane component of the epidermal hemidesmosome,
is recognised by autoantibodies associated with three autoimmune bullous skin disorders: BP,
herpes gestationis and cicatricial pemphigoid. An immunodominant region of BP180 recognised
by sera of BP patients has been mapped to the membrane-proximal noncollagenous stretch
(NC16A) of the BP180 ectodomain. However, BP autoantibodies reactivity to BP180 is not
restricted to NC16A region but also comprises epitopes located in the intracellular and others
extracellular domains. In order to characterise the targeted antigenic sites on the whole BP180
antigen in BP, we have prepared a random BP180 epitope library on bacteriophage l and selected
it with sera from BP patients. BP180 cDNA has been randomly digested and cloned in l as a D
protein fusion on the bacteriophage capsid. At ®rst, the library has been screened by af®nity
selection using three anti-BP180 monoclonal antibodies (mAb). The genome of the selected
recombinant phages bearing BP180 fragments has been sequenced and the minimal recognised
regions mapped. The known BP180 antigenic segments for 1A8c, 233 and 1D1 mAb were
reduced, respectively, to regions of 6 (residues 155±160), 26 (residues 1118±1143) and 31 (residues
1357±1387) aminoacids indicating the potential of this l library to map epitope pattern of BP
patients sera. The l library has then been selected with sera from 10 BP patients and several epitopes
spread over the entire BP180 molecule have been identi®ed. The reactivity of 35 BP patient sera has
been assessed against 10 selected epitopes of BP180 intracellular and extracellular regions. Our
results show that phage display libraries represent an alternative approach to epitope mapping of
humoral response in autoimmune blistering skin diseases. This technique might also be used to
characterise epitope spreading in disease course, to correlate the clinical features to epitope pattern
and to set up a diagnostic ELISA.
006
The Laminin g2 Chain Short Arm Drives Incorporation of Laminin-5 into the
Extracellular Matrix, Sustains Cell Adhesion and Inhibits Cell Migration
G. Meneguzzi, M. Allegra, F. Spirito, O. Pommeret, C. Romero, J.P. Ortonne, and L. Gagnoux-
Palacios
INSERM U385, Medical School, University of Nice, France
Laminin-5 is a basement membrane component that actively promotes adhesion and migration of
epithelial cells. Laminin-5 undergoes extracellular proteolysis of the g2 chain that removes the
NH2-terminal short arm of the polypeptide and reduces the size of laminin-5 from 440 kDa to
400 kDa. The functional consequence of this event remains obscure although lines of evidence
indicate that cleavage of the g2 chain potently stimulated scattering and migration of keratinocytes
and cancer cells. To de®ne the biological role of the g2 chain short-arm, we generated mutant g2
cDNAs that were transfected into the immortalized g2-null cell line LSV5. Mutant pgNC expresses
a recombinant g2 polypeptide with the internal deletion of amino acid sequence (YSGD) that
constitutes the proteolytic cleavage site of the g2 chain. Mutant pgGP modi®es the con®guration of
the g2 chain domain III. Mutants pgIII and pgV carry a deletion affecting the EGF-like repeat 1 of
domain III and repeats 2 and 3 of domain V, respectively. Mutant pgC encodes a polypeptide
lacking the N-terminal domains IV and V that are excised in the extracellular processing of
laminin-5. Mutant pgM corresponds to a mutated g2 chain, missing 73 amino acids of the short
arm, that causes a mild form of junctional epidermolysis bullosa, a recessive inherited skin blistering
disease. By immuno¯uorescence and immunohistochemical studies, cell detachment and adhesion
assays, we found that the g2 short arm drives deposition of laminin-5 into the extracellular matrix
ECM and sustains cell adhesion. Our results demonstrate that the unprocessed 440-kDa form of
laminin-5 is a biologically active adhesion ligand, and that the g2 globular domain IV is involved in
intermolecular interactions that mediate integration of laminin-5 in the ECM and cell attachment.
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Leptin Modulates the Effects of DGAT De®ciency on Fur and Sebaceous Glands in Mice
H.C. Chen, S.J. Smith, B. Tow, P.M. Elias, and R.V. Farese Jr
J. Gladstone Institutes and University of California, San Francisco, California
Acyl:CoA diacylglycerol acyltransferase (DGAT), the enzyme that catalyzes the ®nal step in
triglyceride synthesis, is highly expressed in sebaceous glands of mice. DGAT-de®cient (Dgat±/±)
mice developed sebaceous gland atrophy after puberty, resulting in the production of sebum that
lacked several normal components (including a putative type II wax diester, a major constituent of
mouse sebum). These abnormalities were associated with defective water repulsion and prolonged
hypothermia in Dgat±/± mice after water immersion. Unexpectedly, the histological and functional
abnormalities observed in Dgat±/± mice required the presence of leptin, because leptin-de®cient
(ob/ob) mice with DGAT de®ciency had detectable sebaceous glands and produced normal sebum.
However, 2 weeks of subcutaneous leptin infusion (250 ng per h, a dose that restores normal plasma
leptin levels) led to sebaceous gland atrophy and abnormal sebum composition in Dgat±/± ob/ob
mice, and these ®ndings reverted 2 weeks after the completion of leptin infusion.
Intracerebroventricular leptin infusion (10 ng per h, a dose that does not increase circulating
leptin levels in the periphery) produced similar results, indicating that the effects of leptin on
sebaceous glands in Dgat±/± mice could be mediated entirely through the central nervous system.
Our ®ndings identify DGAT as a key enzyme in the development and functioning of sebaceous
glands and reveal a newly identi®ed relationship between sebaceous glands and leptin that is
mediated through the central nervous system.
008
Comparison of Genetic with Conventional Protein Vaccines: Induction of Protective
Antitumor T Cell Responses Against Tumor Antigen Expressed by pDNA-Based
Vaccine but not Against Recombinant Protein
T.K. Weimann, A. Schneeberger, C. Wagner, P. LuÈhrs, A. Zemann, M. Goos, G. Stingl, and S.N.
Wagner
Departments of Dermatology, University School of Medicine, Essen, Germany and Vienna, Austria
The recent development of genetic vaccines raises the question whether these genetic vaccines are
superior to conventional immunization strategies employing the respective protein for the
induction of protective T cell responses. We therefore cloned the 1.9 kb full length cDNA murine
homologue of human MAA Pmel17/gp100, generated a recombinant baculovirus containing the
respective cDNA sequence by ligation independent cloning, expressed the recombinant protein in
Sf9 insect cells, and con®rmed its identity by SDS-PAGE, Western blot analysis and ELISA with
Pmel17 reactive Ab HMB45. After large scale puri®cation by preparative SDS-PAGE,
electroelution, dialysis and steril ®ltration this recombinant full-length protein was compared
with a pDNA vaccine for the induction of protective antigen-speci®c T cell responses in the
experimental Cloudman M3/DBA/2 mouse melanoma model. Mice genetically immunized with
mPmel17-encoding pDNA showed signi®cant protection against subsequent tumor challenge with
Pmel17+-M3 melanoma cells in contrast to mice immunized with increasing doses of recombinant
protein (p < 0.001 at day 15). Whereas induction of an antigen-speci®c T cell response by
mPmel17-encoding pDNA could be demonstrated by (i) induction of protection against Pmel17+-
but not Pmel17± M3 melanoma sublines, (ii) complete loss of protection by in vivo CD4+/CD8+ T
cell depletion and (iii) the detection of a Pmel17/gp100-speci®c T cell response in CTL assays
antigen-speci®c T cell responses could not be detected in mice immunized with the respective
recombinant protein. These results demonstrate for the ®rst time that i.c. genetic immunization
with antigen-encoding pDNA is superior to immunization with the respective recombinant
protein for the induction of antigen-speci®c, protective antitumor T cell responses in vivo.
009
Human Cathelicidin Antimicrobial Peptide is Induced in Skin Wounding ± Active
Peptide is Detected in Physiologic Healing But Not in Chronic Nonhealing Wounds
J.D. Heilborn, M. Frohm Nilsson, G. Kratz,* G. Weber,² O. Sùrensen,³ and M. StaÊhle-BaÈckdahl
Departments of Dermatology, *Reconstructive Surgery and ²Clinical Genetics, Karolinska Institute,
Stockholm, Sweden; ³Department of Hematology, Rigshospitalet, Copenhagen, Denmark
The antimicrobial peptide hCAP18 is a key effector molecule in innate immunity. hCAP18
consists of a conserved propart, cathelin, and a variable C-terminus called LL-37 in humans. The
peptide was originally isolated from neutrophils and is up-regulated in skin in response to
in¯ammation. The holoprotein is activated by enzymatic processing, releasing the LL-37 peptide
that confers the antimicrobial effects. To further explore its role in barrier protection, we have
studied hCAP18 in human wound healing. In both chronic nonhealing wounds and in
physiological wound healing, there was intense immunoreactvity for hCAP18 in the in¯ammatory
wound bed in®ltrate. Low levels of myeloperoxidase protein, measured with ELISA, were found
in protein extracts from all wounds, indicating only a minimal neutrophil contribution to hCAP18
in these tissues. By in situ hybridization the main signal for hCAP18 was detected in the basal layer
of the epidermal tounge near the wound edge. In physiologic healing, hCAP18 was rapidly up-
regulated attaining maximum levels at 12 h postwounding and declining to basal prewounding
levels at 14 days. hCAP18 protein levels in chronic wounds were only 20% of maximum levels
detected in the physiologically healing wounds. Furthermore, with Western blot, processed active
peptide was only seen in these latter wounds and not in the chronic wounds. In our
nonin¯ammatory ex-vivo wound healing model, hCAP18 was up-regulated in the migrating
keratinocytes persisting at re-epithelialization by days 5±7, indicating that in¯ammation is not
required for induction of hCAP18 gene expression. hCAP18 is the only cathelin protein in human,
but the porcine protein, PR-39, a member of the same gene family, is known to induce syndecans
mediating growth-factor responses in pig wounds. The precise role for hCAP18 in wound healing
remains to be fully established, however, the lack of active LL-37 peptide in chronic nonhealing
wounds may contribute to the impaired healing process.
010
Adoptive Immunity Does Not Modulate Clonal Expansion of UV-Induced p53-Mutant
Clones or Their Early Phase Regression
E. Remenyik, N.M. Wikonkal, W. Zhang, and D.E. Brash
Debrecen Hungary and New Haven, USA
The P53 tumor suppressor protein has a central role in the development of UV induced sqamous
cell carcinomas in human and mouse. P53 protein is not expressed in immunohistochemically
detectable amounts in the epidermis in normal conditions. If the half-life of the protein is increased
due to the regulation or mutation it can be detected by immunoperoxidase staining. According to
previous studies clusters of keratinocytes staining positive for p53 can be found after chronic UVB
irradiation. Most of these p53 positive clones harbor p53 mutations and might represent
precancerous lesions. The kinetics of clone development and regression are not well understood.
To determine whether the immune system has an effect on the formation or elimination of p53
immunopositive clones, immunode®cient mice were used. Mice in which the RAG-1 gene has
been knocked out are de®cient in adoptive immune response due to loss of the recombinase
required for B and T cell development. Shaved RAG-1 KO and corresponding C57BL/6 WT
mice were irradiated with 750 J per m2 UVB daily 5 times per week for 7±11 weeks. Groups of
mice were euthanized at 7, 9, 11 weeks. UVB treatment was stopped at 7 and 9 weeks for another
two groups of mice which were kept alive without UVB for 2 more weeks. Whole mounts of
epidermis were prepared and immunoperoxidase staining was performed using CM5 polyclonal
antibody. The number of p53 positive clones per area and the number of cells/clone were counted
under the microscope and statistically analyzed. The number of clones per area increased with
irradiation time. After longer irradiation there were more large clones. Statistical analysis revealed
no signi®cant difference in clones per area between WT and RAG-1 KO mice at 7, 9 or 11 weeks.
2 weeks after the UV irradiation was stopped on the 7th or 9th week, the number of clones had
decreased in both WT and KO mice without signi®cant difference between the two groups.
Unirradiated WT and KO mice had no p53 positive clones. Our results indicate that (a) UV light is
necessary to produce clones, (b) longer irradiation time increases the number and size of clones, (c)
without UV light the clones showed regression, (d) the adoptive, antigen speci®c, immunity is not
involved in preventing the development of p53 clones, and (e) adoptive immunity is not involved
in the early regression of p53 positive clones. The innate immunity, keratinocyte apoptosis, and the
epidermal turnover may contribute to the regression of the clones.
011
The Signaling Function of Integrin b4 Requires Palmitoylation of the Protein
L. Gagnoux-Palacios, M. Dans, W. van't Hof, A. Mariotti, M.D. Resh, and F.G. Giancotti
Cellular Biochemistry and Biophysics Program, Memorial Sloan Kettering Cancer Center, New York, New
York
Integrin a6b4 is a major receptor for the adhesion ligand laminin-5. Its interaction with laminin-5
leads to the formation of hemidesmosome in strati®ed epithelia. We have previously shown that
a6b4 can activate the Ras-Erk signalling pathway by direct recruitment of the signaling protein
Shc to the tyrosine phosphorylated cytoplasmic domain of b4. Shc is an SH2-PTB domain adaptor
which links various tyrosine kinases to Ras by recruiting the Grb2/mSOS complex to the plasma
membrane. Shc activation is essential for a normal growth of epithelial cells such as keratinocytes.
Here we report that the b4 cytoplasmic domain is covalently modi®ed by the post-translational
addition of a palmitic acid on a cysteine residue, and that palmitoylation is differentially modulated
in a variety of cell lines. By directed mutagenesis of the b4 cytoplasmic domain we show that
palmitoylation occurs close to the transmembrane domain of the polypeptide. By sucrose gradient
¯oatation assay we also show that b4 partially localizes into rafts, speci®c microdomains of the
plasma membrane enriched in cholesterol and glycosphingolipids, and that such a localization is
dependent on palmitoylation. We also demonstrated that palmitoylation-de®cient b4 mutant
preserves the adhesion capacity and ability to assemble hemidesmosomes. However, by transient
tranfection assays in HUVECs cells, we show that this mutant does not signal to ERK and that the
Src familly kinase are essential for ERK phosphorylation in response to b4 ligation. In addition, we
assess that the fraction of b4 found in the rafts associates with a Src family kinase which is enriched
in the rafts, possibly Yes or Fyn. Our data suggest that the absence of ERK phosphorylation
correlates with the inability of the palmitoylation-de®cient b4 to localize into rafts and to interact
with a Src kinase, which indicates that rafts play a crucial role in the signalling pathways of the
integrin a6b4.
012
Development of an Active Mouse Model of Pemphigus Vulgaris, a Life Threatening
Skin Disease, by DNA Immunization
G. Zhang, J. Uitto, and R.F. Ghohestani
Immunodermatology Unit, Department of Dermatology and Cutaneous Biology and Jefferson Institute of
Molecular Medicine, Philadelphia, Pennsylvania
Pemphigus Vulagaris (PV) is a life threatening skin disease mediated by IgG antibodies to
desmoglein-3 (Dsg3), a member of cadherin supergene family of cell-cell adhesion molecules.
Development of an animal model of PV is crucial for development of novel approaches in antigen-
speci®c immunotherapy of the disease. We here present our data on successful development of PV-
like lesions in a speci®c strain of mouse by DNA immunization. cDNA coding for the full length
mouse Dsg3 was conjugated with Flag sequence and subcloned into a mammalian expression
vector under a CMV promoter. The resulting construct, using in vitro transfection studies, was
shown to express the full length Dsg3 as con®rmed by Western blot using anti-Flag and anti-Dsg3
antibodies. The endotoxin free cDNA was then delivered by particle bomardement. The mice
developed anti-Dsg3 autoantibodies as detected by immuno¯uorescence microscopy, Elisa and
Western blot. Clinically, the mice developed hair loss, and mucosal lesions. Adoptive transfer of
splenocytes from affected mice into SCID mice further demonstrated the ability of autoreactive
lymphocytes in development of PV-like lesions. This is the ®rst demonstration of an active mouse
model of PV by DNA immunization. This model would provide an invaluable tool for exploring
the immunopathology of PV and development of novel immunotherapeutical approaches.
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Ribozyme Gene Therapy for Keratin Disorders
A. Terron and W.H.I. McLean
Dundee, UK
There are now 17 keratin genes that are known to be involved in autosomal dominant
genodermatoses and other inherited epithelial disorders. Due to the dominant-negative effect of
mutant keratins, conventional gene replacement therapy is not appropriate for these diseases.
Ribozymes are small catalytic RNA molecules which can be designed to cleave mRNA molecules
at speci®c sites. A total of 19 potential ribozyme sites in the K14 mRNA were evaluated and
constructs were made for the ®ve sites showing best predicted RNA folding characteristics.
Ribozymes were protected from RNAse degradation in vivo by addition of hairpin sequences
derived from the U1 snRNA, a naturally occurring small RNA molecule that escapes nuclease
attack. Ribozymes directed against the ®ve chosen sites were constructed as mini-genes driven by
the U1 snRNA promoter in a modi®ed plasmid vector. The ability of these ribozymes to cleave
K14 RNA was investigated under a wide range of conditions both in vitro and in cultured cells.
Three ribozymes were capable of cleaving K14 mRNA in vitro. Furthermore, two were capable of
rapidly cleaving more than 90% of K14 mRNA following transfection of the ribozyme plasmids
into cultured keratinocytes. These experiments show (a) that ribozymes are capable of speci®cally
degrading even high-abundance mRNA species such as keratins; and (b) pave the way for gene
therapy where all endogenous keratin mRNA might be ablated and replaced by a modi®ed
``ribozyme-immune'' keratin gene. In addition, it should be possible to develop ribozymes that
target speci®c keratin mutations.
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Proteasome Inhibitor PS519 Reduces Superantigen-Mediated T-Cell Activation and
Severity of Psoriasis in a SCID-Hu Model
T.M. Zollner, M. Podda, H.A. Beschmann, S. Diehl, C. Pien,* P.J. Elliott,* R. Kaufmann, and
W.H. Boehncke
Department of Dermatology, University of Frankfurt, Germany; *Millennium Pharm. Inc., Boston,
Massachusetts
Psoriasis is a T-cell mediated skin disease characterized by the in®ltration of activated leukocytes
and the presence of a distinct in¯ammatory pattern. There is increasing evidence that bacterial
superantigen-mediated activation of T-cells plays a pivotal role in the induction of psoriasis. NF-
kB is a transcription factor which is involved in the induction of many pro-in¯ammatory
molecules known to be up-regulated in psoriasis. We therefore addressed the question whether
attenuation of NF-kB activation by the proteasome inhibitor PS-519 may suppress T-cell mediated
responses and may be effective in the treatment of psoriasis. PBMCs of four healthy volunteers
were stimulated with the superantigen TSST-1 (100 ng per mL) in the absence or presence of
nontoxic concentrations of PS-519 (1±10 mg per mL). We found a dose-dependent inhibition of
lymphocyte proliferation of up to 95% compared to TSST-1 treated cells. Additionally, the
expression of T-cell activation markers such as CD69, CD25 and HLA-DR was markedly reduced
in PS-519 treated, TSST-1 stimulated cultures. Cytokine production by superantigen-stimulated
PBMCs was dramatically and signi®cantly reduced in PS519 treated cultures (IL-1b, TNF-a,
IFNg). The effects of PS-519 on the severity of psoriasis was assessed in a xenogenic SCID-hu
transplantation model. Lesional psoriatic skin obtained from different donors was transplanted onto
SCID mice. After 28 days, SCID mice were treated once daily either with PS-519 intraperitoneally
(20 mg per mouse; n = 8) or with vehicle for 28 days (n = 4). Thereafter, 20S proteasome activity
was determined in the blood and the human transplanted skin examined by immunohistochem-
istry. As expected, 20S proteasome activity was markedly reduced in PS-519 treated mice
(0.22 6 0.01 [pmol AMC per s per mg protein]) compared to untreated mice (1.53 6 0.05;
mean 6 SEM). In PS-519 treated grafts, normalization of epidermal architecture including loss of
papillomatosis and marked reduction of akanthosis was observed. We conclude that the proteasome
inhibitor PS-519 reduces superantigen mediated T-cell activation in vitro and shows antipsoriatic
ef®cacy in the SCID-hu model.
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Psoriasin (S100a7) is a Major and Potent E. coli-Selective Antimicrobial Protein of
Healthy Human Skin
R. GlaÈser, J. Harder, J. Bartels, E. Christophers, and J.-M. SchroÈder
Kiel, Germany
Human skin is markedly resistant towards infection by Gram-negative bacteria, in particular E. coli.
We therefore hypothesised that human skin might contain factors that control E. coli growth. In
order to prove this hypothesis we analysed protein extracts obtained from healthy donors heel
stratum corneum and psoriatic scales for the presence of E. coli killing factors using the radial plate
diffusion antimicrobial assay system with E. coli as read-out-system. Heparin-sepharose-HPLC
followed by preparative reversed-phase- and cation-exchange-HPLC revealed microheteroge-
neous microbicidal 10 kDa proteins by SDS-PAGE that could be puri®ed from both, heel callus
and psoriatic scales, in hundreds of microgram amounts. All isolated 10 kDa proteins showed a
blocked NH2-terminus. Peptide mapping with subsequent protein sequencing as well as
electrospray-ionisation-mass-spectrometry revealed all proteins to be identical with post-
translationally modi®ed forms of the S100-protein psoriasin. The predominant psoriasin variants
showed at physiologic concentrations in the microdilution assay system bactericidal activity for
E. coli (LD90 < 10 mg per mL), not however, for P. aeruginosa, S. aureus and C. albicans at
concentrations below 200 mg per mL, indicating a speci®city for E. coli. Using realtime-RT-
PCR with intron-spanning primer pairs we found psoriasin mRNA unexpectedly to be expressed
at a high level in healthy skin, respiratory epithelia and normal primary keratinocyte cultures.
Because psoriasin protein is nearly 10-fold more abundant in psoriatic scales vs. healthy donors
callus, we speculated that psoriasin expression ± in contrast to previous suggestions ± is inducible.
To prove this hypothesis we investigated mRNA-levels in primary keratinocytes after treatment
with various in¯ammatory cytokines. Psoriasin-mRNA was induced 16 h after stimulation with
either TNF-a, both IL-1-forms and IL-6. Furthermore, the contact with various microorganisms
induced psoriasin-mRNA with the mucoid form of P. aeruginosa being the most potent one. In
order to elucidate the mechanism how E. coli is killed by psoriasin, we also analysed psoriasin-
treated E. coli ultrastructurally. Unlike the treatment with defensins no signs of membrane
alteration were seen, which indicates that psoriasin kills E. coli by a unique mechanism. In
conclusion, our ®ndings demonstrate that a major biological function of psoriasin might be to
prevent infections of the skin with E. coli.
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Interleukin-12 Suppresses Ultraviolet Radiation-Induced Apoptosis by Inducing DNA
Repair
A. Schwarz, S. StaÈnder, M. Berneburg, K. Grobe-Heitmeyer, J. Krutmann, and T. Schwarz
Departments of Dermatology, MuÈnster and DuÈsseldorf, Germany
We recently observed that the immunomodulatory cytokine interleukin 12 (IL-12) protects
keratinocytes from ultraviolet radiation (UV)-induced apoptosis in vitro. Accordingly, i.c. injection
of IL-12 into mice before UV exposure suppresses the formation of sunburn cells. Interestingly,
UV-induced DNA damage was found signi®cantly reduced both in vitro and vivo when DNA was
extracted several hours after UV exposure. In contrast when DNA was extracted immediately after
UV exposure, the amounts of UV-induced DNA lesions were the same irrespective whether IL-12
was applied or not. This implies that IL-12 removes UV-induced DNA lesions by inducing DNA
repair. Accordingly, expression of a UV-damaged chloramophenicol acetyltransferase expression
vector was signi®cantly induced when transfected into cells pretreated with IL-12, compared with
diluent treated cells. These ®ndings were con®rmed by the comet assay. Comet formation which is
not only an indicator for the severity of DNA damage but also for the ef®cacy of incision during
nucleotide excision repair was induced by IL-12, indicating that IL-12 induces DNA repair.
Accordingly, RNase protection assay revealed that IL-12 induces the expression of particular
components of the nucleotide excision repair complex. The enhanced repair capacity induced by
IL-12 improved cell survival as demonstrated by enhanced colony-forming ability of both
transformed and normal human kerationcytes after UV irradiation. Taken together, this study for
the ®rst time demonstrates (i) that cytokines can protect cells from apoptosis induced by DNA
damaging UV radiation via inducing DNA repair and (ii) that nucleotide excision repair can be
manipulated by cytokines.
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Collagen XVII is Processed by TACE and Other Sheddases
C-W. Franzke, K. Tasanen,² H. SchaÈcke,* N. Koshikawa,³ V. Quaranta,³ Z. Zhou,§ K.
Tryggvason,§ and L. Bruckner-Tuderman
*University of MuÈnster, Germany; ²University of Oulu, Finland; ³Scripps Research Institute, USA;
§Karolinska Institute, Sweden
Collagen XVII is a structural component of the hemidesmosomes and exists in two forms, as
180 kDa type II transmembrane protein and as soluble 120 kDa ectodomain, which corresponds to
the extracellular domain of collagen XVII. We have previously shown that the ectodomain was
generated by proteases, which were subjected to a furin-mediated process. In this work we
identi®ed the enzymes, which release the ectodomain from the cell surface. Time chase
experiments with biotinylated cultured keratinocytes showed that the soluble ectodomain was
stable in the medium for more than 48 h. The use of domain speci®c antibodies demonstrates that
the authentic shedding product contains at least a part of the NC16A domain and the C-terminus
of the collagen XVII molecule. Collagen XVII-shedding of cultured keratinocytes was enhanced
by phorbol esters and inhibited by phenanthroline, MMP- and sheddase-targeting hydroxamates
and TIMP-3, but not by TIMP-1, TIMP-2, a selective gelatinase inhibitor and serine protease
inhibitors. The candidate enzymes MMP-2, MMP-9 and MT1-MMP, which are involved in
proteolytic cascades on keratinocyte surfaces, were excluded, since they cleaved puri®ed collagen
XVII to a nonphysiological fragment and MMP-2 and MT1-MMP-de®cient cells showed normal
collagen XVII-shedding. Promising candidate enzymes are members of the ADAMs, like the
prototype sheddase TACE, ADAM-10 and ADAM-9. All these sheddases contain a putative furin-
activation site in their molecule. RT-PCR analysis and immunoblotting demonstrate that TACE,
ADAM-10 and ADAM-9 were expressed and activated in human keratinocytes.
Immunohistological analysis of human skin revealed that especially TACE- and ADAM-9 were
mainly restricted to basal keratinocytes and therefore showed a localization comparable with
collagen XVII. To verify the role of TACE in collagen XVII-shedding, HaCaT cells were
transfected with full-length murine TACE-cDNA. A dose dependent increase of ectodomain-
shedding, with a concomitant decrease of full-length collagen XVII were shown. In addition,
TACE-de®cient murine keratinocytes showed signi®cantly reduced collagen XVII-shedding. The
results support the conclusion that TACE contributes to collagen XVII-shedding from the
keratinocyte surface. Further studies will determine the identity of the other sheddases, which are
also involved in this process.
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Identi®cation of ERBIN, a Novel LAP/LERP Protein, as Interaction Partner of the
Hemidesmosomal Proteins Bullous Pemphigoid Antigen 1 and the Integrin b4 Subunit
L. Fontao, B. Favre, J. Koster, R. Shafaatian, F. Jaunin, J. -H. Saurat, A. Sonnenberg, and L.
Borradori
The bullous pemphigoid antigen 1 (eBPAG1) is a component of hemidesmosomes (HD),
junctional adhesion complexes in strati®ed epithelia. While its COOH-terminus interacts with
intermediate ®laments, its NH2-terminus is important for its localization into HD. To identify
proteins which interact with the NH2-terminus of human eBPAG1, we performed a yeast two-
hybrid screen, which uncovered a novel protein belonging to the LAP/LERP (for LRR and PDZ
domain) protein family with 16 NH2-terminal leucine rich repeats (LRR) and a COOH-terminal
PDZ domain. The gene for this LAP/LERP protein comprises at least 26 exons located on the
long arm of chromosome 5. In most human tissues, several transcripts were detected differing in
the coding region situated upstream of or within the PDZ domain. One of the encoded variants
was found to correspond to the recently described protein ERBIN. In yeast and in in vitro binding
experiments ERBIN was shown to interact not only with eBPAG1, but also with the COOH-
terminal region of the cytoplasmic domain of the integrin b4 subunit, another component of HD.
Antibodies raised against the COOH-terminus showed that ERBIN is expressed in keratinocytes.
In transfected epithelial cells the protein, however, was not localized in HD but either diffusely
distributed over the cytoplasm or concentrated at the basolateral plasma membrane. Since ERBIN
has previously been shown to interact with the transmembrane tyrosine kinase receptor Erb-B2,
which in turn associates with the integrin b4 subunit, we suggest that ERBIN provides a link
between HD assembly and Erb-B2 receptor signaling.
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Increased Expression of Human Toll-Receptor Homologues by Human Keratinocytes
may Contribute to the Activation of Innate Immunity in Infected Skin
J. Bartels, J. Harder, E. Christophers, and J.-M. SchroÈder
Kiel, Germany
The ability to sense the presence of pathogenic organisms is part of the active role of human
keratinocytes in mounting an innate immune response resulting in the release of antimicrobial
peptides which kill invading microorganisms. To explain our ®ndings of epithelial peptide
antibiotic b-defensins 2 and 3 (hBD-2, hBD-3) induction after contact with microorganisms, we
speculated about a role of keratinocyte-derived pathogen pattern recognition receptors. Using
semiquantitative and real-time RT-PCR with gene speci®c primers we detected mRNA
expression of human Toll-like receptors (hTLRs) in cultured primary human keratinocytes (NHK)
and the keratinocyte cell line HaCaT. While hTLR 1 and 7 mRNA species seem to be expressed
in HaCaT keratinocytes at a low level (after stimulation with heat inactivated Pseudomonas
aeruginosa), stronger RT-PCR signals were found for hTLR 2±6. Interestingly, upon incubation
with heat inactivated Pseudomonas aeruginosa or Staphylococcus aureus, we found up-regulated
expression of mRNA encoding Toll-like receptors hTLR2 and hTLR4 in NHK and HaCaT cells.
Relative induction of hTLR4 was found most prominent in NHK and after keratinocyte contact
with heat killed Gram-negative Pseudomonas microorganisms. Increased expression of and signalling
by hTLR2 (with lipoteichoic acids derived from Gram-positive bacteria as ligands) and/or hTLR4
(with lipopolysaccharides from Gram-negative bacteria as ligands), and perhaps other Toll-receptor
homologues, may contribute to the activation and maintenance of innate immunity in infected
skin.
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Interleukin-18 is a Key Proximal Mediator in the Regulation of Langerhans Cell
Migration and Contact Hypersensitivity in Mice
C. Antonopoulos, M. Cumberbatch,* J.B. Mee, R.J. Dearman,* F.Y. Liew,² I. Kimber,* and
R.W. Groves
Centre for Dermatology, University College London, UK; *Syngenta Central Toxicology Laboratory,
Maccles®eld, UK; ²Department of Immunology and Bacteriology, University of Glasgow, UK
Langerhans cell (LC) migration from the epidermis to regional lymph nodes is a tightly regulated
process, and current data suggest that interleukin (IL)-1b and tumour necrosis factor-a (TNF-a)
are involved. In the present investigations we have assessed the role of IL-18, a cytokine
structurally similar to IL-1b, in the regulation of LC migration and contact hypersensitivity (CHS)
utilising IL-18 knock-out (KO) mice. To determine whether IL-18 is required for optimal contact
sensitisation, IL-18 KO and wild type (WT) mice were sensitised on abdominal skin with 1%
oxazolone (OX) and challenged on the dorsum of one ear 5 days later with 0.5% OX. Vigorous ear
swelling responses were observed in WT mice, but this response was inhibited by 36% (n = 3; p
< 0.05) in IL-18 KO mice. This attenuated response was completely restored in IL-18 KO mice by
local intradermal injection of IL-18 (50 ng) immediately prior to sensitisation with OX (n = 3)
suggesting that the defect in IL-18 KO mice was in the afferent phase of the CHS response.
Identical administration of IL-18 to WT mice did not affect the CHS response. To examine the
effect of IL-18 on allergen-induced LC migration, epidermal LC density was determined following
topical application of 1% OX. OX treatment caused a signi®cant decline in MHC class II+
epidermal LC density 4 h after application in WT mice (26%, n = 3; p < 0.05) but this was absent in
IL-18 KO mice. Intradermal injection of exogenous IL-1b, TNF-a or IL-18 (50 ng each, n = 3)
lead to equivalent LC migration in both IL-18 KO and WT mice, indicating that, given an
appropriate signal, IL-18 KO LC are able to migrate normally. Finally, intradermal injection of IL-
18 prior to topical sensitisation with 1% OX in caspase-1 de®cient mice (which have impaired
release of both IL-1b and IL-18) failed to restore the attenuated CHS response, whereas IL-1b
pretreatment resulted in complete restoration (n = 3). These results indicate that IL-18 is a key
proximal mediator of LC migration and CHS, acting upstream of IL-1b, and that this cytokine
may play a central role in the regulation of cutaneous immune responses.
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APC-Independent T Cell Activation of Hapten-Speci®c CD4+ T Cells
A. Cavani, F. Nasorri, S. Sebastiani, V. Mariani, and G. Girolomoni
Laboratory of Immunology, Istituto Dermopatico dell'Immacolata, IRCCS, Rome, Italy
Dendritic cells (DCs) are crucial for the initiation of allergic contact dermatitis (ACD) to haptens.
However, the expression of ACD is largely DC-independent, and the mechanisms responsible for
T lymphocyte activation at the site of hapten challenge have not been fully elucidated. We have
investigated the APC requirement of nickel (Ni)-speci®c CD4+ lymphocytes isolated from the
blood of 6 allergic individuals. 42 out of 121 (35%) T cell clones (Tccs) proliferated in vitro to Ni in
the absence of professional APCs, suggesting a direct T-T Ni-presentation. Ni recognition by
APC-independent clones was MHC class II restricted, was not in¯uenced by CD28 triggering, and
occurred independently from the activation state of the Tccs. Additionally, the epitope recognized
by these Tccs did not require processing, as indicated by experiments performed with ®xed APCs.
APC-independent and -dependent Tccs expressed similar levels of MHC class II and B7
molecules, and did not differ in their antigen presenting capacity, since they both induced
comparable activation of APC-independent, but not -dependent Tccs. T-T presentation induced
prominent CD3/TCR down-regulation, CD25 up-regulation and IFN-g release, although to a
lesser extent compared to those induced by DCs. Finally, T-T presentation was not followed by T
cell anergy, as indicated by the capacity of T cells to respond to the hapten after multiple cycles of
activation with Ni in the absence of professional APCs. Our data suggest that APC-independent T
cell activation could represent an important mechanism for the initiation and ampli®cation of
ACD.
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The Role of T-T±Cell Interactions for Differentiation of Antigen-Speci®c Helper T
Cells In Vivo
A. Schipf, O. Egeter, R. RoÈder, and M. RoÈcken
Department of Dermatology, Ludwig-Maximilians University, Munich, Germany
During stimulation with antigen naive CD4+ T helper (Th) cells acquire the capacity to produce
large amounts of cytokines. During this priming Th cells tend to differentiate into polarized
interferon g (IFNg) producing Th1 or IL-4 producing Th2 cells. Even though mechanisms
regulating Th1 and Th2 differentiation in vitro are well described, the initial event responsible for
the Th1 or Th2 differentiation in vitro remains open. Importantly, the primary source providing the
IL-4 responsible for T cell differentiation toward a Th2 phenotype is unknown. Here we asked
whether differentiated memory cells could provide this IL-4 during T-T±cell interactions in vivo.
To address this question we established an in vivo system, using Th cells from transgenic mice with
TCR speci®c for either the OVA or the HA peptide. Following the adoptive transfer of naive HA-
Th cells or fully differentiated OVA-Th2 cells, we determined whether OVA-Th2 cells could
in¯uence the differentiation of the naive HA-Th cells, when stimulated with speci®c peptide and
Complete Freund Adjuvans (CFA), which strongly promotes Th1 development. Both, naive and
Th2 memory T cells migrated to draining lymph nodes and spleen, even in absence of a speci®c
stimulus. Following injection of both, antigen and peptide, the numbers of speci®c Th cells
increased again, in nodes and the spleen. Importantly, the presence of Th2 memory T cells alone
did not impact the in vivo differentiation of naive HA-Th cells, stimulated with peptide and CFA.
However, when both Th cell populations were activated simultaneously, OVA-Th2 deviated the
phenotype of the freshly activated HA-Th cells toward a Th2 phenotype, directly showing that
activated Th2 populations can instruct the differentiation of concomitantly activated naive Th cells.
This may contribute to the spreading of Th2 immunity, frequently observed during the
development of atopic diseases.
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Central Role of CD4+ T Cells in the Psoriasiform Skin Disease of CD18 Hypomorphic
Mice
D. Keb, T. Peters, J. Zamek, C. Wickenhauser, S. Tawadros, C. SunderkoÈtter, W. MuÈller, T.
Krieg, and K. Scharffetter-Kochanek
Cologne and MuÈnster, Germany
Recently we reported a polygenic mouse model in the PL/J strain resembling human psoriasis
which ± due to a hypomorphic mutation in the CD18 gene ± reveals a severe reduction of CD18
(b2-integrin) expression to 10% of PL/J wild type mice. Immunostainings revealed a signi®cant
increase (p < 0.0001) in CD4+ T cells, CD8+ T cells and macrophages in CD18 hypomorphic
compared to wild type mice (n = 3). Since CD4+ T cells have been suggested to play a key role in a
variety of in¯ammatory processes either via initiation and ampli®cation of CD8+ cytotoxic effector
functions or recruitment and stimulation of macrophages with keratinocyte proliferation and CD4+
T cell stimulating properties, we have used CD4+ T cell depleting antibodies in vivo to study the
pathogenic role of CD18 hypomorphic mice. I.p. administration of the af®nity puri®ed
monoclonal rat anti mouse antibody (GK1.5) at a concentration of 150 mg 3 times a week resulted
in an almost complete reduction (> 95%) of circulating and skin localized CD4+ cells as judged by
FACS analysis and immunohistochemistry. Using an adapted PASI score, we found a complete
resolution in two (10±1) and an almost complete resolution in 1 animal (9±2). Similarly affected
CD18 hypomorphic mice treated with CD8+ depleting or isotype matched control antibodies did
not show any improvement of the PASI score, suggesting a central CD8 6 independent role of
CD4+ T cells in the pathogenesis of the psoriasiform skin disease. As CD18 expression has been
reported to be signi®cantly reduced in psoriasis patients and in order to study whether the level of
CD18 expression has an impact on the development and severity of the disease, we have generated
a PL/J mouse line which ± in contrast to the herein used PL/J hypomorphic CD18 mice ± reveal a
complete de®ciency in CD18 (CD18 null mutation). Interestingly, the PL/J CD18 null mice did
neither develop any psoriasiform skin disease nor any CD4+ skin in®ltration during an observation
period of > 2 years supporting the view that the pathogenic involvement of CD4+ T cells in the
skin disorder of the PL/J CD18 hypomorphic mice depends on a gene dose effect with reduced
expression of the CD18 protein.
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Critical Role of CD18 in Lymphoid Tissue Organization and T-Dependent B Cell
Response
T. Peters, W. Bloch, C. Wickenhauser, C.E. Leuker, S. Tawadros, D. Keb, R. Hinrichs, K.
Addicks, T. Krieg, W. MuÈller, and K. Scharffetter-Kochanek
Cologne, Germany
b2 integrins play a central role in host defence and if speci®cally mutated lead to a disorder known
as leukocyte adhesion de®ciency 1 (LAD1) in humans. Mice with a CD18 null mutation suffer
from recurrent bacterial infections, impaired wound healing and skin ulcers closely resembling
human LAD1. We here report on the impact of CD18 de®ciency on the organization of lymphoid
tissue, B cell differentiation, germinal center formation and T-dependent B cell response. CD18
null mice show a complex B cell phenotype including a severe increase in plasma cells leading to a
10- to 20-fold elvated serum IgG and light chain amyloid deposits. Furthermore we detected a
signi®cant increase in serum interleukin-6 levels. Since IL-6 is a potent enhancer of plasma cell
formation and immunoglobulin secretion, we have established a CD18xIL-6 double-null mouse
model in which the bias of IL-6 on overall antibody production was destinctly abolished, as we
could show by IgG serum levels that were reduced to those of wild type (wt). Subsequently, CD18
single de®cient, CD18xIL-6 double-null and wt control mice were immunized with the T-
dependent antigen (4-hydroxy-3-nitrophenyl)acetyl (NP) chicken gglobulin (CGG) to analyze
speci®c antibody production. All animals were re-injected with the soluble antigen at day 34 to
further study the secondary immune response. The detection of serum NP-speci®c antibodies
showed only a slightly retarded and decreased primary response in both mutants, whereas class
switch and af®nity maturation occurred as in wt mice. In the secondary immune response virtually
no difference to wt controls existed indicating a normal memory B cell generation and function.
These results were completely unexpected, as conventional histology and immunohistochemistry
with stainings for proliferation (mKi-67), germinal center B cells (peanut agglutinin), T-cell and
dendritic cell markers of all major lymphoid tissues which were performed at three time points after
primary immunization had revealed a completely resolved architecture of the lymphoid tissues
without any initiation of classical germinal center reactions. In ultrastructural analysis the tight
membrane adhesions (< 5 nm) between lymphocytes and dendritic cells observed in wt mice
(n = 6) were missing in CD18 null mutants (n = 6) in all lymphoid tissue sections analyzed (lymph
nodes, spleen, Peyer's patches, tonsils). However, rudimentary bridges of membrane contacts
existed. We here provide further evidence that formerly described lymphoid structures and
germinal center formation are not necessarily required to mount an antigen speci®c immune
response, but that residual structures can compensate.
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b1 Integrin-Mediated Interaction of T Cells and Extracellular Matrix Proteins (ECMP):
Identi®cation of Novel Inhibitors by Random Oligopeptide Phage Display Library
Screening
W.H. Rao and R. Camp
Leicester, UK
Our previous work suggested that integrin a chain-speci®c antagonists may be of limited bene®t in
anti-in¯ammatory therapy (Rao et al. J Immunol 165:4935±4940, 2000), as they inhibit the effects
on cells of speci®c ECMP amongst a redundancy of such matrices. We have therefore used a phage
display library expressing 3.7 3 109 independent cyclic 7-mer peptides (New England Biolabs) to
identify novel, broad spectrum antagonists that recognise the common b1 integrin chain. A CD8+
T cell line (106 cells) was incubated with 2 3 1011 phage, washed and speci®cally bound phage
eluted with an excess (50 mg per mL) of the b1 chain-speci®c mAb, 4B4, which has potent, broad
spectrum inhibitory effects on ECMP-mediated T cell activation. Supernatant phage were
ampli®ed in E. coli and subjected to two further rounds of binding, elution and ampli®cation. Final
supernatant was plated and 40 plaques isolated. Sequencing of variable DNA revealed a series of
identical clones expressing cysteine-¯anked cyclic peptides. Peptides expressed by the most
abundant clones (Cys-PSSVRHS-Cys, 7 clones; and Cys-SLRPLEI-Cys, 5 clones) were
synthesised, cyclized and > 95% puri®ed. These peptides inhibited adhesion of CD4+ T cells to
type I collagen and ®bronectin only weakly (IC50 > 250 mM), whereas their effects on T cell
activation by anti-CD3 coimmobilised with collagen or ®bronectin were more potent (IC50
approx 20 mM). We have thus identi®ed peptides that inhibit b1 integrin-mediated signalling but
may not in¯uence cellular binding to ECMP and thus tissue integrity. These agents may be of
therapeutic interest in psoriasis.
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Isolation of Autoreactive T Helper 1 and 2 Clones by MACS Secretion Assay: A New and
Sensitive Approach to Monitor T Cell Reactivity in Pemphigus
C. Veldman, A. Stauber, and M. Hertl
Erlangen, Germany
Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are characterized by autoantibodies to the
desmosomal glycoproteins desmoglein 3 (Dsg3) and desmoglein 1 (Dsg1), respectively. The
relevance of autoantibodies is well-de®ned, but the cellular immune mechanisms involved in
autoantibody formation are mostly unknown. In this study, peripheral Dsg-speci®c T cell clones of
Th1 (IFN-c secretion) and Th2 type (IL-4 secretion) were cloned by MACS secretion assay. A
total of 5 patients with PV and 2 patients with PF were studied. All patients showed IgG1 and IgG4
reactivity to Dsg1 (PF) or Dsg3 (PV). Patients with acute onset disease (PV = 1; PF = 1) had a Th1/
Th2 cell ratio of 2.5 : 1. Patients with chronic active disease (PV = 2; PF = 1) had signi®cantly more
Th1 than Th2 cells (ratio 20 : 1) while patients in remission (PV = 2) had a Th1/Th2 cell ratio of
1 : 1. From each patient, 96 Th1 and 96 Th2 cell clones were generated after stimulation of PBMC
with Dsg1/3 of whom 8±14% were responsive to Dsg1/3 (SI: 3±28; background: 1200 cpm).
Upon in vitro-stimulation with Dsg1/3, all of the autoreactive Th1 and Th2 cells maintained their
cytokine secretion pattern. In vitro responsiveness to Dsg1/3 of the autoreactive T cells declined
over time: by the 8th re-stimulation, only 3% of the T cell clones proliferated in response to Dsg1
(SI: 3±4.5; background: 750 cpm) or Dsg3 (SI: 3±6; background: 750 cpm). Noteworthy, T cell
clones of patients with chronic active or remittent disease and immunosuppressive treatment lost
their proliferative capacity after the 2nd re-stimulation with Dsg1/3. These observations strongly
suggest a bias towards the selection of distinct autoreactive Th1 and Th2 clones upon repeated in
vitro stimulation with Dsg1/3. The MACS secretion assay allows for the screening of a wide
spectrum of autoreactiveTh1 and Th2 cells which will facilitate the identi®cation of the relevant
immunodominant T cell epitopes of Dsg1 and Dsg3 and of the role that Th cells play in the
pathogenesis of pemphigus.
027
Antibodies to BP180, But Not to BP230, Induce Subepidermal Blisters in Cryosections
of Human Skin
C. Sitaru, E. Schmidt, S. Petermann, L.S. Munteanu, E.-B. BroÈcker, and D. Zillikens
Department of Dermatology, University of WuÈrzburg, Germany
Bullous pemphigoid (BP) is a subepidermal autoimmune blistering disease associated with
autoantibodies to the hemidesmosomal bullous pemphigoid antigens 180 (BP180) and 230
(BP230). Most sera from BP patients recognize epitopes clustered within the 16th noncollagenous
(NC16A) domain of BP180. In a passive transfer mouse model of BP, rabbit antibodies against
murine BP180 induce subepidermal blisters when injected into neonatal mice. In addition, using
cryosections of human skin, patients'sera were previously shown to generate dermal-epidermal
separation when coincubated with leukocytes and complement from healthy volunteers. However,
the speci®city of pathogenic autoantibodies found in the peripheral blood of BP patients has not
yet been elucidated. In the present study, by the use of the cryosection model, we show that sera
from all of 11 BP patients and from 2 rabbits, immunized against human BP180 NC16A, induced a
dermal-epidermal separation. This ®nding was con®rmed with the use of IgG puri®ed from
patients' sera, while sera and puri®ed IgG from healthy controls or preimmune rabbits were not
pathogenic. Interestingly, patients' autoantibodies af®nity-puri®ed against a recombinant form of
BP180 NC16A, coupled to an agarose matrix, retained their blister-inducing capacity. In contrast,
patients' IgG, that was depleted of reactivity to NC16A, lost this ability. In addition, patients'
autoantibodies puri®ed against a recombinant fragment of the C-terminus of BP180 as well as
monoclonal and polyclonal antibodies to both intracellular and C-terminal sites of BP180 did not
induce subepidermal splits in this model, neither did monoclonal antibodies to BP230. For the ®rst
time, we demonstrate the pathogenic relevance of autoantibodies to BP180 from patients with BP.
Autoantigenic sites mediating this effect localize to the NC16A domain of human BP180. This
experimental model should greatly facilitate the further dissection of the cellular and humoral
pathogenesis of blister formation in human BP.
028
Intra-Epidermal Blister Formation in a Patient with Non-Herlitz Junctional
Epidermolysis Bullosa who is Compound Heterozygous for COL17A1 Mutations
M.F. Jonkman, G. van der Steege, and H.H. Pas
Centre for Blistering Skin Diseases, Department of Dermatology, Groningen, the Netherlands
Non-Herlitz junctional epidermolysis bullosa is a nonlethal variant of junctional epidermolysis
bullosa with an autosomal recessive inheritance pattern. Pathogenic mutations have been found in
the COL17A1 gene encoding type XVII collagen, a homotrimeric, hemidesmosomal
transmembrane protein. The ultrastructural plane of cleavage for type XVII collagen-de®cient
non-Herlitz JEB is consistently through the lamina lucida. In this study, we describe a child with
type XVII collagen de®ciency having an unusual intraepidermal level of blister formation, just
above the plasma membrane. Immuno¯uorescence microscopy of nonlesional skin showed absence
of the type XVII collagen endodomain and presence, although reduced, of the shed type XVII
collagen ectodomain, synonymously to linear IgA disease antigen. Intact type XVII collagen was
entirely nondetectable in lesional skin and in cultured keratinocytes of the patient. RT-PCR and
sequence analysis of mRNA, in combination with DNA analysis, identi®ed two novel mutations in
COL17A1: a 3¢-acceptor splice site mutation in intron 21 (COL17A1: 1877±2 A > C), and a single
base pair deletion in exon 48 (COL17A1: 3432delT). This latter exon 48 mutation results in out-
of-frame reading, thereby generating a premature termination codon, and in addition to in-frame
exon 48 skipping at very low abundance. The splice site mutation in intron 21 results in skipping of
exon 22 or to use of an alternative splice site in exon 22. Both events lead to in-frame transcripts
that code for polypeptides with a small deletion in the 15th collagen (COL15) domain of type
XVII collagen. The intraepidermal, nonjunctional, blister formation in this patient may be caused
by different turnover rates between type XVII collagen in transmembrane position (high turnover)
vs. shed type XVII collagen ectodomain in the lamina lucida (low turnover). We speculate that
residual type XVII collagen ectodomain present in the lamina lucida has adhesive properties, which
strengtens the lamina lucida, making the BP180-de®cient hemidesmosomal plaque the locus
minoris resistensiae in this patient.
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Recombinant Analysis of Collagen XVII Shedding and Triple-Helix Formation
K. Tasanen, C. Franzke, L. Borradori, and L. Bruckner-Tuderman
Oulu, Finland, Geneva Switzerland, and MuÈnster, Germany
Collagen XVII, a transmembrane hemidesmosomal component, is mutated in junctional
epidermolysis bullosa and acts as an autoantigen in blistering skin diseases. It exists in two forms,
as the full-length, triple-helical transmembrane molecule and as a 120-kDa cleaved ectodomain.
The shedding occurs in the noncollagenous NC16a domain adjacent to the transmembrane region,
but the exact cleavage site and the detailed mechanism are not known. Here an expression vector
coding for the full-length collagen XVII was modi®ed by three different deletions in the NC16a
domain, and the mutated collagens were transiently expressed in COS-7 cells. The deletion of the
hole NC16a domain inhibited the shedding of the ectodomain into the cell media, and also a
minor deletion of amino acids 508±559 impeded the cleavage. In contrast, the deletion of the ®rst
18 amino acids of the NC16a domain neither prevented the shedding nor reduced the amount the
shed ectodomain. Trypsin digestions as probes for protein folding indicated that all three different
deleted recombinant collagens could fold into a stable triple-helical conformation with melting
temperatures over the body temperature. In summary, our results show that furin or furin-like
proteinases are not the genuine convertase responsible for the release collagen XVII since the
shedding was not inhibited by the deletion of the 18 ®rst amino acids of NC16a domain containing
the putative furin/PACE recognition sequence R-I-R-R. Interestingly, the triple-helix folding of
collagen XVII does not require the presence of the ®rst 18 amino acids of the NC16a domain
which are homologous to a suggested association domain of collagen XIII, another transmembrane
collagen.
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Ultraviolet Irradiation Downregulates type II TGF-b Receptors Resulting in Inhibition
of Connective Tissue Growth Factor-Dependent Type I Procollagen Gene Expression in
Human Skin In Vivo and Human Skin Fibroblasts
G.J. Fisher, T. Quan, T. He, and J.J. Voorhees
Department of Dermatology, University of Michigan, Ann Arbor, MI
Reduced synthesis of type I procollagen (COL-I) contributes substantially to impaired dermal
function in photoaged human skin. Transforming growth factor-b (TGF-b)/Smad pathway,
directly and indirectly through induction of connective tissue growth factor (CTGF), regulates
COL-I synthesis. We have investigated the mechanism by which UV irradiation impairs
production of COL-I in human skin in vivo and cultured human skin ®broblasts (FBs). UV
irradiation (2MED, UVB source) inhibited type II TGF-b receptor (59%), but not type I TGF-b
receptor, CTGF (56%), and COL-I (52%) mRNA expression (p < 0.05, n = 6) 8 h post UV, as
determined by real-time RT/PCR and in situ hybridization, in the dermis of human skin in vivo.
Cultured human skin FBs constitutively expressed TGF-b1/2/3, CTGF, and COL-I mRNAs and
proteins. Neutralizing pan-TGF-b antibody reduced CTGF and COL-I mRNA 58% and 79%,
respectively (p < 0.05, n = 3), indicating that CTGF and COL-I expression are dependent on
TGF-b. UV irradiation (30 mJ per cm2, UVB source) of cultured human skin FBs resulted in a
time dependent inhibition of CTGF (76%, p < 0.05, n = 3) and COL-I (76%, p < 0.05, n = 3)
mRNA expression. UV reduced TGF-b-dependent binding of stimulatory transcription factors to
TGF-b/Smad response elements in the CTGF and COL-I(aÂ2) gene promoters. UV reduced type
II, but not type I, TGF-b receptor mRNA and protein levels, and speci®c cell surface TGF
binding 71%, within 8 h post UV (p < 0.05, n = 4). This down-regulation of TGF-b type II
receptor resulted from reduced gene transcription. Overexpression of type II TGF-aÃ receptor
prevented UV induced reduction of COL-I gene expression. These data demonstrate that down-
regulation of type II TGF-b receptors is responsible for UV reduction of TGF-b-regulated CTGF
and COL-I gene expression in human skin FBs. Therefore, UV down-regulation of type II TGF-b
receptors is a critical mediator of reduced COL-I synthesis in photoaging.
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Gelatinolytic Activity in Melanoma Biopsies is Concentrated in Areas of Tumor±
Stroma-Interactions and Does Not Colocalize with the Expression of Matrix
Metalloproteinases
P. Kurschat, C. Wickenhauser, W. Groth, and C. Mauch
Department of Dermatology, University of Cologne, Germany
The involvement of extracellular matrix degrading enzymes like matrix metalloproteinases and
serine proteases during the process of tumor invasion and metastasis is well established. The
progression of malignant melanoma has been correlated to the expression of MMP-2, and the in
vitro invasiveness of melanoma cells is dependent on the activation of MMP-2 by MT1-MMP. To
study the distribution of gelatinolytic activity on tissue sections we performed in situ zymography.
This technique allows to localize areas where the balance of proteases and inhibitors is altered to
favour the breakdown of extracellular matrix molecules. In 28/41 (68%) of primary tumors and 6/
6 lymph node metastases considerable proteolysis was detected at the invading part of the tumor
and within connective tissue septal structures inside the tumor. By microdissection and gelatin
substrate zymography we could attribute this gelatinolytic activity to activated MMP-2. In general,
gelatinolysis was concentrated at sites where melanoma cells had contact to the extracellular matrix,
indicating an important role of tumor±stroma interactions for the regulation of proteolytic activity.
These data are in agreement with the observation that melanoma cells in vitro activate MMP-2 only
upon contact with native type I collagen. Next we investigated the expression and localization of
MMP-2 and MT1-MMP in melanoma biopsies by immunohistochemistry. We investigated 41
primary melanomas and 6 lymph node metastases. In all cases both enzymes could be detected on
the tumor cells as well as on adjacent connective tissue cells in variable amounts. In lymph node
metastases MMP-staining was weaker compared to primary tumors. The detection of
metalloproteinases like MMP-2 by immunohistochemical staining even in areas with no effective
gelatinolytic activity strongly emphasizes the importance of more fuctional assays like in situ
zymography when investigating balanced systems like proteases and their inhibitors. The presence
of proteases alone is not necessarily linked to degradation of the corresponding substrates. The
effective proteolytic capacity seems to be in¯uenced by environmental factors like the extracellular
matrix.
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Invasion of Melanoma Cells into Dermal Extracellular Matrix In Vitro: Evidence for a
Role of Cysteine Proteases in Matrix Degradation
R. DennhoÈfer, P. Kurschat, P. Zigrino, A. Bosserhoff,* G. van Muijen,² T. Krieg, C. Mauch, and
N. Hunzelmann
Department of Dermatology, University of Cologne, Cologne, Germany; *Department of Pathology,
University of Aachen, Aachen, Germany; ²Department of Pathology, University of Nijmwegen, Nijmwegen,
Netherlands
Local invasion of melanoma cells into the dermal connective tissue is the ®rst step in the complex
process of metastasis. Recently, we have developed an improved skin organ culture model that
allows the detailed study of melanoma cell invasion in vitro. In this model high (BLM) or low (530)
invasive melanoma cells were seeded on the dermal side of dead deepidermized dermis and the
composits were cultured for 14 d at the air/liquid interface. The high invasive cells rapidly invade
the tissue, whereas the low invasive cells do not enter the tissue. As it is well known that
proteolytic alteration of the extracellular matrix (ECM) is a key event in tumor cell invasion, we
investigated the expression and enzyme activity of different proteases. Immunohistochemistry of
this in vitro grown melanoma reveals the expression of different members of the matrix
metalloproteinase (MMP) family as well as urokinase plasminogen activator (uPA) only by the
BLM cells and the cysteine protease cathepsin B in both cell lines. To analyze the enzymatic
activity of these different proteases in the process of ECM degradation, we performed in-situ
gelatin zymography of cryosections under different environmental conditions. Areas of gelatinolysis
were only detected in composits cultured with the high invasive BLM cells. Interestingly, in-situ
zymograms incubated with an acidic buffer, which favours cysteine protease activity show much
more gelatinolysis compared with zymograms incubated with a neutral buffer which favours
neutral protease activity. Furthermore, the gelatinolytic activity at acidic conditions is inhibited by
E-64 and Leupeptin, both inhibitors of cysteine proteases, but not by EDTA, an inhibitor of
MMPs. As cysteine proteases like cathepsin B are capable of degrading different components of the
extracellular matrix, these results indicate a major role for acidic proteases for the invasive process
of melanoma cells in vitro.
033
Adenovirus-Transduced DC Induce Broad but Mainly Virus-Speci®c Immune
Responses in Human CD8+ T Cells
A. Tuettenberg, H. Jonuleit, T. TuÈting, J. BruÈck, J. Knop, and A.H. Enk
Mainz, Germany
Genetic immunization through ex vivo transduction of dendritic cells (DC) with adenoviral vectors
(Ad) has been suggested to be an effective approach to enhance antitumor immunity by activating a
broad range of peptide-speci®c CD8+ T cells. In our study, we wanted to analyze whether the in
vitro priming of T cells with gp100-transduced, mature DC resulted in a more ef®cient induction
of CTL when compared to peptide-pulsed DC. Transduction of DC using adenoviral vectors did
not affect their phenotype and resulted in DC strongly expressing the melanoma antigen gp100 as
assessed by antibody staining. T cells stimulated with Ad-transduced DC (Ad-DC) showed an
earlier and stronger up-regulation of cytokines (IFN-g, IL-2) after stimulation as compared with T
cells stimulated with peptide-pulsed DC. Furthermore, T cells stimulated with Ad-DC showed
reactivity against several gp100-epitopes, suggesting the simultaneous presentation of multiple
peptide-epitopes in an immunogenic form. Surprisingly, gp100-speci®c T cell responses induced
by Ad-DC decreased upon several restimulations while in parallel, Ad-virus-speci®c, MHC class-I
restricted T cell responses were elicited. In comparison, only peptide-pulsed DC were able to
induce long-lasting, melanoma antigen speci®c cytotoxic T cells. Thus, antiadenoviral T cell
responses may provide a ``helper'' effect by inducing the release of high amounts of IL-2 and IFN-g
and therewith enhance CTL induction. In addition, priming with Ad-DC might help to identify
the epitope speci®city of CD8+ T cells in individual melanoma patients and may be useful for
de®ning relevant peptides for vaccination strategies in these patients. A prime/boost vaccination
strategy with the initial induction of immune responses by Ad-DC and a boost with peptide-
loaded DC at later stages should be evaluated based on these data.
034
PolyG-Oligodinucleotides Containing CpG Motifs have no Bene®cial Impact on the
Induction of Antitumoral Cytotoxicity in CD8-T-Cells when used in a Therapeutic
Model
M. Mempel, D. Abeck, F. Lemaitre, C. Ronet, L. Dubertret, P. Kourilsky, G. Gachelin, and P.
Musette
Institut Pasteur, HoÃpital St. Louis, Department of Dermatology, Paris, Munich
CpG ODNs using ¯anking polyG sequences have been reported to act preferentially on the
proliferation of CD8-T-cells by transmitting a signal through the formation of hexameric structures
and subsequent activation of scavenger receptors. We have tested the capacity of the polyG-CpG-
ODN1628 to induce proliferation of antitumoral CD8 cells in the well described P815 mouse
mastocytoma tumor model. For this purpose animals were challenged with the tumor and
subsequently injected with 30 mg ODN 1628 or a control oligo in the tumor area for 12 days.
Neither tumor growth nor survival time showed differences between the two groups. When
looking for the quantitative induction of tumor-speci®c CD8 cells against the two dominant tumor
epitopes (P1A and P1E) by tetramer staining (Kd-P1E and Ld-P1A) and by CDR3 spectratyping
which is able to identify the magnitude of the public response against P1A and P1E (Vb1-Jb1.2 and
Vb1-Jb2.5) we found similar induction in both groups. To exclude differences in the induction of
cytotoxicity we tested puri®ed T-cells from the draining lymph nodes and the spleen of the
injected animals in a Cr51-release assay using labeled P815 as targets. Additionally we sorted
antitumor-speci®c CD8 cells by FACS sorting and analyzed this population in the two groups for
cytotoxicity associated molecules including granzyme B, perforine, IFNg and FasL by quantitative
Taqman assisted RT-PCR. Again, no differences in direct cytotoxicity or in the expression of
cytotoxicity associated molecules were detected in the two groups. In order to screen for the
described in vitro activity of ODN 1628 we used a model for the activation of antigen speci®c CD8
cells by preparing CD8 cells from a TCR tg mouse in which all CD8 cells use the T-cell receptor
speci®c for the LCMV antigen gp 33. Using these cells in the appropriate antigen stimulating
conditions we found a clear increase in the proliferation rate of cells stimulated in the presence of
ODN 1628 as compared to the control. However, when the activated cells were sorted again (as
determined by the expression of CD 69), we found no differences in the transcription of
cytotoxicity associated molecules as determined by quantitative Taqman PCR. Thus, although
capable of inducing CD8 cell proliferation in vitro, polyG-CpG-ODNs are not suitable to enhance
antitumor speci®c CD8 cell response in vivo in our model.
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Antigen-Speci®c, Poly Cation-Based Vaccines: Mode of Action
P. LuÈhrs, W. Schmidt,* M. Buschle,* M. Goos,² S.N. Wagner,² G. Stingl, and A. Schneeberger
DIAID, Department of Dermatol., University of Vienna Medical School; *Intercell, Vienna, Austria;
²Department of Dermatol., University of Essen Medical School, Germany
Injection of tumor antigens together with poly aminoacids (e.g. poly arginine, poly lysine) has been
shown to protect animals against tumor challenge. The goal of this study was to unravel the
mechanism(s) underlying this phenomenon. For this purpose, we used bgalactosidase (bgal) as a
surrogate antigen. DBA/2 mice were injected i.d. on days 0 and 14 with bgal complexed to poly
arginine (thereafter referred to as protein vaccine (PV)) and inoculated on day 24 with bgal-
expressing RENCA cells. PV treatment protected 8/8 animals against a challenge with
RENCAlacz, but none of 5 against the parental RENCA cells. Antigen-speci®c protection was
found in only 3/8 bgal recipients. None of the negative control animals (naive, pArg recipients)
but 7/8 mice that had received pDNA coding for bgal (positive control) were able to reject the
RENCAlacz inoculum. To test whether PV administration induces a bgal-speci®c immune
response, animals received two i.d. injections and were then analyzed for speci®c B and T cells. As
for the tumor protection assay, PV injection was superior to bgal administration in its ability to
induce speci®c Abs as well as IFN-g-producing T cells recognizing the immunodominant class I-
restricted bgal epitope. In vivo T cell depletion studies demonstrated that the protective effect is
critically dependent on CD8+ but not on CD4+ T cells. Speci®c Abs appeared not to contribute to
the tumor-destructive events as they failed to stain intact RENCAlacz cells. Interestingly, priming
of CD8+ T lymphocytes required the presence of CD4+ cells when mice were immunized with
bgal pDNA but not when using the PV. To learn more about the fate of the PV at the injection
sites, these were removed at de®ned time points (1.5 h, 1 and 11 d after injection) and thus treated
animals were analyzed for bgal-speci®c immunity on day 14. Results obtained showed that
removal of the i-site as early as 1.5 h after PV application does not affect the elicitation of bgal-
speci®c T and B cells. Evaluation of the draining lymph nodes revealed the presence of bgal protein
already by 1.5 h after its i.d. injection. Cells displaying the immunodominant, class I-restricted
peptide epitope were ®rst detected 24 h after PV treatment followed by the appearance of antigen-
speci®c T cells on day 5. Together, these results extend our knowledge on the immunostimulatory
properties of poly cations by demonstrating that their coadministration with bgal triggers a
protective and speci®c CD8 T cell response independent of (i) CD4+ T helper lymphocytes and (i)
the prolonged presence of the i-site. It remains to be seen whether this is due to the ability of poly
cations to act on the T cells themselves, the antigen presenting cells involved or both.
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IL-1a and IL-1ra are Homeostatically Regulated in Murine Keratinocytes In Vitro and
In Vivo
J.B. Mee, C. Antonopoulos, S. Poole,* and R.W. Groves
Centre for Dermatology, University College London; *Division of Endocrinology, NIBSC, Potters Bar, UK
Interleukin (IL)-1a is a potent proin¯ammatory cytokine constitutively expressed by keratinocytes
and comprises one member of an expanding gene family including IL-1b, IL-18 and the speci®c
inhibitory molecule, IL-1 receptor antagonist (IL-1ra). Although homeostatic regulation of this
system has been suspected, there is currently little evidence for this. PAM 212 keratinocytes were
exposed to increasing concentrations of IL-1a or IL-1ra for 24 h and ELISA performed to assess
IL-1ra or IL-1a production, respectively. In this system, IL-1ra release was induced in a dose-
dependent manner following addition of mIL-1a from 105 6 38 pg per mL (unstimulated) to
2185 6 104 pg per mL (10 ng per mL IL-1a, n = 5 experiments). Similarly, treatment of
keratinocytes with IL-1ra resulted in increased IL-1a release in a dose dependent fashion with
maximal IL-1a release (1043 6 57 pg per mL) at 1 ng per mL IL-1ra (n = 3). In each case, addition
of a blocking anti-IL-1 receptor type 1 (IL-1R1) antibody inhibited release of the induced
cytokine, indicating that the feedback loop involved IL-1R1. Supernatant LDH content was not
increased by keratinocyte stimulation excluding cell death as a cause of the cytokine release. To
determine whether a similar phenomenon occurred in vivo we examined cytokine release by
epidermal sheets derived from previously described transgenic mice in which over-expression of
IL-1a or IL-1ra was targeted to basal keratinocytes. In concordance with our in vitro ®ndings,
epidermal sheets from IL-1a transgenic mice released increased IL-1ra (5006 6 140 pg per mL)
compared with wildtype animals (611 6 18 pg per mL, n = 3) and this increase was speci®cally
inhibited by the presence of an anti-IL-1R1 antibody. Conversely, increased IL-1a release was
observed in two independent IL-1ra transgenic lines (678 6 35 pg per mL and 530 6 121 pg per
mL) compared with wildtype mice (164 6 29 pg per mL) and this increase was also reduced to
wildtype levels by antibody blockade. These ®ndings provide the ®rst evidence for the presence in
keratinocytes of a homeostatic mechanism mediated via the type-1 IL-1 receptor in which
production of IL-1 agonists and antagonists are mutually interdependent. Our ®ndings provide an
explanation for the cutaneous in¯ammatory response to IL-1ra previously observed in clinical trials
and underscore the complexity of the keratinocyte cytokine network.
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UVB-Induced Skin In¯ammation in Mice is Mast Cell-Dependent
M. Metz, J. Knop, and M. Maurer
Department of Dermatology, University Mainz, Germany
We have recently shown that endothelin-1 (ET-1) induces pronounced in¯ammatory responses in
murine skin and that ET-1-induced skin in¯ammation is MC-dependent. Here, we have studied
the role of mast cells (MC) in UVB-induced dermatitis, a cutaneous in¯ammatory reaction
characterized by immediate and strong up-regulation of ET-1 expression by epidermal
keratinocytes. Balb/c mice were used in extensive pilot experiments to characterize cutaneous
in¯ammation after irradiation of ears with UVB in nonpigmented murine skin. UVB (500 mJ per
cm2) induced a robust in¯ammatory reaction in Balb/c mice, as assessed by repeated measurements
of ear swelling (90 6 12 mm, at 18 h). Ear skin of genetically MC-de®cient KitW/KitW±v-mice that is
also not pigmented exhibited signi®cantly reduced swelling responses after UVB irradiation
(24.1 6 5.1 mm at 18 h, p < 0.001). To test whether the adoptive transfer of MC to MC-de®cient
mice would restore impaired in¯ammatory responses to UVB, we irradiated KitW/KitW±v-mice
reconstituted with bone marrow-derived cultured MC (left ears, KitW/KitW±v + BMCMCs) or
vehicle (right ears, KitW/KitW±v + Veh). Earswelling in MC-reconstituted ears after UVB
irradiation was signi®cantly increased as compared to UVB-treated control ears (KitW/KitW±
v + BMCMCs: 78.7 6 11.9 mm vs. KitW/KitW±v + Veh: 24.1 6 5.1 mm at 18 h, p < 0.005),
indicating that UVB-induced in¯ammation in murine skin is, at least in part, MC-dependent.
Since UVB irradiation rapidly up-regulates expression of ET-1, one of the most potent MC-
secretagogues, we hypothesize that ET-1-mediated activation of dermal MC contributes to UVB-
induced cutaneous in¯ammation.
038
Epidermal Overexpression of Stratum Corneum Chymotryptic Enzyme in Mice; a
Model for Chronic Itchy Dermatitis
A. Ny, L. Hansson, A. BaÈckman, M. Edlund, E. Ekholm, B. Ekstrand HammarstroÈm, J. ToÈrnell, P.
Wallbrandt, H. Wennbo, and T. Egelrud
UmeaÊ and MoÈlndal, Sweden
The serine protease stratum corneum chymotryptic enzyme (SCCE) is believed to play a role in
the desquamation process. Excessive expression of SCCE was recently shown in the epidermis of
psoriatic patients and we have also found SCCE overexpressed in chronic lesions of atopic
dermatitis. To further elucidate the possible involvement of SCCE in skin pathology, we produced
transgenic mice that overexpressed human scce mRNA under a viral promoter. Phenotypic changes
were only found in skin. The transgenic mice expressed human SCCE in suprabasal epidermal
keratinocytes and furthermore, developed pathological skin changes similar to those seen in
in¯ammatory skin diseases in humans, such as increased epidermal thickness, hyperkeratosis and
dermal in¯ammation. In addition, these mice also showed signs of severe itching. Our results
suggest that SCCE may be involved in the pathophysiology of in¯ammatory skin diseases and is
therefore a potential target for tissue-speci®c treatments.
039
Induction of an Intralesional Th2 Phenotype and Regression of Psoriasis During
Interleukin 4 Therapy of Humans
P. Thomas, K. Ghoreschi, S. Breit, M. Dugas,* R. Mailhammer,² B. Summer, T. Biedermann, J.
Prinz, C. Sander, G. Plewig, and M. RoÈcken
Department of Dermatology, *Medical statistics and ²GSF Institute of Hematology, Ludwig-Maximilians-
University Munich, Germany
The in¯ammation leading to psoriasis is dominated by interferon-g producing tpye 1 T cells.
Immune deviation of type 1 into interleukin-4 (IL-4) dominated type 2 responses improves
in¯ammatory autoimmune diseases in mice. Since IL-4 ef®ciently induces IL-4 in human T cells,
we investigated safety and ef®ciency of systemic IL-4 application in the treatment of severe
psoriasis in a dose escalation study. Five groups, each including 4 patients, were attributed to
increasing doses of IL-4. The IL-4 was self-injected over a period of 6 weeks. The follow up
included weekly PASI documentation, skin biopsy and analysis of a series of immune parameters
that potentially can be affected by IL-4. A total of 22 patients was recruited, 20 terminated the
study, two interrupted. Only in one patient side-effects > grade I were observed. In 18/20 patients
the PASI decreased by 60±80% within six weeks and no rebound occured during the 6 weeks of
follow up. Mononuclear cells including T cells, CD4/CD8-ratio and neutrophil counts remained
unchanged. The number of eosinophilic granulocytes increased signi®cantly, while the number of
B cells decreased slightly. Upon direct ex vivo analysis CD4+ and CD8+ T cells produced similar
amounts of IL-2, TNF-a or IFN-g before and during therapy. In sharp contrast, a small (6 2%) but
distinct population of IL-4 producing CD4+ T cells was induced during therapy. No IL-4
producing CD8+ T cells were detected. Induction of IL-4+ CD4+ T cells was associated with a
strong reduction in CCR5+ T cells and a reduction of the IFN-g/IL-4 ratio up to 100 fold, as
determined by quantitative real time PCR, in the psoriatic lesions. Thus, the signi®cant
improvement of psoriasis during IL-4 therapy was associated with a strong shift of a Th1 towards a
Th2 phenotype. Since IL-4 was, in addition, well tolerated, IL-4 induced immune deviation may
be a promising therapy for human in¯ammatory autoimmune diseases.
040
TNF- and IL-1 Signal Transduction Pathways are Crucially Involved in Wound Healing
M. Schunck,* J.-M. Jensen,*³ C. Neumann,* S. Schuetze,² and E. Proksch*
*Department of Dermatology, University of Kiel, Germany; ²Institute of Immunology, University of Kiel,
Germany; ³Harvard Skin Disease Research Center, Brigham, and Women'sHospital, Boston, Massachusetts
Previously, it has been shown that the in¯ammatory cytokines TNF and IL-1 are activated in
wounds (Lit.). TNF and IL-1 regulate proliferation, differentiation and apoptosis. TNF and IL-1
signal transduction involves TNF receptor p55 (TNF-R55), IL-1 receptor I (IL-1-RI), acid and
neutral sphingomyelinase (A- and N-SMase) and the TNF-R55 adapter protein FAN, important
for the activation of N-SMase. We explored the function of this signaling pathways in wild type
and in transgenic mice. Full thickness skin wounds of 1.5 cm diameter were induced and healing
was examined after photography and computer-assistant evaluation. In TNF-R55 de®cient mice
we found a signi®cant delay in wound healing related to a reduced reepithelization. A severe delay
in the healing process occurred in TNF-R55/IL-1 double decient animals. In these animals not
only reepithelization, but also wound contraction were nearly absent. In wild type mice an early
increase in epidermal proliferation during wound healing was found. The increase in proliferation
was reduced in FAN cytokine receptor de®cient mice. A late increase in A- and N-SMase activity
during epidermal differentiation occurred in wild type, but not in de®cient mice. In FAN de®cient
mice we found a reduction in reepithelization showing the importance of N-SMase for this
process. In summary, we showed that TNF and IL-1 signal transduction including TNF-R55, the
adapter protein FAN, IL-1-RI, and A- and N-SMase are important for wound healing.
041
Caspase-14 But Not Caspase-3 and Caspase-8 Expression by Epidermal Keratinocytes is
Regulated by Retinoids in a Differentiation-Associated Manner
M. Rendl, J. Ban, C. Mayer, B. Lengauer, L. Eckhart, W. Declerq,* and E. Tschachler
Department of Dermatology, University of Vienna Medical School, Vienna, Austria; *Department of
Molecular Biology, University of Ghent, Gent, Belgium; CE.R.I.E.S. Neuilly, France
Caspase-14 is the only member of the caspase family that shows a restricted tissue expression. It is
mainly con®ned to epidermal keratinocytes (KC) and in contrast to other caspases, is not activated
during apoptosis induced by UV-irradiation or cytotoxic substances. Since it is cleaved under
conditions leading to terminal differentiation of KC we suggested that caspase-14 plays a role in the
physiological cell death of KC leading to skin barrier formation. Here we show that retinoic acid
(RA), at concentrations inhibiting terminal differentiation of KC, strongly suppressed caspase-14
mRNA and protein expression by KC in monolayer culture and in a 3-dimensional in vitro model
of differentiating human epidermis (skin equivalent, SE). By contrast, the expression of the caspases
3 and 8, which are both activated during conventional apoptosis, was increased and unchanged,
respectively, after RA treatment. In addition to inhibitio of differentiation in SE, RA treatment
lead to KC apoptosis and activation of caspase-3, which was undetectable in differentiated control
SE. Since this occurred in the absence of detectable caspase-14, our data demonstrate that caspase-
14 is dispensible for KC apoptosis. The fact that in contrast to caspase-3 and caspase-8, caspase-14 is
regulated by retinoids comparable to other KC differentiation-associated proteins, strongly suggests
that this caspase, but not caspase-3 and ±8, plays a role in terminal KC differentiation and skin
barrier formation.
042
The Antiapoptotic bcl-2 Proteins are Highest and Caspases are Not Activated in Basal
Keratinocytes Expressing High Levels of p63
A. Marconi, C. Fila, S. Bertellini, M. Pignatti, S. Krajewski,* J.C. Reed,* A. Giannetti, and C.
Pincelli
Institute of Dermatology, University of Modena and Reggio Emilia, Italy and *The Burnham Institute, La
Jolla, California
A keratinocyte population enriched in stem cells, expressing highest levels of b1-integrin, is
protected from ``anoikis'' (apoptosis from loss of adhesion). The aim was to evaluate the
intracellular mechanisms involved in keratinocyte ``anoikis''. To this purpose, we isolated three
populations of keratinocytes, based on their adhesive properties to type IV collagen: rapidly
adhering cells (pop 1), overnight adhering cells (pop 2), and not adhering cells (pop 3). Apoptosis
was striking in cultured epidermis reconstructed on de-epidermized dermis (RE-DED) from pop
3, nearly absent in RE-DED from pop 1 and intermediate in RE-DED from pop 2, as shown by
TUNEL. p63 transcription factor, a stem cell marker with antiapoptotic functions, was more
expressed in pop 1 than in pop 2, and nearly absent in pop 3 from cultured keratinocytes, as
measured by Western blot. Caspase-8 and Bid were processed in pop 2 and 3, but not in pop 1.
Bax and Bad protein expression was high in pop 3, decreased in pop 2, and very low or nearly
absent in pop 1. On the other hand, Bcl-2, Bcl-xL and Mcl1 levels were markedly higher in pop 1
than in pop 2, and were absent in pop 3. Caspase-9 and ± 6 were activated in pop 3 and, to a lesser
extent, in pop 2, while they were not activated in pop 1. Caspase-3 and PARP were cleaved only
in pop 3. The IAP protein survivin was more expressed in pop 1 than in pop 2, while the cleaved
fragment of hILP/XIAP was higher in pop 3 than in pop 2, and absent in pop 1. These results
con®rm that keratinocytes enriched in stem cells are protected from ``anoikis''. In addition, this
work shed light on the intracellular events during ``anoikis''.
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Stat3 in Epidermal Keratinocytes Functions as UV-Sensor
S. Sano, M. Kira, S. Takagi, M. Tarutani, J. Takeda, S. Itami, and K. Yoshikawa
Osaka, Japan
We investigated the antiapoptotic role of epidermal Stat3 using keratinocyte-speci®c Stat3-
disrupted mice, in which ¯oxed Stat3 is ablated by Cre recombinase under the control of the
keratin 5 promoter. Upon UVB irradiation, they exhibited an increased number of apoptotic
keratinocytes, which was ef®ciently reversed by topical application of Stat3 gene. These results
indicate that Stat3 in keratinocytes functions as an antiapoptotic regulator, so that keratinocytes
survive against UV stress. We next examined the UVB effect on Stat3 in normal keratinocytes.
UVB irradiation induced an early disappearance of tyrosyl-phosphorylated Stat3, followed by
down-regulation of mRNAs of Bcl-xL and Stat3. Finally, Stat3 and Bcl-xL proteins disappeared
on Western blotting 24 h after the irradiation. Interestingly, topical application of Stat3 gene
rescued normal keratinocytes from UV-induced apoptosis as well as Stat3-disrupted keratinocytes.
These results suggest that Stat3 ®rstly senses UVB to lose its transcriptional activity, leading to
down-regulation of gene expression of Stat3 itself and antiapoptotic molecules such as Bcl-xL at its
downstream. We conclude that Stat3 in keratinocytes dictates the fate of keratinocytes in two
opposite ways; survival or apoptosis which may help to reduce the future oncogenic potential.
044
The p63 Serves as a Regulator of Keratinocyte Progenitor Ability During Wound
Epithelialization
B. Noszczyk and S. Majewski
Warsaw, Poland
The p63 protein was recently identi®ed is a p53 homologue. Several isoforms of p63 lacking the
acidic N terminus are expressed in the epidermis. These isoforms denominated as DNp63 are
known to play a role in maintaining the proliferative potential of keratinocytes and preventing their
terminal differentiation. More recently the p63 protein was found to identify the keratinocyte stem
cell or progenitor cell population. The purpose of the study was to evaluate whether the p63
protein plays a role during wound epithelialization. For this purpose serial biopsies (n = 32) of
human healing wounds taken 1±28 days after the injury were analyzed with the use of
immunohistochemistry. The DNp63 expression in keratinocytes was compared with a cellular
proliferation marker expression ± a Ki67 protein. The DNp63 expression in the keratinocytes of
migrating epithelial tongue was found decreased dramatically from the 1st day of epithelialization.
At the same time, cells in the proliferating wound border, as revealed by Ki67 expression, were
positively stained for p63 in the basal and several suprabasal layers. Similarly a few basal cells in the
migrating epidermal tongue showed the p63 expression despite the fact that the majority of cells in
this area were p63 negative. We speculate that down-regulation of DNp63 expression in the
keratinocytes of migrating epidermal tongue enable these cells to leave out the progenitor
compartment and to differentiate into a migratory phenotype. Up-regulated protein expression in
the proliferating wound border may be necessary to prevent cells differentiation and to support
their proliferative ability indispensable to yield new cells for epithelialization. Similarly scattered
basal cells positive for DNp63 in the migrating epidermis, may be prerequisite for progenitor cell
potential transfer and its maintenance in the restored epidermis covering the scar.
045
Activation of p38 Mitogen-Activated Protein Kinase Enhances Matrix
Metalloproteinase-1 and ±3 Expression by Stabilization of mRNA in Dermal Fibroblasts
N. Reunanen, M. Foschi, J. Han, and V.-M. KaÈhaÈri
Turku, Finland; Florence, Italy; and La Jolla, California
We have examined the role of p38 mitogen-activated protein kinase (MAPK) signaling pathway in
the regulation of collagenase-1 (matrix metalloproteinase-1, MMP-1) and stromelysin-1 (MMP-3)
expression in normal human skin ®broblasts. Tumor necrosis factor-a (TNF-a) activated
extracellular signal-regulated kinase (ERK)1,2, Jun ± N-terminal kinase (JNK), and p38 MAPK in
dermal ®broblasts. TNF-a-elicited induction of MMP-1 and MMP-3 mRNA was potently
inhibited by speci®c p38 MAPK inhibitor SB203580, whereas blocking the ERK1,2 pathway
(Raf/MEK1,2/ERK1,2) by MEK1,2 activation inhibitor PD98059 had no effect under similar
circumstances. Adenoviral gene delivery of constitutively active MKK3b together with wild type
p38a greatly enhanced the production of proMMP-1 and proMMP-3. The enhancement of
MMP-1 mRNA expression was 8.2-fold and that of MMP-3 1.9-fold. The increase in MMP-1
and MMP-3 mRNAs was associated with a delayed decay rate, because infection with an
adenovirus for constitutively active MKK3b together with wild type p38a increased the half-life of
MMP-1 mRNA from 2.3 h to 59 h, and the half-life of MMP-3 mRNA from 2.2 h to 48 h, as
compared to control-infected cells. These results identify a novel mechanism by which MKK3b/
p38a signaling pathway regulates MMP-1 and MMP-3 expression in ®broblasts.
046
RNase 7, a Novel Broadspectrum Antimicrobial Protein from Healthy Skin
J. Harder, J. Bartels, E. Christophers, and J.-M. SchroÈder
Kiel, Germany
Human skin is highly resistant against the wide variety of potential harmful microorganisms to
which it is constantly exposed. The basis for this natural resistance is not fully understood but one
reason might be the release of antimicrobial proteins. We previously proved this hypothesis by the
isolation of the Gram-negative bacteria killing peptide antibiotic human b-defensin-2 and very
recently by the isolation of the broadspectrum peptide antibiotic human b-defensin-3. Since these
two peptides were highly induced at sites of in¯ammation (i.e. in psoriatic lesions), but nearly
absent in normal skin, we addressed the question, whether healthy skin contains antimicrobial
peptides, especially those with activity against Gram-positive bacteria like St. aureus. To answer this
question we analysed heel callus extracts for the presence of St. aureus killing activity and found
high antimicrobial activity. This activity was puri®ed using Heparin-sepharose chromatography
followed by reversed phase and cation-exchange-HPLC. This led to the isolation of a highly
cationic, antimicrobial protein (20 kDa by SDS-PAGE). N-terminal amino acid sequence analysis
revealed a novel sequence with structural similarity to members of the RNase A superfamily, such
as eosinophil cationic protein (ECP) and eosinophil-derived neurotoxin (EDN). Therefore we
termed this novel antimicrobial protein RNase 7. Cloning the corresponding cDNA revealed
keratinocytes as a cellular source. Interestingly RNase 7 gene expression was found to be induced
by proin¯ammatory cytokines and bacteria. RNase 7 hydrolysed t-RNA indicating enzymatic
RNase activity and killed Staphylococcus aureus and several other skin-relevant microorganisms at
micromolar concentrations. Therefore we conclude that RNase 7 might participate in a ®rst-line
chemical defense system of healthy normal skin and might help to protect human skin from
infections.
047
Characterization of Three Novel Candidate Genes in the MHC Region with Regard to
Psoriasis Susceptibility
S.J. Holm, K.P. O'Brien, L. Mallbris, L. CarleÂn, and M. StaÊhle-BaÈckdahl
Department of Dermatology, Karolinska, Sweden
Psoriasis is a common skin disease that affects 2±3% of the Caucasian population. The psoriasis
susceptibility locus PSORS1 on chromosome 6p21 is now of a suf®ciently small size to allow
comprehensive in silico cloning of putative candidate genes. We have identi®ed three novel
candidates in this area (Candidate In Psoriasis Susceptibility 1±3, CIPS1-CIPS3). Both CIPS2 and
CIPS3 genes are located telomeric to the HCR gene while CIPS1 lies centromeric. We ampli®ed
all 11 exons of these three genes in 10 PCR fragments and sequenced each from both ends in a
series of Swedish psoriasis individuals, while comparing them to healthy population matched
controls. Assembly of resulting sequences was performed in the Staden sequence assembly package
and polymorphisms were identi®ed using the Trace-Diff function. Using this association analysis
we have found signi®cant association to psoriasis by SNPs in all three genes. Further strati®cation
reveals that the association of CIPS1 and CIPS2 can be explained by linkage disequilibrium with
Cw*0602. Furthermore, the strongest associated SNP in CIPS3 is located in an exon which
appears to be untranslated and is absent in an alternative splice variant. The role of this SNP in
psoriasis and the possible biological signi®cance of CIPS3 splice variants requires further study.
With no remaining psoriasis candidates genes, we are left with the intriguing possibility of a
synergistic effect of multiple genes or the reexamination of the role of HLA-C in psoriasis.
048
Nuclear Translocation of NF-IL6 (C/EBPb) is Associated with Induction of Keratin 6 in
Abnormal Epidermis
J. Vyas, I.A. McKay,* and P.E. Bowden
Department of Dermatology, UWCM, Cardiff, UK; *Centre for Cutaneous Research, QMWC, London,
UK
It is established that keratin mutations cause genodermatoses. However, genotype-phenotype
relationships remain unclear and how mutations cause the observed pathology is not understood.
We have demonstrated that epidermolysis associated with genodermatoses is accompanied by
increased expression of inducible keratins (K6, K16 and K17). These keratins are induced in other
hyperproliferative states, absent in normal epidermis and constitutively expressed in skin
appendages (hair follicle, sebaceous gland, and sweat gland). Their transcriptional regulation is
not fully understood and it is not clear how tissue-speci®c gene regulation occurs. While studying
transcription factors in normal and diseased epidermis (psoriasis, genodermatoses and wound
healing), we have found that NF-IL6 is intimately connected with K6 and K16 gene expression.
We have examined the control of K6 expression in vivo and ®nd that translocation of NFIL-6 to
the nucleus of suprabasal cells is always coincident with K6 expression. Frozen skin biopsies from
normal subjects (4) and patients (8) with psoriasis or genodermatoses (EH, IBS, EPPK with de®ned
mutations) were cryostat sectioned and treated with antibodies to K6, NFIL-6 or both. They were
visualised with streptavidin-FITC or antibody conjugated Texas Red. Sections were examined by
¯uorescence photomicroscopy and confocal microscopy. Control sections with no primary antisera
were prepared and some sections were incubated with propidium iodide (nuclear speci®c stain).
NFIL-6 was cytoplasmic in basal cells, nuclear in suprabasal cells and absent from cornifying
granular cells. Nuclear NFIL-6 was present in mid-epidermis of normal skin, dramatically increased
in suprabasal cells of psoriatic epidermis and variably increased in the genodermatoses examined.
Nuclear translocation of NFIL-6 was always accompanied by K6 expression in abnormal but not in
normal epidermis. Thus, NFIL-6 is necessary but not suf®cient for induction of K6 gene
expression and other factors must be involved in this complex process.
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Genetic Immunization of Mice with a Fusion Protein Between EGFP and Murine TRP2
Circumvents T Cell Tolerance and Mediates Protective Immunity to Melanoma
J. Steitz, J. BruÈck, and T. TuÈting
Department of Dermatology, University of Mainz, Germany
We previously showed that genetic immunization of C57BL/6 mice with cDNA encoding human
but not murine TRP2 was able to induce cellular and humoral immune responses to murine TRP2
associated with protection against metastatic growth of B16 melanoma. In the present study we
investigated whether murine TRP2 could be rendered immunogenic when fused in frame to the
¯uorescent foreign protein EGFP. Using PCR techniques we constructed a cDNA encoding
EGFP followed by aa30±517 of murine TRP2. Expression of both EGFP and murine TRP2 could
be con®rmed by immunocytochemistry and ¯uorescence microscopy in transiently transfected 293
cells. Importantly, genetic immunization of mice with EGFP-mTRP2 using the gene gun induced
TRP2-reactive CD8+ T cells associated with coat depigmentation as a sign of autoimmune-
mediated destruction of melanocytes. Furthermore, immunization with recombinant adenovirus
encoding EGFP-mTRP2 provided signi®cant protection against metastatic growth of B16
melanoma. These results provide important insights for the development of antigen-speci®c
immunotherapy of melanoma.
050
Molecular Genetic Analysis in a Large Group of Families and Sporadic Cases Affected by
Incontinentia Pigmenti: Genomic Rearrangement, New Mutations and Genotype-
Phenotype Correlations
G. Tadini, T. Bardaro, T. Esposito, S. Ferrucci, M. Vanotti, M. Bellinvia, S. Percivalle, and M.
D'Urso
Incontinentia Pigmenti (IP) is an uncommon genetic skin disease, inherited as an X-linked
dominant trait, carachterized by four classic cutaneous stages, perinatal in¯ammatory vescicles,-
verrucous patches, a distinctive linear-reticular hyperpigmented pattern and a terminal atrophic
stage. The disease is usually lethal in males and in the affected females IP causes highly variable
abnormalities of the skin and adnexa, teeth, eyes and central nervous system. The gene responsible
for IP has been found near the factorVIII locus in Xq28 and is the gene for NF-kB essential
modulator (NEMO) that is required for the activation of the transcription factor NF-kB and is
relevant for many in¯ammatory, immune and apoptotic pathways. The molecular genetic studies
were performed in 12 families (28 subjects) affected by classic IP and in 6 sporadic cases, including
two males, analysing genomic DNA from the proband, the parents and the maternal grandmothers,
with an age ranging from six months to 70 years. The results con®rm that genomic rerrangement in
NEMO gene, namely large deletion of part of the gene within intron 3 and 3¢ of exon 10, is the
most frequent genetic abnormalities in IP patients, accounting for 18 out of 24 cases (8 families out
of 12) and for 1 of the 6 sporadic cases. These deletions are absent in the two male cases and in one
female in which mutation analysis of NEMO gene has been undertaken. In 1 sporadic case and in 1
family two new point mutation in the sequence of NEMO gene has been found. Interestingly in
one of the two males a preliminary biochemical study revealed abnormalities in the pattern of
cytokines related to immune modulation and apoptosis. The ®nding of genetic abnormalities of the
NEMO gene in probands with classic four-stage disease, correlates strictly in mothers and
grandmothers with the presence or absence of any sign of the disease, allowing us to de®ne familiar
and sporadic cases of IP, following the origin of the disease in all considered families.
051
Smad7 Binds the Transcriptional Coactivator p300 and Represses the Expression of
Extracellular Matrix Genes in Dermal Fibroblasts
K. Korang, O. Ferrigno, A. Giordano, and A. Mauviel
INSERM U532, HoÃpital Saint Louis, Paris, France, and Jefferson Cancer Institute, Thomas Jefferson
University Philadelphia, Pennsylvania
Smad7 is an inhibitory Smad which acts as a negative regulator of transforming growth factor-b
(TGF-b) signaling. Smad7 stably interacts with activated TGF-b type I receptor and interferes with
the phosphorylation of receptor-regulated Smads. Recently it has been shown that Smad7 can be
located in the nucleus, suggesting a direct role on gene transcription. To explore potential
functions of Smad7 in the nucleus, we ectopically expressed Smad7 in dermal ®broblasts, together
with various promoter/reporter gene constructs. In addition to blocking TGF-b-mediated Smad-
speci®c gene transcription, Smad7 was also found to directly inhibit the acitvity of the minimal
SV40 promoter, which contains a TATA box. Similarly, Smad7 was found to repress the activity of
the human COL1A2 promoter, which also contains a TATA box. The latter does not seem to play
a role in mediating Smad7 effect, as the activity of the human COL7A1 promoter, which is TATA
box less, was also repressed by ectopic expression of full length Smad7. Smad7-driven repression of
the minimal SV40 promoter could be antagonized by cotransfecting the transcriptional coactivator
p300. Using a mammalian two-hybrid system we identi®ed a direct interaction between Smad7
and p300. Using various deletion constructs for p300, we identi®ed the region between amino
acids 1732±2414 as binding Smad7. This region corresponds to the CH3 domain of p300, which is
capable of binding members of the basal transcription machinery such as the TATA-box-binding
protein (TBP), and TFIIB. No interaction of Smad7 with TBP was observed in a mammalian two-
hybrid system. We propose a model in which Smad7 binds the CH3 domain of p300, thereby
preventing the binding of TBP to p300 and subsequent gene transactivation. This mechanism may
be responsible for the inhibitory effect of Smad7 on some extracellular matrix genes in dermal
®broblasts.
052
Effects of Mutations in ATP2A2 on Calcium Transport Across Sarco/Endoplasmic
Reticulum (ER) Membrane
J. Dhitavat,* L. Dode,* N. Leslie, S. Burge, and A. Hovnanian
Oxford, UK. *These authors contributed equally to the work
ATP2A2 has been identi®ed as the causative gene for Darier's disease (DD). This gene encodes the
sarco/endoplasmic reticulum Ca2+-ATPase (SERCA2b) pump, which transports Ca2+ from the
cytosol into the ER. This study aims to investigate the effects of ATP2A2 mutations identi®ed in
DD patients on SERCA2 function. Several missense mutations have been engineered into
ATP2A2 full-length cDNA clones by site-directed mutagenesis. The wild type and the mutants
were transiently over expressed in COS-1 cells. Microsomes were then isolated from these cells
using a lysis/ultracentrifugation procedure. To determine the localisation and the expression level
of mutant proteins in comparison with the wild type SERCA2b, immunodetection analysis
including immunocytochemistry on intact cells and Western blotting of microsomal protein was
performed using a SERCA2b speci®c antibody. The function of the SERCA2b pump was assessed
by an oxalate-stimulated Ca2+ transport method. Our results have shown that mutations in
ATP2A2 impair Ca2+ transport activity of the SERCA2b pump. These results provide evidence for
functional alteration of SERCA2 mutants in DD and improve our knowledge of the structural and
functional relationship in SERCA2.
053
K6irs; a New Cytokeratin in the Inner Root Sheath of the Human Hair Follicle
M.A. Rogers, L. Langbein,* S. Praetzel,* N. Aoki,² H. Winter, and J. Schweizer
Division of Tumor Cell Regulation and *Cell Biology, German Cancer Research Center, Heidelberg,
Germany; ²Department of Dermatology, Niigata Universita, Niigata, Japan
Analysis of the EMBO/Genebank database in an attempt to identify a human ortholog of a recently
described cytokeratin, mK6irs, found in the inner root sheath of the mouse hair follicle, lead to the
identi®cation of a ca 80 kb Bacterial Arti®cial Chromosome (BAC) clone harboring six type II
cytokeratin genes and one keratin pseudogene. One end of this clone overlapped the recently
described type II hair keratin gene cluster. The genes found included human K6irs, K5, K6a, a
gene similar to K6e, K6b, K6hf, and the pseudogene yhHbA. Analysis of a human scalp cDNA
library lead to the discovery of a full length K6irs cDNA transcript. Two dimensional separation of
hair follicle keratin extracts and Western blot analysis showed the presence of multiple K6irs
isoelectric variants present in the same region as that of the known K6 cytokeratins. In situ
hybridization, indirect immuno¯uorescence microscopy as well as electron microscopy showed an
exclusive expression of K6irs in the inner root sheath of the hair follicle. This expression initiated
in the hair cell matrix region and showed a partially staggered expression in all three layers (Henle-,
Huxley-, and cuticule layer) of the inner root sheath.
054
Identi®cation of Binding Partners of the 72 kDa Heat Shock Protein in Human
Keratinocytes by Two-Hybrid Analysis
C. Kokesch, A. Gsur, C. Riedl, J. Schmid, and F. Trautinger
Vienna, Austria
The 72 kDa heat shock protein (hsp72) is a stress inducible molecular chaperone that is involved in
the protection from proteotoxic stress. In contrast to other cells and tissues human keratinocytes in
situ and in culture express high levels of hsp72 without prior stress exposure. To identify proteins
that interact with hsp72 in human keratinocytes we employed a yeast two-hybrid system
(Matchmaker 2, Clontech). The yeast strain PJ69±4a was cotransformed with a keratinocyte-
derived cDNA library (the ``prey'') and the complete coding sequence of human hsp72 (hsp70a,
the ``bait''), cloned into the appropriate yeast expression vectors. Bait±prey interactions were
detected by reporter gene activation and con®rmed by back-transformation. The interacting
proteins were identi®ed by cDNA isolation, sequencing, and GenBank comparison. The two-
hybrid screen revealed interaction of hsp72 with SP100 (nuclear dot protein), thrombospondin,
EGF-containing ®bulin-like extracellular matrix protein (EFEMP1), and expressed sequence tags
represented in GenBank. To further con®rm the expression and colocalization of SP100 and hsp72
in human keratinocytes in situ we used immuno¯uorescence and confocal laser scan microscopy.
SP100 is expressed in the nuclei of keratinocytes in culture and in situ (``nuclear dots''). Double
staining revealed colocalization of hsp72 and SP100 in some of these dots in unstressed and heat
treated HNK, and in normal human skin in situ. No colocalization could be detected in the
squamous cell carcinoma cell line A431. These results for the ®rst time describe the speci®c
interaction of a nuclear protein (of as yet unidenti®ed function) with hsp72 in human
keratinocytes. Further characterization of hsp72-binding proteins will help to understand the
function of hsp72 in human epidermis and its role in the protection of keratinocytes from
environmental stress.
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Corneodesmosin, a Component of Epidermal Corneocyte Desmosomes, Displays
Homophilic Adhesive Properties
N. Jonca, M. Guerrin, C. Caubet, K. Hadjiolova, H. Gallinaro, M. Simon, and G. Serre
Department of Biology and Pathology of the Cell, INSERM CJF 9602-IFR30, Toulouse-Purpan School of
Medicine, Toulouse, France
Corneodesmosomes, the modi®ed desmosomes of the uppermost layers of epidermis, play an
important role in corneocyte cohesion. Corneodesmosin (Cdsn) is a secreted glycoprotein located
in the corneodesmosomal core and covalently linked to the corni®ed envelope of corneocytes. Its
glycine- and serine-rich NH2-terminal domain may fold as structural motifs similar to the glycine
loops (GL) described in epidermal cytokeratins and loricrin, and proposed to display adhesive
properties. A chimeric protein comprising human Cdsn linked to the transmembrane and
cytoplasmic domains of mouse E-cadherin was expressed in mouse ®broblasts to test the ability of
Cdsn to promote cell-cell adhesion. Classic aggregation assays indicated that Cdsn mediates Ca2+-
independent homophilic cell aggregation. To assess the involvement of the GL domain in
adhesion, full-length Cdsn, Cdsn lacking this domain, or this domain alone were expressed as
GST-fusion proteins and were tested for protein±protein interactions by overlay binding assays.
The results con®rmed the homophilic interactions of Cdsn. Moreover, they indicated that its
NH2-terminal GL domain is suf®cient but not strictly necessary to promote binding, suggesting
that it is not the only domain bearing adhesive properties. Altogether, these results provide the ®rst
experimental evidence of the adhesive properties of Cdsn and of the involvement of its GL domain
in cell adhesion.
056
Corneodesmosin is a Preferred Substrate of Both Stratum Corneum Tryptic Enzyme
(SCTE) and Stratum Corneum Chymotryptic Enzyme (SCCE)
M. Simon, D. Bernard,* M. Guerrin, T. Egelrud,² R. Schmidt,* and G. Serre
INSERM CJF 96±02, Toulouse, France; *L'OREÂAL, Life Science Research, Clichy, France;
²Department of Dermatology, University Hospital, UmeaÊ, Sweden
Corneodesmosin (Cdsn) is an adhesive protein located in the extracellular part of the desmosomes
in the upper layers of the epidermis. Synthesised by granular keratinocytes as a 52±56 kDa protein,
Cdsn is progressively proteolysed during corneocyte maturation. At the epidermis surface, its
cleavage which is necessary for desquamation to occur, only leaves intact the central domain of the
protein, probably devoid of adhesive properties. The responsible proteases are unknown but SCCE
and SCTE, 2 enzymes present in the stratum corneum (SC) and suggested to be involved in
corneodesmosome degradation, are good candidates. To test whether Cdsn is a substrate of the
enzymes, extracts of human epidermis were treated with epidermal SCTE and with either
recombinant or epidermal SCCE. Treatments were performed at pH 7.4 and pH 5.6, the latter
being closer to the physiological pH of the SC. Proteins were then immunoblotted with antibodies
directed to Cdsn but also to desmogleins and desmocollins, the desmosomal cadherins which are
also present in the extracellular part of the corneodesmosomes. At pH 7.4, both SCTE and SCCE
degraded Cdsn. SCTE generated two immunoreactive fragments of 48 and 35 kDa, whereas SCCE
generated several fragments from 48 to 15 kDa. Both enzymes also degraded desmocollins.
However, desmogleins as well as most of the proteins of the extracts including involucrin, were
unaffected. Identical results were obtained with the epidermal or recombinant SCCE. At pH 5.6,
only Cdsn was degraded by SCTE, but somewhat less ef®ciently than at pH 7.4. Proteolysis of
Cdsn by SCCE was also observed. The results demonstrate that Cdsn is a preferred substrate of
both SCCE and SCTE in vitro, and suggest that the two proteases are involved in the proteolytic
maturation of the protein in the SC. They support previous studies showing the importance of
both enzymes in desmosome degradation and in desquamation.
057
Functional Analyses of Connexin Mutations in Keratinocytes
D.P. Kelsell,W. Di, J.E.A. Common, E.L. Rugg, and I.M. Leigh
Centre for Cutaneous Research, Barts and London School of Medicine and Dentistry, Queen Mary,
University of London, London E1 2AT, UK
The ®ndings of germline connexin mutations in skin disease have shown that intercellular
communication via gap junctions is an important mechanism by which the normal epidermis
develops and differentiates. Distinct mutations in four connexins, Cx26, Cx30.3, Cx30 and Cx31,
have been found either to underlie hearing loss and/or three types of hyperproliferative epidermal
disease: Vohwinkel's syndrome, Hidrotic Ectodermal Dysplasia and Erythrokeratoderma variabilis.
These genetic studies show that different connexin molecules and mutations have distinct
junctional channel properties with regard to the co-ordination of epidermal differentiation. Tissue
biopsies from patients in conjunction with cell culture models (both keratinocytes and HeLa cells)
transfected with GFP tagged connexin fusion proteins are being used to study details of mutant
connexins with regard to junction assembly and function. For example, immunohistochemical
analysis of a palm biopsy taken from an affected site of an EKV patient harbouring the Arg42Pro
mutation in Cx31 revealed cytoplasmic location of the Cx31 protein. GFP constructs of wildtype
Cx31 and Cx31Arg42Pro mutant DNA were transfected separately into primary keratinocytes.
48 h post-transfection, the wtCx31/GFP fusion protein was localised at the plasma membrane of
keratinocytes with the characteristic punctate staining and distribution of gap junction plaques
between adjoining cells. In contrast to wtCx31/GFP, the Arg42ProCx31/GFP fusion protein was
localised in the cytoplasm as demonstrated for endogenous Cx31 in affected EKV palm skin. These
data show that the mutation prevents the protein reaching the plasma membrane and forming
intercellular channels. Other connexin mutations such as M34T, D66H and R75W in Cx26,
M190L in Cx30.3 and G11R in Cx30 in addition to cSNPs have been analysed in this way and
will be described. These data show the effect of mutation on the processing of connexin proteins
and will provide useful molecular tools towards understanding the effect of speci®c connexin
mutations on gap junctional intercellular communication.
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An Inducible Mouse Model for Epidermolytic Hyperkeratosis: De®ning the Role of
Stem Cells in Mosaic Skin Disorders
M.J. Arin, M.A. Longley, X.J. Wang, and D.R. Roop
Cologne, Germany and Houston, Texas
Mosaic skin disorders are characterized by the presence of at least two genetically distinct cell
populations from the same differentiation lineage within the same tissue. The mechanisms that lead
to clinical mosaicism are poorly understood. It remains unclear, how certain genetic defects lead to
a mosaic disease, whereas others never become apparent in the same tissue. To study the molecular
and cellular basis of mosaicism, we established a mouse model for the autosomal-dominant skin
blistering disorder, epidermolytic hyperkeratosis (EHK) which is characterized by a generalized and
a mosaic form. This genetic model allows activation of a somatic K10 mutation in epidermal stem
cells in a spatially and temporally controlled manner using an inducible Cre recombinase. Topical
application of the inducer (RU486) to a circumscribed area of the skin resulted in a phenotype
characteristic of mosaic diseases, with patches of affected and unaffected skin. The EHK lesions
persisted after 3±5 topical applications of RU486, to date for over 12 months. Our results indicate
that lack of selective pressure against certain mutations in epidermal stem cells leads to mosaic
phenotypes. This ®nding has important implications for the development of new strategies for
somatic gene therapy of dominant genodermatoses.
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The Elovl3 Gene is Required for Normal Development of Hair Follicles and Skin Barrier
Function
R. Westerberg, P. Tvrdik, B. UndeÂn, J-E. MaÊnsson, L. NoreÂn, A. Asadi, R. ToftgaÊrd, MR.
Capecchi, and A. Jacobsson
Stockholm University, Sweden, University of Utah, Utah; Karolinska Institute, Sweden and Sahlgren's
University Hospital, Sweden
Esteri®ed or as free acyl chains, very long chain fatty acids (VLCFA) are indispensable for the
formation and function of the permeability layer of the skin. Elovl3 is a tissue speci®c expressed
gene whose product belongs to a highly conserved family of microsomal enzymes involved in the
formation of VLCFA and sphingolipids from yeast to man. Here, we report a novel mechanism,
which involves the Elovl3 gene product in the formation of hair follicles and the function of skin
barrier. Expression analysis of the Elovl3 gene revealed a distinct expression in the sebocytes in the
sebaceous glands and in the epithelial cells of the hair follicles. By disruption of the Elovl3 gene by
homologous recombination in mouse, we show that ELOVL3 participates in the formation of
esteri®ed VLCFA in the hair follicles and the sebaceous glands, and that these lipid compounds are
essential for the barrier function of the skin. The Elovl3-ablated mice displayed a sparse hair coat
and dry, atopic skin. The pilosebaceous system was hyperplastic and the hair lipid content was
disturbed with exceptionally high levels of eicosenoic acid (20 : 1). A functional consequence of
this is that Elovl3-ablated mice exhibited a severe defect in water repulsion and increased trans-
epidermal water loss.
060
Inhibition of Androgen Receptor Expression in Human Sebocytes In Vitro by Antisense
Oligonucleotides
S. Fimmel, A. Saborowsky, B. Bogdanoff, C.E. Orfanos, and C.C. Zouboulis
Berlin, Germany
The effects of androgens on the skin are in¯uenced by the amount of nuclear androgen receptor
(AR) molecules available in skin cells. Androgen activity on the skin can be inhibited by systemic
administration of compounds that exhibit strong AR af®nity and antagonize binding of androgen
molecules to AR. Androgens are the best-known stimulators of sebaceous gland activity,
enhancing lipogenesis, proliferation and terminal differentiation of human sebocytes in vivo and in
vitro. In this study we applied a new technology to realize the same purpose; we tested thioat- and
ribosyl-antisense oligonucleotides against the AR. Antisense molecules are highly speci®c because
they bind to mRNA targets at multiple levels of interaction at a single receptor site. To transfer
antisense oligonucleotides into human SZ95 sebocytes we developed a cationic liposome-mediated
transfection system with DOTAP. The transfection ef®ciency was assessed using FITC-labeled
(ACTG)5 random oligonucleotides that were detected within the nucleus. The expression of AR
on mRNA and protein levels was investigated by semiquantitative RT-PCR and Western
blotting. The transient transfection of SZ95 sebocytes with thioat (0.4 and 1.0 mM) and 2`-methyl-
ribosyl (0.4 and 1.0 mM) antisense oligonucleotides resulted in a diminished protein expression of
the AR after 24 h. After longer recovery times the AR protein expression in transfected SZ95
sebocytes reached again the level of native AR expression. The most successful transient control of
AR expression was detected with 1.0 mM 2¢-methyl-ribosyl antisense after 14 h and revealed a 87%
inhibition of AR expression compared with native SZ95 sebocytes. The biological effect of several
modi®ed antisense-oligonucleotides was evaluated by estimating the proliferation pattern of
androgen-challenged sebocytes treated with antisense-oligonucleotides.
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Protein A Immunoadsorption: A Novel and Effective Treatment of Pemphigus
E. Schmidt, E. Klinker,* A. Opitz,* C. Sitaru, S. Herzog, J. Trcka, M. Goebeler, E.-B. BroÈcker,
and D. Zillikens
Departments of Dermatology and *Transfusion Medicine, University of WuÈrzburg, Germany
Pemphigus foliaceus (PF) and pemphigus vulgaris (PV) are autoimmune blistering diseases
associated with antibodies to desmoglein (Dsg) 1 and Dsg 3. The pathogenic relevance of
antibodies to these desmogleins has been demonstrated by passive transfer into neonatal mice
where the intradermal injection of IgG, puri®ed from the serum of PF or PV patients, induces
acantholysis. Preadsorption of PV/PF IgG with recombinant Dsg3/Dsg 1 inhibits blister formation
in the mice. Based on these data, we treated 4 patients (PV n = 3, PF n = 1) by immunoadsorption
using a regenerable staphylococcal protein A adsorber which selectively removes immunoglobulins
from the circulation. During each PA-IA, 2±3 plasma volumes (6±8 L) were processed resulting in
a decrease of antibodies to Dsg 1/Dsg 3 by more than 90%. Three of our patients had been
refractory to various treatment modalities and in 1 patient, PA-IA was chosen as the ®rst treatment.
All patients had high levels of circulating autoantibodies as detected by indirect immuno¯uor-
escence on monkey oesophagus and ELISA using recombinant desmoglein 1 and 3. Within a
period of 4±24 weeks, skin lesions cleared completely in all patients. Concurrently, levels of
circulating antibodies became negative in 2 patients and declined markedly in the other 2 cases.
Three patients have now been free of skin lesions during a follow-up period of 8±84 weeks. At the
same time, intervals between PA-IA were extended from initially 1 week to 3 weeks; in 1 case, PA-
IA has now been tapered off for more than 1 years without relapse. In all patients, the
accompanying dose of oral methylprednisolone (initially 0.5 mg per kg body weight per d) could
be greatly reduced. In summary, our data suggest that PA-IA is a rational, effective, and safe
therapy for pemphigus and warrant the wider use of PA-IA for this indication.
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Functional Thyroid Peroxidase Autoantibodies of IgE Class in Patients with Chronic
Urticaria
A. Hanau, S.M. McLachlan,* J. Guo,* P. Staubach, F. Siebenhaar, H.J. Peter, M. Metz, J. Knop,
B. Rapoport,* and M. Maurer
Department of Dermatology, University Mainz, Germany; *Autoimmune Disease Unit, Cedars-Sinai
Research Institute, Los Angeles, California
Chronic urticaria (CU), a frequent dermatosis caused by autoimmunity, allergy, chronic infection
or pseudoallergy among other mechanisms, has been reported to be preceded by autoantibody-
mediated autoimmune diseases including thyroid autoimmunity. Speculating that thyroid
autoantibodies may be involved in the pathogenesis of CU, we have characterized the prevalence,
Ig class pattern and function of antibodies against thyroid peroxidase (TPO) in patients with CU.
Out of 116 CU-patients tested, 23 (19.8%) exhibited increased IgG-antibodies to TPO (IgG-
TPO-Ab), as assessed by ELISA (p < 0.005 compared to 5.6% in healthy controls). Interestingly,
virtually all IgG-TPO-Ab-positive (88%, n = 17), but none of 33 IgG-anti-TPO-negative CU-
patients, also exhibited TPO-Ab class IgE (p < 0.005), as assessed by immunoprecipitation. To test
whether these IgE-TPO-Ab are functional, mouse mast cells (MC) expressing human FceRI were
loaded with serum IgE-fractions of IgE-TPO-Ab-positive or IgE-TPO-Ab-negative CU-patients.
MC degranulation was determined after stimulation with human recombinant TPO (rhTPO) by
measuring release of b-hexosaminidase. IgE-TPO-Ab-pretreated MC showed signi®cantly
increased release of b-hexosaminidase (17.3 6 1.2%) after stimulation with rhTPO as compared
to MC pretreated with IgE-fractions of IgE-TPO-Ab-negative CU-patients (3.4 6 0.2%, p < 0.05)
or IgE-TPO-Ab-pretreated MC stimulated with vehicle (4.7 6 0.3%, p < 0.05). Our ®ndings
con®rm a high incidence of increased thyroid antibodies in patients with CU and show for the ®rst
time that a signi®cant percentage of CU-patients exhibits ``autoallergic'' TPO-Ab of IgE class,
capable of activating MC in the presence of TPO. Thus, ``allergy to self'' may be a novel
mechanism involved in the pathogenesis of chronic urticaria.
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Low-Dose Long-Term IL-10 Treatment Prolongs the Disease-Free Interval in Psoriasis
M. Friedrich, W. Sterry, A. Klein, W. -D. DoÈcke, and K. Asadullah
Berlin, Germany
The ability of intermediate-term IL-10 therapy to reduce the severity of exacerbated psoriasis has
been demonstrated recently. The objective of this study was to determine the safety and potency of
long-term, low-dose IL-10 application in order to prolong the duration of psoriasis remission. We
performed a placebo-controlled, double-blind, phase II clinical trial using rhIL-10 in patients with
chronic plaque psoriasis in remission. Patients received nonlesional subcutaneous injections with
either IL-10 (10 mg per kg body weight; n = 8) or placebo (n = 11) 3 times per week for 4 month.
Immunological investigations (plasma parameters, mitogen-induced lymphokine secretion in
whole blood) were performed monthly. Overall the treatment was well tolerated. Only moderate
and nonpersisting effects on hematopoetic cells were observed. Renal and hepatotoxicity were
excluded. One patient each from the placebo and IL-10 treatment groups prematurely drop out of
the study for private reasons and were excluded from the further analyses. In the placebo group
almost all patients (9/10±90%) showed a relapse of psoriatic disease during the 4 month observation
period. In contrast to this, only 2 out of 7 patients (26.6%) relapsed in the IL-10-treated group. The
mean relapse-free interval during study time was 102 days in the IL-10 group in comparison to
66 days in the placebo group. In Kaplan Meier analysis the relapse incidence was signi®cantly
different in the IL-10 and the placebo groups (p = 0.022 Log Rank test). In accordancy with results
from therapeutic psoriasis studies, IL-10 treatment led to in tendency lower IFN-g and higher IL-4
secretion capacities. Moreover, for all patients a signi®cant negative correlation between the ex vivo
mitogen-induced IL-4 secretion and PASI was demonstrated (r = 0.36, p < 0.01). Remarkably, the
2 psoriasis patients who relapsed in the IL-10 group lacked immunological signs for IL-10
reactivity. Our data suggest that low-dose, long-term therapy with rhIL-10 is safe and clinically
effective to prolong the disease-free interval in psoriasis. Consequently, its value should be further
determined in larger trials including dose-®nding studies. Moreover, the value of long-term IL-10
treatment for the prevention of re-exacerbation of other in¯ammatory disorders with a similar
immunological pro®le, as in¯ammatory bowel disease, rheumatoid arthritis and transplant
rejection, should be analyzed.
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Neutralization of the Dendritic Cell Speci®c Costimulatory Molecule, Dectin-2, Breaks
UV-Induced Tolerance
Y. Aragane, A. Maeda, F. Yamazaki, K. Matsushita, A. Kawada, T. Tezuka, and K. Ariizumi*
Department of Dermatology, Kinki University School of Medicine, Japan; *South-western Medical Center,
University of Texas at Dallas, Texas
Ultraviolet (UV) light abrogates contact hypersensitivity (CHS) responses and induces hapten-
speci®c tolerance. Although this phenomenon has long been appreciated, molecules speci®cally
involved in this pathway still remains to be shown. We could show currently that dectin-2 (Dec2),
the dendritic cell-speci®c C-type lectin receptor, selectively mediates UV-induced tolerance, but
not the induction of CHS, when Dec2 is functionally neutralized before sensitization. Since the
establishment of tolerance needs speci®c signals at resensitization with haptens, i.e. the Fas/FasL
system, we questioned whether Dec2 confers signals to establish tolerance in a speci®c way.
Therefore, C3H/HeN mice that were exposed to low doses of UV light over 4 days (d) and
hapten-sensitized through radiated-skin area with dinitro¯uorobenzene showed profound
inhibition of the CHS response. UV-treated mice resensitized 14 d after the ®rst challenge
displayed hapten-speci®c tolerance. Intravenous (i.v.) injection of soluble Dec2 (sol-Dec2), an
antagonist of cognate Dec2 expressed on dendritic cells, before resensitization abrogate UV-
induced tolerance, however, tolerance is not affected at all when sol-Dec2 is i.v. injected before
rechallenge, demonstrating that neutralization of Dec2 breaks UV-induced tolerance. As control
experiments, mice that were not UV-exposed but hapten-sensitized were resensitized and
rechallenged showed the vigorous ear swelling response, which was not affected upon injection of
sol-Dec2 before resensitization or rechallenge. Adoptive transfer of T cells from regional lymph
nodes of UV-exposed mice treated with sol-Dec2 had no effect on the CHS response in recipient
mice, whereas the transfer of T cells from UV-treated mice inhibited the immune response. These
®ndings indicate that sol-Dec2 can selectively breaks UV-induced tolerance without affecting
effector routes of the CHS response, thereby demonstrating that Dec2 plays a central role in
generation of immunological tolerance by UV light.
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A Crucial Role of Dectin-2 to Establish UV-Induced Tolerance by Supressor T Cells
A. Maeda, Y. Aragane, F. Yamazaki, K. Matsushita, A. Kawada, T. Tezuka, and K. Ariizumi*
Department of Dermatology, Kinki University School of Medicine, *South-western Medical Center,
University of Texas at Dallas, Texas
Ultraviolet (UV) light abrogates the contact hypersensitivity (CHS) response and induces hapten-
speci®c tolerance. In this context, it is well accepted that suppressor T cells play a pivotal role in the
induction of tolerance. Biological signi®cance of suppressor T cells is best demonstrated that those
cells may reproduce the UV-induced immunosuppressive phenotype upon transfer to naõÈve
animals by activating molecules, i.e. Fas/Fas ligand system, in T cell-transferred recipient animals.
However, it still remains to be shown how signals in recipients are activated. Therefore, we
focused on Dectin-2 (Dec2), the dendritic cell speci®c C-type lectin receptor with costimulatory
functions. C3H/HeN mice that were ®rst exposed to low doses of UV for 4 consecutive days (d)
and sensitized with dinitro¯uorobenzene through UV-radiated skin areas exhibited profound
suppression of CHS as compared to those only sensitized and challenged, but not UV-exposed,
indicating that the induction of UV-induced immunosuppression. T cells were isolated from those
animals and transferred to naõÈve recipients, resulting in marked suppression of CHS in recipient
mice. To address whether Dec2 is involved in this process, naõÈve mice that were intravenously
(i.v.) injected with sol-Dec2, an antagonist for cognate Dec2 expressed on dendritic cells or with its
irrelevant control protein, DFHR, were transferred with T cells from UV-tolerized or non-UV
exposed animals 3 h after the injection. 1 d after the transfer those mice were sensitized and
challenged. While immunosuppression of CHS induced in transferred-animals was not affected at
all upon i.v. injection of DFHR, which, however, was signi®cantly restored by i.v.injection with
sol-Dec2. In addition, transfer of T cells from non-UV-exposed, but hapten-sensitized animals
produced vigorous the ear swelling response in recipients, which was not affected upon
i.v.injection of DFHR nor of sol-Dec2. Together, our present study demonstrates that Dec-2
selectively plays a decisive role in the induction of tolerance by suppressor T cells. Furthermore,
this is the ®rst demonstration of the presence of Dec2-dependent signaling pathways from
suppressor T cells to dendritic cells in order to establish immune tolerance by UV light.
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Down-Regulation of HLA Class I Transcription in Advanced Melanoma Metastasis
J. Willers, M. Urosevic, E. Laine, R. Geertsen, G. Burg, and R. Dummer
Department of Dermatology, University Hospital Zurich, CH-8091 Zurich
The HLA class I complex is operative in almost all cells and allows the immune system to monitor
all tissue for the presence of viral infections or tumors. The presentation of endogeneous
synthesized peptides in association with HLA class I allows the activation of CD8+ lymphocytes.
Tumor cells often fail to present antigenic peptides resulting in an immune escape of metastasizing
cells. We try to illuminate possible molecular mechanisms leading to a lack of antigen presentation.
A panel of 32 malignant melanoma short-time cultures were analyzed geno- and phenotypically for
HLA gene expression. Transcriptional activities of HLA-A, -B and -G genes were monitored using
new quantitative LightCyclerTM PCR technology and compared. Since in 30 metastasis the
genomic analysis revealed the presence of the corresponding HLA class I allospeci®cities despite
reduced protein expression on the cell surface we explored the possibility of a transcriptional gene
regulation. There was no correlation observed between down-regulation of HLA-A and HLA-B
but between gene expression and gene transcription levels. Additionally, an overall reduction of
HLA class I gene transcription in melanoma metastasis was observed over the time for individual
patients. Therefore, we postulate a transcriptional regulation of the HLA class I gene expression in
melanoma involved in immune escape processes. The documented HLA down-regulation in
malignant melanoma metastasis suggests a central role for HLA in tumor progression and limits the
ef®cacy of speci®c immunotherapy.
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Loss of E-Cadherin Expression in Melanoma Cells Involves Upregulation of the
Transcriptional Repressor Snail
I. Poser, D. DomõÂnguez,* A. de Herreros,* A. Varnai, R. Buettner, and A.K. Bosserhoff
Institute of Pathology, Medical School RWTH Aachen, Germany; *Unitat de Biologia Cellular i Molecular,
Institut Municipal d'Investigacio Medica, Universitat Pompeu Fabra, Barcelona, Spain
Malignant transformation of melanocytes frequently coincides with loss of E-Cadherin expression.
We could show that loss of E-Cadherin in melanoma cell lines does not involve mutations in the
E-Cadherin gene, promoter methylation or alterations in expression of AP-2 transcription factors
as suggested previously. In a panel of different melanoma cell lines E-Cadherin expression was
negatively regulated by up-regulation of the transcription factor Snail. In comparison to primary
human melanocytes, where Snail expression was not detected by RT-PCR, signi®cant expression
was found in all eight melanoma cell lines. In parallel, Western blot and RT-PCR analysis revealed
strong reduction of E-Cadherin expression in the melanoma cells. Consistently, transient
transfection of a Snail expression plasmid into human primary melanocytes led to signi®cant down-
regulation of E-Cadherin, whereas transient and stable transfection of an antisense snail construct
induced reexpression of E-Cadherin in Mel Ju and Mel Im melanomas. In summary, we conclude
that activation of Snail expression plays an important role in down-regulation of E-Cadherin and
tumorigenesis of malignant melanomas.
068
Increased Susceptibility to Skin Carcinogenesis in Mast Cell-De®cient Mice
F. Siebenhaar, J. Knop, and M. Maurer
Department of Dermatology, University Mainz, Germany
Mast cells (MC) have been reported to accumulate at sites of cutaneous tumor formation where
they are suspected to be involved in growth promotion and angiogenesis. To test whether MC
modulate the development of epidermal tumors, MC-de®cient KitW/KitW±v-mice were subjected
to a two-stage skin carcinogenesis model. KitW/KitW±v-mice and normal Kit+/+-mice were treated
topically with a carcinogen (DMBA, single application) followed by a promotor (TPA, 2x/week
for 17 weeks). Papillomas were ®rst found in both genotypes 9 weeks after the start of promotion.
Unexpectedly, KitW/KitW±v-mice proceeded to develop tumors signi®cantly faster than normal
Kit+/+-mice: After 12 weeks of treatment 82% of KitW/KitW±v-mice (n = 28), but only 35% of
Kit+/+-mice (n = 40), showed >1 papilloma (data pooled from 3 independent experiments, p
< 0005). Interestingly, after 12 weeks of treatment KitW/KitW±v-mice also exhibited more
papillomas per treatment site (3.1 6 0.4 papillomas per mouse) as compared to Kit+/+-mice
(1.4 6 0.4 papillomas per mouse, p < 0.02). Suspecting that MC release products required for
resistance to de novo carcinogenesis, we tested whether MC undergo degranulation during repeated
TPA treatment. As assessed by histomorphometric analysis, virtually all subepidermal MC treated
for 16 weeks exhibited signs of extensive (70 6 7.5%) or moderate (29 6 5%) degranulation, while
subcutaneous MC were activated to a markedly lesser extent (40 6 10.5% not degranulated, p
< 0.05). These ®ndings suggest that activated MC confer resistance to skin tumor development.
Our data also extend the view of MC as salient skin sentinels in the context of innate immune
responses.
069
Impaired Control of Skin Infection with Pseudomonas Aeruginosa in the Absence of
Mast Cells
W. Syska, J. Knop, and M. Maurer
Department of Dermatology, University Mainz, Germany
We and others have recently shown that peritoneal mast cells (MC) play a central role in the
initiation of ef®cient innate immune responses in acute septic peritonitis. To test whether skin MC
populations contribute to resistance and containment of bacterial infections, we subjected
genetically MC-de®cient KitW/KitW±v-mice to skin infections with Pseudomonas aeruginosa (PA).
Female KitW/KitW±v-mice and normal+/+ littermates (Kit+/+) were injected subcutaneously with
~8 3 106 colony forming units of PA (0.1 mL, shaved lower back), and the size of skin lesions,
characterized by in®ltration and subsequent necrosis, was assessed by planimetric analysis (every 2±
6 h, for 72 h). Developing skin lesions in KitW/KitW±v-mice were markedly larger (up to 3 fold)
than in Kit+/+ mice at all time points. Kit+/+ skin lesion size reached a maximum at 14 h after
infection (0.7 6 0.2 cm2 vs. 1.4 6 0.7 cm2 in KitW/KitW±v), while lesions in KitW/KitW±v-mice
continued to increase for 36 h following infection (1.6 6 0.6 cm2 vs. 0.6 6 0.1 cm2 in Kit+/+ at
36 h). Virtually all KitW/KitW±v-mice, but no Kit+/+ mouse, exhibited piloerection, a sign of
systemic infection, as soon as 12 h and up to 50 h after PA-injection, indicating systemic
dissemination of PA. Therefore, clinical symptoms of sepsis were assessed with the help of a clinical
disease score, grading the degree of spontaneous activity, social behavior and ¯ight reaction
(maximum value of 3). Clinical disease after injection of PA in KitW/KitW±v-mice started earlier and
was more severe than in Kit+/+ mice (KitW/KitW±v: 1.8 6 0.2 vs. Kit+/+: 0.7 6 0.3 at 2 h, p
< 0.05). Clinical disease score values in Kit+/+ mice, but not in KitW/KitW±v mice, started to drop
12 h after infection (0.5 6 0.2 vs. 1.7 6 0.3 in KitW/KitW±v at 14 h, p = 0.02), indicating that
recovery from PA-induced morbidity is impaired in MC-de®cient mice. Our data suggest that MC
(1) control the size of skin lesions in PA infection and (2) promote containment of PA at the site of
skin infection. These ®ndings implicate MC as potential effector cells in the context of bacterial
skin infections.
070
Association Between p53 Codon 72 Polymorphism and Susceptibility to Skin Cancer
C.A. Harwood, T. Crook, L. Brooks, D.A. Kelly, A.R. Young, J. Breuer, T.P. Millard, C.M.
Lewis, I.M. Leigh, A. Storey, and J.M. McGregor
London, UK
Up-regulation of p53 protein induces either growth arrest or apoptosis and this is signalled from a
highly conserved p53 domain between codons 64±92, where a functional polymorphism results in
either proline (p53±72P) or arginine (p53±72R) at position 72. Preliminary studies suggest that
p53±72R may be a risk factor for cervical cancer and preferential mutation and retention of the
p53±72R allele has been demonstrated in other squamous cell cancers. We have examined the
relationship of the polymorphism and nonmelanoma skin cancer by determining the association
with susceptibility to sunburn (as assessed by skin phototype and minimal erythemal dose), p53
mutations, loss of heterozygosity and human papillomavirus status. We found a signi®cant
relationship between p53±72R and susceptibility to sunburn (p = 0.0001 for trend) and between
p53±72R and nonmelanoma skin cancer in renal transplant recipients (p = 0.01) but not in
immunocompetent patients compared to skin type matched controls. p53 sequence data revealed
mutations in 30/70 (42.9%) nonmelanoma skin cancers, 28 (93%) of which were in the p53±72R
allele. Loss of heterozygosity occurred more frequently in p53±72RP than in p53±72RR tumours
(p = 0.0001) with preferential loss of p53±72P in heterozygotes (p = 0.016), irrespective of the
mutant status of the concomitant allele. Together these data infer functional differences between
polymorphic forms of p53 that are likely to be relevant to skin carcinogenesis.
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Mutations of the INK4A-arf and p53 Tumor Suppressors Genes in Genital Carcinoma
N. Sou®r,* C. Vilmer, O. Thibaudeau, F. Bachevalier, G. Deslestaing, B. Cavelier-Balloy,* and
N. Basset-SeÂguin
Inserm U532, Polyclinique de Dermatologie, *Service d'Anatomie Pathologique, HoÃpital Saint-Louis, Paris,
France
The INK4A-ARF locus (encoding the P16INK4a and P14ARF proteins) and the p53 genes are
important cell cycle regulators. They are inactivated by UV-induced mutations in skin carcinomas
from both sporadic and XP patients. In genital cancer p53 can be inactivated by either mutation or
interaction with oncogenic HPV E6 protein. Very few studies have looked at the status of
p16INK4A-ARF in genital tumors. In this work we have looked for mutations in the p16INK4A-
ARF locus (exon 1a, 1b, 2) and the p53 gene (exon 4±8) by PCR SSCP and sequencing in genital
cancers (N = 10), 7 developped on lichen sclerosus (LS) and 3 on HPV-related genital lesions. We
also analysed precursor lesions LS (N = 22) or condyloma (N = 3), and normal surrounding genital
skin (N = 14). Our preliminary results show that both p53 and p16INK4A-ARF are frequently
mutated in genital cancer as mutations are present in at least 60% and 40% of the tumors,
respectively. Three additionnal abnormal band shifts are currently analyzed. Additionnally,
cumulation of mutations in both INK4A-ARF and p53 are so far observed in 40% of the tumors
strongly suggesting a selection advantage of double mutants. Characterization of the mutations
showed 3 C > T transitions and 4 tranversions for the p53 gene (in exons 5, 7 and 8), a mutational
pattern radically different from the one of UV induced skin tumors. For the INK4A-ARF locus
only C > T transitions were observed in exon 2 common between p16INK4A and p14ARF genes,
with a hot spot on codon 80 (Arg80Ter). Conversly no mutation was observed in precursors
lesions and normal skin. Immunohistochemical localization of the p53 protein was performed in 3
tumors and in 22 LS and showed stabilisation of the p53 protein in 66% and 27%, respectively.
These results show that both p16INK4A-ARF locus and the p53 gene are important molecular
targets in genital carcinogenesis. They appear as late even in tumor progession as they are found
mutated mostly in cancer and not in prescursor lesion. Association for inactivation of both the
p16INK4A-ARF locus and the p53 genes seem to be an important event in genital skin
carcinogenesis.
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The Antimalarial Artesunate Acts Also as a Potent Anticancer Drug via both p53-
Dependent and -Independent Pathways
J.O. Funk, H.O. Weber, P. Rauch, and T. Efferth*
Erlangen and *Mainz, Germany
Artesunate, a semisynthetic derivative of artemisinin, the active compound of the plant Artemisia
annua, shows remarkable activity against otherwise multidrug resistant Plasmodium falciparum and
vivax malaria. Artesunate has now been analyzed for its anticancer activity against 55 cell lines of
the National Cancer Institute Human Tumor Drug Screen Panel. Artesunate, in comparable molar
ranges as established cytostatic drugs, was most active against leukemia and colon cancer cell lines.
Intermediate GI50 values were obtained for most other cell lines, including otherwise
chemoresistant tumors like renal cancer and melanoma. Interestingly, MDR1/P-glycoprotein
overexpressing multidrug-resistant cancer cells did not show cross-resistance to artesunate
compared to sensitive parental cells, and no correlation with MDR1 mRNA expression or MDR1
transporter functionality was observed. Moreover, GI50 values were identical among cell lines with
wild-type and mutated p53 tumor suppressor protein as well as induced or uninduced p21CIP1
CDK inhibitor. This unusual quality of artesunate was further analyzed in a p53+/+p21+/+ cancer
cell line and its respective knockout counterparts. Artesunate, in a time- and dose-dependent
manner, potently induced cell cycle arrest, as judged by profound inhibition of the retinoblastoma
G1/S pathway, and apoptosis in p53
+/+ as well as in isogenic p53±/±, p21±/±, and 14±3-3 s±/± cells.
This points to overlapping but distinct pathways at the G1/S checkpoint activated by artesunate.
Taken together, our results and the low toxicity documented in large clinical malaria studies are
clues that artesunate may be a promising candidate for the therapy of tumors resistant to
conventional chemotherapy, including melanoma.
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Determination of Sequence Diversity in the Gene for Collagen XVII in Autoimmune
Blistering Disease Patients Shows Conservation of the NC16A1 Domain
S. Winsey,*² L. Lonie,² J. Allen,* A. Smith,² M. Zimmer,² and F. Wojnarowska*
*Department of Dermatology, The Churchill Hospital and ²The Wellcome Trust Centre for Human
Genetics, Oxford University, Oxford, UK
The autoimmune blistering diseases of the skin are characterised by autoantibody attack of type
XVII Collagen (BP180). Collagen XVII forms an adhesion complex, which extends from the basal
keratinocytes into the basement membrane zone. Autoantibody attack is directed at the NCA16
domain positioned between the membrane-spanning domain and the long extracellular
collagenous tail of the molecule. Sequence variation of the gene which codes for collagen XVII
(Collagen 17A1) was determined in a panel of 29 Caucasian individuals using DHPLC analysis on
the WAVE TM DNA Fragment Analysis System (Transgenomic) and DNA sequencing of the
exons which were shown to have changes. Of the 29 individuals 11 had bullous pemphigoid, 8 had
cicatricial pemphigoid and 10 had linear IgA disease. All had autoantibodies to the basement
membrane zone speci®cally collagen XVII. 19 polymorphisms were identi®ed in 29 individuals.
All were single base substitutions. The majority of variable sites were found in noncoding regions.
Of the variable sites characterised in coding regions; four had variations that resulted in amino-acid
substitutions and four were silent substitutions. No polymorphisms were found in exon 18, which
codes for the NCA16 domain. All previously reported polymorphisms were con®rmed. These
results show that although the gene for collagen XVII is polymorphic, the region encoding for
NCA16 does not tolerate polymorphisms, which may alter the structure of the encoded molecule.
This suggests the structure of this region is strictly conserved to maintain its function.
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Sera from Patients with Cicatricial Pemphigoid React with both C- and N-Terminal
Sites on the BP180 NC16A Domain, in Contrast to Sera from most Bullous Pemphigoid
and Pemphigoid Gestationis Patients
A. Kromminga, C. Sitaru,² J. Meyer, R. Arndt, E. Schmidt,² E. Christophers,* E.B. BroÈcker,²
and D. Zillikens²
Institute of Immunol, Pathol, and Mol Biol, Hamburg; *Department of Dermatol, University of Kiel;
²Department of Dermatol, University of WuÈrzburg, Germany
Bullous pemphigoid (BP), pemphigoid (herpes) gestationis (PG), cicatricial pemphigoid (CP), and
lichen planus pemphigoides (LPP), are autoimmune subepidermal bullous diseases that are
characterized by circulating autoantibodies to the transmembrane hemidesmosomal protein
BP180/type XVII collagen. Previous studies demonstrated that the majority of patients with BP,
PG, and LPP show antibodies to an immunodominant, membrane-proximal noncollagenous
domain (NC16A) on the extracellular portion of BP180. By the use of nonoverlapping peptides of
the NC16A domain, we previously demonstrated that autoantibodies from BP and PG patients
mainly react with epitopes clustered within the N-terminus of this immunodominant site of
BP180; antibodies from patients with LPP also recognized the C-terminal portion of NC16A.
However, some of these results had been obtained indirectly by preadsorption studies. The aim of
the present study was to analyze the ®ne speci®city of autoantibodies to NC16A in sera from
patients with CP and to compare their reactivity with antibodies from BP, PG, and LPP patients
using a series of new overlapping fragments covering the entire NC16A domain. We con®rm that
BP and PG sera mainly react with N-terminal epitopes of NC16A, whereas sera from patients with
LPP also bind to C-terminal portions of this domain. Interestingly, out of 10 patients with CP,
seven reacted with NC16A; within NC16A, these sera bound to both C-terminal fragments and a
N-terminal epitope right next to the cell membrane. Our data demonstrate a heterogeneous
binding pattern of autoantibodies to BP180 NC16A in patients with CP.
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False-Negative Results in Immunoblot Assay of Serum IgA Antibodies Reactive with
the 180-kDa Bullous Pemphigoid Antigen (BP180): the Importance of Primary
Incubation Temperature
H.H. Pas, G.J. Kloosterhuis, and M.F. Jonkman
Centre for Blistering Skin Diseases, Department of Dermatology, University Hospital, Groningen, the
Netherlands
One of the methods to assess the antigen speci®city of circulating antibodies in acquired
immunobullous dermatoses is immunoblotting. In fact many of the target antigens known today
have initially been discovered by this technique. This success has made immunoblotting into a
widely used diagnostic tool for discriminating between diseases that show similar patterns by serum
immuno¯uorescence, but in which the actual target antigens may differ. Since immunoblotting
seems a relatively simple technique with easy results, many laboratories use it for identi®cation of
the antigen-speci®city of serum autoantibodies but protocols and assay conditions may differ
signi®cantly between laboratories. For instance the incubation temperature during the ®rst step, the
contact between ®lter-bound antigen and patient serum, is in the literature often given as
``ambient'' or ``room'' temperature. In the current study we show that in IgA-immunoblotting
assays for BP180 it particularly is this ®rst step which may be crucial for obtaining a reliable result.
Being faced with irreproducible results in seemingly identical assays we carefully evaluated each
step of the protocol. Here we show that increasing the primary incubation temperature from room
temperature (19±20°C) to 37°C results in a dramatic improvement of IgA-binding to BP180. A
test panel of 11 sera was selected from patients who, in skin or conjunctival biopsies, had linear
EBMZ-IgA deposits, which sometimes were accompanied by linear IgG. Based on clinical
presentation and immunopathological criteria these patients suffered from bullous pemphigoid
(n = 1), cicatricial pemphigoid with or without ocular involvement (n = 5), ocular cicatricial
pemphigoid (n = 4) or linear IgA bullous dermatosis (n = 1). This test panel was assayed by
immunoblot at different primary incubation temperatures. Where at room temperature no or
incidental binding to BP180 was observed, IgA from 10 out the 11 sera clearly bound BP180 when
incubated at 37°C.
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Saccharomyces cerevisiae and Pichia pastoris as a Novel Source for Production of Human
Bullous Pemphigoid Antigen 230 (BP230)
E. Laf®tte, R. Shafaatian, B. Favre, L. Fontao, J. Koster,* J-H. Saurat, M. Monod, and L.
Borradori
Departments of Dermatology, University of Geneva and Lausanne, Switzerland; *The Netherlands Cancer
Institute, Amsterdam, the Netherlands
BP230 is a protein of 2649 amino acids of the plakin family, that was originally identi®ed as a major
autoantigen in bullous pemphigoid (BP). The protein is a constituent of junctional complexes
called hemidesmosomes and is involved in cytoskeletal organization. To better de®ne its role as
cytoskeletal linker and as target antigen of BP, we have attempted to produce BP230 and its entire
770 residue tail in fusion with the FLAGTM peptide (F) (F-BP2301±2649) and GST (GST-BP2301880±
2649), respectively, using yeasts S. cerevisiae and P. pastoris expression systems. Immunoblot analysis of
extracts of yeasts transformed with expression vectors for BP230 and the deletion mutant
demonstrated that P. pastoris was not able to produce F-BP230 1±2649, whereas S. cerevisiae expressed
minor amounts of the protein, which appeared proteolytically degraded. In contrast, both
S. cerevisiae and P. pastoris produced GST-BP2301880±2649. A time course analysis in S. cerevisiae
revealed that the optimal time of induction was 48 h. Furthermore, the level of production of
GST-BP2301880±2649 in S. cerevisiae was higher than in P. pastoris (42.5 ng vs. 5 ng per 100 mg of
extracts) and higher than the amount of native BP230 in cultured keratinocytes. The expressed
GST-BP2301880±2649 was only partially soluble in buffers containing 6 M urea and/or 1% Triton-
100, making its puri®cation dif®cult. Finally, when the reactivity of BP sera against yeast extracts
was assayed, 12 of 17 (71%) BP sera were found to be reactive with GST-BP2301880±2649, while no
reactivity was observed with 6 of 6 (0%) sera from normal volunteers. In conclusion, S. cerevisiae
yeast represents a novel source for the production of truncated forms of BP230, but not for the
wild-type protein. The expressed recombinants may be useful tools for the diagnosis of BP and
related disorders.
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Comparison of Alterations of Basement Membrane Zone in a Course of Pemphigoid
and Epidermolysis Bullosa Acquisita: Three Dimensional Reconstruction of BMZ in
Laser Scanning Confocal Microscopy
K. Wozniak and C. Kowalewski
Department of Dermatology, Warsaw University of Medicine, Poland
Pemphigoid and epidermolysis bullosa acquisita (EBA) are characterized by the presence of in vivo
bound and circulating anti basement membrane zone (BMZ) antibodies directed against different
antigens localized in upper part of lamina lucida and in sublamina densa regions, respectively. The
alterations of BMZ during the process of the diseases leading eventually to blister formation. The
present study was undertaken to compare alterations of various regions of the BMZ in pemphigoid
and EBA using laser scanning confocal microscopy (LSCM). Biopsies taken from perilesional skin
of pemphigoid and EBA were cut into 20 mm thick slides followed by immuno¯uorescence
labeling with antibody against b-4 intergin (lamina lucida marker-upper part), antibody against
epiligrin (lamina lucida marker-lower part), antibodies directed against collagen type IV and N-
terminal end of collagen VII (lamina densa-LD markers), antibody directed against C-terminal end
of collagen type VII (sublamina densa-SLD marker). Three dimensional reconstruction of various
regions of BMZ was performed by computer programme integrated with LSCM. Our studies
revealed numerous invaginations of BMZ on the level of lamina lucida and lamina densa in a case
of pemphigoid. However continuous character of BMZ was preserved. In EBA case, in contrast to
pemphigoid, discontinous staining on the level of SLD region was noticed and large clumps of
collagen VII vertically orientated to the BMZ extended into the deep dermis were observed. Our
study have shown that alteration of BMZ in pemphigoid mainly refers to lamina lucida whereas in
EBA to sublamina densa region. The alterations of different regions of BMZ in pemphigoid and
EBA could be responsible for discrepancy in the level of blister formation and course of the
diseases.
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Mixed Antibody Response in Paraneoplastic Pemphigus
J. Allen, D. Dean, C.Gooptu, V. Gudi, H.S. Young, J. Langtry, and F. Wojnarowska
Oxford and Manchester, UK, Aberdeen and Sunderland, Scotland
The increased awareness of paraneoplastic pemphigus (PNP) as a clinical entity has resulted in
larger series of patients becoming available for study. Our group comprised 7 patients with PNP, 3
associated with chronic lymphocytic leukaemia, 1 with follicular lymphoma, 1 with Castleman's
disease, 1 with non-Hodgkin's lymphoma, and 1 patient with metastatic laryngeal carcinoma.
Immunohistochemistry was used to ascertain the autoantibody and complement pro®le (IgG/IgA/
C3) in these 7 patients, and immunoblotting on keratinocyte and/or epidermal skin extracts to
determine the speci®c antigens targeted. All 7 patients ful®lled the clinical, histological and
immunopathological criteria for PNP with I/C staining by DIF, cell surface and BMZ staining by
IMF, all showed positive IMF staining on rodent bladder, and bound 2 or more of the plakin
family of PNP antigens. In addition to IgG and C3, PNP was also strongly associated with IgA
antibodies. Four patient's sera showed IgA cell surface and BMZ binding by IMF, 5 sera bound the
190 kDa antigen and 1 the 170 kDa antigen by immunoblotting. In addition 2 sera reacted against
the 250 kDa antigen. The single patient with a negative IgA response by IMF and blot analysis was
undergoing immunoglobulin replacement fortnightly for variable immunode®ciency. The
presence of IgA did not appear to be related to the clinical picture or treatment. Our results
suggest that the IgA plays a signi®cant role in the immune response in many PNP patients, and
emphasises the heterogeneity and complexity of the disease.
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CD8 Lymphocytes are Involved in the Pathogenesis of Acantholysis In Vivo
C. Feliciani, P. Toto, B. Wang, A. Tulli, and D.N. Sauder
Chieti, Italy and Sunnybrook HSC, Canada
Pemphigus Vulgaris (PV) is an autoimmune bullous skin disease characterized by antibodies
directed against the desmosomal cadherin desmoglein-3. Recent studies have demonstrated a role
for T lymphocytes in the pathogenesis of acantholysis. Activated T cells are present within PV
lesions, and T-cell derived cytokines have been shown to be involved in acantholysis. A selective
epidermal accumulation of activated CD8+ T cells has been found in paraneoplastic pemphigus
where apoptosis has been identi®ed as a key mechanism of keratinocyte death. It has been also
suggested that cell-mediated cytotoxic reactions are probably related to enhanced proteolytic
activity in the site of bullous eruption in PV. To further delineate the potential role of CD8
lymphocytes in the pathogenesis of acantholysis, we performed passive transfer experiments with
PV IgG in gene targeted mutant mice. Our results demonstrated that CD8 de®cient mice are
signi®cantly less sensitive to the development of PV lesions than wild type mice. These data
indicate a role for CD8 lymphocytes in PV acantholysis and suggest that cytotoxic reactions leading
to apoptosis of keratinocytes may play a role in the development of lesions in PV.
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CD40-CD40L Expression in Lesional and Unaffected Skin of Pemphigus
B. Giomi, M. Caproni, E. Pestelli, W. Volpi, and P. Fabbri
Florence, Italy
CD40 is a surface antigen of B and T cells, mononuclear and antigen-presenting cells (APCs),
endothelial cells and some epithelial cells that interacts with a speci®c ligand (the so called CD40L)
which is only transiently and slightly expressed by normal T cells, but conversely preferentially
expressed by CD4+ activated T lymphocytes. The CD40-CD40L signaling process is a pivotal
component of multiple immunoregulatory pathways, such as the up-regulation of IgE synthesis or
the in vivo priming of Th1 cells via the stimulation of IL12 secretion by APCs. In this study we
tried to investigate if CD40-CD40L ligation, that usually represents a step of antigen presentation
in limph nodes, could have a role in blister formation of pemphigus. In particular, we supposed it
could promote the ``cognate interaction'' between T and B cells, leading to a skin model in which
humoral and cellular immunity co-operate to the pathomechanism of the disease. To this purpose,
an immunohistochemical technique (APAAP) using monoclonal antibodies (MoAbs) for CD40
and CD40L was performed on cutaneous biopsies taken from lesional and healthy skin of 6
pemphigus patients (3 affected by pemphigus vulgaris -PV- and 3 by pemphigus foliaceus -PF-).
Furthermore, healthy subjects were used as negative control. In lesional skin of pemphigus patients,
a focal perivascular staining for CD40L was found in two biopsies (1 PV, 1 PF), while two patients
(2 PF) showed only groups of 3±4 big CD40L positive(+) cells localised in the upper dermis. The
epidermal staining was always negative. CD40+ cells were detected in the basal layer of the
epidermis and a positive staining was also found in the vascular and perivascular dermal sites of all
patients. In unaffected skin, a weak positive staining for CD40L was demonstrated in the
perivascular dermal areas. An intense staining for CD40 was evident on the epidermal cells. In all
biopsies CD40+ cells were also found around dermal vessels and appendages, and in one case, we
demonstrated CD40+ cells even scattered in the upper dermis. On the contrary, we did not ®nd
any CD40+ or CD40L+ cell in the biopsies from healthy donors. Taken together, our results point
out a higher expression of both CD40-CD40L in lesional than in healthy skin. It might be
conceivable therefore the activation of these antigens plays an additional pathogenic role to the
production of autoantibodies and following immuno-mediated ¯ogosis of pemphigus.
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Atypical Bullous Skin Disease Associated with SjoÈgren's Syndrome
M. Kiss, R. Gyulai, M. Mehravaran, L. KovaÂcs, Gy Pokorny, S. Husz, and A. Dobozy
Szeged, Hungary
In unusual circumstances, patients with systemic autoimmune diseases can develop subepidermal
blisters, and one of the mechanisms whereby this occurs is through the development of
autoantibodies against the type VII collagen. A 56-year-old Caucasian woman with primary
SjoÈgren's syndrome developed a subepidermal bullous eruption, which responded well to
medium-dose oral prednisolone therapy. Histology on the perilesional skin revealed subepidermal
cleavage with edema formation in the papillary dermis, and polymorphic in®ltration perivascularly.
Direct immuno¯uorescence examination demonstrated linear IgG and C3 deposition along the
basement membrane zone. On indirect immuno¯uorescence, the circulating IgG autoantibodies
from the patient's serum labeled exclusively the dermal side of salt-split normal human skin.
Immunoblotting examination on dermal protein extracts revealed circulating autoantibodies
against the intact tissue type VII collagen in the patient's serum. Circulating autoantibodies against
speci®c bullous pemphigoid antigens (BP230 and BP180) were not detected. We suggest that the
presence of antitype VII collagen autoantibodies was directly connected with the blistering skin
eruptions in the patient (possibly a generalized in¯ammatory EBA) and these autoantibodies may
contribute to the initiation of bullous skin symptoms in other autoimmune disorders.
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Tissue Transglutaminase (TGc) is a Minor Antigen in Autoimmune Disease
Independent of Gluten Sensitive Enteropathy
M. SaÂrdy, M. CsikoÂs, C. Geisen, K. Preisz, E. Tomsits, U. ToÈx, J. Wieslander, S. KaÂrpaÂti, M.
Paulsson, and N. Smyth
Budapest, Hungary, Cologne, Germany, and Lund, Sweden
TGc is the major autoantigen of coeliac disease and dermatitis herpetiformis. To characterize its
wider autoantigenic role, sera from patients with other disorders were analyzed. Sera from 304
patients with autoimmune diseases and 122 patients with diseases involving organ speci®c
enhanced cell death were compared to those from 39 patients with coeliac disease and 56 with
dermatitis herpetiformis and 84 samples from people with diseases of nonautoimmune origin or
without known disease. IgA antibodies against tissue transglutaminase were detected using human
and guinea pig antigens in an ELISA system. Anti-gliadin and antiendomysium antibodies were
also determined. Fourty nine percent of sera from patients with autoimmune disorders reacted with
the human TGc. However, no association of these conditions with gluten sensitive enteropathy
could be shown. Healthy controls were negative. While IgA antibodies against TGc are a major
feature in coeliac disease and dermatitis herpetiformis, they also occur in patients with other
disorders. Antibodies against TGc might accompany and promote autoimmune diseases, allowing
their use in the prognosis of disease activity. Further, the presence of such antibodies in sera from
patients with autoimmune disease should not alone be taken as the basis for the diagnosis of coeliac
disease or dermatitis herpetiformis.
083
Analysis of Vascular Immunoglobulin and C3 Deposition in Skin of 116 Dermatitis
Herpetiformis Patients
K. Preisz and S. KaÂrpaÂti
Budapest, Hungary
Previously, we had observed vascular immunoglobulin and complement deposition in the skin of
several dermatitis herpetiformis (DH) patients. Therefore, we decided to study the signi®cance of
this ®nding. We investigated skin biopsy samples taken from 116 patients with DH. In all cases the
diagnosis of DH was con®rmed with the presence of granular IgA staining in the papillary dermis.
In 40 out of 116 patients studied with direct immuno¯uorescence we found a signi®cant vascular
staining accompanying the DH speci®c IgA ¯uorescence. The distribution of staining pattern using
antihuman IgA, IgM, and C3 antibodies was the following: IgA vascular positivity in 12 patients,
IgM in 9 patients, C3 in 7 cases. Both IgA and C3 positivity was detected in 6, IgM and C3 in 4,
IgM and IgA in 2 skin samples. We think that this is a signi®cant ®nding, which is not a speci®c
symptom in DH, but can help us to understand the pathomechanism of the disease.
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The Identi®cation of Mutations in Keratin 9 Using Denaturing High Performance
Liquid Chromatography
E.L. Rugg, A. Wilgoss, H.P. Stevens, I.M. Leigh, and D.P. Kelsell
London, UK
Epidermolytic palmoplantar keratoderma (EPPK) is characterised by diffuse keratoderma of palm
and sole skin and is caused by mutations keratin 9 (K9). We have investigated the use of denaturing
high performance liquid chromatography (dHPLC) to screen patients with palmoplantar
keratoderma for K9 mutations. DNA from affected individuals from three families and 56
unrelated control samples were analysed for sequence variations in exon 1 of K9. PCR products
encoding this region were subjected to heteroduplex analysis by dHPLC using the WAVETM
system. Identi®ed heterozygotic variations were con®rmed by DNA sequencing. All samples from
affected individuals resulted in complex dHPLC pro®les which varied between families. Control
samples resolved as either a single peak or a distinct multipeak pro®le. DNA sequencing con®rmed
different mutations in each family. In two cases previously reported mutations were identi®ed
which resulted in the change of arginine162 to glutamine or tryptophan. In the third case a novel
mutation was found which changed valine170 to methionine. The multipeaked dHPLC pro®le
generated by control DNA resulted from a noncoding polymorphism in codon 142 (A426C). The
identi®cation of K9 mutations con®rmed the diagnosis of EPPK in all three families. dHPLC
resolved each heterozygous sequence variation as a different pro®le and provides a rapid and
accurate method of screening for pathogenic and polymorphic DNA sequence variations.
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Analysis of X-Chromosome Inactivation in Normal Human Epidermis and in Basal Cell
Cancer
A. Asplund, Z. Guo, AÊ . Persson,* X. Hu, C. Wassberg, J. Lundeberg,* and F. PonteÂn
Department of Genetics and Pathology, University Hospital, Uppsala, Sweden; *Royal Institute of
Technology, Department of Biotechnology, Stockholm, Sweden
During early development of the female embryo, one X-chromosome is randomly inactivated in
each cell. As a result of growth, migration and differentiation, the adult female becomes a mosaic of
cells with either the paternal or the maternal X-chromosome inactivated. It is not known what
structure the X-chromosome inactivation pattern has in skin of normal individuals. We
investigated normal skin from four healthy females, heterozygous for the HUMARA microsatellite
on the X-chromosome. Following careful microdissection, DNA from adjacent epidermal samples
consisting of approximately 35 basal keratinocytes was digested with the methylation-sensitive
enzyme HpaII. The inactivated X-chromosome remained intact due to extensive methylation.
The enzyme digested DNA was ampli®ed using PCR and fragments were analyzed for size.
Through examination of adjacent samples and consecutive sections, we found normal human skin
to be composed of a ®ne mosaic of tiles with either maternal or paternal X-chromosome
inactivated. The sizes of these tiles were between 20 and 350 basal cells in diameter. The described
method has a potential to resolve the clonal status of normal as well as pathological conditions, and
provide important information on early carcinogenesis. We are currently analyzing basal cell
cancer, a tumor dependent on a speci®c connective tissue stroma. Previous studies of tumors with a
conspicious stroma component, including biphasic tumors have revealed synovial sarcoma to be a
true biphasic tumor whereas phylloides tumor of the breast showed a clonal pattern in the stromal
component but not in the epithelial compartment. Preliminary results have uncovered that a subset
of basal cell cancers exhibit a polyclonal epithelial component, whereas the stroma appears to be of
polyclonal origin regardless of clonal status of the epithelial part of the tumor (unpublished data).
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A Polymorphism in the PTCH Tumor Suppressor Gene may be Responsible for
Multiple Basal Cell Cancers
N. Wikonkal, D. Brash, D. Leffell, D. Knezevich, A. Asplund, A. Gustavsson, J. Lundeberg, and F.
PonteÂn
Budapest, Hungary, New Haven, Conneticut, and Uppsala, Sweden
We report a polymorphism at codon 1315 in the PTCH gene, a tumor suppressor gene that plays
an important role in the pathogenesis of basal cell cancer (BCC), and show that this polymorphic
locus may affect succeptability for BCC. In DNA of nontumor origin obtained from patients with
multiple BCC's, we found an allelic variant of the originally published sequence in exon 22 of
PTCH where Pro (CCC) occurs instead of the Leu (CTC), which has previously been published as
wild-type. In a large set of DNA samples from patients with different genetic background and
history for cutaneous malignancy, we analyzed the allele pattern of this codon to ®nd that patients
with several BCC's differ in the allele distribution from the control group by having a lower
frequency of the Leucine allele. The fact that this polymorphism leads to an amino acid substitution
between two amino acids whose chemical characteristics greatly differs further supports our notion.
In addition, we also studied allelic loss from tumor DNA of patients heterozygous for this allele and
found that a selective loss of alleles can be found in certain patients.
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Primary Epidermal Cells from Porokeratosis-Affected Patients are not Hypersensitive to
UVB or X Irradiation
M. D'Errico,*² M. Teson,² A. Calcagnile,* B. Didona,² R. Corona,² G. Zambruno,² and E.
Dogliotti*
*Istituto Superiore di Sanita¢; ²Istituto Dermopatico dell'Immacolata, IRCCS, Rome, Italy
The porokeratosis (PK) are a group of skin disorders characterized by the presence of
hyperkeratotic plaques which tend to occur at sun-exposed sites. In the case of disseminated
super®cial actinic porokeratosis (DSAP) a modest hypersensitivity to X irradiation of primary
®broblasts from affected subjects has been reported. In this study we have compared the response to
X-rays and UVB radiation of primary keratinocytes and ®broblasts from normal and DSAP-
affected subjects. No difference in radiosensitivity was detected when the clonal cell survival of
lesional and nonlesional cells from DSAP-affected patients was compared with that of their normal
counterpart (cultures from age-matched controls). In general, epidermal keratinocytes were X- and
UVB-radiation resistant when compared with ®broblasts. As in the case of radiosensitivity, the
response to apoptosis induced by X-rays and UVB was similar in both lesional and non lesional
DSAP keratinocytes and in the age-matched controls. Interestingly, primary ®broblasts were
refractory to apoptosis in response to either X-rays or UVB treatment while keratinocytes
underwent apoptosis after exposure to UVB radiation but not after X-ray exposure. These data
clearly indicate that the actinic character of this skin pathology is not due to hypersensitivity to
either ionizing or UVB radiation. Mutations in the p53 gene, which are often associated with UV-
related skin carcinogenesis, were analysed in a set of porokeratosis lesions. P53 mutations were
rarely detected (2/15 lesions examined) and were not UV-speci®c, con®rming that exposure to
solar radiation does not play a key role in the etiology of porokeratosis. Preliminary data suggest
that premature senescence of keratinocytes might be involved in the development of porokeratotic
lesions.
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Comparison of Gene Expression Between Basal Cell Carcinomas and Squamous Cell
Carcinomas
C. Marionnet, C. Lalou, K. Mollier, M. Chazal, and N. Basset-SeÂguin
INSERM U532, Paris, France
Basal cell carcinomas (BCC) and squamous carcinomas (SCC) are distinct epithelial skin cancers
arising from keratinocytes. BCC grow slowly, nearly never metastases, whereas SCC are invasive
tumors with a greater metastatic potential. Some molecular clues for these pathologies have been
described (for example alterations in the sonic hedgehog signalling pathway in BCC). In order to
investigate other molecular events in the etiology and differential invasiveness of skin carcinomas,
we compared large scale gene expression of 7 BCC and 5 SCC with the use of Human Atlas
Cancer cDNA expression array (1176 genes, Clontech). For each patient RNA was extracted from
tumor and non tumoral control skin. (33)P-labeled cDNA probes were synthesized with Clontech
speci®c primers. The hybridation signal was acquired with a Storm phosphorimager and quanti®ed
using the ImageQuant software (Amersham Pharmacia Biotech). Differential expression between
tumor and control skin was considered when the ratio of normalized data was above 2 or under
0.5. Among the 1176 genes, 207 genes 6 64 (21%) were differentially expressed between BCC
and control skin. 326 genes 6 86 (38%) were differentially expressed between SCC and control
skin. 49 similar genes were modulated in 5/7 BCC and 149 in 4/5 SCC. 24 identical genes were
modulated in both 5/7 BCC and 4/5 SCC. These included genes involved in cell proliferation,
differentiation and interaction with extracellular matrix. Only one gene was speci®cally
overexpressed in BCC: the GEM GTPase gene (implicated in cellular response to growth
stimulation). It was 5 fold increased in BCC whereas not modulated or detected in all the studied
SCC. 19 genes were speci®cally modulated in SCC including rhoC and genes implicated in cell-
cycle regulation, apoptosis, cellular adhesion and matrix remodeling. Some of these genes may
potentially be involved in invasive and metastatic phenotype. In conclusion, this study shows that
gene expression in skin carcinomas is vastly modi®ed in comparison with non tumoral skin.
Comparison analysis between SCC and BCC shows common and speci®c gene modulations
which are currently explored. Speci®cally expressed genes could represent new molecular keys for
tumor development and local agressivity.
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Molecular Basis of Skin Cancer: Large Scale Analysis of Differentially Gene Expression
in BCC and SCC
T. Welss,* M. Papoutsaki,*² J. Reifenberger,* G. Michel,* T. Ruzicka,* and H.F. Abts*
*Department of Dermatology, Heinrich-Heine University, DuÈsseldorf, Germany; ²Department of
Dermatology, University of Rome ``Tor Vergata'', Italy
Basal cell carcinoma (BCC) represents the most common malignant neoplasm in humans. BCC
occurs primarily in sun exposed areas of the skin. This relationship between sun exposure and
carcinogenesis of BCC is based on mutagenic and immunosuppressive effects of the UV range in
sunlight. Manifested, UVB induced mutations of DNA could lead to a not physiological expression
of cellular genes and altered proteins. Thus, the phenotype of the malignant keratinocyte is
expected to be associated with an altered expression pro®le compared to the normal counterpart of
the tumor cell. The aim of this study is to detect differentially expressed genes involved in the
pathophysiology of BCC. Here we used human cDNA expression arrays containing 588 cDNA
sequences of known genes immobilized on nylon membranes. The membranes were differentially
hybridized with labeled cDNA-libraries of pooled BCC- or normal skin samples (NS). In order to
investigate the detected differentially gene expression in individual samples we performed
semiquantitative RT-PCR using 10 BCC-, 2 SCC-, 11 NS- specimens, HaCaT and normal
human keratinocytes (NHK). From the 588 arrayed genes we identi®ed 100 expressed in human
keratinocytes. Comparing the expression patterns of the arrayed cDNAs revealed 18 differentially
expressed genes, from which 6 were down- and 12 were up-regulated in BCC. The majority of
these dysregulated genes (9) are associated with transcription- and cell cycle- control. 4
differentially expressed genes take part in the immunological response, 3 genes belong to a
functional group of detoxifying and antioxidizing enzymes and two genes are coding for proteins
involved in cell matrix or cell-cell contact.
090
No Evidence of Deregulated Patched-Hedgehog Signaling Pathway in Trichoblastomas
and other Tumors Arising within Nevus Sebaceous
M. Takata, M. Tojo, K. Ohara, M. Yamada, and K. Takehara
Kanazawa, Fukushima and Tokyo, Japan
Nevus sebaceous (NS) is a congenital malformation of the skin within which a number of
neoplasms showing adnexal differentiation may arise. Recently, deletions in the patched (PTCH)
gene region were reported in NS and constitutive activation of the PTCH-hedgehog signaling
pathway was implicated in the development of tumors arising within NS. To further substantiate a
role of PTCH hedgehog signaling pathway in secondary tumors arising within NS, we examined
11 NS associated with secondary tumors for loss of heterozygosity (LOH) of the PTCH gene
region by microsatellite PCR and PTCH mRNA expression by in situ hybridization.
Unexpectedly, however, none of the tumors (including 8 trichoblastomas) and NS lesions showed
LOH at any polymorphic loci close to the PTCH gene. Furthermore, none of the NS lesions and
secondary tumors gave detectable signals for PTCH mRNA. In contrast, 4 of 11 sporadic BCCs,
that were examined for comparison, showed LOH at the PTCH gene locus (p < 0.05), and
moderate to strong signals for PTCH mRNA was observed in all 7 BCC tumors examined
(p < 0.0001). The ®ndings in the present study do not support the view that the deregulation of the
PTCH-hedgehog signaling pathway is involved in the pathogenesis of NS and associated tumors,
and show that, although morphologically similar, tricoblastomas and BCCs have different
molecular pathogenesis.
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Lamin Expression in Normal Skin, Actinic Keratosis, Squamous Cell Carcinoma and
Basal Cell Carcinoma
C.M.L.J. Tilli, F.C.S. Ramaekers,* and H.A.M. Neumann
Department of Dermatology, University Hospital Maastricht, Maastricht, the Netherlands; *Department of
Molecular Cell Biology, University of Maastricht, Maastricht, the Netherlands
Aberant expression patterns of lamins have been described in various types of cancer, and the
expression is dependent on the subtype of cancer, its aggressiveness, proliferative capacity and
degree of differentiation. This study aims at establishing the expression patterns of lamins in normal
human skin, actinic keratosis (AK), squamous cell carcinoma (SCC) and basal cell carcinoma
(BCC). Expression patterns of the individual lamin subtypes were immunohistochemically studied.
In normal skin lamin A yielded positive staining in the suprabasal cell compartment of the
epidermis, whereas the basal cells were mostly unstained. The BCCs and SCCs stained practically
homogeneously positive, and the epidermis overlying BCC and SCC stained practically
homogeneously positive in the basal cells and remarkably strong in the suprabasal cells. In AK,
the basal cell layer of the epidermis stained homogeneously positive for lamin A, and the suprabasal
compartment showed strongly positive staining. Lamin C was only occasionally expressed in the
basal cells of normal epidermis, whereas the suprabasal cells stained strongly positive. In BCCs,
lamin C was predominatly present as nucleolar structures, only occasionally was staining of the
nucleolar envelop seen. The SCCs stained strongly positive for lamin C, and the staining was
predominantly ring shaped. The epidermis overlying BCC and SCC stained strongly positive. The
expression of lamin C in AK in the basal cells resembled the expression pattern seen in the
epidermis overlying BCC and SCC, but in the suprabasal compartment the staining showed a
nucleolar staining. Lamin B1 and B2 stained all cell types in normal skin. The BCCs, SCCs and the
epidermis overlying BCC stained strongly positive. The epidermis overlying SCC showed only
occasionally staining for lamin B1 in both the basal and the suprabasal cells, whereas lamin B2 was
homogeneously expressed in the basal cells and strongly expressed in the suprabasal cells. AK also
stained strongly positive for both lamin B1 and B2. We can conclude that there is an abnormal
expression of lamins in both premalignant and malignant lesions. Furthermore, the lamin A
expression in the basal cell layer of the epidermis overlying BCC may suggest involvement in the
primary process.
093
Somatic Mutation of hMLH1 in a Primary Skin Melanoma
E. Pagani, D. Castiglia, E. Alvino, G. Marra,* P. Vernole,² R. Pepponi, E. CannavoÁ, G.
Zambruno, and S. D'Atri
IDI-IRCCS; Institute of Neurobiology and Molecular Medicine-CNR, Rome, Italy; *Institute of Medical
Radiobiology, University of Zurich, Switzerland; ²Department of Public Health and Cell Biology,
University of `Tor Vergata', Rome, Italy
Mutations in the mismatch repair system (MRS) genes have been identi®ed in hereditary
nonpolyposis colorectal cancer syndrome and in a low percentage of sporadic tumors presenting
high levels of microsatellite instability (MSI). While MSI has been reported in a variable proportion
of cutaneous melanomas, no mutations in MRS genes have been described so far in this tumor. We
identi®ed a human melanoma cell line, PR-Mel, which was defective in mismatch repair, did not
express the MRS proteins hMLH1 and PMS2 and showed high levels of MSI. The cell line was
then analyzed for genetic defects in the hMLH1 gene using an RNA-based screening approach on
total RNA. RT-PCR encompassing the cDNA region containing exons 14±18, showed a single
aberrant band corresponding to a shorter transcript lacking exon 16. Sequence analysis at genomic
DNA level revealed the presence of a G to A transition at position ±1 of the acceptor splice site of
intron 15, in keeping with exon 16-skipping. The somatic mutation, named 1732±1G®A, was
also detected in genomic DNA from both the primary skin melanoma and the cutaneous metastasis
from which the PR-Mel cell line had been established. Immunohistochemistry con®rmed the
absence of hMLH1 and PMS2 expression in the tumor specimens. Both the cell line and tumor
samples appeared homozygous for the mutation, suggesting that the normal allele was lost. Indeed,
cytogenetic analysis of PR-Mel cells revealed a 3p deletion possibly including the hMLH1 gene.
The identi®cation of the novel mutation 1732±1G®A expands the repertoire of hMLH1
mutations clustered in the region spanning exons 15 and 16. Moreover, the ®nding of somatic
hMLH1 genetic defects in a primary skin melanoma suggests that inactivation of MRS genes may
be involved in the development of at least some cases of sporadic melanoma.
094
Expression of p16 in Relapsing and Nonrelapsing Very Thin Melanoma
L.A. Fear®eld, A. Rowe, N. Francis,* C. Fisher,² B. McCann,³ R.M. MacKie,§ M.E. Gore,² and
C.B. Bunker
§University of Glasgow, ³Norfolk and Norwich Hospital, ²Royal Marsden Hospitals, *Charing Cross and
Chelsea and Westminster Hospitals, Imperial College School of Medicine (START Laboratory), London,
UK
There is now good evidence that mutation or loss of the tumour suppressor gene p16 is an
important factor in the pathogenesis of familial and sporadic melanoma (MM). Most patients with
very thin MM (Breslow thickness less than 0.76 mm) are cured by excision however, 2±10%
relapse with local or metastatic disease. Previous studies have shown lack of expression of p16 in
relapsing MM but there have been no speci®c studies looking at very thin MM. We have therefore
studied the expression of p16 in relapsing and nonrelapsing very thin MM. 18 patients (M:F 7 : 11,
median age 47 (28±63) years) were identi®ed with very thin relapsing MM (median Breslow
thickness 0.56 mm) and compared with 28 appropriately matched controls (M:F 8 : 20, median age
44 (23±84) years: median Breslow thickness 0.5 mm) who had been followed up for at least 5 years.
Immunohistochemistry was performed on formalin ®xed sections with antip16 antibody. Tumours
were scored for intensity of immune reactivity (IR) on a scale from 0 (no or weak IR) to 4 (very
intense IR). Also positive nuclei were counted in at least 5 high power ®elds (150 3 150 mm)
randomly selected throughout each representative tumour. Overall the expression of p16 was less
in the patient group than the control group: p16 IR (patients, median 1.5, IQR 0.83±1.95;
controls 2.4, 1.5±3); number of positive nuclei (patients 33.5%, 19±40.5; controls 44.5%, 33.1±
55.1). However the differences were not signi®cant (Kruskal±Wallis). This study suggests that the
expression of p16 is reduced in patients with relapsing very thin MM but does not prove a
signi®cant correlation between tumorigenicity and loss of p16 IR.
095
Peptides Binding to MIA (Melanoma Inhibitory Activity) Inhibit MIA Function In Vitro
A. Bosserhoff, R. Stoll,* I. Breibach, T.A. Holak,* and R. Buettner
Institute of Pathology, RWTH Aachen; *Max Planck Institute of Biochemistry, Munich; Germany
Analysing the function of MIA, a protein strongly expressed in melanoma cells but not in
melanocytes, we determined strong inhibition of attachment by MIA plating melanoma cells onto
®bronectin, laminin and tenascin. No inhibition of attachment to collagen type I, II and IV, HSPG
and vitronectin was observed. In in vivo assays we further showed that MIA plays an important role
in melanoma metastasis. Recently, we could solve the 3-dimensional structure of MIA using
NMR techniques. MIA adopts a SH3 domain-like fold with two disul®de bridges stabilizing the
protein. MIA is the ®rst extracellular protein found to have a SH3 domain fold. A phage display
experiment generated proline rich heptapeptide sequences, typical for SH3 domain ligands, which
were shown by NMR and ELISA assays to bind to human MIA. In invasion assays using the
Boyden Chamber model two of those peptides inhibited MIA action in a dose-dependent manner.
Further studies have to evaluate if blocking MIA with these peptides in vivo can be used in
melanoma therapy.
096
The Inhibitory Effect of Vitamin D3 and Retinoids on the Selected Mechanisms of
Tumor Invasion
D. Nowicka, M. Marczak, B. Mlynarczyk, W. Bollag, S. Jablonska, and S. Majewski
Warsaw, Poland and Basle, Switzerland
Vitamin A and D derivatives were shown to exert various antitumor effects, both in experimental
and clinical studies. The aim of the study was to evaluate the effect of 9-cis retinoic acid, all-trans
retinoic acid and calcitriol (1,25(OH)2D3) on the invasive potential of SKv (human cancer cells
derived from bowenoid papulosis lesion, found to harbor human papillomavirus 16 DNA) and L1
(murine sarcoma) tumor cell lines. We studied the adherence of the tumor cells preincubated with
the examined compounds to culture plates covered with various extracellular matrix (ECM)
components, including collagen I, collagen IV, ®bronectin and laminin. The attached cells were
stained with cristal violet and their number was measured colorimetrically. We also determined the
activity of matrix metalloproteinases (MMPs) in the supernatants from the tumor cells incubated
with the tested compounds. The proteins of the culture medium were separated electrophoretically
on the polyacrylamide gels containing 0.1% gelatin. After the 24 h-incubation the gels were stained
with Coomassie blue to visualise the gelatinolytic bands. The preincubation of tumor cells with
retinoids at the concentration of 10±7 M or calciriol 10±6±10±8 M, signi®cantly inhibited their
adhesion to the ECM components, especially to collagen I and IV. In case of calcitriol this effect
was dose-dependent. In the gelatin zymography we observed the down-regulation of the MMPs
activity in the supernatants from the cell cultures incubated with examined agents. The observed
inhibitory effects of calcitriol and retinoids on tumor cell adhesion to ECM components as well as
MMPs activity may contribute to the antineoplastic potential of retinoids and vitamin D
derivatives.
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CD4+ T-Cells Activated by the Polyaromatic Hydrocarbon DMBA Augment its
Carcinogenic Activity in Skin
C.A. Elmets, B. Bjarnason, E. Anderson, N. Iranikhah, and H. Xu
Birmingham, Alabama, USA
The objective of this study was to characterize the T-cells that are activated following topical
application of polyaromatic hydrocarbons (PAH) and to determine whether they participate in
PAH-induced skin tumorigenesis. Application of the carcinogenic PAH, 7,12-dimethylbenz(a)an-
thracene (DMBA) to the skin of C3H/HeN mice resulted in the development of contact
hypersensitivity to that agent. In vivo administration of anti-CD8 antibodies prior to sensitization
abrogated the response, whereas in vivo depletion with anti-CD4 antibodies augmented DMBA
contact hypersensitivity. Treatment of CD4+ knockout mice on a C3H background with DMBA
was also found to increase DMBA contact hypersensitivity. When ELISAs were performed on T-
cells from DMBA treated mice, CD8+ T-cells were found to produce interferon-g and little or no
IL-4, whereas CD4+ T-cells were found to elaborate both IL-4 and interferon-g. To determine if
CD4+ T-cells participated in PAH skin tumorigenesis, CD4+ knockout and wild type mice were
subjected to a DMBA skin tumorigenesis protocol. CD4+ knockout mice developed 80% fewer
tumors than wild type mice. The percent of mice with tumors and the number of tumors/tumor
bearing mice were also decreased in CD4+ knockout mice. Immunopreventive strategies which
suppress the activation of CD4+ T-cells may be successful in reducing PAH skin cancer
development.
098
Reduction of Tumor Formation in Scid Mice Xenotransplanted with Human Melanoma
Cell Line by Cimetidine and a Tamoxifene Derivate
H. Hegyesi,* J. Hunyadi, G. Martin,² E. LaÂzaÂr-MolnaÂr,* P. KovaÂcs,* E. Rivera,³ N. SzincsaÂk, A.
Falus,*³ and I. JuhaÂsz
Department of Dermatology, Medical and Health Science Center, Debrecen University, Debrecen, Hungary;
*Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary;
²Laboratory of Radioisotopes, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Argentina;
³Molecular Immunology Research Group, Hungarian Academy of Sciences, Budapest, Hungary
Histamine is produced by many cells expressing histidine decarboxylase (HDC), an enzyme
responsible for its synthesis. Since melanoma cells and tissue contain relatively large amount of
histamine, the functional signi®cance of this ®nding was examined by speci®c antihistamines
among in vitro using human melanoma cell line HT168 and in vivo by inoculating human
melanoma cell line HT168 to immunode®cient (SCID) mice. Our data show that H2 receptor
antagonist cimetidine if combined with a tamoxifene derivate, DPPE (N,N-diethyl-2-{4-
(phenylmethyl)phenoxy}-ethanamine-HCl), in addition to their capacity for inhibition of in vitro
proliferation a strong reduction of melanoma tumour mass is seen in vivo with increased survival of
the recipient mice. These changes are accompanied by enhanced in®ltration of interferon
producing mouse macrophages into the tumor tissue of human origin. We suggest, that probably
two different mechanisms are acting concordantly, direct proliferation inhibition of the tumor cells
by an H2 receptor antagonist and activation of a nonspeci®c local immune response, characterized
by interferon g production. These ®ndings may help to elucidate the possibility of involvement of a
designed antihistamine strategy in melanoma therapy.
099
Microarray and Comparative Genomic Hybridisation Studies of Primary Cutaneous
Lymphomas
X. Mao, D. Lillington,* B. Young,* R. Russell-Jones, and S. Whittaker
Skin Tumour Unit, St. John's Institute of Dermatology, St. Thomas Hospital; *ICRF Department of
Medical Oncology, Bart's Hospital, London, UK
Primary cutaneous lymphomas (PCL) represent a heterogeneous group of T- and B-cell neoplasms
primarily involving the skin. Little is known, however, about the pathogenesis of PCL. To address
this issue we have investigated 31 cases of primary cutaneous T-cell lymphoma (CTCL) and 33
cases of primary cutaneous B-cell lymphoma (CBCL) using microarray and comparative genomic
hybridisation (CGH) techniques. We observed chromosome imbalances (CI) in 22 of 31 CTCL
cases (71%) and in 20 of 33 CBCL cases (61%) using CGH. The most frequent DNA copy number
changes seen in CTCL were losses of 1p (39%), 17p (19%), 10q (16%) and gains of 17q (29%) and 4
(26%). While the most common CI noted in CBCL were gains of 18q/18 (60%), 7p/7 (40%), 4q
(20%), 20 (15%), 21q (15%) and loss of 6q (15%). By using microarray based genomic analysis
technique, we detected gains of copy number of the oncogenes PAK1 in 6 of 7 CTCL cases,
RAF1 and JUNB1 in 5 cases, CTSB, FGFR, ZNF and BCR in 4 cases, and loss of FGR in 2 cases.
We identi®ed gains of SAS in 3 of 4 CBCL cases, BCL2 in 2 case, and loss of ESR in 2 cases.
Increased copy number of bcl2 was also con®rmed in 4 CBCL cases using real-time PCR. In
conclusion, we have identi®ed different patterns of recurrent genetic abnormalities and
ampli®cation of oncogenes in CTCL and CBCL. These ®ndings provide the basis for further
investigation of the molecular pathogenesis of PCL.
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Deletions on the Long Arm of Chromosome 6 in Primary Cutaneous B-Cell Lymphoma
F.J. Child, X. Mao, T.J. Mitchell, S. Fereira, R. Russell-Jones, and S.J. Whittaker
London, UK
Abnormalities of the long arm of chromosome 6 (6q) involving 6q16±27 have been reported in a
variety of malignancies including non-Hodgkin's lymphoma (NHL). Earlier studies using either
FISH and/or loss of heterozygosity (LOH) techniques in systemic NHL, and B-CLL have
identi®ed 3 regions of minimal deletion (at 6q21, 6q23, and 6q25±27). These regions of allelic loss
may indicate the sites of speci®c tumour suppressor genes (TSG's) whose inactivation may be
responsible for tumorigenesis or disease progression. The aim of our study was to identify regions
of chromosomal loss on 6q in 35 cases of primary cutaneous B-cell lymphoma (PCBCL) using
LOH techniques. Genomic DNA extracted from both tumour and control samples from each
patient (a dominant clonal immunoglobulin heavy chain gene rearrangement in tumour, but not
control samples) was ampli®ed using PCR and 17 microsatellite markers for the region 6q15±27.
Radiolabelled PCR products were separated by 6% denaturing PAGE and analysed by
autoradiography. LOH was identi®ed in 3/7 high-grade cases (region of minimal deletion
6q16±21 between D6S434, and D6S447), and 1/28 with low-grade disease at 6q21 (D6S302). Our
data suggest that 6q loss may be important in high-grade (region of deletion 6q16±21) but not in
low-grade PCBCL. Microdissection to ensure that tumour DNA was highly represented, would
help con®rm this conclusion. Possible TSG's include CCNC (involved in cell cycle procession),
BLIMP-1 (involved in B-cell differentiation), and CD24 (encodes a leukocyte surface antigen).
Further mapping of this region is required to de®ne the region of allelic loss more accurately, and
may increase the rate of 6q loss in both high, and low-grade PCBCL.
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Chromosome Aberrations Associate with Progression or Remission in Cutaneous T-
Cell Lymphoma
L. Karenko, S. Sarna, M. KaÈhkoÈnen, and A. Ranki
Helsinki and Tampere, Finland
To evaluate the use of chromosomal abnormalities in clinical follow-up we studied the associations
between peripheral blood clonal or nonclonal chromosomal abnormalities and the clinical activity
of cutaneous T-cell lymphoma (CTCL) or large plaque parapsoriasis (Pps). Five patients with Pps,
8 with mycosis fungoides and two with SeÂzary syndrome were followed for the average of
54 months. Two to 4 blood samples of each patient were analyzed with G-banding and enzyme-
detected in situ-hybridization (EDISH) for chromosomes 1,6,8,9,11,13,15 and 17, previously
shown to be frequently aberrated in CTCL. The method allows the use of two probes
simultaneously, and gives archivable preparations. Statistically, patients in different diagnostic
groups, patients with CTCL, all patients together, and patients with active disease, differed from
healthy or PUVA-treated controls for all chromosomes studied with EDISH or G-banding
(p < 0.01 to p < 0.05). Patients in remission differed from healthy controls for chromosomes 1, 6,
and 11 (p < 0.01 to p < 0.05, EDISH). Patients with active, progressing disease differed from
patients in remission for aberrations of chromosomes 1,6,8,11 and 17. All 11 samples representing
active, progressing disease showed elevated level of chromosome 8 aberrations in EDISH, but so
did also 34% of samples representing nonprogressive disease. The agreement rate of both the
change in chromosomal aberration rate and in clinical condition between two samples was
statistically signi®cant for chromosomes 1,8,9,15 (G-banding) and 17 (G-banding and EDISH;
6 > 0.5±0.6). Six of seven patients (5 CTCL, 1 Pp patient) with a chromosomal clone in G-banding
showed a continuously active disease. Four of them, but no other patients, died within two and a
half year from the detection of the clone. Thus, chromosomal aberrations associate with the activity
of CTCL, and have prognostic signi®cance. In EDISH, several probes should be used in the
follow-up. Aberrations of chromosomes 1,6 and 11, although increasing with activity of the
disease, seem to be a hallmark of an existing disease, detected even in remission. Aberrations of
chromosomes 8 and 17 associate especially with active or progressive disease
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NFkB Gene Family Member Expression in CTCL Skin Lesions and IKB Downregulation
in CTCL Cell Lines
U. DoÈbbeling, J. Kamarashev, C. Zhang, R. Dummer, G. Burg, and F.O. Nestle
Department of Dermatology, University Hospital Zurich, Switzerland
The NFkB gene family codes for a series of important transcription factors. Normally NFkB
proteins translocate from the cytoplasm to the nucleus only after induction, however,
constitutively activated NFkB proteins could lead to aberrant gene expression and cell
transformation. Here we investigated whether NFkB proteins are constitutively present in the
nuclei of CTCL cells, and whether the constitutive NFkB activities are due to decreased
concentrations of NFkB inhibiting IkB proteins. The DNA binding of NFkB proteins was studied
by electrophoretic mobility shift assays (EMSA). To determine the expression and localization of
NFkB proteins we performed immunohistochemical stainings with antibodies directed against the
proteins p50, p52, p65, RelB, c-Rel and Bcl-3. The expression of IkB proteins in CTCL cell lines
was investigated by Western blotting. The EMSA and Western blot experiments show, that all 6
tested NFkB proteins are present in the nuclei of the three tested CTCL cell lines, and that at least
three of them bind to DNA. Nuclear Bcl-3 and p52 was found in lesions of almost all patients (11/
11 and 10/11, respectively). Nuclear p50, p65 and RelB was found in approximately 50% of the
patients (5±6/11), nuclear c-Rel only in 3 of 11 patients. The nuclear localization of the latter 4
proteins was restricted to more advanced stages of the disease. In the CTCL cell lines we found that
the levels of IkB a and IkB b were strongly reduced in comparison to other cell lines. Our results
indicate that reduced IkB levels may be reponsible for the constitutive NFkB activities in CTCL
cells and that constitutive NFkB activities also occur in vivo.
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Determination of the Localization of Tryptophan Hydroxylase (TrH)-Immunoreactive
(IR) Cells in Normal Healthy Human Skin
J. Chen, K. Yoshimura, A. Slominski, and O. Johansson
Stockholm, Sweden and New York, New York
This study has investigated the immunohistochemical localization of TrH, which is the initial and
rate-limiting enzyme in the serotonin biosynthesis and also involved in the ®rst nonrate-limiting
step in the biosynthesis of melatonin, in normal healthy human skin. Thus, the aim was to ®nd out
what kind of cells that have the potential to produce serotonin (5-HT) locally in the skin.
Immuno¯uorescence single-staining of TrH was used to determine the localization of TrH, and
double-staining of TrH and the human histocompatibility complex class?subregion DR (HLA-
DR), as well as TrH and the melanoma-associated antigen (NKI-beteb), was used to explore the
presumed TrH-IR cell types. HLA-DR and NKI-beteb are the commonly used markers for
Langerhans cells and melanocytes, respectively. The results show that TrH-IR cells are identical to
Langerhans cells (LC) in the epidermis, to LC around the sebaceous glands and vessels of the
dermis, and to melanocytes in the epidermal stratum basale. Possibly also some few Merkel cells in
the stratum basale, according to their cellular morphology, could be TrH-IR. We conclude that
Langerhans cells, melanocytes and possibly some few Merkel cells in the normal healthy human
skin have the potential to locally produce 5-HT.
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Adam 9 Expression in Normal Skin, Wound Healing and Carcinoma
P. Zigrino, M. Plomann,* C. Mauch, and R. Nischt
Department of Dermatology and *Department of Biochemistry II, University of Cologne, Germany
ADAM 9 is a cell surface protease involved in the shedding of molecules such as HB-EGF. Besides
its role as metalloproteinase, ADAM 9 is also thought to mediate cell±cell interactions. Therefore,
regulation of ADAM 9 expression might represent an important control mechanism for the release
of growth factors and for cell migration. Recent reports have indicated a possible role of PACSINs
(3 isoforms of cytoplasmic phosphoproteins involved in vesicular traf®cking) in the regulation of
ADAMs function. The aim of this study was to analyze expression of ADAM 9 and PACSINs in
skin during physiological and pathological processes as wound healing and tumor progression. A
polyclonal antibody was used to detect ADAM 9 in cryosections of adult human and mouse skin.
In normal skin ADAM 9 expressing cells were localized in the basal layer of the epidermis. Due to
the importance of basal keratinocyte during re-epithelialization of skin wounds, we analyzed
expression of ADAM 9 during excisional wound repair. At day 3 postinjury, no changes in
expression were found in uninvolved skin. However, ADAM 9 was found associated with all
keratinocytes at the migrating front. At day 7, when re-epithelialization was almost complete,
ADAM 9 expression was reduced in the outer most layers of the epidermis. In human skin tumors,
e.g. basal and squamous cell carcinomas there was no ADAM 9 expression detected whereas
expression in unaffected skin was unchanged. In normal mouse skin, PACSIN 3 was mainly
located in the muscle tissue beneath the dermis. Interestingly, PACSIN 2 was found to be
coexpressed with ADAM 9 in basal layers of the epidermis. During wound repair PACSIN 2
expression is also restricted to the basal keratinocytes at the migrating front as well as in the newly
formed epidermis. Interestingly, as observed for ADAM 9, PACSIN 2 expression was barely
detectable in human skin tumors. These results suggest the involvement of ADAM 9 in the control
and maintenance of skin homeostasis. The absence of ADAM 9 expression observed in epidermal
tumor cells might indicate a role for ADAM 9 in tumor progression. Finally, this study suggests a
putative role for PACSIN 2 in the regulation of ADAM 9 expression.
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Comparison of Two Types of Ex Vivo Models: Hairless Rat Skin on Static Cell and
Reconstructed Human Epidermis
C. Gelis, S. Girard,* A. Mavon,* P. Vicendo, and N. Paillous
Laboratoire des IMRCP, UMR 5623, UniversiteÂ Paul Sabatier, Toulouse, France; *Institut de recherche
Pierre Fabre, Vigoulet Auzil, France
For ethic reasons, alternative methods to animal experiments are needed. Thus in the last past few
years, a lot of methods such as reconstructed skin appeared. In order to explore the validity of this
new generation of ex-vivo models, skin modi®cations under solar or UVA irradiation were studied
by means of two ex vivo assays. The ®rst one is constituted by skin samples from hairless rat ®xed on
a static cell system and maintained with DMEM nutritive medium. The other model is a
reconstructed human epidermis model (RHE; SkinethicTM) maintained on special growth
medium. In both cases, skin samples were irradiated with a Muller reactor equipped with a 450-W
xenon lamp, a mirror and a WG 320 mm (1.5 mm) ®lter for solar irradiation and WG 335 (2 mm)
and UG 11 (2 mm) ®lter for UVA irradiation. The histological modi®cations of the skin were
evaluated after irradiation with doses corresponding to 20 DEM (solar spectra) and 60 J per cm2
(UVA spectra). The viability of the skin was monitored by the MTT assay. After 24 h, the decrease
in viability of skin samples due to experimental conditions was evaluated at around 18%. A solar
irradiation gave rise to a decrease in viability of 40.5% for rat skin and is more important for RHE.
With an UVA irradiation, an important decrease of the viability was observed and evaluated
around 60%.The effect of an irradiation solar or UVA is similar on hairless rat skin maintained on
static model and reconstructed human epidermis (skinethicTM). The histological studies showed a
more drastic effect on the reconstructed human epidermis than on the hairless rat skin, 24 h after
the irradiation. The skin displayed an important number of vacuoles, a contraction of the cells in all
the epidermis with a separation of the different cell layers. The evaluation of sunburn cells on
histological sections, 24 h after the irradiation, showed, respectively, for hairless rat skin and
reconstructed human epidermis an average of 1.67 and 1.86 sunburn cells for a solar irradiation, 1
and 1.2 for an UVA irradiation. The sensibility of the reconstructed human epidermis is greater
because the number of cell layers is less important than on hairless rat skin. Meanwhile, the two
results were similar. In conclusion, these two models were similar in reactivity and data obtained
on rat skin samples may be extrapolated.
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Laser Capture Microdissection: A Potential Tool for Studies on Epidermal Expression of
Kallikreins
I. Andersson, C. Grabbe, M. Brattsand, and T. Egelrud
UmeaÊ, Sweden
The human kallikrein (KLK) gene family which consists of at least 15 serine proteases located at
19q13.4, include the epidermal proteases stratum corneum chymotryptic enzyme (SCCE; KLK7),
and stratum corneum tryptic enzyme (SCTE, KLK5). We have previously puri®ed, and
characterized these two enzymes, which may both be involved in desquamation, and possibly also
in skin in¯ammation. SCCE and SCTE are produced as zymogens, suggesting they may be part of
a proteolytic cascade. This system may include also other kallikreins, since we and others have
found that several members of the kallikrein family, in addition to SCCE and SCTE, are also
expressed by keratinocyte cell lines and by as yet unidenti®ed cells in whole skin. The aim of the
present study was to evaluate Laser Capture Microdissection (LCM) in combination with RT-
PCR as a possible tool for elucidating the expression of kallikreins in different parts of human skin.
Freeze cut, 6 mm sections of 4 mm punch biopsies of normal skin was microdissected with LCM
and three factions were collected: papillary dermis, basal membrane zone, and suprabasal epidermis.
From each fraction RNA was prepared and ampli®ed by RT-PCR with primers speci®c for a
number of kallikreins. As markers of separation ef®ciency we used primers for keratin 14 and
keratin 10. Our results show that, the amounts of material obtained from 3 to 6 sections is suf®cient
for detection of transcripts, also of those occurring in small amounts. However, as compared to
most other tissues the super®cial parts of skin seems to be more dif®cult to fractionate with
available standard protocols for LCM, possibly due to the inherent cohesiveness of the epidermis.
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Latent TGF-b Binding Protein LTBP-2 Decreases Cell Adhesion to Fibronectin
M. HyytiaÈinen and J. Keski-Oja
Laboratory of Cell Biology, Biomedicum Helsinki, and Departments of Virology and Pathology, The
Haartman Institute, University of Helsinki, Finland
Latent TGF-b binding protein LTBP-2 belongs to the LTBP-®brillin extracellular matrix protein
superfamily. We have analyzed the effects of recombinant LTBP-2 on human ®brosarcoma (HT-
1080) and ®broblast cell adhesion using LTBP-2 and its recombinant fragments in quantitative cell
adhesion assays as well as morphological studies. Unexpectedly, full length LTBP-2 protein was
found to decrease cell adhesion to ®bronectin. The antiadhesive effect toward ®bronectin was
much less prominent than toward collagen type I. LTBP-2 mediated its effects only when present
in the growth substratum, not as soluble protein. LTBP-2 had similar although less prominent
effects on the adhesion of ®broblasts in quantitative adhesion assays. Although full length LTBP-2
was antiadhesive towards ®bronectin, its N-terminal domain alone mediated ®broblast adhesion,
but did not augment actin stress ®ber formation. The morphology of ®broblasts was changed
substantially when plated on substratum coated with ®bronectin and LTBP-2 or some of its
recombinant fusion protein fragments. Fibroblastic cells cultured on full length LTBP-2 and
®bronectin exhibited less adherent morphology showing altered actin cytoskeletons, but they
formed extensive membrane ruf¯es. Unexpectedly, the actin cytoskeleton disturbing effect,
displayed by the full-length protein, was localized to the N-terminal adhesive region of LTBP-2.
Cells grown on substratum coated with this fragment were less spread when compared to both the
cells plated on ®bronectin or adhesive fragment alone. The observations suggest coordinated roles
for LTBP-2 together with ®bronectin in the regulation of cell adhesion, and have implications in
the regulation of wound healing.
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Procyanidin B-2, a Protein Kinase C (PKC) Inhibitor Possessing the Ability to Promote
Hair Growth, Modulates the PKC Isozyme Expression in Hair Epithelial Cells
T. Takahashi and A. Kamimura
Tsukuba, Japan
Procyanidin B-2 [epicatechin-(4b®8)-epicatechin] is a polyphenol compound classi®ed as a
proanthocyanidnin, which we have identi®ed in apples which acts as a hair-growing factor in the
murine model both in vitro and in vivo. Procyanidin B-2 is also known as a compound showing
selective PKC inhibition. In this study, we investigated the mechanisms of action of hair-growing
activity possessed by procyanidin B-2 focusing on its effects on PKC pathway in hair epithelial
cells. We examined whether it modulates the expression or translocation of PKC isozymes in hair
epithelial cells and whether it modulates the intracellular calcium level in hair epithelial cells. As a
result, we observed that procyanidin B-2 reduces the expression of PKC-a, -bI, -bII, and -h in
cultured murine hair epithelial cells and also inhibits the translocation of these isozymes to the
particulate fraction of hair epithelial cells. Procyanidin B-2 did not affect intracellular calcium level
in hair epithelial cells. We speculate that the hair-growing mechanisms of procyanidin B-2 are at
least partially related to its down-regulation of PKC isozymes or its inhibition of translocation of
PKC isozymes to the particulate fraction of hair epithelial cells, in addition to its selective PKC
inhibition.
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Is Desquamation Regulated by a Serine Protease Cascade?
M. Brattsand, Y. Haasum, and T. Egelrud
UmeaÊ, Sweden
We have previously puri®ed and characterized two epidermal proteases, stratum corneum
chymotryptic enzyme (SCCE), and stratum corneum tryptic enzyme (SCTE). Both enzymes,
which may be involved in desquamation and possibly also in skin in¯ammation, are produced as
zymogens which can be activated by tryptic cleavage. SCCE and SCTE may thus be part of a
proteolytic cascade with as yet unidenti®ed activating enzymes. In the present study we addressed
the question whether it was possible to produce catalytically active recombinant SCTE in amounts
suf®cient to allow a further characterization of its catalytic properties, including its potential role as
an activating enzyme for pro-SCCE. The cDNA of pro-SCTE was modi®ed in order to replace
the native activation site with an enterokinase cleavage sequence and inserted into an insect cell
expression vector. The expressed protein was puri®ed by a combination of reversed phase and
ionic exchange chromatography, and was shown to be converted to active protease by treatment
with enterokinase. The active recombinant enzyme was incubated with recombinant pro-SCCE,
and proteolytic activity was analyzed with chromogenic peptide substrates and zymography.
Protease activation in the stratum corneum may be an important regulatory mechanism of
desquamation. The results showed that recombinant SCTE could convert pro-SCCE to active
SCCE at a low but signi®cant rate. The majority of the total SCCE found in the stratum corneum
is present as pro-enzyme. This suggests that the activation of SCCE is slow under physiological
conditions. We conclude that SCTE can act as an SCCE-activator.
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Effects of Subtoxic Doses of Aldehydes and/or UV-Irradiation on Primary Human
Dermal Fibroblasts In Vitro Depend on Culture Conditions
B. Held, D. SchaÈfer,* G. Emri, K. Schremmel, C. Herbst, S. Goerdt, and C. Bayerl
Department of Dermatology, *Department of ENT, University Medical Center Mannheim, Germany
Aldehydes are ubiquitous found in the environment. Subtoxic conentrations of aldehydes are
components of cosmetics, textile ®nishers, desinfectants, tobacco smoke and chipboards affecting
skin and respiratory epithelia. Toxic effects of high doses have been demonstrated. Effects of
subtoxic aldehyde doses (below MAK-value; maximal workplace concentration: 600 mg per m3 per
8 h) and in addition to other subtoxic stresses, e.g. UV-irradiation were not tested yet. Subtoxic
concentrations of acetaldehyde, formaldehyde, and acrolein (10 mM), exposed for 8 h, with/
without UV-irradiation (15 mJ per cm2 UVB) were evaluated using primary human dermal
®broblasts under serum-free and serum-supplemented culture conditions. Expression of MIB 1,
p53, involucrin, HSP 72 and HSP 27 were examined immunocytochemically. Proliferation was
quanti®ed ¯uorometrically 24, 48, and 72 h after aldehyde-exposure using the AlamarBlue assay.
Aldehyde-induced DNA-damage was evaluated by COMET-assay. None of the aldehydes and
UV-irradiation tested induced DNA-damage or in¯uenced p53-expression. Involucrine-
expression was slightly elevated by all aldehydes. Acetaldehyde slightly up-regulated HSP 27-
and HSP 72-, and increased MIB 1- expression. Formaldehyde slightly increased HSP 27-
expression, but highly HSP 72-expression. Acroleine highly up-regulated HSP 27 and HSP 72 but
inhibited MIB 1. 24 h after coexposure to aldehydes and UV-irradiation formaldehyde induced a
higher proliferation rate than acetaldehyde under serum-free conditions, which was opposite under
serum-supplemented conditions. Up to 72 h after coexposure to aldehydes and UV-irradiation
proliferation was reduced under serum-free but elevated under serum-supplemented conditions,
compared to controls. A subtoxic concentration of aldehydes had evident effects on cultured cells.
Co-exposure to aldehydes and UV-irradiation reduced viability of cells in culture. Effects of
aldehydes on protein-expression and proliferation depended on culture conditions used. Optimised
cell culture conditions are essential for the evaluation of subtoxic aldehyde effects and will be used
for the investigation of mediator synthesis, e.g. cytokines and prostanoids.
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Human Dermal Fibroblasts Escape from the Long-Term Phenocopy of Senescence
Induced by Psoralen Photoactivation
W. Ma, M. Wlaschek, P. Brenneisen, L. Schneider, C. Hommel, C. Hellweg, H. Sauer, M.
Wartenberg, G. Herrmann, and K. Scharffetter-Kochanek
University of Cologne, Cologne, Germany
We have previously shown that following psoralen photoactivation (PUVA treatment) human
dermal ®broblasts undergo long-term growth arrest as well as morphological and functional
changes reminiscent of cellular senescence. In the absence of molecular data what constitutes
normal senescence, it has been dif®cult to decide whether these PUVA-induced changes re¯ect
cellular senescence or rather a mimic thereof. We herein report that PUVA-induced growth arrest,
the senescent phenotype and the long-term induction of senescence-associated aÃ-galactosidase and
matrix-metalloprotease-1 (MMP-1) are fully reversible at days 100±130 post PUVA treatment in
four independently tested ®broblast strains. The late returning growth capacity in PUVA-treated
®broblasts is neither due to transformation nor immortalization as shown by anchorage dependent
growth, unchanged telomerase activity, accelerated telomere shortening with increasing
cumulative population doublings, and a decrease in overall growth rates (cumulative population
doublings) in ®broblasts in their regrowing phase post PUVA treatment. We, furthermore, provide
evidence that PUVA-treated ®broblasts retain a memory of the preceding PUVA damage as in
their regrowing state they reached the stationary phase of replicative senescence at a much lower
cumulative population doubling compared to mock-treated control ®broblasts of the same strain.
Oxidative telomere shortening may be involved as a stress sensor responsible for damage recording
and limited population dynamics. Collectively, our data suggest that PUVA-induced changes do
not fully re¯ect replicative senescence but rather represent a long-term transient phenocopy
thereof. The herein reported model is particularly suited to elucidate mechanisms underlying the
long-term transient growth arrest and related functional changes.
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Blockade of Advanced Glycation End-Products (AGEs)-Receptor for AGEs (RAGE)
Interaction Suppress Human Melanoma Cell Growth
R. Abe, T. Shimizu, H. Watanabe, H. Chowei,* N. Sasaki,* M. Takeuchi,² Z. Makita,³ and H.
Shimizu
Department of Dermatology, Hokkaido University School of Medicine, *Department of Neuropsychiatry,
Sapporo Medical University, ²Faculty of Pharmaceutical Science, Hokuriku University, ³Department of
Medicine, Kurume University School of Medicine
Previous immunological demonstration of AGE in several human tissues suggests that AGE may be
involved in aging processes, diabetic complications, and atherosclerosis. In addition, the receptor
for advanced glycation end products (RAGE), one of the receptors for AGEs, has been reported to
interact with distinct molecules implicated in homeostasis, development and in¯ammation.
Recently it was reported that RAGE regulates the invasiveness, growth, and movement of
malignant cells, required for malignancy. In order to investigative the role of AGEs-RAGE in
human melanoma, we examined the cell growth effect of AGEs (AGE1-5, CML: carbox-
ymethyllysine) and RAGE in melanoma cells. AGE1±5were able to up-regulate the proliferation
rate of G361 cells, human melanoma cell line, dose-dependently. We also demonstrated that the
cell proliferation rates of G361 cells were inhibited by anti-RAGE Ab treatment compared to
nonimmune IgG treatment of control cells. Immunohistochemical analysis with these antibodies
revealed that a strong staining for AGE1-5 and RAGE in melanoma cells. Our results indicate that
both AGEs immunoreactivity is highly positive and RAGE is expressed in the human melanoma
cells and that AGEs/RAGE interactions promote melanoma cell proliferation in vitro. This work
opens the way to develop new strategies using modulate AGE±AGE receptor interactions to treat
malignant tumors.
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Ascorbate and a-Tocopherol Decrease in Human Skin During Aging
M. Podda, M. Grundmann-Kollmann, H. Beschmann, J. Fuchs, T.M. Zollner, and R. Kaufmann
Frankfurt, Germany
Despite increasing evidence that reactive oxygen species play a role in aging, photoaging, and aging
associated skin diseases, data about the antioxidant capacity of skin during the aging process are
very scarce. For human studies this may be partially due to technical dif®culties in measuring low
molecular weight antioxidants in skin. We established a re®ned methodology for the measurement
of low molecular weight antioxidants, which allowed us to look for potential changes in ascorbate,
a-tocopherol and urate skin concentrations during aging. Furthermore, to account for inherent
differences in skin layers which re¯ect predominantly exogenously exposed and nonexposed skin,
frozen skin biopsy punches were horizontally dissected into an upper layer of 1.5 mm and a lower
one of 1.5 mm thickness. We found a signi®cant difference between the amount of ascorbate and
a-tocopherol present in the upper 1.5 mm skin (epidermis and upper dermis) compared to the
lower dermal compartment (lower dermis and parts of subcutis). Ascorbate was seven folds higher
in the upper 1.5 mm whereas a-tocopherol had a 6 fold higher concentration in the lower 1.5 mm
skin. Ascorbate showed a signi®cant decrease with increasing age in the upper 1.5 mm (p < 0.05)
and a-tocopherol concentration decreased with increasing age in both compartments (p < 0.01 and
p < 0.05), while urate did not show any correlation with age. A decrease of antioxidants has been
described in other organs in humans. The data reported in this study indicate that there is a
signi®cant decrease of two major small molecular weight antioxidants in human skin during the
aging process. Hence, it seems reasonable to suggest a higher dietary intake of fruits and vegetables
for older people as one possibility to increase ascorbate and a-tocopherol levels.
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Induction of SSP3502 by Sodium Lauryl Sulfate in Human Skin: an Early Marker for
Skin Irritation?
L. Ingeborg,A. Boxman, P.J. Hensbergen, R.C. van der Schors,* D.P. Bruynzeel,² C.P. Tensen,
and M. Ponec
Department of Dermatol. LUMC, Leiden, the Netherlands; *Department of Mol. Cell. Neurobiol., VU,
Amsterdam, the Netherlands; ²Department of Dermatol., VUMC, Amsterdam, the Netherlands
To evaluate the potential toxic hazard for human skin, individual compounds as well as end
products are being screened extensively, mainly focusing on acute skin toxicity. Using proteomics,
the aim of the present study was a search for markers of which the expression changes after mild
irritation. For this, sodium lauryl sulfate (SLS) was applied topically on excised human skin.
Epidermal proteins were isolated from SLS-treated skin specimens hardly showing any
morphological changes. Subsequently, the proteins were analysed by 2 dimensional polyacrylamide
gel electrophoresis (2D-PAGE) and proteins that signi®cantly increased or decreased after SLS-
treatment in a dose-dependent way were characterised by mass spectrometry. We identi®ed 7
proteins as potentially new epidermal markers for skin irritation. Among these 7 proteins, SSP3502
was recognized as the most prominently up-regulated protein in all four experiments. Using an
antibody raised to SSP3502, a strong staining was seen in the SLS-treated skin, whereas in the
vehicle controls only weak staining was observed. Moreover, staining was also observed after
topical application of SLS in vivo on skin of healthy volunteers. SSP3502 may therefore be used as
an early marker of skin irritation and eventually as a novel tool in the clinic allowing testing the
sensitivity of patients for a panel of irritants.
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HSP70-Rich Yeast Extract Offers a New Approach to Skin Care and Treatment
J.M. Botto, K. Cucumel, E. Bauza, C. Dal Farra, and N. Domloge
Biochemistry and Dermatology Departments, Seporga, Sophia Antipolis, France
Scienti®c data have shown that stress induction of Heat Shock Proteins (Hsp), the widely expressed
chaperons, helps cell survival and tolerance to stress. Here we bring evidence that providing the cell
with Yeast-Hsp extract, in a stress free manner, gives higher protection to the cell and improves its
defense against different stresses. An extract rich with yeast-induced Hsp70 and heat shock factor
(which regulates Hsp expression) was prepared by Biotechnology and administered to the cells in
these studies. Dose studies were conducted on human ®broblasts during various points over time.
Total protein extract as well as total RNA were prepared. Hsp70 expression was examined by
immunoblotting. In parallel, Hsp70 mRNA level was studied in Northern blot experiments.
Immunoblotting studies demonstrated that ®broblasts treated with the yeast extract-Hsp show a
very rapid increase (within 30 min) in their Hsp70 content. The Northern blot experiments
revealed a transient and reproducible Hsp70 mRNA expression increase 3±5 h after the incubation
with the yeast extract. Supported by the great sequence homology of 70% to 85% with human
Hsp, our result suggests that the early increase in Hsp is due to yeast Hsp. Additional studies
showed that cells treated with yeast Hsp demonstrate no sign of cell stress and a signi®cant
immediate increase in their thermal and UV tolerance. Moreover, this bene®cial effect was
con®rmed by studies on ex vivo skin. These interesting results provide the ®rst evidence that Hsp70
extract stress-free administration to the cells enhances their protection and defense from stress.
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Glucocorticoids Induced the Production and Gene Expression of IL-1?l through NF-eÃbb
and AP-1 Activation in Murine Epidermal Cells
S. Awad, H. Yokozeki, Y. Miyazaki, K. Igawa, K. Minatohara, T. Satoh, and K. Nishioka
Department of Dermatology and Immunodermatology, Graduate School, Tokyo Medical and Dental
University, Tokyo, Japan
To investigate the mechanism of the glucocorticoids (GC)-induced augmentation of skin response,
we have recently reported the modulatory effect of GC on the regulation of cytokines produced by
keratinocytes stimulated with various chemicals in vitro (Miyazaki Y et al. JID 115; 746±753, 2000).
In that report, we demonstrated that a low concentration of GC augments both NF-eÃBB and AP-1
activity in the hapten-stimulated Pam 212 cells (Keratinocyte cell line). To clarify the mechanism
of the GC-induced augmentation of cytokine production, we examined the modulatory effect of
GC on keratinocytes without any stimulation. 10±4 M GC inhibited the production of IL-1? from
Pam 212 cells; however, 10-8-10-10 M GC signi®cantly enhanced the production of IL-1?M by
Pam cells at both the protein and mRNA levels. In contrast, GC had no or non signi®cant effect
on the production of either TNF-?t, IL-6, IL-10, or GM-CSF by Pam 212 cells incubated for 6 h.
Electrophoretic mobility shift assay (EMSA) revealed that 10-10-10-12 M GC induced the NF-eÃBB
activation in Pam 212 cells, while 10-8-10-10 M augmented the AP-1 signal. Furthermore,
pyrrolidinedithiocarbamate (PDTC) partially inhibited the IL-1?F production and completely
inhibited NF-eÃBB activation by Pam 212 cells. On the other hand, MAP-Kinase inhibitors
(PD98059 or SB202190) abrogated both the low concentration of GC-induced IL-1?o production
and AP-1 activation. These data indicated that the low concentrations of glucocorticoids can
induce the augmentation of IL-1?T production from nonstimulated keratinocytes mediated mainly
through AP-1 pathway and partially through NF-eÃBB.
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Corticotropin Releasing Hormone Receptor mRNA Levels are Regulated by
Testosterone, 17b-Estradiol and Growth Hormone in Human Sebocytes
M. Young, H. Seltmann, N. Hiroi, S.R. Bornstein, and C. Zouboulis
Berlin and DuÈsseldorf, Germany and Bethesda, USA
Hypothalamic-pituitary-adrenal (HPA) axis equivalent pathway has been proposed to function in
mammalian skin in response to dyshomeostatic stimuli. Sebaceous glands seem to be involved in
this type of response as they express receptors for a-melanocyte-stimulating hormone (a-MSH),
vasoactive intestinal polypeptide, neuropeptide Y, and calcitonin gene-related peptide (CGRP). a-
MSH and CGRP are not produced by human sebocytes but regulate their cytokine synthesis in a
paracrine manner. Moreover, steroid hormones exhibit a dinstinct action on genes related to
immune and neuroendocrine regulation. Because corticotropin releasing hormone (CRH) is the
most proximal element of the HPA axis we investigated the mRNA levels of CRH and CRH
receptors (CRH-Rs) in SZ95 sebocytes and their regulation by several hormones using TaqMan
RT-PCR. CRH mRNA was neither expressed nor induced by the hormones tested. In contrast,
CRH-R1 and CRH-R2 mRNA were detectable in SZ95 sebocytes at similar levels after 6 h in
serum-free culture. CRH-R1 levels signi®cantly increased at 24 h (CRH-R1/CRH-R2 = 2). 17b-
Estradiol stimulated CRH-R1 mRNA levels at 6 h, whereas testosterone at a high concentration
(10±7 M) annulled CRH-R1 and CRH-R2 mRNA expression at 24 h. Growth hormone (10±7 M)
annulled CRH-R1 and increased CRH-R2 mRNA levels at 24 h. Dehydroepiandrosterone and
insulin growth factor-1 barely in¯uenced CRH-R mRNA levels. All hormones tested did not
regulate intrinsic SZ95 sebocyte necrosis. In conclusion, CRH-Rs but not CRH mRNA were
detected, indicating that CRH is also a paracrine hormone for human sebocytes. CRH-R1 is the
slightly predominant type. The low CRH-R1 mRNA levels in testosterone-treated sebocytes
correlate with those found in telogen hair follicles and the high levels in 17b-estrogen-treated
sebocytes with those detected in anagen follicles. The switch of predominant CRH-R1 mRNA
expression to a sole CRH-R2 expression by growth hormone indicates a possible switch of ligands;
growth hormone may facilitate CRH-R binding of sauvagine- and urotensin I-like molecules,
instead of CRH. Therefore, CRH-Rs are likely to be involved in sebaceous gland response to
dyshomeostatic stimuli and this response may be regulated by several hormones.
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Sebocytes are the Key Regulators of Androgen Homeostasis in Human Skin
M. Fritsch, C.E. Orfanos, and C. Zouboulis
Berlin, Germany
The mRNA expression patterns of androgen receptor and androgen metabolizing enzymes 3b-
hydroxysteroid dehydrogenase/D5±4-isomerase (D5±3b-HSD), 17b-hydroxysteroid dehydrogenase
(17b-HSD), 5a-reductase and 3a-hydroxysteroid dehydrogenase (3a-HSD) were investigated in
three different cell populations, SZ95 sebocytes, HaCaT keratinocytes and MeWo melanoma cells
by means of RT-PCR. Restriction analysis of cDNA fragments was performed to identify
isozymes of D5±3b-HSD and 3a-HSD. In addition, 3H-dihydroepiandrosterone and 3H-testoste-
rone were used as substrates to determine the metabolic activity of these enzymes in SZ95
sebocytes, primary sebocyte cultures and HaCaT keratinocytes. Furthermore, the effects of the
selective 5a-reductase type 1 and 2 inhibitors, MK386 and dihydro®nasteride, respectively, and of
the D5±3b-HSD inhibitor cyproterone acetate on androgen metabolism were investigated.
Androgen receptor mRNA was detected in SZ95 sebocytes and HaCaT keratinocytes but not in
MeWo melanoma cells, whereas D5±3b-HSD isotype 1 mRNA and metabolic activity were only
found in SZ95 sebocytes. The enzyme activity could be inhibited by cyproterone acetate. Type 2
17b-HSD, type 1 5a-reductase and 3a-HSD mRNA were expressed in all three cell populations
tested, while type 3 17b-HSD mRNA could only be detected in SZ95 sebocytes. The major
metabolic steps of testosterone in SZ95 sebocytes, primary sebocyte cultures and HaCaT
keratinocytes were its conversion to androstenedione by 17b-HSD and further to 5a-androstane-
dione by 5a-reductase. The type 1 5a-reductase selective inhibitor MK386, but not the type 2
selective inhibitor dihydro®nasteride, inhibited 5a-reductase at low concentrations in SZ95
sebocytes and HaCaT keratinocytes. 5a-Androstanedione was degraded to androsterone by 3a-
HSD which exhibited a stronger activity in HaCaT keratinocytes than in SZ95 sebocytes and in
primary sebocyte cultures. Lower levels of 5a-dihydrotestosterone and 5a-androstanediol were
also detected in all cells tested. In conclusion, speci®c enzyme expression and activity in sebo-cytes
and keratinocytes seem to allocate different duties to these cells in vitro: Sebocytes are able to
synthesize testosterone from adrenal precursors and to inactivate it in order to maintain androgen
homeostasis, while keratinocytes are rather responsible for androgen degradation.
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Ethanol Stimulates the Proliferation of HaCaT Keratinocytes.The Possible Role of
Alcohol in Exacerbating Psoriasis
AÂ . Farkas, L. KemeÂny, M. SzeÂll, Z.S. Bata-CsoÈrgoÄ, and A. Dobozy
Szeged, Hungary
Alcohol abuse can precipitate the hyperproliferative skin disease psoriasis vulgaris. The mechanism
by which alcohol affects this disease is still elusive. Previously we found that acetone, which
exceeds its normal endogenous level in the blood of heavy drinkers, up-regulated the a5 integrin
mRNA levels and induced the proliferation of HaCaT cells. In the present study we examined
how ethanol affects the proliferation, the IL-8 mRNA production and the mRNA levels of genes
characteristic for proliferating keratinocytes such as a5 integrin, keratinocyte growth factor
receptor and cyclin D1 of HaCaT cells, a commonly used model to study psoriatic keratinocytes.
HaCaT keratinocytes were incubated for 72 h in the presence of different ethanol concentrations
(2.1375 mM±1.71 mM) and the number of viable cells was determined by the MTT assay. After
HaCaT cells were treated with 4275 mM ethanol concentration the expression of IL-8, a5 integrin,
keratinocyte growth factor receptor and cyclin D1 genes was studied by semiquantitative RT-
PCR at different time points (0.5 h, 3 h, 6 h). Band intensities of RT-PCR products were
quanti®ed by densitometric scanning and values were normalized against the b-actin housekeeping
gene. Our data showed that ethanol induced the proliferating potential of HaCaT cells (maximum
increase was observed at 4275 mM ethanol concentration) and at all time points a5 integrin,
keratinocyte growth factor receptor and cyclin D1 mRNA levels were higher compared to the
controls, wheras ethanol did not alter the IL-8 production of HaCaT cells. Our present results
suggest that ethanol enhances the proliferation of HaCaT cells and also the expression of different
genes supposed to be involved in the pathogenesis of psoriasis. This stimulatory effect of ethanol on
human keratinocytes may be one of the reasons why psoriasis can be precipitated by alcohol
misuse.
120
Phototoxicity to Diuretics and Antidiabetics in the Cultured Keratinocyte Cell Line
HaCaT. Evaluation by Clonogenic Assay and Single Cell Gel Electrophoresis (Comet
Assay)
E. Selvaag, A.B. Petersen, R. Gniadecki, T. Thorn, and H.C. Wulf
Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Denmark
The oral antidiabetics tolbutamide, glibenclamide, and glipizide, and the diuretics bendro-
¯umethiazide, butizide, furosemide, hydrochlorothiazide, and trichlormethiazide were investigated
for their potential to cause phototoxicity in the HaCaT cell line. The cells were incubated with
different concentrations of the drugs and then exposed to UVA1 irradiation. Cell survival was
evaluated in a clonogenic assay and phototoxic DNA damage was investigated by the single cell gel
elctrophoresis (comet assay). The effects of the antioxidants L-ascorbic acid, and a-tocopherol on
oxidative DNA damage were also assessed. Bendro¯umethiazide, furosemide, hydrochlorothiazide,
trichlormethiazide, or tolbutamide induced dose-dependent phototoxicity in the clonogenic assay.
Cells incubated with bendro¯umethiazide, tolbutamide, and glibenclamide, and irradiated with
UVA1 demonstrated an increased oxidative DNA damage revealed as alkali-labile sites in the
comet assay. Pre-treatment with L-ascorbic acid, or a-tocopherol, suppressed the UVA-induced
DNA damage in cells incubated with 1 mM of bendro¯umethiazide, furosemide, glibenclamide,
glipizide, tolbutamide, and trichloromethiazide, further implying the involvement of reactive
oxygen species in the phototoxic DNA damage. These results indicate a link between phototoxic
and photocancerogenic potential of the sulfonamide-derived oral antidiabetic and diuretic drugs, as
it has previously been recognized for psoralen, chlorpromazine, and ¯uoroquinolones. Excessive
exposure to UV light may be deleterious for patients treated with oral antidiabetic and diuretic
drugs.
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Stimulation of Water Flux and Epidermal Differentiation on Reconstructed Human
Epidermis by an Ajuga Turkestanica Extract
M. Dumas, C. Gondran, P. Barre, R. Joly, R. Sougrat,* J.M. Verbavatz,* and F. BonteÂ
L.V.M.H. R., and D. Branche Parfums et CosmeÂtiques, Saint-Jean-de-Braye and Service de Biologie
Cellulaire, CEA/Saclay, Gif-sur-Yvette, France
Aquaporin belongs to a family of water channel proteins involved in water and solute transport
particularly in epithelial cells. Epidermis is a strati®ed and keratinized epithelium, and forms the
primary barrier to body water loss. The purpose of this work was to examine the effect of an Ajuga
turkestanica extract (AT), enriched in iridoids and turkesterone, both on aquaporin mediated water
¯ux and differentiation process of the reconstructed human epidermis (RHE). Using a polyclonal
antiaquaporin 3 antibody, Western blot on human epidermis and immuno¯uorescence on isolated
human skin cross section demonstrated the presence of aquaporin 3. This aquaporin was located at
the keratinocyte plasma membrane. Functionality of water channel was also examined (n = 3) on
native stripped and 3 weeks RHE. Osmotically induced water ¯ux (150 mOsm) were
comparable, > 50% inhibited by 1 mM HgCl2, a known inhibitor of aquaporin, and fully stopped
by acidic pH, pointing out the major role of aquaporins in epidermal water movement. Measurable
spontaneous water ¯ux were also present in stripped native skin and RHE. After 17 days RHE
treatment at a ®nal concentration of 2.5 mg per mL, AT signi®cantly increased these water ¯ux
compared to nontreated controls (0.12 6 0.03 vs. ±0.015 6 0.048 mL per min per cm2).
Interestingly, treated RHE exhibited a more developed horny layer. Electron microscopy
revealed more well differentiated desmosomes, sticker corni®ed envelope and thinner corneocytes
with narrow intercellular spaces and more numerous corneodesmosome structures, compacted and
well-oriented keratin network connected to desmosomal plaques. AT appears to be a good
candidate for the regulation of skin hydration by stimulating spontaneous water ¯ux, terminal
differentiation and cohesion of human epidermis.
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PermacolTM as a Possible Dermal Substitute for Full Thickness Wounds
J.E. Stewart and S.M. Morley
University of Dundee, UK
The suitability of PermacolTM as a biocompatible dermal graft to aid the healing of full thickness
wounds has been investigated both in vivo and in vitro. PermacolTM is an acellular porcine-derived
dermal collagen implant (CE class III), used clinically for permanent tissue repair. Unlike other
collagen implants, it retains it's native ®brous dermal collagen structure, and has been cross-linked
to stabilise against enzymatic digestion in vivo using hexamethyl- diisocyanate (HMDI). For the in
vivo study, 0.35 mm thick PermacolTM sheet was grafted into 1 cm2 full thickness surgical wounds
created on the backs of male PVG rats. Wounds were covered with nonadhesive semiocclusive
dressing (Opsite), bandaged for up to 21 days and allowed to heal. Care was taken not to allow
PermacolTM to dry out at any time. Wounds were inspected, photographed and biopsied at 14 and
28 days, and 3 months postgrafting. Upon inspection, grafts had retained their original proportions,
with little or no wound contraction. No overt signs of localised in¯ammatory reaction were seen.
By 14 days, grafts were beginning to integrate into the surrounding tissue, and by 28 days they had
become fully re-epithelialised. Histological analysis showed complete integration of grafts at this
stage, with recellularisation by dermal ®broblasts, and attachment of normal strati®ed epidermis.
For the in vitro study, the ability of PermacolTM to form a three-dimensional skin equivalent has
been investigated. For this purpose, PermacolTM pieces were seeded with human dermal ®broblasts
and primary epidermal keratinocytes and maintained in culture for up to 28 days. Cultures were
®xed for analysis by histology, immunohistochemistry and elecrton microscopy. Results so far have
demonstrated proliferation of ®broblasts to con¯uence, attachment of keratinocytes and de novo
expression of basement membrane components in these cultures. We believe that PermacolTM has
potential as a biocompatible dermal implant to aid the healing of problematic full thickness
wounds, either in its original form or more likely as a modifed form speci®cally for this purpose.
Clinical studies to con®rm this are currently being conducted.
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Altered Keratin 16 Gene Expression in Acute and Chronic Wounds Involves the
Transcription Factor NF-IL6
G.K. Patel,*² I.A. McKay,³ A.Y. Finlay,* K.G. Harding,² and P.E. Bowden*
*Department of Dermatology; ²Wound Healing Research Unit, UWCM, Cardiff; ³UK and Centre for
Cutaneous Research, QMWC, London, UK
Acute and chronic wounds are characterised by altered keratin expression involving up-regulation
of inducible keratins (K6, K16 and K17). These keratins are also induced in other
hyperproliferative states, absent in normal epidermis and constitutively expressed in skin
appendages (hair follicle, sebaceous gland, and sweat gland). Their transcriptional regulation in
terms of tissue-speci®c gene regulation in not fully understood. In studies examining various
transcription factors in normal and diseased epidermis (psoriasis, genodermatoses and wound
healing), we have found that NF-IL6 is intimately connected with K16 but not K17 gene
expression. We have examined the control of K16 and K17 expression in vivo and ®nd that
translocation of NFIL-6 to the nucleus of suprabasal cells is coincident with cytoplasmic K16
expression but not K17 expression. Frozen skin biopsies from 10 patients with chronic venous leg
ulceration (VLU), psoriatic patients (4) and normal controls (4) were cryostat sectioned and treated
with antibodies to K16 or K17 alone, or together with NFIL-6. They were visualised with
streptavidin-FITC or antibody conjugated Texas Red. Sections were examined by ¯uorescence
photomicroscopy and confocal microscopy. Control sections with no primary antisera were
prepared and some sections were incubated with propidium iodide (nuclear speci®c stain). NFIL-6
was cytoplasmic in basal cells, nuclear in suprabasal cells and absent from upper granular cells.
Nuclear NFIL-6 was present in mid-epidermis of normal skin but dramatically increased in
epidermal suprabasal cells at the edge and at the periphery of acute and chronic wounds. Nuclear
translocation of NFIL-6 was always accompanied by K16 expression in wounded but not in
normal epidermis and was independent of K17 expression. Thus, NFIL-6 is necessary but not
suf®cient for induction of K16 gene expression and unlikely to be involved in K17 expression.
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Keratin Expression in Reconstituted Human Skin is Markedly Affected by Retinoids
Acting via the Retinoic Acid Receptor a
M. Virtanen, H. ToÈrmaÈ, O. Rollman, A. SirsjoÈ,* and A. Vahlquist
*Uppsala and Stockholm, Sweden
Retinoids are used therapeutically in keratinizing disorders but their in¯uence on epidermal keratin
expression is poorly understood. In vivo, suprabasal keratinocytes normally express K1, K2e and
K10, whereas cultured cells also express K4 and K13 which are present in mucous epithelia or
appear in the granular layer after topical application of retinoic acid (RA) to normal skin. To learn
more about the retinoid-regulation of keratin expression under in vivo-like conditions, we studied
human keratinocytes grown on de-epidermized dermis in 0.5% serum which produced a normal-
looking epidermis that expressed high amounts of K1, K2e and K10 mRNA by real-time PCR,
but only minimal amounts of K4 and K13. Addition of RA to the medium for 48 h caused dose-
dependent increase in K4/K13 and down-regulation of K2e mRNA. By studying 10 retinoid
agonists with different af®nities for the RAR and RXR isoforms, the reciprocal effects on K2e and
K4/K13 could be connected to the RARa agonists. One of these agonists, Am580, caused a
concerted up-regulation of K4/K13 and down-regulation of K2e that was apparent already 8 h
after drug addition and that was 10±100 fold already at 10±8 M of the retinoid. The effects on K4
and K13 were markedly inhibited by coaddition of a panRAR antagonist (AGN193109), whereas
the down-regulation of K2e was less affected. In conclusion, RARa agonists modulate keratin
expression, which may be involved in the mechanism of action of retinoids in epidermal diseases.
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The Tape Stripping of Human Skin: An Approach for Studying Human Epidermal
Gene Expression Using Real Time Quantitative RT-PCR
K. Lazou, M. Bonnet-Duquennoy, L. CrabbeÂ, P. AndreÂ, P. Perrier, and R. KurfuÈrst
LVMH Branche Parfums et CosmeÂtiques, Laboratoires R&D, St Jean de Braye, France
Biopsies are used for gene expression studies of human skin. Biopsies are invasive and request an
ethical approval from an ethics committee. The technique of tape stripping has been reported for
studying damaged skin. The purpose of this work was to evaluate an alternative approach to skin
biopsies for investigating gene expression of healthy volunteers' epidermis using the tape stripping
approach. Firstly, we carried out two series of stripping on the volar forearm skin: 20 strips and
after 72 h, 8 strips, in order to collect cells containing a nucleus. Secondly, total RNA extraction
was conducted using cells obtained with stripping after 72 h. Finally, after a non speci®c reverse
transcription, a real time quantitative PCR (LightCycler, Roche) was performed on the 26S
ribosomal protein cDNA. We were able to detect the sequence for the 26S ribosomal protein
indicating that the tape stripping technique could be a noninvasive alternative method for isolating
epidermal cells and for studying gene expression at the epidermis level.
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The Catalog of Human Hair Keratins. Expression of the Six Type II Members in the
Hair Follicle and the Complete Catalog of Human Hair Keratins
L. Langbein, M.A. Rogers,* H. Winter,* S. Praetzel, and J. Schweizer*
Division of Cell Biology, *Division of Tumor Cell Regulation, German Cancer Research Center, Im
Neuenheimer Feld 280, D-69120 Heidelberg, Germany
The human type II hair keratin subfamily consists of six individual members which can be divided
into two groups. Group A members hHb1, hHb3, and hHb6 are structurally related, while group
C members hHb2, hHb4, and hHb5 are rather distinct. Speci®c antisera against the individual hair
keratins were used to establish the two-dimensional catalog of human type II hair keratins. In this
catalog, hHb5 showed up as a series of isoelectric variants, well separated from a lower, more acidic
and complex protein streak containing isoelectric variants of hair keratins hHb1, hHb2, hHb3 and
hHb6. Both in situ hybridization and immunohistochemistry on anagen hair follicles showed that
hHb5 and hHb2 de®ned early stages of hair differentiation in the matrix (hHb5) and cuticle (hHb5,
hHb2), respectively. While cuticular differentiation proceeded without expression of further type
II hair keratins, cortex cells simultaneously expressed hHb1, hHb3, and hHb6 at an advanced stage
of differentiation. In contrast, hHb4, undetectable in hair follicle extracts and sections, could be
identi®ed as the largest and most alkaline member of this subfamily in cytoskeletal extracts of dorsal
tongue. This hair keratin was localized in the posterior compartment of the tongue ®liform
papillae. Comparative analysis of type II with the previously published type I hair keratin
expression pro®les suggested speci®c, but more likely, also random keratin pairing principles
during trichocyte differentiation. Finally, by combining the type I and II hair keratin catalogs with
that of cytokeratins, we present the complete catalog of presently known human hair-/
cytokeratins.
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Identi®cation of Epidermal Stem Cells with a Combination of Flow Cytometry, Cell
Culture and Image Processing
M.M. van Rossum, W.A.H. CloõÈn, M.E.J. Franssen, P.C.M. van de Kerkhof, and P.E.J. van Erp
Department of Dermatology, University Medical Centre St. Radboud, Nijmegen, the Netherlands
Epidermal keratinocytes can cell kinetically be distinguished into three categories with different
functional and morphological characteristics. Stem cells (strong expression of b1-integrin) that have
an unlimited clonal potential, transient amplifying cells (weak expression of b1-integrin) with a
limited number of cell divisions and terminally differentiated cells (no expression of b1-integrin)
that lost the ability to divide. Our ®nal objective was to de®ne these different epidermal
subpopulations on the basis of their phenotype and clonal potential. In this investigation, a ¯ow
cytometric assessment and cell culture experiments were optimised for selecting potential stem
cells. At ®rst we determined which method was optimal to obtain single cell suspensions. With that
method we sorted ¯ow cytometrically three subpopulations: cells that were negative, weakly
positive (dim cells) and strongly positive (bright cells) for b1-integrin expression. Subsequently, the
clonal potential of these three subpopulations was investigated in cell culture experiments. In order
to visualise colonies earlier, ¯uorescent DNA dyes were added. Image processing was used to
detect ¯uorescent colonies and record growth characteristics. Incubation in 0.25% trypsin solution
overnight was the optimal method to obtain single cell suspensions, which were minimally
damaged and retained their clonal potential. From the celI suspensions that were prepared with this
method, only the b1-integrin-dim and -bright cells had the ability to form substantial numbers of
colonies. In the latter subpopulation more colonies were formed than in the ®rst one. By means of
the use of ¯uorescent DNA dyes, it was possible to visualise colonies at an early stadium. However,
it turned out that keratinocytes could not stand up to the required concentrations of some of the
dyes. By linking the area of the colony to the number of cells in that colony, it was possible to
determine growth rates of the cells. In conclusion, after ¯ow cytometric sorting with an optimised
protocol, we were able to demonstrate that colonies were formed in the b1-integrin-dim and ±
bright subpopulation. These colonies could be visualised early with the use of ¯uorescent dyes.
The use of image processing allowed early detection of colonies and determination of growth rates.
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Fas/fas Ligand Pathway Involved in Arsenic-Induced Apoptosis in Cultured
Keratinocytes
H.S. Yu, W.T. Liao, and K.L. Chang
Kaohsiung, Taiwan
Epidermiological studies demonstrated that long-term exposure to arsenic induces arsenical skin
cancers, including Bowen's disease. Histologically, it shows proliferating and apoptotic
characteristics at Bowen's disease lesion. To investigate how arsenic induces cellular apoptotic
death, we exposed cultured human foreskin keratinocytes to different concentrations of sodium
arsenite for 48 h, the expression of apoptotic proteins and receptors were detected by Western
blotting and ¯ow cytometry. Arsenic enhanced keratinocytes proliferation at low concentrations,
however, apoptosis was induced at high concentrations (?5 mM). Arsenic enhanced p53 expression
and arrested keratinocytes cell cycle at G0/G1 phase. The level of apoptotic protein Bax was
increased in a Bcl-2 down regulated manner when keratinocytes were exposed to arsenic. The
expression of several apoptosis related receptors were then detected, we found cell membrane Fas
and Fas ligand (FasL) increased through arsenic treatment. Increased expressions of Fas related
proteins such as FADD were observed. Caspase cascade was also activated as evidenced by
increased caspase 3 and 8. Our results suggest that Fas/FasL pathway is involved in arsenic induced
apoptosis in cultured keratinocytes.
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Anti-Apoptotic Mechanisms in UV-Mediated Apoptosis: Cross-Class Inhibition of the
Lysosomal Cystein Proteinase Cathepsin L by the Novel Ov-Serpin Hurpin (PI13)
H.F. Abts, T. Welss, J. Sun,* J.A. Irving,* R.N. Pike,* P.I. Bird,* and T. Ruzicka
Department of Dermatology Heinrich-Heine University, DuÈsseldorf, Germany; *Department of Biochemistry
and Molecular Biology, Monash University, Melbourne, Australia
The novel serine proteinase inhibitor hurpin (proteinase inhibitor 13, PI13) has been linked to
differentiation and apoptosis in human keratinocytes due to its repression after UV-irradiation and
over expression in psoriatic skin lesions. Despite the fact that hurpin is a typical ovalbumin serpin
with a hinge region that implicates an inhibitory capacity, a cognate target serine proteinase has yet
not been identi®ed. In order to determine the inhibitory capacity of hurpin we have expressed the
recombinant histidine-tagged hurpin protein (rHP) in yeast and puri®ed by metal chelat af®nity-
and subsequently ion exchange- chromatography. The yeast protein shows the serpin typcial
transition from the stressed to the relaxed form as analyzed by transversal urea gradient gel (TUG)
analysis. Until now, no inhibitory capacity of the rHP could be demonstrated for a variety of serine
proteinases. In contrast the rHP was identi®ed as a potent cross-class inhibitor of the archetypal
lysosomal cysteine proteinase cathepsin L (CatL). rHP demonstrates a concentration dependent
inhibition of CatL with a kass of 3.80 3 105 M±1 s±1. This rate constant implicates that hurpin is able
to inhibit CatL at physiological concentrations. Also the leakage of cathepsins due to stress induced
dysruption of lysosoms has been reported. Moreover lysosomal cathepsins are capable of activating
executors of apotosis like caspase 3. The inhibition of CatL by hurpin is therefore further
supporting the hypothesis of hurpin as an antiapoptotic protein and gives an example for possible
physiological functions of serpins in the skin.
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Development of a High-Throughput Model for Screening of Anti Psoriatic Drugs Using
Expression of Green Fluorescent Protein Under The SKALP/Ela®n Promoter
A. Pol and J. Schalkwijk
Nijmegen, the Netherlands
Psoriasis is a common skin disease in which the cutaneous lesions are characterised by benign
epidermal hyperplasia, abnormal differentiation, in¯ammation, and changes in the dermal
vasculature. It is very likely that a combination of immunological predisposition (autoimmunity,
superantigen stimulation) and keratinocyte abnormalities is key to the disease mechanism. It has
been postulated that epidermal keratinocytes are actively involved in the pathogenesis of psoriasis.
These cells form a signalling interface between the external and internal milieu by secreting
cytokines and growth factors that act on in¯ammatory cells, and alter keratinocyte growth in a
paracrine-autocrine manner. Keratinocytes of the psoriatic lesion are hyperproliferative and display
an abnormal differentiation program characterised by the induction of genes that are not expressed
by keratinocytes in normal skin such as the cytokeratins CK6, CK16, CK17 and the proteinase
inhibitor SKALP otherwise known as ela®n. Expression of these genes can be used as surrogate
markers for psoriasis or other disorders with abnormalities in epidermal differentiation, in drug
screening procedures of large compound libraries. A high-throughput screening model was
developed for detection of pharmacologically active drugs in a 96-well culture model based on a
permanent transfected keratinocyte cell line (HaCaT) that uses expression of the Enhanced Green
Fluorescent Protein under control of the SKALP/ela®n promoter. Induction of the SKALP
promoter by TNFa, results in increased expression levels of the secreted SKALP-EGFP fusion
protein. The model system will be further validated to de®ne for which classes of drugs it can be
used. Preliminary results indicate that these models can be used to monitor the effects of retinoids
and MAPkinase inhibitors on cellular differentiation. This suggests that these models can be useful
for screening drugs that act via the keratinocyte as the primary target cell, which could lead to
improved pharmacotherapy of psoriasis and irritant contact dermatitis.
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Irradiation with UV-Light Causes Downregulation of 12(S)-Hydroxyeicosatetra-Enoic
Acid Receptors in Cultured Psoriatic Epidermal Cells
P. Arenberger, I. Obstova, B. Havlickova, and E. Matouskova
Prague, Czech Republic
On the cell surface, receptors could be affected during treatment with arti®cial UV sources or
during skin irradiation for cosmetic reasons. Because 12-hydroxyeicosatetraenoic acid (12-HETE)
is considered to be the main epidermal eicosanoid, and is assumed to have both pathophysiological
effects in in¯ammatory skin diseases such as psoriasis and atopic eczema as well as a physiological
role in cutaneous biology, we decided to show the UV-light effect on 12-HETE cell surface
receptors. Therefore, the present work studied the effects of single and repeated irradiations with
selected UV-B light of 313 nm from a Waldmann F 85/100 W ± TL-01 bulb on the 12(S)-HETE
receptors in psoriatic epidermal cells. UV-light in vitro (50±150 J per m2) induced a down-
regulation of 12(S)HETE receptors in a dose-dependent manner. The above described effect
occurred after a latency period of 6 h and reached its maximum at 7.5 h. In vitro, a single UV
irradiation (150 J per m2) or repeated irradiation (50 J per m2) developed a 55% receptor down-
regulation (Bmax); however, the receptor af®nity remained unchanged. The down-regulation of
12-HETE receptors on keratinocytes developed after the UV-B iradiation may contribute to the
explanation of its effects in phototherapy or photoaging.
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NF1 Tumor Suppressor Gene Expression is Markedly Aberrant in Psoriatic Skin In Vivo
and During Cellular Differentiation In Vitro
S.-L. Karvonen, A.-S. BjoÈrkstrand, M. Nissinen, J. Koivunen, H. YlaÈ-Outinen, and J. Peltonen
Oulu and Tampere, Finland
We have previously shown that psoriatic lesions display reduced tumor suppressor NF1 protein
immunoreactivity in epidermis compared to the perilesional skin. In the present study, the
expression of NF1 gene was studied in vivo and in psoriatic cell cultures using in situ (ISH) and
northern hybridization, Western blot analysis and immunohisto-chemistry. The results showed
that the level of NF1 protein was slightly reduced also in psoriatic cells in vitro. Moreover, psoriatic
keratinocytes showed less intercellular variations than normal cells in immunolabeling with NF1
protein. ISH revealed that NF1 mRNA displayed reduced expression in lesional psoriatic skin
compared to perilesional and normal skin. The subcellular distribution of NF1mRNA displayed
also alterations in psoriatic keratinocytes during cellular differentiation in vitro. The results suggest
that cultured nonlesional psoriatic keratinocytes were almost equally diseased as lesional cells. In
contrast in vivo, marked differences were observed between lesional and perilesional skin in
immunolabeling and in situ hybridization. NF1 protein is known to accelerate the inactivation of
ras-GTP in various cell types. Thus our ®ndings with aberrant distribution and expression of NF1
protein and mRNA may be causative to previously described increased activation of ras in psoriatic
lesions. This ®nding is interesting because psoriasis is a proliferative disease with uncontrolled cell
division, but lacking invasiveness and relative resistance to transformation.
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Targetting NF1 mRNA During Cellular Differentiation
J. Koivunen, H. YlaÈ-Outinen, S.L. Karvonen, M. Nissinen, S. Peltonen, and J. Peltonen
Oulu and Turku, Finland
We have previously demonstrated that NF1 tumor suppressor protein and cytokeratin 14 form a
high±af®nity interaction during the formation of cell-cell junctions in cultured keratinocytes,
which were induced to differentiate by raising the extracellular calcium concentration. This
prompted us to study the distribution of NF1 mRNA under the same conditions. The present
study utilized cultures of human keratinocytes which can be used as a well documented cell
differentiation model, and which have been successfully used for studies on expression and
functions of the NF1 protein. Skin samples were obtained from operations carried out for cosmetic
reasons from 10 healthy persons (aged 20±67 years). Keratinocytes (3rd to 8th passages) were used
for experimentation. Prior experimentation, cells were seeded on slides for ISH experiments or on
coverslips for protein detection and grown until about 40±60% con¯uence in serum-free low
calcium keratinocyte growth medium. The medium was subsequently changed to de®ned KGM
containing either low < 0.1 mM or high 1.8 mM calcium concentration. Cells were harvested at
time points of 0, 0.5, 1, 2, 4, 8, 12, 16, 24 and 48 h and ®xed. A NF1-speci®c 650 nt DIG-labeled
cRNA probe was used for ISH. The cRNA/NF1 mRNA hybrids were detected by two
alternative immunocytochemical methods. The ®ndings of the present study highlight the fact that
targeting of NF1 tumor suppressor mRNA takes place in contact forming and in migrating cells.
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Analysis of Immunogold Particles Representative of Neuro®bromatosis Type 1 (NF1)
Protein in Human Epidermis
T. Kuorilehto, J. Koivunen, S. Peltonen, and J. Peltonen
Oulu and Turku, Finland
Background We have previously shown that the NF1 Protein is associated with cytokeratin
®laments of epidermal keratinocytes (Koivunen et al. 2000). In this study, we have investigated this
association in more detail using pre-embedding immunoelectron microscopy and analyzing the
distribution of immunogold particles in bundles of intermediate ®laments.
Samples and methods 5 3 5 mm pieces of normal human skin were ®xed in 3%
paraformaldehyde for 2 h and incubated in sucrose. The tissue was frozen in liquid nitrogen and
cut into 50±60 mm frozen sections. The primary antibody, NF1GRP(D), was incubated with skin
sections for 2 h. The samples were then washed and incubated with goat anti rabbit IgG coupled to
10 nm gold particles. After the incubation and washes the sections were ®xed with 5%
glutaraldehyde and embedded in EPON 812. Numerical analysis of the distribution of
immunogold particles were carried out using MCID-M4 (version 3.0, Rev 1.1, Imaging
Research Inc., St. Catharine, Canada).
Findings The highest number of immunogold particles representative of NF1 protein in human
skin was counted in the basal layer of the epidermis, while the spinous and granular layers were
markedly less intensely labeled. Most of the immunogold was associated with bundles of
cytokeratin within the cells. More speci®cally, most intense labeling for NF1 protein was located to
the lateral aspects of cytokeratin bundles. Numerical analysis of the distance between two closest
immunogold particles in keratinocyte was 48.1 6 14.19 nm (SD). No immunogold particles were,
detected in the extracellular matrix, attesting to the low level of unspeci®c background signal in the
specimens analyzed. It should be noted that the signal for NF1 protein in the nuclei of
keratinocytes hardly exceeded that of the background.
Conclusions The highest concentration of gold particles representative of NF1 protein were
detected on the lateral aspects of cytokeratin bundles within the basal keratinocytes of human
epidermis. Here, the distance between two closest immunogold particles was 48.1 nm. We
speculate that this distance is somehow connected with the periodicity of cytokeratin bundles based
on the 48 nm length of cytokeratin monomers.
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Soybean Iso¯avones and Endocrine Related Factors of Human Hair Follicle Cells
Lachgar, M.E. Balana, N. Bouveur, M. Charveron, and Y. Gall
Pierre Fabre Research Institute, FaculteÂ de MeÂdecine Rangueil, Toulouse, France
Numerous studies have shown that non steroidal phytoestrogens (PHO) possess a broad spectrum
of biological properties given them the potential to in¯uence human physiology and hormone
dependent-diseases such as inhibition of 5a-reductase activity in prostate cancer. The mechanisms
by which these PHO exert their effect are tissue-speci®c and multifactorial. The impact of PHO
on hair growth was less extensively investigated. These data led us to study ®rstly the effect of PHO
on hair growth in organ culture and then to investigate the hypothesis that the hormonal responses
of hair follicle cells in vitro are linked to the effects of PHO on 5a-reductase, aromatase and steroid
receptors expression. The direct effect of PHO on hair growth was assessed on human isolated hair
follicle. We evaluated by RT-PCR analysis the effect of a total plant extract: soya in comparison
with two free forms (genistein, daidzein) and two conjugated forms (daidzin,puerarin) on the
expression of type 1 5a-reductase gene expression. We also evaluated their effect on aromatase
expression by cultured human hair follicle dermal papilla cells (DPC). In parallel, we evaluated by
Western-blot and RT-PCR the effect of PHO on androgen and estrogen a and b receptors
expression by DPC. Our results showed a signi®cant inhibition of 5a-reductase gene expression in
the presence of PHO (±21% inhibition for 1 mM genistein and ±17% for 1 mM puerarin).
Aromatase was seen to be markedly increased in the presence of genistein and daidzein (+76%
stimulation for 1 mM genistein and +45% for 1 mM daidzein). Western-blot analysis showed a high
stimulation of estrogen receptor b in the presence of PHO. The increase induced by soya extract at
10 mg per mL (+58.5%) is higher to that of 1 mM genistein (+43%) and 1 mM daidzein (+43% and
+41% stimulation, respectively). PHO also promoted estrogen receptors a expression by DPC.
However, the stimulation is less effective (+27% stimulation for 1 mM genistein, +9% for 1 mM
daidzein and +15.5% for soya extract at 10 mg per mL). A decrease of androgens receptors protein
expression is observed in the presence of PHO (±16% for 5 mM daidzein and ±30% for 5 mM
genistein). An improvement of hair follicle growth is observed in the presence of PHO (+30% hair
growth with soya extract vs. controls). Our results suggest that PHO may act on the modulation of
the main actors of testosterone metabolism in human hair follicle cells.
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Altered Retinol Metabolism and Expression of Retinoid Receptors During
Differentiation of Cultured Keratinocytes Results in Altered Retinoid Signaling
T. Karlsson, A. Vahlquist, and H. ToÈrmaÈ
Department of Medical Sciences, Section of Dermatology and Venereology, Uppsala University, Sweden
Retinoids have profound effects on keratinocyte phenotype both in vitro and in vivo. These
biological effects are primarily mediated by binding of the active metabolite all-trans-retinoic acid
(RA) to nuclear retinoic acid receptors (RAR-a, -g) which heterodimerize with 9-cis retinoic acid
receptors (RXRs). These complexes might cause transcriptional changes directly or by interfering
with other signaling pathways. Here, we examine retinoid signaling in cultured human
keratinocytes during terminal differentiation induced by exposure to calcium, the phorbol ester
PMA and interferon-g (IFNg). By using quantitative real-time PCR a time-dependent decrease in
the mRNA expression of RAR-a/-g and RXRa was found in cells exposed to both PMA and
IFNg for up to 48 h. In contrast, calcium-induced differentiation resulted in a 3-fold and 2-fold
transcriptional up-regulation of RAR-g and RXRa, respectively. Western blot analysis of nuclear
extracts revealed concomitant changes in protein levels of the retinoid receptors. Both RAR-g and
RXR-a were induced by calcium but substantially reduced after 48 h exposure to PMA and IFNg
(to between 5 and 20% compared to control cells). Metabolism of [3H]retinol to active RAR
ligands as analysed by high-pressure liquid chromatography was increased by IFNg and, more
potently, PMA. Used as a marker for retinoid activity, the expression of the RA-inducible gene
CRABPII, was rapidly and massively up-regulated at both mRNA and protein level by the
phorbol ester but persistently down-regulated by IFNg which might be due to titration of mutual
coactivators. In all, our results show that retinoid signaling appear to be altered in differentiating
keratinocytes but that the changes depend on how differentiation is accomplished.
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Tight Junctions in Human Epidermis
S. Peltonen, M. Malminen, K. Pummi, S.-L. Karvonen, and J. Peltonen
Turku and Oulu, Finland
This study demonstrates the presence of tight junction components ZO-1 and occludin in adult
and developing human epidermis. Indirect immuno¯uorescence labeling and immunoelectron
microscopy with antibodies to ZO-1 and occludin localized tight junctions to a narrow zone of the
granular cells of adult epidermis. Double immunolabeling for tight junction components and
adherens junction or desmosome proteins suggested that occludin is more speci®c for tight
junctions than ZO-1. In developing skin, tight junctions interconnected the peridermal cells, and
after the fetal strati®cation localized to the granular cell layer. Immunolabeling of psoriasis, lichen
planus and ichthyosis vulgaris, representing aberrant differentiation of the epidermis, showed that
these conditions were associated with relocation of ZO-1 to the spinous cells. Cultures of
differentiating epidermal keratinocytes revealed ZO-1 and occludin at the intercellular contacts.
However, these tight junction proteins colocalized relatively late when the fusion zone had
assumed a linear appearance. This suggests that the formation of adherens junctions and
desmosomes precedes that of tight junctions. We speculate that the epidermal barrier, isolating the
human body from external environment, is in part formed by tight junctions of stratum
granulosum. Tight junctions may be important especially during fetal development and in
pathological conditions affecting the epidermal lipid barrier.
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Induction of Gap Junction Proteins in Epithelial Skin Tumours and Adjacent Epidermis
N.K. Haass, J.M. Brandner, P. von den Driesch, S. Kief, E. Wladykowski, P. Houdek, and I. Moll
Department of Dermatology and Venerology, University Hospital Hamburg-Eppendorf, 20246 Hamburg,
Germany
Gap junctions are communicating channels that connect adjacent cells to allow communication by
exchange of small molecules. They consist of two connexons (one of each cell), each formed by six
transmembrane proteins called connexins. Fourteen different connexins (Cx) are known, seven of
which are expressed in normal human skin. The expression of different connexins allowing speci®c
molecules to pass through the channel thus controls the speci®city of cell-cell-communication. In
this work we concentrated on the expression of Cx30, Cx26 and Cx43 in epithelial skin tumours
compared to normal interfollicular epidermis. Investigations were performed by immuno¯uor-
escence microscopy of frozen sections using previously described speci®c antibodies. As previously
shown Cx30 and Cx26 are not present in normal interfollicular epidermis. In contrast Cx30 and at
a lower degree also Cx26 are expressed in basal cell carcinoma (BCC) and squamous cell carcinoma
(SCC). Interestingly Cx30 is also found in normal interfollicular epidermis neighbouring SCCs.
Similarily in certain cases there is an expression of Cx30 in the epidermis surrounding a malignant
melanoma. But there is no expression of Cx30 in normal epidermis adjacent to BCCs. Cx43 is
expressed in both epithelial tumours investigated, but at a lower degree than in normal epidermis.
These results clearly show in epithelial tumours an induction of Cx30 and at a lower degree also of
Cx26 and in contrast a down-regulation of Cx43. Therefore the induction Cx30 and Cx26 and the
down-regulation of Cx43 seems to characterize activated and hyperproliferative tissue, which in
consequence means, that Cx30 could be used as a marker for hyperproliferation. Ongoing
investigations will elucidate the function of Cx30 in hyperproliferative tissues.
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Desmosomes Exhibit Site-Speci®c Features in Human Palm Skin
H. Wan, T. Dopping-Hepenstal, M. Gratian, M.G. Stone,* J.A. McGrath, and R.A.J. Eady
Department of Cell and Molecular Pathology, St John's Institute of Dermatology, GKT School of Medicine,
*Richard Dimbleby Cancer Research/ICRF laboratory, St Thomas' Hospital, London, UK
Mutations in genes encoding various desmosome (DM) constituents have recently been found to
underlie a number of hereditary skin disorders characterized by abnormal thickening of
palmoplantar skin. These sites may be preferentially involved because they are subjected to
extensive physical stress. An alternative hypothesis is that there are instrinsic differences between
DMs in normal palmoplantar skin and DMs in skin from other sites. We therefore compared a
variety of morphological, immunohistochemical and biochemical properties of skin and cultured
keratinocytes from normal human palm and breast samples. Using pan-antibodies directed against
desmogleins and desmocollins, confocal microscopy showed that these DM cadherins exhibited a
reciprocal graded distribution across the epidermis. Desmogleins were more abundantly expressed
in the basal layer while the expression of desmocollins increased suprabasally. However, the
expression pro®les differed in detail between the two types of skin. In palm skin, from the mid-
spinous layer upwards, staining for both DM cadherins as well as for desmoplakin was attenuated,
suggesting a possible transitional change in DM organization. Staining for involucrin, a marker of
terminal differentiation, started at the lower part of this zone, and was followed sequentially by the
expression of transglutaminase, ®laggrin, and ®nally, loricrin. By contrast, in breast skin, DM
expression appeared more uniform across the epidermis and expression of the differentiation
markers was con®ned to a much thinner zone nearer to the skin surface. A suspension-induced
differentiation assay showed that involucrin expression occurred earlier in palm keratinocytes than
in breast cells, and at 4±8 h, the number of involucrin-positive cells from the palm was almost twice
the value obtained for the breast. Furthermore, Western blotting using cultured keratinocytes from
both sites revealed increased expression of major DM constituent proteins in palm vs. breast cells.
The differences in the expression of DM constituents between the two sites might account for the
apparent `dose' effects of certain mutant DM genes preferentially involving palmoplantar
epidermis.
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Expression and Localisation of Various Tight-Junction-Proteins in the Human
Epidermis and Various Diseases
J.M. Brandner, N.K. Haass, S. Kief, E. Wladykowski, P. Houdek, and I. Moll
Department of Dermatology and Venerology, University Hospital Hamburg-Eppendorf, D-20246 Hamburg
Tight-Junctions (TJ) are cell-cell-junctions which are quite well characterized in simple epithelia
and endothelia. There they form tight connections between the plasmamembranes of
neighbouring cells to prevent the paracellular ¯ux and to maintain cell polarity, therefore being
a main contribution to the barrier function of these tissues. Interestingely, the composition of TJ
varies in different tissues,seemingly re¯ecting their different barrier function. In human epidermis,
existence, structure and composition of putative Tight-Junctions are still in discussion. In earlier
reports we have shown the localisation of the Tight-Junction-proteins claudin-1, occludin and
protein ZO-1 in human epidermis and cultured keratinocytes. Now we can show by RT-PCR
that at least 6 more claudins are expressed in human skin/keratinocytes, even more stressing the
striking high number of TJ-proteins and hinting for an important function of TJ in epidermis. To
elucidate a possible barrier-function of TJ we investigated various diseases connected with an
impaired barrier, e.g. eczema, psoriasis and wounding. We can show a change of TJ-protein
expression. The data presented here indicate the existence of TJ-similar structures in human
epidermis, especially in the stratum granulosum. Moreover, a contribution to the barrier function
of the epidermis could be possible. Future experiments, especially electron-microscopy and dye
transfer experiments shall elucidate this.
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Desmocollin Isotypes in the Corneodesmosome; Processing During Stratum Corneum
Maturation
A. Watkinson, C.R. Harding, J. Richardson, and I.A. King
Sharnbrook and London, U.K
To investigate the expression of desmocollin (dsc) isotypes in corneodesmosomes and to identify
the patterns of processing during desquamation we have used speci®c antisera raised against the N-
terminal extracellular regions of the three human desmocollin isotypes. Tape strip depth analysis in
association with immunoblotting and indirect immuno¯uorescence were used to identify and
localise these proteins. All three isotypes were detected in human stratum corneum; dsc1 was the
predominant form, although signi®cant levels of dsc3 were detected while dsc2 was only a minor
component. All three isotypes showed signi®cant proteolytic processing and increased degradation
towards the peripheral layers, with slightly different processing patterns for each variant. Indirect
immuno¯uorescence revealed that dsc1 and dsc3 were localised on the corneocyte ridge regions,
whereas dsc2 was more diffuse. Exhaustive extraction of the corneocytes to produce corni®ed
envelopes demonstrated that desmocollins were cross-linked into this structure. Pertubation of
desquamation with the soap-induced dryness model revealed, elevated levels of all three isotypes
and their respective proteolytic fragments. Conclusion: (1) all three dsc isotypes were detected in
human stratum corneum with dsc1 being the predominant variant; (2) all isotypes were extensively
proteolytically processed with increased degradation towards the periphery; (3) signi®cant levels of
dsc were cross-linked into the corni®ed envelope; (4) dsc degradation was perturbed in soap-
induced dryskin.
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Calpain Isozymes 1 and 2 (CAPN1 and 2) and Calpastatin in Epithelial Human Skin
Tumors
J. Reichrath, M. Seifert,* T. Mitschele, U. Claassen,² A. Kerber, V. Meineke,³ W. Tilgen, and C.
Welter*
Departments of Dermatology, *Human Genetics and ²Pathology, University of Saarland, Homburg, and
³Institut fuÈr Strahlenbiologie, SanitaÈtsakademie der Bundeswehr, MuÈnchen; Germany
Calpain, also named CAPN (for calcium activated neutral protease), represents an ubiquitious
intracellular cytoplasmic nonlysosomal cysteine endopeptidase. Two major isozymes are known,
named calpain 1 and 2, requiring micromolar and millimolar calcium concentrations for activation,
respectively. Many substrates of the different calpain isoenzymes known today, such as the
transcription factors c-Fos and c-Jun, the tumor suppressor protein p53, protein kinase C, pp60src,
and the adhesion molecule integrin have been implicated in the pathogenesis of various human
tumors including squamous (SCC) and basal (BCC) cell carcinomas of human skin, suggesting an
important role of the calpain isoenzymes in malignant diseases. We have analyzed for the ®rst time
protein and mRNA expression of CAPN1 and CAPN2 in BCCs and SCCs of human skin.
Interestingly, CAPN1 immunoreactivity (streptavidin-peroxidase technique) was markedly
reduced in BCCs as compared to normal human skin (NS) or SCCs, while in contrast CAPN1
mRNA levels (real time PCR, LightCycler) were markedly elevated in BCCs (14,96 copies per
unit) and SCCs (17,74 c per u) as compared to NS (o,135 c per u). No differences were found
analyzing mRNA expression of CAPN2 (northern analysis) as well as immunoreactivity of
CAPN2 and the endogenous CAPN-inhibitor calpastatin in NS, BCCs and SCCs. Our ®ndings
indicate that calpain isozymes may be involved in the tumorigenesis and growth regulation of
BCCs and SCCs. Pharmacological modulation of calpain activity may be a target for the treatment
of SCCs.
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Analysis of the Vitamin D System in Basal and Squamous Cell Carcinomas of Human
Skin
T. Mitschele, B. Diesel,* R. Maas,* V. Meineke,² A. Wagner, J. Kamradt, W. Tilgen, E. Meese,*
and J. Reichrath
Departments of Dermatology and *Human Genetics, UniversitaÈtskliniken des Saarlandes, Homburg;
²Institute of Radiobiology, Federal Armed Forces Medical Academy, Munich; Germany
Using real time PCR (LightCycler), we have analyzed basal cell carcinomas (BCC), squamous cell
carcinomas (SCC) and normal human skin (NS) for mRNA expression of vitamin D receptor
(VDR) and of the main enzymes involved in the synthesis and metabolism of calcitriol (vitamin D-
25-hydroxy-lase [25-OHase], 25-hydroxyvitamin D±1 a-hydroxylase [1a-OHase], 1,25-dihy-
droxyvitamin D-24-hydroxylase [24-OHase]). RNA for VDR, 25-OHase, 1a-OHase, and 24-
OHase was detected in BCCs, SCCs and NS. Interestingly, RNA for VDR (BCCs: 35,2 copies
per unit; SCCs: 44,7 c per u; NS: 0,07 c per u) and 25-OHase (BCCs: 0,94 c per u; SCCs: 34,63 c
per u; NS: 0043 c per u) was up-regulated in BCCs and SCCs as compared to NS. Additionally,
we performed conventional RT-PCR with total RNA from NS and BCCs to determine the
expression of 1a-OHase. In both tissues, we report for the ®rst time splice variants of 1a-OHase.
Using a streptavidin-peroxidase technique and a panel of different monoclonal antibodies, protein
expression of VDR and 24-OHase was analyzed immunohistochemically. Intensity of VDR and
24-OHase immunoreactivity was increased in SCCs and BCCs as compared to NS. However,
staining did not correlate with histological type or grading of skin tumors. Comparing VDR-
staining with staining for Ki-67, cytokeratin 10 and transglutaminase K, no correlation was found.
Our ®ndings indicate that (i) BCCs and SCCs may be considered as potential targets for prevention
or therapy with new vitamin D analogs that exert little or no calcemic side-effects (ii) VDR
expression is not exclusive-ly regulated by the proliferative activity or by the differentiation of
these tumor cells, but by additional, unknown mechanisms (iii) synthesis and metabolism of
vitamin D metabolites may regulate growth of BCCs and SCCs (iv) pharmacological modulation
of vitamin D synthesis or metabolism may be a target for treatment of SCCs. The function of
alternative transcripts of 1a-OHase that we here describe for the ®rst time in BCCs and NS and its
effect on activity level has to be investigated in future experiments.
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Development of a Natural Whitening Agent from Macro Alguae Extract Undaria
Pinni®tida
J. Franchi, C. Marteau, I. Renimel, S. Darnault, A. Saunois, and P. AndreÂ
LVMH Branche Parfums et CosmeÂtiques, Laboratoire R&D, St Jean de Braye, France
The micro alguae Undaria pinni®tida (UP) are widely consume in Asian countries. Besides its
nutritional qualities owing the presence of amino acids, polyols, vitamins and oligoelements, it has
attracted special interest for medicines such as anti viral, anti cancer or antibiotics¼ Using it as the
starting material, three aqueous fractions were obtained after ultra®ltration, and tested for their
activity on mushroom tyrosinase. The maximum enzyme inhibition (43%) was registered with the
UP3 fraction. We then examined depigmenting ef®ciency by inhibition of melanogenesis of
human melamona cells (M4Be). We measured a decrease of melanin synthesis by 35%.
Complementary analysis of other macra alguae extracts demonstrated its speci®city of action. In
addition, the UP3 fraction was evaluated on human adult melanocytes (a decrease in melanin
content of 55% was obtained at 1 mg per mL) to con®rm the compound's suitability for use in
cosmetic skin-whitening products.
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Human Melanocortin 1 Receptor (MC1R) Variants are Restricted in their Ability to
Stimulate cAMP in B16-G4F Cells
S. Robinson and E. Healy
Southampton, UK
Case control and kindred studies have demonstrated an association between variants of the human
melanocortin 1 receptor (MC1R) gene and red hair and fair skin. Previous studies investigating
signalling of human MC1R receptor variants have employed transient transfections of cell lines
which are not related to the melanocyte lineage (e.g. COS and HEK293). Studies on the function
of MC1R variants using primary melanocytes are also limited by a lack of control over background
genetic variations. The mouse B16-G4F melanoma cell line does not constitutively express murine
Mc1r. We therefore generated stable B16-G4F transfectants with wild type human MC1R and
separately with Arg151Cys and Arg160Trp variants using electroporation and subsequent selection
with G418. Stably transfected cell lines expressing wild type MC1R (n = 3) were able to
signi®cantly increase cAMP production when stimulated by a melanocyte stimulating hormone at
concentrations of 10-6±10-9 Molar. By contrast, the transfected Arg151Cys (n = 3) and Arg160Trp
(n = 4) B16-G4F cell lines were unable to stimulate cAMP production to the same extent, despite a
similar cAMP response to 3-Isobutyl-1-methylxanthine (IBMX) as that seen in the wild type
MC1R transfected cell lines. The results show that MC1R variant receptors are compromised in
their ability to signal via cAMP when expressed within cells of the melanocyte lineage.
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Patterns of Single Nucleotide Polymorphism's (SNP's) in the Melanocortin 1 Receptor
(MC1R) Gene
A.J. Ray, R. Harding,* and J.L. Rees²
University of Newcastle upon Tyne, *University of Oxford and ²University of Edinburgh, UK
The melanocortin 1 receptor (MC1R) plays a key role in human pigmentation. Individuals
homozygous or compound heterozygous for the Arg142His, Arg151Cys, Arg160Trp or
Asp294His variants of MC1R have red hair and a lighter skin colour, a phenotype which is
thought to be subject to selective pressure. Population studies of a number of SNP's within MC1R
have revealed strong functional constraint of the gene in Africa and relaxation of this constraint in
populations outside of Africa, for example in Europe and Asia. To further analyse selection of
MC1R, we have examined 2Kb of DNA ¯anking the gene and have studied the patterns of these
polymorphisms in a number of Caucasian (n = 31), African (n = 27) and Asian (n = 9) alleles. 12
SNP's were identi®ed, 8 within 1100 bp of DNA 5¢ of MC1R and 4 within 800 bp of DNA 3¢ of
MC1R. No SNP's were identi®ed in the second exon of MC1R (MC1RB). The African
population was the most polymorphic, in contrast to the results of SNP's within the MC1R gene.
A number of haplotypes spanning MC1R (951 bp) and the ¯anking SNP's (2Kb) were inferred
statistically and these were used to propose a gene tree of probable mutation events. Several MC1R
variants (Arg142His, Arg151Cys and Asp294His) were exclusively associated with one haplotype,
although it was not possible to attribute this to selection.
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b-Carotene Uptake and Bioconversion to Retinol is Different in Human Melanocytes
and Keratinocytes
E. Andersson, A. Vahlquist, and I. Rosdahl
LinkoÈping and Uppsala, Sweden
Epidemiological studies have associated a high dietary intake of b-carotene with reduced cancer
risk. In addition to being a vitamin A precursor, b-carotene has antioxidant properties and increases
the immune response. These functions are important in the defence against ultraviolet induced skin
cancer. Human skin contains high levels of both b-carotene and vitamin A. It is not known if b-
carotene can be converted to vitamin A in the skin and thereby affect cellular differentiation and
growth in this tissue. We used primary cultures of human keratinocytes and melanocytes to study
the uptake of authentic or 14C-labelled b-carotene and its possible bioconversion to vitamin A.
The levels of b-carotene and vitamin A were analyzed with HPLC technique. The uptake of b-
carotene was much higher in melanocytes than in keratinocytes corresponding to a 5-fold
difference in the intracellular fraction after 2 days of incubation. An increased level of cellular
vitamin A was noted after 1 day of b-carotene incubation. The conversion of [14C]b-carotene to
[14C]vitamin A peaked at 24 h of incubation in both keratinocytes and melanocytes. In conclusion,
melanocytes are especially prone to store b-carotene which is converted to vitamin A in human
melanocytes and keratinocytes. Local storage together with conversion of b-carotene to vitamin A
in the skin, might be two powerful processes protecting the outer shield of the body towards UV
induced skin cancer.
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The Role of Human Myosin Va Isoforms in Human Epidermal Melanocytes
W. Westbroek, J. Lambert, A.M. Mommaas, H.K. Koerten, N.P. Smit, and J.M. Naeyaert
Ghent, Belgium and Leiden, the Netherlands
The actin based motor Myosin Va is a homodimer consisting of two 190 kDa myosin heavy chains,
each with an N-terminal head domain provided with an actin-and ATP- binding site and a
relatively long neck domain. The two heavy chains subsequently dimerize into a central coiled coil
stalk followed by the globular tail, with a presumed role in cargo binding. The role of this motor
protein in melanosome transport was partially elucidated when studying pigmentary dilution in
mouse dilute mutants and patients with the autosomal recessive Griscelli syndrome. Previously we
discovered that the human Myosin Va produces different transcripts in a cell type speci®c manner,
with splicing occurring in the C-terminal portion of the gene. The biological role of the isoforms
found in human epidermal melanocytes is still unknown. Therefore, we constructed GFP-fusion
proteins (pEGFP-C1 vector) comprising the human Myosin Va C-terminus alternative transcripts.
Confocal microscopy on human epidermal melanocytes transiently transfected with GFP fused to
six different exon combinations of the domain where alternative splicing occurs, reveals a diffuse
pattern throughout the cytoplasm with a dense perinuclear localization, excluding the nucleus.
Five constructs consisting of GFP, ®ve different exon combinations and the entire downstream C-
terminal tail show a distinct speci®c pattern of localization, again excluding the nucleus. The
localization pattern of these ®ve constructs can be de®ned in three categories. ACE and ABCE
accumulate into a distinct perinucleair dot. ABCDEF and ACDEF are concentrated in the cortex
of the plasma membrane and in the periphery and the tips of the dendrites. ABCEF is present in
distinct linear organized dots throughout the cytoplasm and the dendrites. To obtain detailed
information about the exact subcellular (co)-localization of the isoforms, immuno-electron
microscopy with an anti ± GFP antibody on transfected melanocytes is currently performed. Our
observations indicate that the alternative splice domain has a profound in¯uence on the speci®city
in localization of the tail region. The difference in localization probably involves a difference in
function of the transcripts.
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Establishment and Characterization of an Immortalized Human Epidermal Melanocyte
Cell Line
G. Szabad, A. Pivarcsi, M. SzeÂll, A. Kenderessy SzaboÂ, Zs. Bata, L. KemeÂny, and A. Dobozy
Szeged, Hungary
We report the isolation and partial characterization of a spontaneously immortalized human
epidermal melanocyte cell line (SPAG). Human epidermal melanocytes were isolated and cultured
from normal skin of a healthy Caucasian female undergoing plastic surgery. The evolution of
inde®nitely growing melanocytes appeared spontaneously. These melanocytes have been passaged
over 75 times to date and show no signs of senescence after 1 years of in vitro culturing. These
cells are dendritic, tripolar and bipolar, showing typical melanocyte morphology. SPAG cells have
a diploid kariotype with an isolated defect of the 15th chromosome. This kariotype appears to be
stable with repeated passages. We studied the expression of several cell cycle and melanocyte/
melanoma associated genes in SPAG cells. We detected overexpression of Cyclin D1 protein, a
speci®c marker for G1 cell cycle phase. Tyrosinase expression was veri®ed with nested RT-PCR
in several passages. Messenger RNA expression of MIA (melanoma inhibiting activity, a newly
recognized melanoma speci®c marker) was not detectable in any passage. This immortalized
human epidermal melanocyte cell line (SPAG) could be an important new tool for the study of
diverse aspects of melanocyte biology.
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Gene Expression Pro®ling with cDNA Microarray Technology of Ultraviolet-B
Irradiated Normal Human Melanocytes.Relation to Melanocarcinogenesis
C. ValeÂry, B. Bon, J. Barge, J.J. Grob, and P. Verrando
Marseille, France
Target genes involved in ultraviolet B (UVB) stress response of cutaneous melanocytes, some of
them potentially involved in melanoma development, were identi®ed by cDNA microarray (MA)
technology applied to one-third of the human genome. Cultured normal human melanocytes
(NHM) were subjected to an accute UVB irradiation (100 mJ per cm2). Four hours later, mRNA
were extracted from UVB- and sham-irradiated (control) NHM. Respective mRNA populations
were reverse transcribed for hybridization to 9000 cDNA of human genes on MA. Analyse of
hybridization signals allowed to select 198 genes with a signi®cant differential expression
(DE) = 1.9. 81 were over-expressed, while 117 were under-expressed. Among them, 159
corresponded to DNA known sequences, the encoded proteins being mostly involved in DNA- or
RNA-binding/synthesis/modi®cation and ribosomal proteins. The others were transcription
factors, receptors, channel-related proteins, and tumor suppressors. All of these protein function-
families housed some UVB sensitive genes that have been already involved in melanoma. 39
modulated DNA sequences were Expressed Sequence Tags (EST), waiting for gene characteriza-
tion and protein function. Target known genes were located on all chromosomes but showed a
preferential distribution. Some chromosomes bearing UVB sensitive genes were known to harbor
melanoma loci. Expression studies in melanoma cells and tumors of some selected EST, as well as
comparison of our data with those from other MA studies in melanoma samples, strongly suggest
that several modulated genes play a collective role in melanocarcinogenesis. Our study shed light
on melanoma candidate genes on a large genome scale and encourage us to characterize some of
these EST, two useful steps for further molecular epidemiology investigations and identi®cation of
``gene cluster predictors'' in melanoma.
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Expression of Retinoblastoma Gene in Melanoma Cell Line
A. Sparsa, C. BeÂdane, S. Boulinguez, H. Chable,* G. BarrieÁre,* K. Faucher,* O. Berthier-
Vergnes,* A. Varachaud,* M. Rigaud,* and J.M. Bonnetblanc
Dermatology, *Molecular biology, CHU Dupuytren, Limoges, France
The high incidence of melanoma (4±14%) in retinoblastoma patients suggest that an
oncosuppressor gene, the retinoblastoma gene could play a role in the progression of melanoma.
Therefore we have studied the expression of retinoblastoma gene in three melanoma cell lines. Cell
culture of 3 melanoma cell lines was performed in Mac Coy 5 A medium, 5% of CO2. ARN
extraction and ampli®cation was done by RT-PCR. Western blot was performed with an
antihuman pRb monoclonal antibody (G3-245). The level of protein was quanti®ed by
spectrophotometry. We con®rm the expression of mRNA of retinoblastoma gene and of the
protein Rb in 3 new melanoma cell lines. Despite a different tumorigenicity the level of expression
of protein was identical in all cell lines and positive control MOLT-4. Thus our 3 cell lines express
Rb protein at a pre and post transcriptional level. Quantitative RT PCR could assess wether there
is or not a signi®cant difference between the cell lines and positive control. We cannot exclude the
possibility in some cell lines of a dysfunction of Rb protein secondary to mutations of other
molecules or genes (CDKN2/p16¼).
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Screening of Melanoma Patients for the Presence of Cross-Reactive Autoantibodies
Against Autologous Tumour and Retinal Tissue
C. PfoÈhler, G. Ladewig, A. Kerber, C.E. Thirkill, A. Palmowski, A. Haus, W. Tilgen, K.W.
Ruprecht, and U. Reinhold
The Saarland University Hospital, Homburg/Saar, Germany and University of Davis, California
Melanoma-associated retinopathy (MAR) is a paraneoplastic syndrome in metastatic cutaneous
melanoma. The pathomechanism is understood to result from antibody production against
melanoma-associated antigens which cross-react with epitopes of retinal cells. We recently
analyzed 20 melanoma patients in different stages of disease (stage I-IV, according to the AJCC
tumour classi®cation) for the presence of cross-reactive antibodies against autologous tumour and
retinal tissue. Autologous patient's serum and a polyklonal rabbit-antiretina serum were used to
determine the autoantibody activity on histological sections of primary melanoma, melanoma
metastases, and retinal tissue, respectively. Using a ¯uorescein isothiocyanate- (FITC) conjugated
secondary antibody, a rapid evaluation of the immunologic activity of the serum sample was
permitted. Interestingly, most of the serum samples contained high titers of antibodies that cross-
reacted with retinal tissue as well as with autologous tumor. Our results showed that the percentage
of reactive serum samples was increased in advanced stages of disease and that the presence of
autoantibodies often was an initial symtom leading to the clinical detection of metastases. The
production of MAR-antibodies seems to be insuf®cient to protect against the dissemination of
melanoma cells. Furthermore the presence of MAR-antibodies is associated with a worse
prognosis. These data strongly indicate that a particular melanoma-associated antigen is able to
induce the production of autoantibodies that may cross-react with retinal tissue and may cause the
development of MAR in certain cases.
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Tissue Counter Analysis of Tissue Components in Skin Biopsies ± Evaluation Using Cart
(Classi®cation and Regression Trees)
J. Smolle and A. Gerger
Graz, Austria
In tissue counter analysis, complex histologic sections are overlayed with regularly distributed
measuring masks of equal size and shape, and the digital contents of each mask (or tissue element)
are evaluated by grey level, colour and texture parameters. In this study we assessed the feasability
of tissue counter analysis and classi®cation and regression trees for the quantitative evaluation of
skin biopsies. From randomly selected skin biospies (n = 100) a learning set of tissue elements was
created, differentiating between cellular elements, collageneous elements of the reticular dermis,
fatty elements and other tissue components. Classi®cation and regression trees based on the
learning set were used to automatically classify tissue elements in samples of normal skin (n = 25),
benign common nevi (n = 50), malignant melanoma (n = 50), molluscum contagiosum (n = 25),
and scleroderma (n = 25). The procedure yielded reproducible assessments of the relative amounts
of tissue components in various diagnostic groups (t-test: p < 0.05). Furthermore, a reliable
diagnostic separation between molluscum contagiosum on one hand, and normal human skin on
the other, and between malignant melanoma on one hand, and benign common nevi on the other,
was possible with 100% sensitivity. Tissue counter analysis combined with classi®cation and
regression trees are a suitable approach to the fully automated analysis of histologic sections of skin
biopsies.
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How Should Dermatological Digital Images be Prepared for Presentation, Publication
and Teledermatology
M. Tanaka, S. Kobayashi, and T. Nishikawa
Tokyo, Japan
There is an increasing opportunity to handle digital images for dermatology in presentation,
publication and even teledermatology. It is essential to standardize a quality of digital images
including a focus, a level and a contrast. First to keep high quality in these images are most
important, however, unnecessarily huge images often make your personal computer freeze.
Second, digital images are always unfocused when you scan them by image scanners. We should
therefore optimize the size and focus of these images when we use them for different purposes. As a
standard monitor has pixels of 1024 3 768, this or a little less size is thought to be a suitable size for
a slide for a presentation. In teledermatopathology and teledermoscopy, diagnoses are usually made
on the monitor and the same size is enough and necessary. On the other hand, the images for
publication need more pixels according to the journal to which you submit a paper. When the
publisher requests the print size of 5 3 3.5 inches, you need pixels of 2000 3 1500 at 400 dpi color
printer of high quality. This size is being achieved by a recent digital camera of 3.5 M pixels. The
most prominent feature of the digital image is feasibility of image correction. Concerning the
image processing, we recommend to use a photo retouching software, like PhotoShop q. When a
pathological image in an electronic format is obtained by scanning the image on a slide using a slide
scanner or taken by a digital CCD camera directly connected to a microscope, it is inevitable that
the digitized image is unfocused and low in contrast. The main process of improving the image is
to use a level correction, a tone curve control and an unsharp masking. These procedures should
properly be used in order to recover the original image and should not be used to produce
unnecessary enhancements. In the present study, we have compared examples of printed images of
different quality and the images before and after an image processing. Although there was no
apparent difference between images printed either at 200 or 400 dpi regarding clinical images,
®gures containing lines seemed to need the higher quality. Images sent for teledermatopathology
have greatly been improved after an appropriate image processing.
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Pattern Recognition Analysis of Human Cutaneous Mast Cell Populations by
Topographical Total Body Surface Mapping
A. Weber, J. Knop, and M. Maurer
Department of Dermatology, University Mainz, Germany
Mast cells (MC), important sentinel cells in immediate type hypersensitivity reactions, are abundant
in tissues that interface the external environment, including the skin. However, little is known
about the in¯uence of age, sex, or skin region on size or spatial distribution of MC populations in
normal human skin. Here, we have performed extensive histomorphometric entire body surface
mapping of healthy human skin, analysing MC numbers and distributions in 15 distinct anatomical
skin sites. MC per microscopic ®eld (MF) were quanti®ed in > 5 different skin layers
(subepidermal to subcutaneous) by light microscopy ( 3 400) in toluidine blue-stained 3 mm
sections of tissue samples obtained from > 10 individuals (total n: f = 87, m = 63, ages 10±86) for
the following anatomical sites: trunk (T) = abdomen, thorax, lower or upper back; proximal
extremities (PE) = lower or upper arm, lower or upper leg; distal extremities (DE) = foot, hand;
and face (F) = chin, nose, cheek, forehead, back of head. In all skin sites, regardless of age or sex,
MC numbers in distal skin layers were higher than in proximal skin layers (maximum:
subepidermal = 9.3 6 0.4 MC/MF, minimum: subcutaneous = 1 6 0.1 MC/MF). No differences
in total skin MC numbers and skin layer speci®c MC numbers were found comparing skin
obtained from male or female and from young or old individuals, respectively. Interestingly, total
skin MC numbers were highest in distal skin sites (DE and F; maximum: nose = 9.4 6 0.9 MC/
MF) and lowest in proximal skin sites (T; minimum: abdomen 2.9 6 0.3 MC/MF), while PE
exhibited intermediate MC numbers (upper arm: 3.7 6 0.2 MC/MF, lower arm 4.9 6 0.3 MC/
MF). These data show that cutaneous MC in healthy human dermis localize preferentially to distal
skin layers and sites. One possible explanation for these unexpected ®ndings is that skin site-speci®c
factors such as exposure to UV irradiation or minimal trauma are involved in the regulation of skin
MC numbers.
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CD44 and Hyaluronate in the Differential Diagnosis of Dermato®broma and
Dermato®brosarcoma Protuberans
E. Calikoglu, E. Augsburger, P. Chavaz, J.H. Saurat, and G. Kaya
Geneva, Switzerland
The histological distinction between dermato®broma (DF) and dermato®brosarcoma protuberans
(DFSP) may be extremely dif®cult. CD34 and Factor XIIIa have been used to differentiate DF
from DFSP. However, there is an overlap and lack of speci®city of their expression. CD44 is a
widely distributed integral membrane glycoprotein which is expressed as a multitude of isoforms
generated by alternative splicing of at least 10 different variant exons and post-translational
modi®cations. CD44 is currently thought to be the principal cell surface receptor for hyaluronate
(HA), the major component of the extracellular matrix. In this study we aimed to assess the
expression of standard CD44 (CD44s) and its isoforms (CDv3, CD44v4, CD44v5, CD44v6,
CD44v7, CD44v7v8 and CD44v10), and HA in DF and DFSP. Immunohistochemical staining
was performed on the biopsy specimens of 15 cases of DF and 4 cases of DFSP, using antibodies
which recognize the CD44s and different CD44 isoforms, and hyaluronate binding protein
(HABP). Tumor cells displayed a strong CD44s immunoreactivity in all cases of DF whereas a faint
HA positivity was observed in the tumor stroma. DF cells were negative for CD44v3, CD44v4,
CD44v6, CD44v7 and CD44v7v8 but they showed a strong reactivity for CD44v5 and CD44v10.
In contrast, CD44s expression was signi®cantly reduced or absent in all DFSP lesions and the
tumor stroma displayed a strong staining for HA. Our results indicate that CD44 and HA can be
used as additional diagnostic markers to distinguish DF from DFSP.
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Differentiation of Lichen Sclerosus from Morphea: Three Dimensional Reconstruction
of Basement Membrane Zone and Vascular Network in Laser Scanning Confocal
Microscopy
C. Kowalewski, A. Kozlowska, K. Wozniak, and S. Jablonska
Department of Dermatology, Warsaw University of Medicine, Poland
Morphea and lichen sclerosus (LS) are separate entities in spite of not infrequently overlapping
clinical and histological patterns. Ultrastructural studies on LS showed changes in upper dermis and
alterations of basement membrane zone (BMZ) on the level of lamina densa. The present study was
undertaken to compare alterations of various regions of the BMZ and vascular network in morphea
and LS using laser scanning confocal microscopy. The study included three cases of morphea, three
cases of LS and three cases overlapping clinical and histological criteria of both diseases. Biopsies
from patients' skin and a control biopsy from normal human skin were cut into 20 mm thick slides
and labeled with antibodies against b-4 intergin (lamina lucida marker), collagen IV and N-
terminal end of collagen VII (lamina densa markers) and C-terminal end of collagen VII (sublamina
densa marker) using routine immuno¯uorescence. Three-dimensional reconstruction of various
regions of BMZ showed decreased number and size of the dermal papillae in both LS and morphea
as compared to normal skin. In morphea, ¯attening of BMZ on the level of lamina lucida, lamina
densa and sublamina densa were observed but continuous character of BMZ was preserved,
whereas numerous invaginations and holes were present in LS BMZ. Vascular skin network system
visualized by labeling with anticollagen IV antibody revealed increased angiogenesis in cases of
early morphea, as compared to LS and normal skin. Patients overlapping clinical and histological
patterns of morphea and LS re¯ected alterations of BMZ and vessels characteristic for both diseases.
Three-dimensional reconstruction of BMZ and skin vascular network revealed different alterations
in morphea and LS and its may serve as a valuable investigative tool for differentiation of both
entities, especially in the onset of morbid process where is a diagnostic doubt.
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Clone Speci®c In Situ Hybridization for Preparation of Malignant Cells in Cutaneous T
cell Lymphoma
A. Lukowsky, K. Schreiber, W. Nuernberg, U. Henning, W. Sterry, and J.M. Muche
Berlin, Germany
Clonally dominating T cells represent the malignant cells in cutaneous T cell lymphoma (CTCL).
However, identi®cation of these cells in skin and blood samples from CTCL patients is hampered
by the lack of a speci®c tumour marker. Here we report on a clone speci®c in situ hybridisation
technique speci®cally labelling the malignant cells in paraf®n embedded tissue and in cytospins
using antisense RNA gene probes directed against the individual, tumour speci®c T cell receptor
(TCR) b gene rearrangement. This approach should greatly facilitate the separation and subsequent
investigation of the tumour cells. According to the unique sequence of the clonal TCR b
rearrangement, a clone speci®c TCR b DIG-labelled RNA probe was designed for the Jurkat cell
line and 2 CTCL patients as well and the cells were stained following hybridisation with BCIP/
NBT. The speci®city of the method was demonstrated by controls using corresponding sense
RNA probes, cross hybridisations on sections of other CTCL patients, having the same V b family
rearrangened, and, by dilution experiments of Jurkat cells in other clonal T cell lines. Using our
method the tumour cells can be observed directly by ¯uorescence microscopy or can be isolated by
¯ow cytometry. This in turn facilitates further investigation of their biology giving more insight
into etiology and pathogenesis of CTCL. In addition, the technique is well-suited for the
estimation of tumor cell frequencies in blood or tissues.
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Distribution of Cytochrome P450 (CYP) 2e1 in the Skin: A Novel Marker for
Keratiocyte Differntiation?
Y. Kawakubo, S. Tamiya, Y. Umezawa, T. Matsuyama, A. Ozawa, A. Serizawa, and K.
Shimamura
Isehara, Japan
CYP2E1 is known to be induced in human liver after alcohol intake and recently, expression in the
human keratinocytes was reported. The purpose of the present study is to investigate the expression
of CYP2E1 in the skin from normal subjects and some dermatological disorders including psoriasis
and skin tumors. To detect the CYP2E1 protein expression, immunohistochemical method using
antiserum for CYP2E1 is employed. In the normal epidermis, the protein distributes mainly upper
2/3 part and weak positive staining was observed in the basal layer. In the dermis, vascular
endothelium and eccrine sweat gland except myoepithelium were well stained. Skin specimens
from involved psoriatic skin showed a similar pattern. Positive staining was also observed in the
keratinizing part of squamous cell carcinoma. Basal cell epitheliomata were negatively stained.
Contrary to the neighboring normal eccrine gland, eccrine spiradenoma shows negative result. In
Paget's disease, nested tumor cells were negative while surrounding keratinocytes were well
stained. Together with these results, the enzyme protein expression seems to be dependent on the
cellular differentiation and could be used as discriminator for determination of surgical margin.
160
Balneotherapy Modify Iron and Ascorbic Acid Concentrations in Atopic Dermatitis
Dermis
N. Leveque,* S. Robin,² S. Mary,* P. Muret,*³ S. Makki,*§ J.P. Kantelip,³ A. Berthelot², and
Ph. Humbert*
Laboratories of *Cutaneous Bioengineering, ²Physiology, ³Clinical Pharmacology, §Pharmacy Galenic,
BesancËon, France
Atopic dermatitis (AD) is a chronic in¯ammatory skin disease induced by reactive oxygen species
(ROS). ROS formation is catalysed by iron and they are scavenged by ascorbic acid (AA). The aim
of this work was to determine iron and AA concentrations in atopic dermatitis patient dermis
before and after a balneotherapy and to compare them with iron and AA levels in healthy subject
dermis. Five AD patients and eight healthy subjects were enrolled in this work. Iron and AA were
collected from human dermis by microdialysis and assessed, respectively, by atomic absorption
spectrometry and gas chromatography-mass spectrometry. Iron concentration in AD dermis was
more than twice the iron level in healthy subjects dermis (44.3 6 4.6 mg per liter, 21.4 6 2.3 mg per
liter, respectively; p < 0.05). AA level was lower in AD dermis (46.7 6 0.6 mg per mL) than in
control dermis (237.4 6 8.7 mg per mL; p < 0.05). Iron concentrations decreased and AA level
increased after balneotherapy treatment (35.0 6 4.7 mg per liter; 67.0 6 5.1 mg per liter,
respectively). However, iron and AA concentrations were quite signi®cant different than iron
and AA levels before the treatment (p = 0.06). These results suggest that iron and AA levels could
be an indicator of in¯ammatory tissues and could be implicated in dermatological diseases such as
DA.
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p53 Gene Analysis in Single Cells From Human Skin
L. Gao, AÊ . Persson, B. Berne, J. Lundeberg, and F. Ponten
Department of Genetics and Pathology, Rudbeck Laboratory, University Hospital, Uppsala, Sweden
The advanced laser capture microdissection (LCM) techniques have made it possible to exploit
targeted cells from histologically stained sections without contamination from neighbouring cells.
When combined with optimized techniques for gene ampli®cation and sequencing, detailed
questions relating morphology to genetic background can be addressed. In an effort to obtain
optimized conditions for p53 gene analysis in single cell, we investigated various strategies for
sample preparation and gene ampli®cation. As a result we can amplify six individual exons of the
p53 gene (exons 4±9) in 70% of isolated single cells. In 50% of these cells both alleles are ampli®ed.
p53 mutations were characterized in chronically sun-exposed skin from healthy individuals.
Biopsies were taken from skin which had been subjected to daily summer sun as well as adjacent
skin which had been totally protected from the sun by blue denim fabric (SPF 1700). 172 single-
cell samples were retrieved from 4 biopsies. A total of 14 different mutations were identi®ed in 26/
99 keratinocytes from which the p53 gene could be ampli®ed. Immunohistochemical staining
revealed a small cluster of p53 immunoreactive keratinocytes suggestive of an epidermal p53 clone,
with a diameter of 10±15 basal cells. Two missense mutations (codon 241 and 281) were found in
all layers of epidermis within the p53 clone. In addition rare keratinocytes within the p53 clone
contained additional mutations. In normal skin we also found scattered single cells with typical
UV-induced mutations. The presented data show that p53 mutations are common in normal skin
and that a clone of keratinocytes with a mutated p53 gene prevailed despite two months of total
protection from ultraviolet light.
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Fluorescence Imaging of Epithelialization from Skin Explant Cultures on Acellular
Dermis
O. Rollman, H. Lu, I. Pihl-Lundin, and A. Vahlquist
Uppsala, Sweden
Reconstructed skin models in vitro are valuable tools in morphological studies of epidermis, but are
less suitable for quantitative analysis of the reepithelialization process. We describe an experimental
model which permits sequential measurement of the epidermal outgrowth rate whilst maintaining
the skin tissue in culture and allowing histological or immunohistochemical sampling. A 2-mm
skin-punch explant was used as keratinocyte source and attached to the centre of a circular 8-mm
piece of deepidermized dermis, DED. The combined tissue sample was placed on top of a modi®ed
CellStrainer ®lter and cultured at the air±liquid interface in serum-containing keratinocyte
medium. By this means a multilayered epithelium expanded from the grafted skin tissue,
resurfacing the upper aspect of the DED within a 10±14-day period. Without terminating tissue
culture, the area of epidermal outgrowth was visualized repeatedly by vital staining using
¯uoroprobes at subtoxic concentrations. The usefulness of the method was tested by studying the
effect of hrEGF in the culture medium. It was found that supplementation with hrEGF at 10 ng per
mL not only induced increased immunostaining for the proliferation marker Ki-67 and acanthosis
of the newly formed epidermis, but also enhanced the epithelialization rate as determined by
¯uorescence microscopy and digital image analysis. When treated with hrEGF, the time to attain
75% reepithelialization of the DED was reduced by approximatively 30%. Thus, the combined
effects of rEGF on the resurfacing rate, proliferation index, and histology of neo-epidermis were
demonstrated using one and the same experimental setting. As compared to existing epidermal
culture models this technique permits concurrent analysis of skin epithelialization dynamics and
morphology. The advantages of this simple and miniaturized skin culture model might be useful in
studies of skin epithelialization.
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Lipoma-Like-Liposarcoma of the Skin in the Course of Xeroderma Pigmentosum
D. Mikulska, L. Zalewska-Kubicka, A. Kacalak-Rzepka, and A. Nowak
Department of Dermatology, Pomeranian Academy of Medicine, Szczecin, Poland
Male patient aged 16 years with clinical diagnosis of Xeroderma pigmentosum.Skin lesions were
lentigo, freckles, discolouriastion and hyperpigmentation appeared after the ®rst year of life due to
exposure to sunlight. The number of skin changes was increasing with the patient age. At 6 years
he was referred to the Institute of Oncology, where he was treated for numerous foci of carcinoma
basocellulare. At 8 years he was admitted for the ®rst time to the Department of Dermatology
PAM. Next the patient was treated many times for baso- and squamous carcinomas. The last
hospitalisation of the patient was in September 2000. The nodule (1 cm in diameter) was noted on
the skin of the patients nose with the crust on the surface. The examination revealed changes on
the entire skin involving freckles, lentigo and in uncovered sites numerous foci of excessive
keratosis, hyperpigmentation, discolourisation dryness and thickening of the skin as well as
conjunctivitis with photophobia. Lymph nodes were not enlarged. It was phisical retardation
wheares psychological developement was normal. Genetic examination showed diminution of
DNA synthesis in lymphocytes. Histopathological examination no. 68620 of the skin tumor on the
tip of the nose revealed lipoma like liposarcoma.
164
A Clinicopathologic Study of Basosquamous Carcinoma
L. Zalewska-Kubicka, D. Mikulska, A. Nowak, and H. Krysiak
Department of Dermatology, Pomeranian Academy of Medicine, Szczecin, Poland
1108 patients with skin cancer underwent surgery between 1993 and 1999, at the Department of
Dermatology and Venereology Pomeranian Medical Academy in Szczecin. Histopathologically,
there were 92 (8.3%) cases of basosquamous carcinomas, 800 (72.2%) basal carcinomas and 206
(19.5%) squamous carcinomas. Basosquamous carcinomas were located mainly (77 cases ± 84%) on
the skin of the face (usually cheek, nose and angle of the mouth), the remaining 15 cases (16%)
involved the extremities (forearm, thigh and dorsum of the hand). Histopathologic examination in
92 cases of basosquamous carcinomas reveald the presence in the dermis histologic features of basal
carcinoma and squamous carcinoma (cellular atypy, cancer pearls) together. The electron
microscopic study of 6 basosquamous carcinomas revealed the lack of continuity in the basement
membrane and keratin pearls within the cytoplasm of keratinocytes. All patients underwent safety
margin surgery, the curative effect of which was permanent.
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Long-Term Nicotinamide (NA)-Treated HaCaT Keratinocytes Display Enhanced
Differentiation and Decreased Growth Capacity
A. Harel and O. Bloch
Tel-Aviv, Israel
NA, a derivative of B3 vitamin and precursor of NAD, is known as inhibitor of poly ADP ribose
polymerase (PARP) and weak free radical scavenger. In the present study we examined the effect
of continuous cultivation (6 months) of HaCat keratinocytes in presence of 10 mM or 20 mM NA
on cell differentiation, proliferation and death. Indirect immuno¯uorescent method was used to
determine keratin 10 and involucrin expression; corni®ed envelope formation by light microscopy
was also studied. Cell proliferation was estimated with MTT assay, growth curve was examinated
by light microscopy and cell cycle analysis by FACS. Cell death was investigated by ¯uorescence
microscopy (apoptosis and necrosis) and ¯ow cytometry (DNA fragmentation). Expression and
cleavage of PARP was estimated by Western Blot analysis. In earlier studies we demonstrated
antiproliferative and differentiation-promoting effects of short-term NA treatment (72 h) on HaCat
keratinocytes. In the present study we found that long-term cultivation (6 month) with 10 mM and
20 mM NA resulted in dose-dependent increase of keratin 10 and involucrin expression and
corni®ed envelope formation in HaCat cells. Growth-curve analysis and MTT assay demonstrated
2- to 4-fold decrease in cell proliferation of long-term HaCat cultures treated with 10 mM and
20 mM NA compared with control cells. NA caused accumulation of HaCat cells in S and G2/M
phase and increased level of apoptosis (4.5 6 0.38% in control compared to10.2 6 0.11% and
14.9 6 0.93% in cells treated with 10 mM and 20 mM NA, respectively). Long-term cultivation
with NA did not induce activation of necrotic death of HaCat cells. NA-treated cells showed no
alteration in level of PARP expression compared with untreated cells. In addition, we did not ®nd
cleavage of PARP following NA treatment. Our results indicate that long-term treatment with NA
(6 months) has strong potential to inhibit the proliferation and to stimulate the terminal
differentiation in HaCat keratinocytes.
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In Situ Detection of a Novel Costimulatory Molecule, Dectin-1, on Dendritic Cells in
Psoriasis
K. Matsushita, Y. Aragane, A. Maeda, F. Yamazaki, A. Kawada, T. Tezuka, and K Ariizumi*
Department of Dermatology, Kinki University School of Medicine, Japan; *South-western Medical Center,
University Texas at Dallas, Texas
We have currently identi®ed by using subtractive cDNA cloning technologies a dendritic cell
(DC) speci®c molecule with costimulatory functions, Dectin-1 and ±2, both of which belong to
C-type lectin receptor family. Besides their speci®c expression on DC and the capacity to
selectively mediate UV-induced tolerance in experimental animal models, it is entirely unknown
how Dectin-1 (Dec1) is regulated in diseased conditions in human. Recently, accumulating
evidence suggest that pathogenesis of psoriasis may be attributed to T cell-mediated immunity
which consequently leads to proliferation of epidermal keratinocytes. Based on the fact that DC are
the major player to induce immune responses in skin and that Dec1 is speci®cally expressed on
DC, we were interested to study the expression of Dec1 on psoriasis. Therefore, specimens derived
from skin of patients suffering from psoriasis (n = 15), from atopic dermatitis (n = 8) or of normal
healthy individuals were analyzed for expression of Dec1 by double-immunostaining techniques
using an antibody directed against human Dec1 and an antibody against CD1a, respectively.
Consequently, it was found that the numbers of Dec1+CD1+DC are signi®cantly increased in both
dermis and epidermis of psoriatic skin, while only the less number of the double positive DC were
observed in healthy skin or in atopic skin. Interestingly, while ¯uorescence intensity of CD1a
remained rather unchanged between the samples tested, that of Dec1 was markedly highered on
DC in psoriatic skin as compared to those of atopic or healthy skin, indicating the induction of the
Dec1 expression on DC in psoriasis. Together, these data imply the possible role of Dec1 in
pathogenesis of psoriasis.
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Detection of T-Cell Receptor g Sequences in Patients with Primary Cutaneous CD30+
Large T-Cell Lymphomas by Micromanipulation and Single-Cell PCR
A. Wilks, S. Gellrich, M. Wernicke, A. MuÈller, J.M. Muche, K.C. Jasch, A. Lukowsky, H.
Audring, and W. Sterry
Department of Dermatology and Allergology, ChariteÂ, Humboldt University, Berlin, Germany
The CD30 antigen was ®rst identi®ed in 1982 by Stein et al. as a cell surface marker expressed by
Hodgkin and Reed-Sternberg (H/RS) cells in Hodgkin's disease (HD). This antigen was soon
recognized to play a role in various physiological as well as pathological processes in the organism.
The expression of CD30 is mainly restricted to cells of the immune system, especially lymphocytes.
As a member of the TNFR superfamily the molecule is assumed to be involved in the process of
lymphoid development and differentiation. Several studies indicate CD30 to be a mediator of cell
growth as well as apoptosis depending on different immunological stimuli. However, the exact
mechanisms of CD30 signalling are still unknown. Concerning the diagnosis and prognosis of
different lymphoproliferative disorders such as HD and anaplastic large cell lymphoma (ALCL) the
antigen is of particular interest. In the case of primary cutaneous lymphomas the detection of the
antigen led to the classi®cation of a new type of lymphoma characterized by the predominance of
CD30+ tumor cells and a favourable prognosis. The CD30 positive cutaneous large T-cell
lymphoma (CD30+ CTCL) is de®ned to consist of large lymphoid tumor cells which in at least
75% are positive for the CD30 antigen. A pleasant 5 years survival rate of 90% and the tendency of
this lymphoma to spontaneous regression (in up to 25% of the cases) is thought to be connected
with CD30 signalling. Although the large CD30+ lymphoid cells are accepted to represent the
tumor cell population, this assumption has not been proven on a molecular-biological level yet.
We believe the protein to be a very important participant in the pathogenesis of CD30+ CTCLs.
The aim of this work is to answer the question whether the CD30+ cells in primary cutaneous
CD30+ large T-cell lymphomas belong to the tumor cell population (and if they exclusively do so)
or not. Therefore we isolated CD30+ cells of three patients with CD30+ CTCLs. A total of
212 CD30+ single cells was acquired by hydraulic micromanipulation. 185 of the cells were picked
from the epidermis of tumor lesions and 27 from a cytospin slide of peripheral blood lymphocytes.
In order to identify clonal cell populations, which are thought to represent the tumor cells, we
employed single cell PCR of the T-cell receptor (TCR) g gene followed by direct sequencing. In
119 of the 212 separated cells we succeeded in analysing a rearrangement for the TCR g. In all
three cases a clonal population with a biallelic rearrangement of the TCR g was detected. Beside
these clonal populations which comprise the majority of the isolated cells, all samples showed the
existence of CD30+ cells with polyclonal rearrangements. Additionally one patient showed a
second small cell clone. From the previous work we could prove for the ®rst time in CD30+
CTCLs that the tumor cell population is to be found within the group of CD30+ large lymphoid
cells. According to our results we conclude that the CD30+ large T-lymphocytes do not represent
a uniform tumor cell population, although the morphological and phenotypical occurrence is equal
between clonal and other T-lymphocytes. With regard to the varying but not insigni®cant amount
of polyclonal CD30+ T-cells within the tumor lesions their possible role in the pathogenesis of
CD30+ CTCL should be considered.
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Differential Expression of the CD10 Antigen (Neutral Endopeptidase) in Primary and
Metastatic Malignant Melanomas of the Skin
J. Kanitakis, D. Narvaez, and A. Claudy
Laboratory of Dermatopathology, Department of Dermatology, HoÃp. Ed. Herriot, 69437 Lyon cx 03,
France
The CD10 antigen (neutral endopeptidase, enkephalinase, NEP-24.11:EC 3.4.24.11) is a 100-kDa
cell surface metalloendopeptidase which inactivates by hydrolysis a various proin¯ammatory
peptides. It was initially considered as speci®c of lymphoblasts of acute lymphoblastic leukemia
(CALLA), but is now known to be expressed by a variety of normal and neoplastic nonlymphoid
tissues. In a previous study we observed that the CD10 antigen was expressed by a subset of
cutaneous malignant melanomas (MM). In this study we investigated the expression of the CD10
antigen in a wider variety of MM of the skin in order to get further insight into the signi®cance of
this molecule as a progression marker, and to evaluate a potential usefulness of the CD10 antigen in
dermatopathology. An immunoperoxidase technique was applied on formalin-®xed, paraf®n-
embedded tissue specimens of 72 MM (including 28 primary, 26 metastatic to the skin and 18
lymph-node metastases). The CD10 antigen was expressed by 18/26 (69%) and 11/18 (61%) of
MM metastatic to the skin or the lymph nodes, respectively; by contrast, only 6/28 primary MM
(21%) expressed appreciable CD10 reactivity, which was usually lower (in terms of percentage of
immunoreactive cells) than that found in metastatic MM. The sensibility, speci®city, positive and
negative predictive value of CD10 positivity for metastatic MM was evaluated to 0.66, 0.79, 0.83
and 0.6, respectively. These results suggest that the CD10 antigen is up-regulated during the
process of metastasis in MM. Whereas the explanation for this up-regulation is as yet unclear, the
expression of CD10 appears as an additional immunohistological feature for the differential
diagnosis between primary and metastatic MM.
VOL. 117, NO. 3 SEPTEMBER 2001 ABSTRACTS 793
169
Tumor Thickness, Ki-67-Antigen and Polo-Like Kinase (PLK) Expression in the
Assessment of Proliferative Activity and Prognosis of Thin Malignant Melanomas
(=0.75mm)
L. Kneisel, A. Bernd, K. Strebhardt, A. Binder, M. Wolter, and R. Kaufmann
Frankfurt am Main, Germany
The maximum thickness of malignant melanomas is currently the most important prognostic
factor. In recent years the tumor thickness of excised melanomas has decreased. In Central Europe,
nearly 50% of tumors examined nowadays are less than 0.75 mm thick. However, these thin
melanomas, which should have an excellent prognosis, can metastasize and can be lethal.
Therefore, better prognostic tools are required to identify thin melanomas with high metastatic
potential. Ki-67 is a nuclear antigen expressed in the G1-, S-, G2-, and M-phase of the cell cycle.
Polo-like kinase (PLK), named after the Drosophila gene product polo, codes for a serine/
threonine kinase and regulates multiple steps of the cell cycle, e.g. the spindle formation, cyclin-
dependent kinase activation and M-phase exit. 22 thin metastasized melanomas and 14 thin
melanomas from patients without disseminated disease were analyzed with immunohistochemical
techniques using monoclonal antibodies directed against the proliferation associated antigens PLK
and Ki-67. Two independent operators evaluated stained sections. The PLK and Ki-67 indices
were calculated as the number of positive cells per 1000 totally counted cells (multiplied by 100%).
The maximum tumor thickness was assessed by Breslow's method. Differences of tumor thickness,
Ki-67 and PLK indices between melanomas with and without metastases were tested statistically
using the Mann±Whitney U-test. Neither tumor thickness (p = 0.885450) nor Ki-67-antigen
expression (p = 0.150473) provided a signi®cant prognostic result with respect to metastases. In
contrast, malignant melanomas with metastases expressed PLK at markedly elevated levels
compared to melanomas without metastases (p = 0.000053). Our results demonstrate that the
assessment of Polo-like kinase (PLK) expression in immunohistochemical sections re¯ects the
metastatic potential of thin malignant melanomas (= 0.75 mm).
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Elastin Peptides Upregulate Prommp-2 Activation and Melanoma Cells Migration
through Three-Dimensional Type I Collagen Matrix
C. Ntayi, W. Hornebeck,* and P. Bernard
Department of Dermatology, CNRS FRE 2260; IFR 53-Biomolecules, Faculty of medicine, Reims;
*Department of Biochemistry, CNRS FRE 2260; IFR 53-Biomolecules, Faculty of medicine, Reims
Elastin, as a main constituent of elastin ®bers, plays a prominent role in skin biology. Its enzymic
degradation by gelatinases (MMP-2, MMP-9) leads to the liberation of elastin peptides (E.P.)
which exhibit several biological functions. Particularly, interaction between E.P. and a truncated b
galactosidase elastin/laminin receptor present at the plasma membrane of various cell types was
shown to trigger MMP-expression (Brassart et al. J Biol Chem 2000). We here evidenced that
elastin peptides (50±200 mg per mL) from organo-alkaline or elastase hydrolyses of insoluble elastin
could stimulate MMP-2, but not MMP-1, expression from highly tumorigenic melanoma cells, in
a dose-dependant manner. When those cells were grown within type I collagen gels, in presence of
EDPs, MMP-2 activation was strikingly exacerbated, an effect probably resulting from elastin-
mediated MT1-MMP increased expression (Brassart et al. Clin Exp Metastasis 1998). Parallely,
invasion of type I collagen matrix by melanoma cells was signi®cantly increased. This preliminary
investigation, in keeping with our previous data (Capon et al. Clin Exp Metastasis 1999), indicate
that the main ®brillar matrix macromolecules of human dermis i.e collagen and elastin actively
contribute to tissue invasion, through modulation of MMPs expression and activation, by
melanoma cells.
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Smad3 is Involved in Regulating the Transforming Growth Factor-b Elicited Expression
of Collagenase-3 (MMP-13) in Gingival Fibroblasts
S.-K. Leivonen, A. Chantry, and V.-M. KaÈhaÈri
Turku, Finland; Norwich, UK
Collagenase-3 (MMP-13) is a collagenolytic matrix metalloproteinase with a wide substrate
speci®city, and it is expressed by ®broblasts in gingival wounds. TGF-b is a potent inducer of
MMP-13 gene expression in gingival ®broblasts, and this requires the activation of p38 mitogen-
activated protein kinase pathway. In this study, the role of Smads, the signaling mediators of TGF-
b, in regulating the expression of MMP-13 in gingival ®broblasts has been studied. We have
constructed recombinant HA(haemaglutinin)-tagged Smad2, ±3 and ±4 -adenoviruses, and shown
by Western blotting that they express the corresponding transgenes in infected gingival ®broblasts.
Immunostaining analyses show that the HA-tagged Smads are translocated into the nucleus after
2 h TGF-b1 treatment of infected ®broblasts, indicating that the adenoviruses express functional
Smads. Western and Northern blot analyses show that overexpression of Smad3 enhances the
TGF-b1 elicited expression of MMP-13, which is further induced when Smad4 is coexpressed
with Smad3. In comparison, the TGF-b1 induced levels of TIMP-1 (tissue inhibitor of MMPs)
and type I collagen remain unchanged in response to Smad3 and ±4. In addition, transient
transfections with human MMP-13 promoter and Smad expression vectors indicate that the
activity of MMP-13 promoter is enhanced by Smad3 and ±4. These results provide evidence that
Smad3 is involved in regulating the expression of MMP-13 in gingival ®broblasts.
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Induction of Keratinocyte MMP-9 Expression by Boron and Manganese
N. Chebassier, E.H. Ouijja,* I. Viegas,* A.C. Knol, S. Leroy, and B. DreÂno
INSERM U463, Nantes, France and *Laboratoires Rivadis, Thouars, France
Synthesis of new tissue and maturation of wound by remodelling of the extracellular matrix (ECM)
are two phases involving matrix metalloproteinases (MMPs). Leif R. Lund et al. have reported the
presence of MMP-2, ±3 and ±9 mRNAs in wound healing but in different patterns. In addition,
somme clinical studies on trace elements lead to demonstrate their bene®cial effect on wound
healing. Thus, boron compounds would induce wound healing by acting on ECM and on the
synthesis and secretion of TNF-a. An induction of integrin expression by proliferating and
differentiated keratinocytes after manganese treatment was also described by authors. In the present
study, we have investigated the effect of boron and manganese on MMP-2, ±3 and ±9 keratinocyte
expression. Normal human keratinocytes were cultured in monolayers and incubated with boron
(0.5-1-5-6.46±10 mg per mL) or manganese (0.1±0.2±0.3±0.6±1.5 mg per mL) for 6 h. Cytoplasmic
expression of MMPs was analysed in triplicate by immunohistochemistry. This study revealed an
increase in MMP-9 cytoplasmic expression by keratinocytes incubated with 10 mg per mL of
Boron and more than 0.2 mg per mL of Manganese after 6 h of incubation. No modulation of
MMP-2 and ±3 was noted. During wound healing, MMP-9 mRNAs are just located at the front of
the migrating epidermal layer until 7 days after wounding. Application of these trace-elements on
scars could improve cell migration by their action on MMP-9 expression in keratinocytes of the
migrating front and could explain the clinical results obtained with these trace elements.
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Serum Levels of Tissue Inhibitor of Metalloproteinases 2 in Serum of Systemic Sclerosis
Patients ± Preliminary Results
B. Dziankowska-Bartkowiak, E. Waszczykowska, A. Zalewska, and A. Sysa-JeÃdrzejowska
Department of Dermatology, Medical University of LoÂdy, LoÂdy, Poland
Systemic sclerosis (SSc) is characterised by increased deposition of collagen and other components
of extracellular matrix (ECM) in skin and internal organs. It is not elucidated whether increased
production of collagen or its degradation disturbance is responsible for this process.
Metalloproteinases (MMPs) are regarded as important enzymes in both proteolysis processes of
ECM components and angiogenesis. MMPs activity is regulated by their tissue inhibitors (TIMPs).
The latter are postulated to be involved in neoplastic processes, rheumatoid arthritis and systemic
sclerosis. Tissue inhibitor of metalloproteinase 2 (TIMP-2) can block many enzymes such as
interstitial collagenase, gelatinase and stromelysin, which are in turn involved in ECM metabolism.
The aim of our study was to measure TIMP-2 levels in serum of SSc patients and correlate them
with extensiveness of skin and lung changes evaluated by spirometric method. The study was
performed in the group of 18 SSc patients (8 with limited ± lSSc and 10 with diffuse type ± dSSc;
12 female and 6 male, aged 16±70 years). The control group comprised 10 healthy people.TIMP-2
in serum was measured by ELISA method according to the manufacturer (Amersham,
Buckinghamshire, England). It was demonstrated that mean TIMP-2 level in serum of SSc
patients was slightly increased in comparison to the control group (80.07 ng per mL vs. 77.63 ng
per mL, respectively). There was no statistically signi®cant difference between lSSc patients and
dSSc ones (81.42 ng per mL vs. 78.99 ng per mL, respectively, at p > 0.05). There was no
correlation observed between duration of Raynaud's phenomenon and the degree of skin ®brosis
and serum TIMP-2 levels. Increased TIMP-2 serum levels were observed only in patients who had
ventilation problems of restrictive nature demonstrated on spirometric examination. The obtained
results seems to support the probable role of TIMP-2 in lung ®brosis development in systemic
sclerosis patients.
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Human Serum Components Increase Laminin 5 Synthesis in Human Keratinocytes
S. Amano, N. Akutsu, and T. Nishiyama
Shiseido Life Science Research Center, Yokohama, Japan
Laminin 5 is a major component of the anchoring ®laments that connect epithelial
hemidesmosomes with the basement membrane. In wound healing, laminin 5 is the ®rst basement
membrane component deposited under migrating keratinocytes, and it is known to enhance
keratinocyte migration. Cultured human keratinocytes were concentration-dependently stimulated
to produce laminin 5 by treatment with human acute wound ¯uid, as well as human serum, to
almost the same extent. Human serum was fractionated by Sephacryl S-300 column
chromatography and the effect of each fraction on laminin 5 synthesis by human keratinocytes
was examined. Activities were mostly separated into three groups, high-molecular-weight, IgG,
and albumin fractions. High-molecular fractions, in which ®bronectin is a major component,
enhanced keratinocyte adhesion and increased laminin 5 synthesis in keratinocytes. The active
component may be ®bronectin, since keratinocytes plated on ®bronectin synthesized more laminin
5. IgG fractions also increased laminin 5 synthesis, although release of laminin 5 into the medium
was lower than with the other fractions. The active component in this fraction has not yet been
identi®ed. Albumin fractions increased laminin 5 production and its release into the medium. The
active components might be albumin-binding lipids such as lysophosphatidic acid, lysolecithin and
sphingosin-1-phosphate, which increased laminin 5 synthesis in a concentration-dependent
manner, and cytokines released from platelets, such as TGFa and TGFb1, which also stimulated
laminin 5 synthesis. Moreover, laminin 5 production in keratinocytes was also augmented by an
in¯ammatory cytokine, TNFa, which may be present in acute wounds. These results suggest that
wound ¯uid may facilitate wound repair by stimulating laminin 5 synthesis in keratinocytes.
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The Collagen Cross-Link Hisitdino-Hydroxylysinomerodesmosine is an Artifact
J. Brinckmann, H. Notbohm, P.K. MuÈller, and P.P. Fietzek
LuÈbeck, Germany
An appropriate cross-linking of collagen molecules is an essential prerequisite for proper
biomechanical function of connective tissues. The cross-link histidino-hydroxylysinomerodesmo-
sine (HHMD) has been described as a tetrafunctional cross-link derived from lysine-aldehyde
pathway and was suggested as a major cross-link in skin. An increase in the concentration of
HHMD has been shown for sclerotic skin in localized scleroderma and keloids, while a decrease
has been reported for lipodermatosclerosis. However, there is no convincing evidence that
HHMD is formed under in situ conditions. In this study, we analysed the cross-link pattern of skin
and other HHMD-containing tissues by different analytical procedures. Human tissues (normal
skin, keloids, palmar aponeurosis) underwent various treatments for cross-link analysis. Untreated
tissues were reduced by borohydride and then digested by collagenase or ®rstly digested by
coallgenase and then reduced by borohydride. After hydrolisation (6 N HCL for 24 h at 108°C)
cross-links were analysed with an amino acid analyser. Cross-link analysis yielded in all samples
similar levels of reducible and nonreducible cross-links except HHMD, which was solely found in
the samples which were reduced prior to collagenase digestion. Our study demonstrates, that
HHMD is not present in tissues in situ. HHMD is an artifact which is generated during reduction
of tissues by borohydride. The analysis of HHMD may be indicative for the content of the
intramolecular aldol condensation product (ACP), which plays no role in the mechanical
properties of the ®bre.
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Role of Integrins in Regulation of Dermal Scar Formation in Humans
B. Noszczyk, S. Majewski, E. Klein, O. Holtkoetter, and T. Krieg
Warsaw, Poland; Heidenheim and Cologne, Germany
Cutaneous wound healing is a complex process that involves migration and proliferation of various
cell types including keratinocytes and ®broblasts. Various cytokines and molecules of provisional
extracellular matrix (ECM) within the dermis regulate functions of ®broblasts. The purpose of the
study was to evaluate the role of integrins and several extracellular matrix components during
dermal scar re-organization. Serial biopsies of human wounds healed by primary intention were
obtained from 26 patients who underwent repeated surgery (in a period of 7±35 days) due to the
histological diagnosis of melanoma in situ. The biopsies were analyzed by means of
immunohistochemistry with the use of anti a2, a3, a5, a6, av, b1 and b3 molecules. The
most pronounced changes were observed between days 7 and 35 in the expression of a2, av and
b1 integrins subunits, as well as in the vitronectin expression. The a2 integrin was up-regulated on
dermal ®broblasts between days 7 and 27 after injury. After day 27 the a2 subunit expression
gradually decreased. The av and b1 integrins expression were up-regulated between days 7 and 35
on ®broblasts and endothelium. The vitronectin expression was increased from day 7 onwards and
colocalized to the area of the wounded dermis similarly to the av subunit expression pattern. These
data suggest that human dermal scar ®broblasts use mainly a2, av and b1 integrin subunits during
re-organization of ECM. Changes in the integrin expression may play an important role in the
control of deposition of ECM components associated with scar remodeling.
177
Positive Correlation Between Catalase Activity and Collagen Synthesis in Suction Blister
Fluid
H. Corstjens, A. Oikarinen,* M.J. Richard,² L. Declercq, and D. Maes³
Oevel, Belgium; *Oulu, Finland; ²Grenoble, France and ³Melvile USA
Chronically sun exposed and severely photodamaged skin shows a reduction in collagen synthesis,
while acute UV-irradiation leads to an increase in metalloproteases. These changes could be
mediated by reactive oxygen species (ROS) and/or DNA damage. In this study we evaluated the
endogenous levels of various antioxidant defence systems together with markers of collagen
metabolism. Thirty samples of suction blister ¯uid were collected on the dorsal forearms of human
volunteers. The suction blister ¯uid was analysed for its level of reduced glutathione (GSH) and
catalase activity. Collagenase activity (MMP-2 and MMP-9) was quanti®ed and collagen synthesis
levels were detected as the aminoterminal propeptides of type I and type III procollagen (PINP and
PIIINP). A positive correlation was found between the catalase activity and GSH levels in suction
blister ¯uid (p = 0.01). We observed a positive correlation between the catalase activity and the
levels of PINP and PIIINP (p-values are 0.03 and 0.01, respectively). There was no correlation
between the catalase activity (or GSH levels) and the collagen breakdown rate when measured as
MMP-2 and MMP-9. Evaluation of these data suggests that a low antioxidant status measured as a
low catalase activity and GSH content in suction blister ¯uid coincides with a low collagen (I and
III) synthesis rate. These ®ndings support the in vivo damaging role of ROS, and hydrogen
peroxide in particular, which may contribute to the reduction in collagen synthesis.
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Evidence for Activation of Classical Pathway of Complement in the Noninvolved Skin
of Patients with Systemic Lupus Erythematosus
A. Mohamed, P. Wordsworth, S. Marshall, S. Burge, and F. Wojnarowska
Oxford, UK
The presence of immunoglobulins at the dermo-epidermal junction (DEJ) in patients with lupus
erythematosus (LE) is known as the lupus band. In a previous study we have demonstrated that the
lupus band is relatively restricted to IgG3 subclass which has the longest hinge region, making it
more readily available for C1q. Binding C1q may either activate the classical complement pathway
with the formation of membrane attack complex (MAC) or activation restricted to the early
complement components C1 and C4. Inactivation of C4 produce C4d which remains covalently
attached to the target as a stable marker for complement activation via the classical pathway.
Previous studies have demonstrated the prescence of MAC in the DEJ in lesional skin but not in
normal appearing skin of patients with discoid LE or systemic LE. The aim of this study was to
investigate the presence of C4d in nonlesional skin of patients with systemic LE to detect prior
reactions in which MAC are not demonstrated. This may provide insight into the role of
complement in cutaneous LE. Biopsies from noninvolved skin from 20 systemic LE patients were
investigated by indirect immuno¯uorescence. Skin sections were incubated with C4d Moab then
with FITC-conjugated rabbit antimouse antibody to detect the deposition of C4d. Normal skin
obtained from healthy individuals were used as a control. In 18 out of the 20 biopsies C4d was
detected. C4d appeared as an intense bright ¯uorescent band at the DEJ and in the dermal blood
vessels. C4d was not detected in the normal control skin. The presence of C4d within normal
appearing skin of patients with systemic LE implies activation of complement via the classical
pathway. Activation of complement up to and including the cleavage of C4 may have a protective
role and may partly explain why MAC is not formed in the nonlesional skin of LE patients.
Currently we are investigating the role of complement control proteins in cutaneous LE.
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Antinuclear Autoantibodies in Blood for Transfusions ± a Possible Risk Source For
Recipients?
R. Spiewak and N.M. Stojek
Lublin, Poland
The example of neonatal lupus erythematosus teaches us that transfer of autoantibodies may cause
irreversible effects in the recipient's body. This study was aimed at assessing the prevalence of
autoantibodies in blood for transfusion. Blood samples of 50 donors from a donation centre in
Lublin (eastern Poland) were tested. The donors were all males aged 21±55 (median 35) years,
none was suspected of having autoimmune disease. Enzyme immunoassay was used with the
Varelisa ReCombi ANA Pro®le EIA kit (Pharmacia, and Upjohn) with the following antigens:
dsDNA, RNP, Sm, SS-A/Ro, SS-B/La, Scl-70, CENP, Jo-1. Results: one or more antinuclear
autoantibodies were detected in 6 of 50 blood samples (12%); dsDNA-speci®c autoantibodies were
found in 1, RNP ± in 1, SS-A/Ro ± in 4, and Scl-70 ± in 1 sample. No Sm, SS-B/La, CENP, and
Jo-1-speci®c autoantibodies were detected. We conclude that a closer analysis of possible impact of
autoantibodies in transfusion blood on recipients' health should be undertaken, in order to decide if
screening blood donors for autoantibodies would be reasonable.
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Increased Hydrogen Peroxide Exhalation by Systemic Sclerosis Patients
M.U.E. Szkudlarek, A. Waszczykowska, A. Sysa-JeÃdrzejowska, D. Zalewska, B. Nowak, and
Dziankowska-Bartkowiak
Medical University of LoÂdy, LoÂdy, Poland
Respiratory system disturbances are one of the major death causes in systemic sclerosis (SSc)
patients. Pathomechanism of lung changes is still not fully elucidated. It is assumed that gatherings
of activated fagocytes, which are regarded as a source of reactive free radicals (RFR) are observed
in places of vasculitic and ®brotic changes. Quantity of expired hydrogen peroxide (H2O2) could
be regarded as RTR disturbance exponent. The aim of our study was to correlate quantity of the
expired H2O2 with the degree of lung function damage in systemic sclerosis patients. Twenty-
three SSc patients were included in the study (14 with limited form ± lSSc and 9 with diffuse ±
dSSc). Results of spirometric tests (FVC, FEV1 and FEV1/FVC in percentage of the required
values) and H2O2 levels in condensate of the expired air obtained in SSc patients were correlated
with the values of respective parameters obtained in the control group. Condensate of the expired
air was collected between 8.00 and 12.00 a.m. in all the examined patients. Spectro¯uorometric
method was employed to evaluate H2O2 level in the condensate. Spirometric examination was
performed on the same day. Spirometric results demonstrated that ventilation restriction of the
restriction type was observed in 8 SSc patients, of obstruction type in 7 patients and of combined
type of 3 SSc patients. There were no changes in 5 SSc patients and in all healthy controls. In SSc
patients FVC%, FEV1% and FEV1/FVC% values were as follows 75.87%, 61.86% and 78.74%,
respectively, and in healthy controls 104.25%, 97.75% and 91.11%, respectively (differences
between the groups were statistically signi®cant at p < 0.05 for FVC% and FEV1%). Mean H2O2
levels in the expired air condensate were 810.94 nM in all SSc patients and 343.77 nM in the
control group (p < 0.05). The obtained results seem to support the role of RFR in SSc
pathomechanism. Increased levels of H2O2 in the expired air condensate demonstrate oxidative
stress events in the respiratory tract and correlate with the degree of lung function impairment.
Measurements of H2O2 could be regarded as a noninvasive, adjuvant examination in lung function
evaluation in SSc.
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Regional Variations in Anisotropy of Skin Viscoelasticity in Japanese Women
T. Kitahara, K. Sugata, Y. Sugiyama, T. Nishijima, and Y. Takema
Kao Biological Science Laboratories, Tochigi, Japan
The measurement of running time of acoustical shear wave propagation is excellent for obtaining
skin mechanical properties in a speci®c direction in vivo. Recently a device based on this principle
has been applied for examining multidirectional viscoelasticity in Caucasian forearm skin. In this
study we studied skin viscoelasticity and anisotropy in forearm and facial skin in Japanese females
using this newly developed device. A total of 105 healthy Japanese females (10 s-70 s: 15 subjects to
each decade) were examined in this study. Measurements were taken for the inner surface of the
left forearm in three locations (upper, middle and lower parts), the middle area of the left cheek and
the center of the forehead while extending the arm parallel to the body in the supine position. The
running time of acoustical shear wave propagation between unit distances were evaluated using
Reviscometer (C + K Co., Ltd). Measurements were taken at angles of 0/180°, 45/225°, 90/270°,
and 135/315° oriented against the direction of body axis by rotating the sensor probe with steps of
45° counterclockwise. An overall average of the running time recorded in four directions in the
forearm decreased from the upper to the lower part, but were longer than those in the cheek and
forehead, indicating reduced stiffness in forearm skin. In a mutual comparison of the mean running
time in all directions, although the forehead showed no differences between each direction, the
cheek showed a maximum value at 45/225° and a minimum value at 135/315°. Furthermore in
the upper, middle and lower parts of forearm, maximum values were observed at 90/270°, 135/
315° and 0/180° and the minimum values were observed at 45/225°, 45/225° and 90/270°,
respectively. The ®ndings in this study show the regional variations in skin viscoelasticity and
anisotropy in these areas, and suggest that this measurement is useful for evaluating the
characteristic of skin mechanical properties in each area of the body.
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Age-Related Changes of Skin Viscoelasticity and Anisotropy in Japanese Women
Y. Takema, K. Sugata, Y. Sugiyama, T. Nishijima, and T. Kitahara
Kao Biological Science Laboratories, Tochigi, Japan
Measurement method based on the running time of acoustical shear wave propagation in a multi
direction has been applied for examining age-related changes in mechanical properties of Caucasian
forearm skin. In this study forearm and facial skin in Japanese females was measured with the newly
developed device using this method, changes in skin viscoelasticity and anisotropy with age were
investigated. A total of 105 healthy Japanese females (10 s±70 s: 15 subjects to each decade) were
examined in this study. Measurements were taken for the inner surface of the left forearm in three
locations (upper, middle and lower parts), the middle area of the left cheek and the center of the
forehead while extending the arm parallel to the body in the supine position. The running time of
acoustical shear wave propagation between unit distances were evaluated using Reviscometer
(C+K Co., Ltd). Measurements were taken at angles of 0/180°, 45/225°, 90/270°, and 135/315°
oriented against the direction of body axis by rotating the sensor probe with steps of 45°
counterclockwise. Statistically signi®cant age-related changes of running time in a de®ned
direction were noted in areas except the upper part of the forearm. In the forehead an increasing
tendency was seen at 0/180° and 45/225°, and a decrease at 45/225° together with an increase at
135/315° with age was observed in the middle area of the left cheek. Furthermore in the forearm,
age-dependent decrease was shown in all directions except 135/315° in the lower part and 0/180°
in the middle part. When the coef®cient of variation of values recorded in four directions was
calculated and plotted as a function of age, only the middle area of the cheek showed a signi®cant
decrease age-dependently, indicating reduction in the anisotropy of skin viscoelasticity with age.
These results reveal that age-related changes of viscoelasticity vary with direction and the area of
skin, and suggest that this measurement is useful for evaluating the variation in skin anisotropy with
age.
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Speci®c Furans from Avocado: A New Tool in Dermatology
S. Gahyor, A. Piccirilli,* N. Piccardi,* J.P. Pujol, and P. Msika*
Laboratoire de Biochimie du Tissu Conjonctif, CHU, Caen, France; *R& D Center, Laboratoires
PharmascienceTM, Courbevoie, France
Based on our know-how in the ®elds of lipidic extracts, we have discovered original and speci®c
compounds from avocado, namely Avocadofuran. The aim of this work is to present this new and
original molecule, and especially its biologicals activities on both the dermis and the epidermis.
Avocadofuran (INCI name: heptadecadienyl furan) is obtained from virgin avocado oil. The
drying of the entire fruit is an important step in the process which allows the selective formation of
Avocadofuran. This molecule is then concentrated in a two steps molecular distillation process.
Molecular distillation is a physical process of fractioned evaporation carried out under high
vacuum, and used for heat-sensitive high molecular weight and low volatility products. This long
chain furanic lipid does not have any equivalent in the ®eld of natural compounds. Studies were
®rst performed on normal human skin ®broblasts. Avocadofuran (20 mg per mL) was added directly
in cell culture medium. After 24 h incubation, TGFb-1 production was measured in cell culture
medium using a speci®c ELISA kit assay. In our experimental conditions, Avocadofuran was able
to signi®cantly induce TGFb-1 synthesis compared to non treated cells. This increase in TGFb-1
has been related to an increase in collagen synthesis as demonstrated by the collagenase assay. This
result was con®rmed using antibodies against TGFb. Indeed, when cells were incubated with these
antibodies, the effect of Avocadofuran on collagen secretion was almost completely abolished. In a
second set of experiments, we have checked the effect of Avocadofuran on epidermal lipids
synthesis using human skin explants. We have demonstrated that this molecule was able to
stimulate speci®cally the synthesis of cholesterol and ceramides 1 and 2, without any modi®cation
of the total lipid content of the epidermis. Taken together, these results demonstrate that
Avocadofuran is able to stimulate skin metabolism, both at the dermal and epidermal level of extra
cellular matrix synthesis, especially for the development of a new generation of topical products
intended for the prevention and/or the treatment of skin aging.
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HCR, a Candidate Gene for Psoriasis, is Expressed Differently in Psoriatic Epidermis
Compared with Normal Skin
S. Suomela, K. Asumalahti, E. Snellman, T. Uurasmaa, C. Jansen, S-L. Karvonen, T. Reunala, J.
Karvonen, J. Kere, and U. Saarialho-Kere
Helsinki, Lahti, Turku, Tampere and Oulu, Finland
Psoriasis is associated strongly with the HLA-Cw6 allele. We have shown that one of the genes
near HLA-Cw6, named HCR for a helical coiled coil rod protein, is highly polymorphic and
associates strongly with psoriasis in Finnish patients making it a good candidate gene for the
psoriasis susceptibility locus PSORS1. To further investigate the role of HCR in psoriasis, we
performed immunohistochemistry with rabbit polyclonal antibody on 31 psoriatic lesions, 13
samples of nonlesional skin and 5 biopsies of normal skin. 16 of the psoriatic lesions were untreated,
10 had been treated locally and 5 with peroral medication or UVB. The cytoplasm of basal
keratinocytes in normal skin stained positively with also some nuclear staining suprabasally. Non-
lesional skin did not differ from normal skin, showing cytoplasmic staining basally in 11/13 samples
and suprabasal nuclei were positive in 7/13 samples. In lesional skin, expression was up-regulated
within nuclei and cytoplasm not only basally but also suprabasally above dermal papillae with
attenuated expression in other parts of the epidermis. Positive HCR staining was detected in all
psoriatic untreated lesions and was not appreciably changed in the lesions treated locally with
corticosteroids or calcipotriol. The hyperproliferation marker Ki67 showed inverse patterns of
staining compared to HCR. In contrast to psoriasis, HCR distribution in lichen planus, eczema,
and pityriasis rubra pilaris was similar to nonlesional or normal skin.
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Identi®cation of Differences in Gene Expression Between Nonlesional Psoriatic and
Healthy Epidermis
M. SzeÂll, Z. Bata-CsoÈrgoÄ, A. Pivarcsi, L. KemeÂny, and A. Dobozy
Dermatological Research Group of the Hungarian Academy of Sciences at the Department of Dermatology,
University of Szeged, Hungary
Mechanical injures and T-cell derived cytokines are well-known inducers of psoriasis on the
noninvolved skin of psoriatic patients but not on healthy individuals (Bata-CsoÈrgoÄ, 1995). In order
to ®nd out the cause of this phenomena we investigated the differences between nonlesional
psoriatic and healthy epidermis at the transcription level. Differential display (DD) analysis was
performed comparing the mRNA expression pattern of the nonlesional epidermis of 2 psoriatic
patients and the epidermis of 2 healthy individuals. 25 differentially expressed fragments have been
cloned, analysed by restriction endonucleases and by reverse Southern blot then were sequenced.
Sequence homology searches revealed that the genes for a ras oncogen, RAB10 and ®bronectin are
up-regulated in the nonlesional psoriatic skin. The oncofoetal form of ®bronectin had been already
reported to have an elevated mRNA level in the nonlesional psoriatic epidermis (Ting, 2000),
proving that the used DD method is a powerful tool in our experimental setup. The rest of the
cloned DD fragments showed sequence homologies to cDNAs with yet noncharacterized
functions as well as to genomic sequences. The role of these genes in the proliferation and
differentiation processes of human epidermal keratinocytes are studied in a synchronized HaCaT
cell model by RT-PCR. Both RAB 10 and ®bronectin showed a proliferation-related expression
pattern. Additionally, we demonstrated the expression of the newly identi®ed genes in the
immortalized HaCaT keratinocytes: the expression of several genes was characteristic to discrete
proliferation or differentiation states of the culture while some genes were expressed constitutively
during the development of cell culture. Using the DD technique we were able to detect already
known and yet unknown up-regulated mRNAs in the noninvolved psoriatic skin. The
characterization of the genes for these newly identi®ed transcripts and further analysis of their
expression may bring us closer to the understanding of the genetic background of the
hyperproliferative skin disease, psoriasis.
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Endogenous Retroviral Proteins are Differentially Expressed in Normal Human Skin
and Psoriatic Skin
J.P. MoleÁs, D. Bessis, A. Tesniere, C. Arpin, P.E. Steele, and J.J. Guilhou
Montpellier, France and Cincinatti, USA
Human endogenous retroviruses are classi®ed into 22 families and constitute 2% of the human
genome, but their roles have not been characterized yet. However, increasing evidences suggest
that they could participate during tumor progression and in the pathogenesis of autoimmune
diseases, including multiple sclerosis or polyarthritis rheumatoid. We have investigated whether
these sequences were expressed in normal and pathological skin samples including psoriasis by
using two sera directed against the transmembrane protein of the moloney mouse tumor virus that
contains highly conserved regions within the retroviral family. In protein extracts from normal
human skin, we observed by western-blot two major proteins at 63 and 60 kDa and minor bands at
85, 57 and 29 kDa. These proteins were mainly detected in the insoluble pool suggesting that they
were localized in the membrane or in the cytoskeleton. The different size observed could
correspond to unprocessed proteins. By immuno¯uorescence, a faint and diffuse staining was
observed in all the epidermal layer of a normal skin, however, additional staining were detected in
psoriatic lesions (11/13, 84%). All the basal cells at the bottom of the epidermal ridges contained a
dotty staining in the cytoplasm which could be observed in the juxtalesional psoriatic skin (6/13,
46%) and unfrequently observed in the non lesional psoriatic skin (1/13, 8%). These results also
suggested that this expression could precede the occurrence of the clinical lesion. In reconstituted
epidermis from normal and psoriatic skin biopsies, we observed the same pattern of expression by
immuno¯uorescence as in vivo. By western-blot, no additional band was detected in the protein
extracts of these cultures, but the intensity was ®ve time higher. Finally, circulating epitopes
(29 kDa corresponding to the mature protein) were detected in sera of normal individual and
psoriatic patients. The amount of antigen was three times higher in psoriatic patient than in
control. These results suggest that human endogenous retroviruses are expressed in the epidermis
and that abnormal expression occurs in psoriatic lesion. The characterization of the protein
recognized by these sera would help to further investigate its role in the pathogenesis of psoriasis.
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Heterogeneity of Genetic Mutations in Erythrokeratodermas
E.A. O'Toole, W.L. Di, J. Common, I.M. Leigh, and D.P. Kelsell
London, UK
The erythrokeratodermas represent a group of disorders characterized by the presence of ®xed or
slowly moving erythematous hyperkeratotic plaques. Erythrokeratoderma variabilis (EKV; MIM:
133200) is an autosomal dominant disorder presenting with ®xed, geographic plaques on extensor
surfaces and transient ®gurate red patches at other sites. Progressive symmetric erythrokeratoderma
(PSEK; MIM: 602036) is also inherited as an autosomal dominant condition with incomplete
penetrance and variable expressivity. Hyperkeratotic plaques are distributed symmetrically over the
body, particularly on the limbs and buttocks, but also on the face. Palmoplantar keratoderma is
often present. The main distinction between EKV and PSEK is the presence of variable erythema
in EKV. Mutations in the genes encoding the gap junction proteins Cx31 and Cx30.3 (GJB3) have
been shown to cause EKV. In addition, loricrin mutations in PSEK patients which show clinical
similarities to EKV, have also been described. There are also patients with EKV who do not have
mutations in Cx31, Cx30.3 or loricrin. In summary, diverse mutations result in the clinical
phenotype of erythrokeratoderma. Discovery of new mutations may result in a new classi®cation
of these disorders according to their genetic defects.
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Genetic Analysis of a Severe Case of Netherton-Syndrome and Application for Prenatal
Testing
F.B. MuÈller, I. Hauber,* C. Casper, R. Maiwald,² A. Jung,² H. Jung,² and B.P. Korge
Department of Dermatology, University of Cologne; *Department of Dermatology, University of Heidelberg,
²Institute for Medical Genetics and Molecular Medicine, Cologne; Germany
Netherton Syndrome is a rare autosomal-recessive disease with variable expression. It is de®ned by
a triad of symptoms: congenital ichthyosiform erythrodermia, trichorrhexis invaginata and atopy.
Here we report a case of a female baby from consanguineous parents of Turkish descent exhibited
from birth on a generalised exfoliative erythroderma (GEE). The baby developed recurrent
infections such as otitis media. A high serum IgE level and an aminoaciduria were detectable. Light
microscopy of a skin biopsy revealed a moderate psoriasiforme acanthosis with lack of granular
layer and a thin parakeratotic horny layer. Electron microscopy con®rmed these ®ndings
demonstrating highly undifferentiated keratinocytes (e.g. low amounts of tono®laments and
keratosomes, no keratohyalin granules) that were suggestive of a severe epidermal barrier defect. At
the age of 2 months hair shafts had signs of torsion nodes resembling trichorrhexis invaginata. The
baby continued to suffer from recurrent septicaemia and despite of maximal intensive care support
the baby died at the age of three month due to multiorgan failure secondary to a candida sepsis.
Recurrent severe infections and fatal clinical courses are reported for NS especially when GEE is
present at birth. Recently genetic linkage has been established to the SPINK5 gene locus on
chromosome 5q32 encoding the serine protease inhibitor LEKTI. In our case DNA-sequencing of
the corresponding gene identi®ed a recurrent homozygous mononucleotide deletion (153delT)
resulting in a frame shift that leads to the occurrence of a premature termination codon six residues
downstream of the mutation. As expected both parents were heterozygous for the mutation. In a
new pregnancy of these parents the DNA extracted from amniotic ¯uid had a heterozygous
genotype suggesting that this foetus was phenotypically normal, and subsequently indeed a healthy
baby was born.
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TGk Mutations in a Hungarian Patient with Lamellar Ichthyosis
K. Becker, M. CsikoÂs, Z. Szalai, S. KaÂrpaÂti, and A. HorvaÂth
Budapest, Hungary
Lamellar ichthyosis belongs to the genetically heterogenous group of autosomal recessive ichthyosis
(ARCI). Keratinocyte transglutaminase (TGase I) mutations have been well documented in this
clinical subgroup of the disease. We report a 6-year-old-girl, daughter of healthy, nonconsangui-
nous parents. She has thick, brown adhesive scales on the whole integument and the hairy scalp,
sparing the centrofacial region. Ultrastructural analysis proved large rectangular clefts in groups and
also disseminated in the stratum corneum, corresponding congenital ichthyosis type II, indicating
Tgase I mutations. All 15 exons of the TGase I gene have been ampli®ed and heteroduplexes were
analysed using conformation sensitive gel electrophoresis. Bands of altered mobility were directly
sequenced. We detected two known mutations (A/G substitution in the acceptor splice site of
intron 5 and a G/C transversion in codon 379 of exon 7) in a compound heterozygous pattern.
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Novel and Recurrent Mutations in the Genes Encoding Keratins K6a, K16 and K17 in 13
Cases of Pachyonychia Congenita
A. Terrinoni,*² F.J.D. Smith,* B. Didona,² M. Paradisi,² M. Huber,³ D. Hohl,³ A. David,§ A.
Verloes,¶ I.M. Leigh,** C.S. Munro,²² G. Melino,² and W.H.I. McLean*
*Epithelial Genetics Group, Human Genetics Unit, Department of Molecular and Cellular Pathology,
Ninewells Medical School, Dundee DD1 9SY, UK; ²Biochemistry Laboratory, IDI-IRCCS, c/o
Department Experimental Medicine, University of Rome `Tor Vergata', 00133-Rome, Italy; ³CHUV,
Service de dermato-veÂneÂreÂologie, HoÃpital de Beaumont, Lausanne, Switzerland; §Service de genetique
medicale, Centre Hospitalier, Universitaire de Nantes, Nantes, France; ¶Wallonia Centre for Human
Genetics, Liege University, Liege, Belgium; **Academic Department of Dermatology, Royal London
Hospital, London, UK; ²²Department of Dermatology, Southern General Hospital, Glasgow, UK
Thirteen patients with pachyonychia congenita types 1 and 2 (PC-1, PC-2) were studied, two of
which had a family history of pachyonychia and 11 of which were sporadic cases. Heterozygous
missense or small in-frame insertion/deletion mutations were detected in the genes encoding
keratins K6a, K16 and K17 in all cases. Three novel mutations, F174V, E472K and L469R were
found in the K6a gene. Two novel mutations, M121T and L128Q were detected in K16.
Similarly, three novel mutations L95P, S97del and L99P were found in K17. In addition, we
identi®ed recurrent mutations N171del (three instances) and F174S in K6a and R94H in K17.
Analysis of both phenotype and genotype data led to the following conclusions: (a) K6a or K16
mutations produce the PC-1 phenotype whereas K17 (or K6b) mutations cause PC-2; (b) the
presence of pilosebaceous cysts following puberty is the best indicator of PC-2; (c) prepubescent
patients are more dif®cult to classify due to the lack of cysts; and (d) natal teeth are indicative of
PC-2 although their absence does not preclude the PC-2 phenotype. This study establishes useful
diagnostic criteria for PC-1 and PC-2, which will help limit unnecessary DNA analysis in the
diagnosis and management of this genetically heterogeneous group of genodermatoses.
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Three Novel Keratin 14 Gene Mutations in Dowling-Meara Type Epidermolysis Bullosa
Simplex
M. CsikoÂs, Zs Szalai, K. Becker, EÂ . ToÈroÈk, A. HorvaÂth, and S. KaÂrpaÂti
Budapest, Hungary
In Dowling-Meara type epidermolysis bullosa simplex mutations in genes K5 and K14 encoding
the keratin intedmediate ®laments expressed in basal cells have been identi®ed. In three Hungarian
families with skin fragility and palmoplantar hyperkeratosis ultrastructural studies con®rmed the
diagnosis. Elderly patients displayed milder, younger more severe skin symptoms. We scanned
genomic sequences of keratin 14 gene in three probands. In all cases novel mutations (N123K,
R125G, V133L) in helix 1 A were detected. All three mutations located in the evolutionarily
highly conserved residue of the critical amino-terminal end in the rod domain. These mutations
add to evidence of phenotype-genotype correlation in epidermolysis bullosa simplex, however, an
explanation for the accompanying palmoplantar hyperkeratosis in Dowling-Merara disease is still
missing.
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Spontaneous Differentiation-Related Dissociation of Skin Fragility Syndrome
Keratinocytes in Emerged Cultures
C.K. Laperdrix, N. Wahbi, H. Cohen-Angoulvant, D. Perrot, D. Schmitt, and M. Haftek
INSERM U. 346/CNRS, Department of Dermatology, HCL, Lyon, France
Skin fragility syndrome (SFS) is an autosomal recessive genodermatosis due to mutations in the
plakophilin 1 gene. Our adult patient has been previously followed up as an atypical case of
Netherton syndrome. He presented with curly, sparse hair, transgedient ®ssurated palmo-plantar
keratoderma, nail dystrophy and numerous nummular hyperkeratotic and in¯ammatory lesions of
the skin appearing mainly at regions subjected to a moderate trauma. Skin biopsy was taken from
the normally ±appearing skin and subjected to biochemical, bio-molecular and immunocyto-
chemical analysis. No detection of plakophilin 1 was possible using two monoclonal antibodies
directed to this desmosomal plaque protein but plakoglobin, desmoplakin and desmosomal
cadherins were still present in the epidermis. Desmosomes were infrequent and of small size, poorly
attached to the keratin cytoskeleton. Sequencing of the RT-PCR products obtained from the
extracted mRNAs con®rmed the homozygous mutation of the PKP1 gene diagnosed in J.
McGrath's laboratory (London, U.K.) on a sample of the patient's genomic DNA. The isolated
keratinocytes were subcultured, ®rst on 3T3 ®broblasts then in low-calcium KSFM. The cells
formed little colonies and tended to disperse individually at the periphery. When seeded on dead
desepidermised human dermis and allowed to stratify in immersed conditions, the cultured
keratinocytes reconstructed a multilayer epithelium which would split horizontally soon after
lifting at the air/medium interface. Internal tensions occurring in the upper epidermal layers due to
formation of the stratum corneum apparently provoked spontaneous dissociation, not observed in
normal or Hailey-Hailey control cultures.
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Mutational Spectrum of the D8-D7 Sterol Isomerase Gene and Extent of Biochemical
Defects in Patients with the Conradi-Huenermann±Happle Syndrome
C. Has, U. Seedorf, F. Kannenberg, L. Bruckner-Tuderman, and H. Traupe
Muenster, Germany
The Conradi-Huenermann-Happle (CHH) syndrome is caused by mutations in the D8-D7 sterol
isomerase (emopamil binding protein) gene which result in a metabolic defect of cholesterol
biosynthesis. So far, only a small number of patients have been studied world wide. We wanted to
know whether there is a mutation hot spot and how often somatic and gonadal mosaicism occurs
and whether the extent of biochemical alterations correlate with speci®c mutations. Therefore we
analysed the mutations in the D8-D7 sterol isomerase gene in 16 families with the CHH syndrome,
9 of them previously reported and 7 newly investigated. Using gas chromatography and mass
spectrometry (GC-MS) we also studied the accumulations of cholesterol precursors (8-
dehydrocholesterol and cholest-8(9)-en-3b-ol) in serum of patients and relatives. Among the
new families no further family with evidence for somatic or gonadal mosaicism was found. We
observed a wide spectrum of mutations involving all four exons and no mutational hot spot. In the
newly studied families we found the following novel mutations W47X, W82C, Y11X, a deletion
in exon 4 and an intronic mutation involving the splice site between exon 3 and intron 3. Sterol
accumulation in the serum proved to be very valuable for rapid con®rmation of the diagnosis, but
their extent did not correlate well with speci®c mutations. We conclude that there is a wide
mutational spectrum of the D8-D7 sterol isomerase gene in CHH syndrome patients and altogether
found 14 different mutations in the 16 families. In one family diagnosis of CHH syndrome was
con®rmed by typical GC-MS pro®le, but the mutation could not be resolved.
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Palmoplantar Keratoderma Type Bothnia: Candidate Gene Analysis of the Disease
Locus Region on Chromosome 12q13
L.M. Wennerstrand, M.H. Klingberg, A. LundstroÈm,* and L.K. Lind
Department of Medical Biosciences, Medical Genetics, UmeaÊ University, UmeaÊ, Sweden; *Department of
Public Health and Clinical Medicine, Dermatology, UmeaÊ University, UmeaÊ, Sweden
We have genetically characterised three types of PPK in the northern part of Sweden, of which
Palmoplantar Keratoderma type Bothnia (PPKB) is the most common. PPKB is very common in
the northern part of Sweden and is actually the most common genodermatose in this part of the
country. PPKB is inherited as an autosomal dominant trait and is a diffuse nonepidermolytic PPK,
frequently complicated by dermatophyte infections. The disorder shows strict site speci®city, the
skin of the patients is normal, except for the hands and feet, and there are no associated
malformations or malignancies. We have mapped the disease locus to a 1.5-cM region on
chromosome 12q13, using genotype data from 296 individuals from 15 families with family
members diagnosed with PPKB. To date, this region on chromosome 12q13 is known to harbour
at least 31 genes, however, none of these genes constitute obvious candidates for PPKB. We have
decided to begin our investigations of possible candidate genes with one of the genes in the 12q13
region; the SMARCD1 gene (SWI/SNF-related, matrix-associated, actin-dependent regulator of
chromatin, subfamily D, member 1). It has been suggested that the SWI/SNF complex is involved
in chromatin-remodeling and that tissue speci®c chromatin-remodeling complexes may also play a
role in maintenance or differentiation of diverse cell types. In addition it has been implied that the
transcription of speci®c genes are thought to be chromatin-remodeling dependent. Therefore
SMARCD1 could be a candidate for PPKB since the hyperkeratosis could be a result of distorted
regulation of differentiation of the keratinocytes in epidermis of palmoplantar skin. The coding
regions of the SMARCD1 gene have been analysed by denaturing-high-performance-liquid
chromatography (DHPLC) and identi®ed polymorphisms have been sequenced. So far, no
polymorphism found in the SMARCD1 gene segregates with the disease.
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Linkage to the Wiskott±Aldrich Syndrome Gene in Swedish Patients with Atopic
Dermatitis
M. Bradley,*² C. SoÈderhaÈll,² C-F. Wahlgren,* H. Luthman,² M. NordenskjoÈld,² and I.
Kockum²
*Department of Dermatology and Venereology and ²Department of Molecular Medicine, Karolinska
Hospital, Karolinska Institutet, Stockholm, Sweden
Atopic dermatitis is a multifactorial disorder and most likely caused by common polymorphisms in
many different genes in combination with several environmental factors. In the search for genetic
explanations to atopic dermatitis, the clinical similarity between atopic dermatitis and the eczema
manifestation in patients with Wiskott±Aldrich syndrome (WAS) made the previously identi®ed
WAS gene (located on chromosome Xp11.23) an interesting candidate gene for atopic dermatitis.
We studied linkage and association to the WAS gene using four microsatellite markers in 361
Swedish families with at least two siblings affected with atopic dermatitis (in total 1325 individuals
and 824 affected siblings). In the analyses we followed two different qualitative traits: atopic
dermatitis and elevated allergen-speci®c serum IgE antibodies, and one quantitative trait, a severity
score of atopic dermatitis. We found positive linkage with a maximum lod score (MLS) of 1.68
(p < 0.05) to marker MAOB following the trait severity score of atopic dermatitis. No association
could be seen to either of the traits in this region using the transmission/disequilibrium test (TDT).
Our results indicate that either the WAS gene or another gene in the area contributes to the
severity of the atopic dermatitis phenotype in this material.
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The Association between HLA-DR, DQ Antigens and Vulvar Lichen Sclerosus in UK
X.H. Gao, M. Barnardo, J. Cook, J. Agudelo, S. Marshall, J. Powell, S. Fuggle, and F.
Wojnarowska
Oxford, UK
Preliminary studies showed that certain HLA class II allotypes predominant in lichen sclerosus,
implicating an immunogenetic role in its susceptibility and pathogenesis. To con®rm this
hypothesis, we performed DNA typing for HLA-DR and DQ antigens in the largest ever cohort
of vulvar lichen sclerosus. The patients (both adults and children) were Caucasian females from the
Oxford area, UK. 179 blood DNA samples from the patients were typed using the well established
sequence speci®c primer PCR phototyping method, and the gene frequencies for DR1, DR10,
DR103, DR11, DR12, DR13,DR14, DR15, DR16, DR17, DR4, DR7, DR8, DR9, DQ2,
DQ4, DQ5, DQ6, DQ7, DQ8, DQ9 and DQ3 were compared with that of 602 consecutive
cadaveric donor from UK (mainly local to Oxford) using 2-tailed Fisher's exact test. DR12 was
present in 10.92% of patients compared with 2.68% of controls (p < 0.0005 with Benferroni
adjustment), DR15 in 16.3% of patients v.s 30.18% of controls (p < 0.005), DR17 in 12.10% of
patients v.s 28.04% of controls (p < 0.05), DR7 in 43.22% of patients v.s 29.02% of controls
(p < 0.05); DQ7 was present in 49.02% of patient v.s 34.54% of control (p < 0.005 without
adjustment), DQ3 in 85.96% of patients v.s. 65.06% of controls (p < 0.01). Other allotypes in the
patient group showed no statistical differences with the control group. Our results con®rmed the
previous reports that DQ7 is predominant in lichen sclerosus. There seems to be strong evidence
for a role of DQ7 (tested alleles include DQB1* 0301/0304/0309/0310), DR12 and DR7 in
susceptibility to lichen sclerosus, whilst DR15 and DR17 may have a role in protection from
lichen sclerosus.
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Polymorphisms of the TNF Region are Associated with Pustulosis Palmaris et Plantaris
Among Japanese
H. Niizeki, K. Hashigucci,* T. Naruse,² Y. Yamasaki, H. Inoko,² and T. Nishikawa³
Department Dermatol, Natl Tokyo Medical Ctr, Tokyo, Japan; *Department Otolaryngol, Kitasato Instit
Hosp, Tokyo, Japan; ²Department Mol Lifesci, Tokai University Sch Medical, Isehara, Japan; ³Department
Dermatol, Keio University Sch Medical, Tokyo, Japan
We previously reported that pustulosis palmaris et plantaris (PPP) is associated with polymorphism of
the TNFB gene but not the TNFA gene among Japanese. To identify the susceptible gene for PPP,
we further determined the frequencies of various gene markers with the TNF region. To avoid the
heterogeneity of the disease, we checked the tonsilar provocation test in all patients. According to
the results, the patients group (n = 93) was divided into two groups (48 patients with negative
result, PN and 50 patients with positive result, PP). Detection of alleles of the TNFa, TNFc, TNFd
microsatellites by the PCR- Simple Sequence Length Polymorphism method revealed that the
frequency of TNFd4 is decreased in PN when compared with PP or control group (n = 247, p
< 0.05). However, there are no differences in the frequencies of the TNFa and TNFc alleles
among the patients groups and controls. To identify the telomeric end of the susceptible locus, we
further determined SNP of the TNFB and TNFA gene. Detection of polymorphism in intron 1 of
the TNFB gene (TNFB/NcoI I) revealed that the frequency of allele 2 of the TNFB gene was
increased only in PN but not PP when compared with control (n = 67, p < 0.05). Analyses of
polymorphims in the TNFA gene revealed that the frequency of allele A (±863C, ±857C) was
increased in PN when compared with PP (p < 0.05) or controls (n = 575, p < 0.0005). Moreover,
the frequency of allele B (±863 A) was decreased in PN when compared with PP (p < 0.05) or
controls (p < 0.01) and the frequency of allele D (±857T) was decreased in PN when compared
with controls (p < 0.05). To consider environmental factors for PPP, we set up another control,
chronic tonsillitis; There are any differences in the frequencies of SNP of the TNFA and TNFB
gene between PN/PP and chronic tonsillitis. In conclusion, PN is associated with the TNF region
among Japanese, suggesting that the PN susceptible gene is located between TNFd and TNFB, and
TNFA may be the strong candidate.
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Interactions of Oncogenes, Tumor Suppressor, Mismatch Repair and Apoptosis-
Related Genes in the Development of Melanoma
H. Zhang and I. Rosdahl
LinkoÈping, Sweden
Several genetic alterations have been implicated in the development of malignant melanoma, but
the expression of oncogenes, tumor suppressor, mismatch repair and apoptosis-related genes and
their interactions in melanoma have not been completely clari®ed. We simultaneously examined
the expression of p73, c-erbB-2, ras, p53, Mdm2, p27, DCC, hMLH-1, hMSH-2, bcl-2, Bax and
NF-kB, by immunocytochemistry, in both primary and metastatic melanoma cell lines derived
from melanoma patients. The results showed that p73 was expressed in 7/8 cell lines, but stronger
expressed in the metastatic cells than in the primary melanoma cells. c-erbB-2 was detected in all 8
cell lines and ras in 2/5 metastases. p53 was found in all the cell lines and Mdm2 in 1/8 of the cell
lines. In the same patient, the intensity of p27 expression was decreased from the primary to the
metastatic tumors. bcl-2 was expressed in all the cell lines. Bax was absent in 5/8 cell lines. In the
same patient, Bax was weakly expressed in the primary tumor but lost in the metastases. The data
demonstrate that overexpression of p73, c-erbB-2, p53 and bcl-2, and loss of Mdm2 and Bax may
interact and play important roles in the development and aggressiveness of human melanoma.
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Detection of Clonal k Light Chain Gene Rearrangements in Cutaneous B-Cell
Lymphomas by Polymerase Chain Reaction
B. Pigozzi, M. Mori,* C. Manuelli,* A. Belloni Fortina, A. Peserico, N. Pimpinelli,* and M.
Alaibac
Institute of Dermatology, University of Padua and *Department of Dermatology, University of Florence, Italy
The polymerase chain reaction (PCR) technique has been used to detect clonal B cell populations
in cutaneous biopsy material. Several studies have established PCR-based methods for the
detection of immunoglobulin heavy chain (IgH) gene rearrangement using consensus primers to
the VH and JH regions. Recently, Igk gene rearrangement analysis has been utilized for the clonal
analysis of B-cell lymphomas. Studies have shown that in all Igk B-cell lymphomas and in a very
large majority of Igl B-cell lymphomas, either productive or nonproductive Igk products are
formed Therefore, the rearranged genomic products of Igk represent a marker for B-cell clonality
analysis. In this study we have utilised a single pair of consensus Vk and Jk primers to detect clonal
k light chain rearrangements in a panel of well-characterized cutaneous B-cell lymphomas
(CBCL). DNA was isolated from frozen tissue blocks of 12 cases of CBCL and ampli®ed using a
single pair of Vk and Jk consensus oligonucleotides. B-cell amplicons were analyzed by means of a
nondenaturing polyacrilamide gel method. Using this approach Igk clonal products could be
detected in 3 out of 12 cases of CBCL (25%). This percentage is lower than that demonstrated
using oligoprimers recognizing consensus VH and JH regions (about 50%). The lack of PCR
products in most of the samples investigated could be a result of several reasons. It is possible that
some genes of the Vk and Jk families analyzed may not be ef®ciently ampli®ed with the Vk and Jk
consensus primers. However, the fact that clonal k light chain gene rearrangements were
successfully ampli®ed in 25% of CBCL shows that a PCR analysis is reasonable with the single pair
of primers used and may be used as an adjunct to IgH analysis.
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Monocytes from Patients with Extrinsic and Intrinsic Atopic Dermatitis Exhibit Distinct
Properties
N. Novak, M. Becker, S. Kraft, E. Geiger, H. KluÈken, and T. Bieber
Department of Dermatology, University of Bonn, Germany
Atopic diseases are multifactorial conditions where humoral and cellular immunological
mechanisms play a pivotal role in mounting allergic reactions. Particularly in atopic dermatitis
(AD), it has been reported that monocytes display substantial abnormalities. A majority (70%) of
the AD patients show high concentrations of total and allergen-speci®c IgE in blood and skin; this
form has been individualized as the extrinsic AD. In the so-called intrinsic form (30%) patients have
normal total serum IgE and no detectable allergen-speci®c IgE. This suggests that elevated
allergen-speci®c IgE levels are not a prerequisite in the pathogenesis of at least the intrinsic form,
key mechanisms contributing to the state of disease being therefore still unknown. The present
study was designed to analyze in details monocytes from atopic individuals including allergic
rhinitis (AR) (n = 26), extrinsic (EAD) (n = 37) and intrinsic (IAD) (n = 7) forms of AD under
different aspects and to compare these cells with those from normal nonatopic donors (NA)
(n = 41). Our data show that monocytes from atopic individuals constitutively express signi®cantly
higher amounts of the costimulatory molecule CD40. Additionally, the high af®nity receptor for
IgE (FceRI) and the low af®nity receptor for IgE (CD23) were signi®cantly up-regulated in AR
and EAD but not in IAD and correlated with the expression of the a-chain of the IL-4R (IL-4Ra;
CD124). IL-4Ra was increased in AR and EAD but not in IAD patients and nonatopic controls.
Since the pathophysiological background of IAD is completely elusive, these signi®cant differences
in the phenotype of monocytes from patients with EAD and IAD might be an important aspect in
the investigation of the immunoregulatory mechanisms involved in the pathogenesis of IAD.
Additionally our data might contribute to the development of a diagnostic tool which could enable
us to distinguish between different atopic diseases and nonatopic individuals by simple monocyte-
phenotyping.
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Baff, a Ligand of the TNF Family Expressed by Dendritic Cells, is Involved in T Cell
Activation
B. Huard, P. Schneider,* D. Mauri,* J. Tschopp,* and L. French
Geneva and *Epalinges, Switzerland
In an effort to identify new molecules that could be used in the formulation of vaccine for cancer
immunotherapy, we screened molecules expressed in Dendritic Cells for their immunostimulatory
capacity. Among ligands of the TNF family, BAFF is a recently described member expressed in
dendritic cells with a potent stimulatory activity on B cells. Interestingly, we found that BAFF
induces the proliferation and cytokine secretion of puri®ed human T cells in the presence of a
suboptimal concentration of antibodies to the TCR/CD3 complex. BAFF is additive to the CD28
pathway. Resting T cells (CD4+ and CD8+) as well as primed T cells were found to be responsive
to BAFF. Our data shows that BAFF is a new T cell costimulatory molecule and indicates that this
TNF ligand may not only regulate humoral but also cellular immunity. BAFF may therefore be a
valuable molecule in the formulation of cancer vaccine.
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Bystander Cytolysis of CD4+ T Cells as a Potential Mechanism for CD8+ Effector T Cell
Dominance in Contact Hypersensitivity
J.C. Simon, J. Dudda, and S. Martin
Freiburg, Germany
For many allergic reactions to haptens and metal ions it has recently been shown that CD8+ Tc1
cells rather than CD4+ Th1 cells are the crucial effector cells. We have used the murine model of
contact hypersensitivity (CHS) to the hapten trinitrophenol (TNP) to analyse the mechanisms
underlying the predominance of CD8+ T cells as effector cells. When mice were sensitized by
hapten painting with trinitrochlorobenzene (TNCB) or by i.d. injection of TNP-modi®ed
dendritic cells (DC) an ef®cient ear swelling response was detected following ear challenge with
TNCB. The effector cells isolated from local draining lymph nodes were cytotoxic, IFN-g
producing CD8+ Tc1 cells. Despite the presence of immunogenic TNP-epitopes for CD4+ T cells
on the antigen presenting cells (APC) we did not observe CD4+ T cell priming using ELISPOT
assays. In an in vitro T cell priming system using DC as APC and T cells and APC from Perforin-
de®cient and Fas/FasL-de®cient mice, we could show that soluble factors do not play a role in the
preferential CD8+ T cell priming but that the CD8+ Tc1 effectors lyse the CD4+ T cells in a Fas
dependent manner. In addition, we found that CD4+ T cells can ef®ciently acquire TNP from
antigen presenting cells. Whether the passively acquired antigen is functionally presented on the
CD4+ T cell is currently under investigation. We conclude from our results that bystander cytolysis
of CD4+ T cells could be the mechanism underlying the preferential CD8+ T cell activation
observed for a number of allergic responses to haptens.
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Intracellular Preformed DPIV/CD26 can be Mobilized Rapidly to the Lymphocytic Cell
Surface: Possible Pathogenic Signi®cance for the Atopic Disease Spectrum
A. Ambach, B. Bonnekoh, D. Reinhold, and H. Gollnick
Magdeburg, Germany
The membrane bound protease dipeptidyl peptidase IV (DPIV/CD26) cleaves neuro-peptides,
growth factors, b-chemokines or HIV-1Tat. It is implicated in the pathogene-sis of autoimmune
disorders. Surface levels are known to be elevated in PBLs of patients with atopic dermatitis (AD)
and on birch pollen-speci®c T cell clones. Recently, we demonstrated a severe transport defect for
intracellular proteins in PBLs of atopic pati-ents, namely a hyperreleasability of perforin-granules
from cytotoxic T cells [A. Ambach et al. J Allerg Clin Immunol 2001 in press]. Thus, the elevated
DPIV/CD26 surface levels on PBLs of atopic patients might be due to a disturbed transport
mechanism for preformed DPIV/CD26. To verify this hypothesis we now investigated, if such an
intracellular pool of DPIV/CD26 may exist, and if it can be mobilized rapidly to the cell surface.
Ficoll isolated PBLs of healthy donors and the natural killer cell line YT were stained with anti-
CD26 or anti-CD63 antibodies. Surface staining and intracellular staining was determined
separately. Release of intracellular storage organelles was induced by phor-bol 12-myristate 13-
acetate (PMA) and ionomycin (ION). At various timepoints cells were stained with or without
saponin-permeabilization and analyzed in a ¯ow cytometer. There was a strong intracellular
staining for DPIV/CD26 in the majority of PBLs and YT cells. In addition, DPIV/CD26 surface
staining increased after PMA/ION-stimulation with a time kinetic similar to that found for the
secretory lysosome marker CD63. In summary, evidence is presented for the existence of an
intralymphocytic pool of preformed DPIV/CD26 which can be translocated rapidly to the plasma
membrane following cell activation. Thus, disturbances in the DPIV/CD26 surface level might be
understand-able through the known hyperreleasability for intracellular granula in atopic
lymphocytes.
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The Immune Response of Speci®c T-Cell Hybridomas on Stimulation with Synthetic
Complete Antigens
M. Holmdahl, S.R. Ahlfors, R. Holmdahl, and C. Hansson
Lund, Sweden
Allergic contact dermatitis is mediated by a T-cell response to a hapten-modi®ed peptide.
However no endogenous complete allergen has been chemically de®ned. In this study we have
used a pentadekapeptide, a fragment of collagen II with known af®nity to MHC II, as carrier
peptide. This peptide was modi®ed by addition of haptens. The dinitrophenylmodi®ed peptide
was used for immunisation of mice. Speci®c T-cells were isolated and T-cell hybridomas were
produced. The hybridoma cells were then stimulated by different hapten-modi®ed peptides and
the immunologic response was recorded as the thymidine incorporation. Several clones of speci®c
T-cells were isolated, all with a strong speci®city for the complete antigen used at immunisation
carrying the hapten on a lysine moiety of the carrier peptide chain. No response was achieved
when haptens were added to the sulfhydryl group of homocysteine which were allowed to
substitute lysine in the carrier peptide. A speci®c but much weaker response was obtained when L-
lysine was substituted to D-lysine in the carrier peptide. Neither the unsubstituted carrier peptide
nor this peptide modi®ed with a completely different hapten gave any response in any of the
hybridomas. The results show the speci®city of the formed T-cells hybridomas. We found a
dramatic change in the immunologic response when the amino acid moiety carrying the hapten
was shortened in length and the reactive group of the amino acid was changed from amino to
sulfhydryl. The stereochemical requirements were of importance for the strength of the response.
This immunologic model is generally useful in studying cross-reactivities.
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Instruction of a Th1 Inducing ``DC1'' Phenotype and Resistance to Leishmania Major in
Susceptible BALB/c Mice with Interleukin 4
S. Zimmermann,*² T. Biedermann, H. Himmelrich,³ O. Egeter, A.K. Sakrauski, I. Segmuller,³
A.D. Levine,§ H. Wagner², K. Heeg,*² J.A. Louis³, and M. RoÈcken
Department of Dermatology, Ludwig-Maximilians-University Munich, *Department of Microbiology,
²Technical University of Marburg, ³Institute of Biochemistry, University of Lausanne, Department of
Microbiology, Technical University Munich, §Department of Gastroenterology, Case Western Reserve
University
Resistance and susceptibility to intracellular pathogens are regulated by interleukin (IL-) 12, which
mediates Th1 responses and resistance, and IL-4, which induces Th2 cells and susceptibility. Thus,
inhibition of IL-4 or injection of IL-12 can induce Th1 responses and resistance in otherwise
susceptible BALB/c mice infected with the intracellular parasite Leishmania major (L. major). Here
we show that, paradoxically, IL-4 can instruct dendritic cells (DC) to become a DC1 phenotype
that induces T helper cell differentiation toward a Th1 phenotype. Most importantly, priming
BALB/c mice with IL-4 during infection of DC by L. major and prior to the activation of L. major±
speci®c T cells, converted the susceptible BALB/c mice into a resistant phenotype. IL-4 primed
BAPLB/c mice controlled L. major as ef®ciently as naturally resistant C3H mice and developed
Th1 responses. Anti-IL-12 abrogated IL-4 induced Th1 development and resistance to L. major.
Since immune responses evolve via the consecutive activation of ®rst DC and, subsequently, T
cells, the contrasting effects of IL-4 on DC (induction of Th1 inducing Th1 cells) and T cell
differentiation (induction of Th2 cells) can lead to the maturation of T cells with opposing
functional phenotypes. These ®ndings may impact on the design of cytokine-based immune
therapies currently studied in humans with melanoma or psoriasis.
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Fumaric Acid Ester Induce Selective Reversal of the Interferon g/Interleukin 4 Ratio in
Peripheral Blood CD4+ T Lymphocytes
K. Ghoreschi, P. Thomas, C. Reitmeier, G. Plewig, and M. RoÈcken
Department of Dermatology, Ludwig-Maximilians University, Munich, Germany
Psoriasis is an in¯ammatory T cell mediated autoimmune disease dominated by interferon Error!
Reference source not found. (IFN-g) producing type 1 T cells in®ltrating skin lesions. A
predominant Th1 response is also found in the peripheral blood lymphocytes of the patients.
Systemic therapy with dimethylfumarate is an effective treatment of psoriasis in a large number of
patients but the mechanisms are still unclear. Here we investigated the in vivo effects of fumaric acid
esters (FAE) on peripheral T and B lymphocytes during the therapy of chronic psoriasis. Eighteen
patients were treated with FAE according to a standard regimen. During the ®rst weeks oral FAE
did not exceed 165 mg per day. Subsequently, the dose of FAE was increased individually in
function of the subjective tolerability and the clinical improvement of psoriasis (mean of 645 mg
FAE per day at 2 months of therapy). Serum and freshly isolated peripheral blood mononuclear
cells (PBMC) were analyzed at regular intervals for up to 12 months. Total leukocyte counts and
their relative distribution of leukocyte subsets remained largely unaffected, except for a signi®cant
increase of the eosinophil fraction between week 4 and 6 of therapy and a 7% decline of the total
lymphocyte fraction. The decline in total lymphocytes was not signi®cant during therapy. The
percentage of CD3+ T cells, the CD4/CD8 ratio and the CD19 cell fraction remained unchanged.
Neither CD23 expression on either monocytes or B cells, nor serum IgE levels were in¯uenced by
the therapy even though FAE can induce Th2 type cytokines in vitro. Intracellular cytokine analysis
of freshly isolated, mitogen stimulated T cells showed a signi®cant in vivo increase in interleukin
(IL-) 4 producing CD4+ T-cells around week 6 only. Subsequently the fraction of IFN-g
expressing T cells decreased signi®cantly in the CD4+ but not in the CD8+ subset. This resulted in
a signi®cant reduction of the IFN-g/IL-4 ratio within the CD4+ T cell fraction only. IL-2 and
TNF-a production by CD4+ T-cells remained unchanged. Cell proliferation in response to lectin
mitogen or recall-antigen (tetanus toxoid) was not affected by the FAE therapy. Importantly, the
peripheral suppression of IFN-g producing CD4+ cells was accompanied by a marked decrease of
PASI (> 70%). Thus FAE induce a Th1/Th2 shift obviously by suppressing inappropriately
activated Th1 subsets and may thus ameliorate in¯ammatory autoimmune diseases like psoriasis.
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Carbamazepine-Speci®c T Cells are Detected in Drug-Allergic Patients after Metabolic
Bioactivation by Peripheral Blood Mononuclear Cells
N. Acharya, A. Smith, Z. Hawkins, I. Strickland,* and P.S. Friedmann
Southampton, UK; *Denver, USA
Detection of drug-speci®c lymphocytes in patients with drug allergies is often unsuccessful. We
aimed to see if peripheral blood mononuclear cells (PBMC) could metabolise carbamazepine
(CBZ) to a form able to elicit lymphocyte proliferation and to use our novel 2-phase lymphocyte
proliferation assay to characterise the responding lymphocytes. 13 patients with allergy to CBZ
(erythema multiforme) and 7 patients taking the drug with no problem were tested. PBMC were
incubated with a range of concentrations of CBZ in ¯at-bottomed wells for 48 h. The supernatants
were removed and ®ltered and the remaining adherent cells washed. Fresh PBMC were added to
both the supernatant and the adherent cells for 6 days. Proliferation, detected as 3H-thymidine
uptake, was expressed as stimulation index(SI), compared with antigen-free cultures. All 13 CBZ-
allergic patients gave SI greater than 3 (median 20, IQ range 5±95) when cells were culture in
supernatants; cells cultured with the adherent macrophages or in conventional lymphocyte
proliferation assays failed to respond; the nonallergic patients all gave negative responses. Analysis of
the responding lymphocytes (N = 4) showed they were CD4+ and secreted predominantly IL-5 up
to (1100 pg per mL) with small amounts of IFNg. Addition of ketoconazole (30microM) during
the 48 h incubation, reduced the subsequent lymphocyte SI from a median of 30±6 (N = 4)
suggesting CYP450-mediated metabolism is required. This novel assay allows metabolic
bioactivation of native drugs to generate metabolites recognisable by T cells in vitro. The system
also allows analysis of the T cell phenotype and the metabolic pathways involved in bioactivation.
208
Differential Effects of Tuberculin and Sodium Lauryl Sulphate on Impedance Response
Patterns in Human Skin
M. NyreÂn, L. HagstroÈmer, and L. Emtestam
Stockholm, Sweden
When an electrical potential is applied to human tissue, the pattern of the resulting current ¯ow is
determined by shapes, arrangements, and internal structure of tissue cells. By measurement of the
electrical current patterns over a range of frequencies, well-de®ned indices describing the tissue
structure can be calculated. In this study, we used a pencil probe (diameter 10 mm) to measure
impedance spectra on skin reactions induced by 0.1 mL of PPD (2TU) that was injected
intracutaneously on the volar forearms of 16 adult healthy subjects, all known to be tuberculin-
sensitized. Assessments were performed 3 and 7 days after the injections, using visual scoring, a new
electrical impedance technique and transepidermal water loss. Compared to relevant controls and
reactions induced by sodium lauryl sulphate (SLS), signi®cant changes in the impedance parameters
were found. Unlike the irritant reactions, no signi®cant increase in transepidermal water loss values
in tuberculin reactions were found. This can be explained by the fact that the epidermis is little
affected, since the in¯ammatory process in the tuberculin reaction is located deeper in the dermis
than with the irritant reaction. Characteristics of the electrical impedance spectra may be explained
by changes in cellular and intracellular events, and the current study suggests that electrical
impedance in the described implementation may be used to give good separation of PPD- and
SLS-induced skin reactions.
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Irritant and Allergic Contact Reactions Assessed by Electrical Impedance
M. NyreÂn, N. Kuzmina, and L. Emtestam
Stockholm, Sweden
When an electrical potential is applied to human tissue, the pattern of the resulting current ¯ow is
determined by shapes, arrangements, and internal structure of tissue cells. By measurement of the
electrical current patterns over a range of frequencies, well-de®ned indices describing the tissue
structure can be calculated. We used a pencil probe (diameter 10 mm) to measure impedance
spectra of nickel allergic contact reactions and irritant contact reactions induced by sodium lauryl
sulphate (SLS). Various concentrations of the test substances in distilled water were applied on the
volar forearms of 19 adult women, all known to be nickel allergic. Assessments were performed 3
and 7 days after the applications. Measurements made on the two types of cutaneous reactions were
very well separated. Compared to the reactions induced by SLS, statistically signi®cant changes in
three of the four impedance indices were found on day 3: namely the means of index MIX and
index IMIX (p < 0.001) and the mean of index RIX decreased (p < 0.01). Characteristics of the
electrical impedance spectra may be explained by changes in cellular and intracellular events, and
the current study suggests that electrical impedance in the described implementation may be used
to give good separation of contact reactions of allergic and irritant nature.
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In Vivo Spontaneous Semipublic T Cell Response Against Melanoma (B16) Disappear
During Tumor Rejection Induced by GMCSF
M. Mempel,² P. Kourilsky,² G. Gachelin,² and P. Musette*²
*INSERM U532, HoÃpital Saint-Louis; ²INSERM U277, Institut Pasteur, Paris, France
The numerous studies in mice and humans concerning the T cell repertoire in melanocytic tumor
have resulted in con¯icting data. Ef®cient antimelanocytic responses was found oligoclonal in
spontaneous melanoma rejection and in halo-nevi in human. In contrast, the T cell response to
progressing tumors is more diverse, not to say polyclonal. The present work is aimed at
approaching the in vivo diversity of the b chains of the T-cell receptor (TCR) of the T cells present
in B16 melanoma during tumoral growing and in B16 undergoing immune-mediated regression.
In order to avoid biases introduced by in vitro cloning we have used the ``immunoscope''
technology that permits to describe the BV, BJ and CDR3 length usages of the T cells. C57BL/6
mice were subcutaneously injected in two sites with 105 irradiated B16/F10 transfected with
GMCSF or with PBS as control. At day 14 following the injection mice were injected with 5.105
B16. All mice injected with B16/F10/GMCSF rejected B16 melanoma and were resistant to a new
challenge. Spleen, lymph node, and tumoral total RNA was extracted for TcR repertoire
analysis.the BV-BC PCR products prepared from non rejected B16 tumors in control mice
displayed diverse patterns. Most BV-BC combinations yielded a gaussian signal indicative of an
absence of speci®c stimulation of the corresponding T cells, whereas BV11-BJ2.1 yielded isolated
peaks in 5/5 mice with a unique CDR3 length, indicative of the presence of a semi public antigen-
driven T cell expansion. In vivo distribution of TCR b chain in mice injected with B16/F10/
GMCSF showed a gaussian distribution. The expanded BV11-BJ2.1 T cell clone was not
expanded in the spleen and lymph nodes of B16 resistant mice. In conclusion, disappearance of the
spontaneous semipublic T cell response, and polyclonal T cell expansion are associated with the
ef®ciency of the GMCSF induced immune regression process in B16 melanoma.
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``Natural'' Immune Responses in Melanoma Patients
T.G. Berger, N. Bauer, C. Maczek, A. Hamann, B. Schuler-Thurner, and G. Schuler
Erlangen, Germany
Cell responses against tumor-associated antigens (TAA) have been detected in melanoma patients
following vaccination with tumor-peptides or peptide-pulsed Dendritic Cells. Apart from
individual reports with limited numbers of patients, surprisingly little is known about the ``natural''
immune responses of nonvaccinated patients and their correlation with the course of disease. We
have looked for circulatory T cells in patients with malignant melanoma (primary and metastatic)
recognizing different HLA-A1, A2.1 and A3- restricted tumor peptides using the Elispot-assay.
The phenotype as well as the activation- and homing marker pro®le where further characterized by
intracellular cytokine staining or with the tetramer-technique. In the majority of melanoma
patients the frequency of TAA-recognizing T cells was below the detection limit directly ex vivo or
in frozen samples of peripheral blood mononuclear cells. After only one or two peptide-speci®c
restimulations in vitro we could detect high numbers of TAA-recognizing T-cells particularly in
patients with a rather favorable course of disease. By evaluating more melanoma patients at
different stages or with variable courses of disease we hope to further elucidate the role of TAA-
recognizing T cells in melanoma.
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Coordinated Loss of Melanoma Differentiation Antigens in Metastatic Melanoma
U. Trefzer, S. Reinke, P. KoÈniger, G. Spagnoli, C. SchaÈfer, H. Audring, and W. Sterry
Berlin, Germany, Chieti, Italy and Basle, Switzerland
The melanoma differentiation antigens (MDA) gp100, MART-1 and Tyrosinase are involved in a
common pathway of melanin synthesis and it can be assumed, that disruption of this pathway as
indicated by the common occurence of amelanotic metastases might affect several of these antigens.
Peptides derived from these MDAs are used in immunotherapy of melanoma and antibodies
recognizing these antigens are commonly applied to detect melanocytic lesions. 191 paraf®n
embedded melanoma metastases from 28 patients which had between 2 and 19 (mean 6.8) lesions
were analyzed by immunohistochemistry for the expression of gp100 (antibody HMB-45),
MART-1 (A103) and Tyrosinase (T311), and were compared with the expression pattern of the
cancer testis antigens MAGE-1 (77-b) and MAGE-3 (57-b), as well as with the highly sensitive
antibodies anti-S100 and SM5-1. The overall reactivities were 81.6% (gp100), 79.5% (MART-1),
59.6% (Tyrosinase), 59.1% (MAGE-1), 60.7% (MAGE-3), 91.6% (SM5-1) and 93,2% (S100).
Only 27 lesions (14.1%) were positive for all tumor associated antigens (TAA), while 75 lesions
(39.2%) had lost only one antigen. 87 lesions (45.5%) were negative for several of the antigens.
9.4% of the lesions were negative for Gp100 and MART-1, 11.0% for Gp100 and tyrosinase,
15.2% for MART-1 and tyrosinase and 8.9% for Gp100, MART-1 and tyrosinase, which is up to 6
times higher than the expected calculated loss. Thus, beside a marked heterogeneity, there is a
coordinated loss of MDAs in melanoma which did not include cancer testis antigens and S100 or
SM5-1. Combined loss of gp100 and SM5-1 was only found in 1/191 cases (0.5%) and is thus the
most valuable combination of antibodies for detecting melanoma metastases. Gp100 showed a
strong average staining, while all other antigens stained moderate to strong (MART-1, tyrosinase,
MAGE-3) or moderate (MAGE-1). Only MAGE-3 stained more than 75% of cells within a lesion
by average, while all other antigens were expressed in 50±75% of cells. Single epitope
immunotherapy will be of limited use in the majority of the cases. Even when multiple epitopes are
combined, the higher than expected coordinated loss of MDAs, the low protein expression, the
insuf®cient number of positive cells within a lesion in conjunction with other tumor escape
mechanisms might be an explanation for the modest clinical effectiveness of antigen-speci®c
immunotherapeutical approaches of melanoma.
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Expression of CD40 and the Mitogenic Peptide Hormone Receptors Vasopressin V1 and
Kinin B1 and B2 Receptors in Psoriatic Epidermis
M.A. Vidal, P. Ehrenfeld, A. Astroza, M.I. Moreno, J. Figueroa, C. Salem, C.B. Gonzalez, C.D.
Figueroa, and M. Concha
Universidad Austral de Chile, Valdivia, Chile
Keratinocytes express various receptors that once activated induce in some cases cell proliferation
and in others inhibition of DNA synthesis, effects that could be relevant in the pathogenesis and/or
perpetuation of skin diseases like psoriasis. Since CD40 has been involved in keratinocyte
differentiation, and peptide hormones such as kinins and vasopressin are mitogenic in different
cellular systems, we wonder if the psoriatic epidermis express kinin B1 and B2 and vasopressin V1
receptors and whether they are associated to CD40 expression. Binding of a speci®c iodinated B1
agonist (Tyr-Lys-Aca-Lys-des[Arg9]-bradykinin) was restricted to basal layers of the lesional
epidermis; whereas a B2 agonist (Tyr-bradykinin), bound the whole lesional epithelium. Normal
epidermis displayed an equivalent pattern of binding but of lesser reactivity. Similar results were
obtained using antibodies that recognize the B1 (Merck, and Co. Inc., USA) and B2 receptors.
Interestingly, the cellular layers involved in these reactions were also immunoreactive to V1 and
Ki-67. Keratinocytes of normal epidermis were less immunoreactive to V1 and Ki-67 but
exhibited greater staining to CD40 than psoriatic lesions. Further, a speci®c biotinylated probe
con®rmed the expression of B1 receptor mRNA in psoriatic keratinocytes and, to a lesser extent,
in normal epidermis. Future studies should elucidate the relative contribution of CD40 and
mitogenic peptides to both keratinocyte proliferation and differentiation disorder, and/or to the
in¯ammatory process in psoriasis.
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Tissue Transglutaminase is Overexpressed in Psoriasis and Palmoplantar Pustulosis
I. Pihl Lundin, E. Hagforsen, and G. MichaeÈlsson
Department of Medical Sciences/Dermatology, and Venereology, University Hospital, S-751 85 Uppsala,
Sweden
Several transglutaminases (TG) are expressed in the skin, e.g. keratinocyte TG (kTG or TG 1) in
the granular layer in normal skin and Factor XIIIa in the dermis. In psoriasis lesions the normal
kTG pattern is replaced by a staining of the upper part of stratum spinosum and Factor XIIIa is
highly overexpressed in the papillary dermis. Tissue transglutaminase (tTG or TG 2) has recently
been identi®ed as the main autoantigen in coeliac disease. tTG is associated with angiogenesis and
there is an increased expression/activity in wound healing. Subgroups of patients with psoriasis and
palmoplantar pustulosis (PPP) have antibodies to gliadin but most of them have no antibodies to
endomysium/transglutaminase. In PPP there is an increased prevalence of coeliac disease. Psoriasis
and PPP patients with antibodies to gliadin improve on gluten-free diet but the mechanisms are
unknown. The aim of this study was to compare with immunohistochemistry the expression of
tissue transglutaminase in involved and noninvolved skin in psoriasis and PPP with that in
corresponding sites in healthy subjects. In normal skin, tTG was expressed in in blood vessels, the
dermal part of the sweat gland and in the arrector muscle whereas the expression in the hair follicle
was weak. In psoriasis lesions there was an increased staining, mainly localized to the endothelium
in the papillary dermis but in many specimens all layers of the epidermis were also stained. In PPP
this abnormal pattern was even more pronounced with stronger staining intensity of the
endothelium than in psoriasis. The conclusion is that tTG is highly overexpressed in involved
psoriasis and PPP skin. In PPP the strongest expression is in the papillary endothelium, recently
demonstrated to be the target of an autoimmune reaction.
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CD3+CD56+ NK T Cells are Signi®cantly Decreased in the Peripheral Blood of Patients
with Psoriasis
A. Koreck, A. SuraÂnyi, A. Farkas, Zs Bata-CsoÈrgoÄ, L. KemeÂny, and A. Dobozy
Szeged, Hungary
Psoriasis is a chronic, infalmmatory, hyperproliferative skin disease, in which autoimmunity plays a
great role. Natural killer T cells (NK T cells), are suggested to be involved in the pathogenesis of
different autoimmune diseases. To examine the involvement of CD3+CD56+ NK T cells in the
pathogenesis of psoriasis, we investigated the lymphocyte subpopulations obtained from blood
samples of psoriatic patients before and after treatment, and of healthy controls, using two-colour
¯ow cytometry. We found no signi®cant differences between total T cells, total B cells, T helper
cells, T cytotoxic cells and NK cells in patients with psoriasis before and after treatment and in
controls. Increased percentage of memory T cells and decreased percentage of naive T cells was
detected in patients compared to controls. Treatments used in this study had no effect on memory
and naive T cells. The CD3+CD56+ NK T cells of psoriatic patients were signi®cantly decreased in
relative to controls. The percentage of CD3+CD56+ NK T cells increased after different
antipsoriatic therapies, but remained signi®cantly lower than those found in controls. CD3+CD56+
NK T cells of healthy controls were capable of rapid activation, while in psoriatic patients activated
NK T cells were almost absent. The decrease in the number of CD3+CD56+ NK T cells may
represent an intrinsic characteristic feature of patients with psoriasis, which is supported by the fact
that after treatment NK T cells do not reach the values found in controls. In conclusion our results
suggest that CD3+CD56+ NK T cells could be actively involved in the development of Th1
mediated autoimmune diseases
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Palmoplantar Pustulosis ± An Autoimmune Disease Induced by Smoking?
E. Hagforsen and G. MichaeÈlsson
Department of Medical Sciences, Dermatology, University hospital, Uppsala, Sweden
The mechanisms underlying the in¯ammation in palmoplantar pustulosis (PPP) are not known.
Most PPP patients (95%) are smokers. There is a high prevalence of autoimmune disease in PPP
patients. The target for the in¯ammation seems to be the acrosyringium, which has lost its normal
pattern. In the acrosyringium there is a strong expression of nicotinic receptors of a-7 type. We
previously found antibodies (ab) to nicotinic receptors in PPP sera. Forty-seven per cent of the
PPP sera showed an immuno¯uorescence on endothelial cells in specimens from normal palmar
skin from a nonsmoker, especially in the papillary dermis. The staining intensity was stronger in
PPP patients with nAChR ab than in those without nAChR ab. We wanted to study if sera from
PPP patients reacted differently on palmar skin from a smoker compared to the nonsmoker.
Immuno¯uorescense (IF) with sera from 45 PPP patients was performed on sections from palmar
skin from a smoking healthy person. The immuno¯uorescense showed positive structures in the
papillary dermis like those expressed on normal palmar skin from the nonsmoker (e.g. endothelial
cells), but in addition there was also immuno¯uorescence in the sweat duct and gland. The
interpretation is that smoking induces an up-regulation of an antigen in normal palmar skin. PPP
might be an autoimmune disease and nicotine might be of importance for the start and
maintenance of the disease.
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High Af®nity IgE Receptors on Antigen Presenting Cells (APC): a Therapeutic Target
in Atopy?
D. Cooper, J. Hales, D. Shah, and R. Camp
Leicester, UK
IgE-facilitated allergen presentation via FceRI may be a key pathogenic mechanism whereby
atopic T cells are potently activated by APC. However, the validity of the high af®nity FceRI±IgE
interaction as a therapeutic target is uncertain, as prior lactic acid stripping of IgE from APC is
reported as essential for antibody-mediated FceRI blockade. In contrast, we have shown that the in
vitro proliferative responses of atopic peripheral blood mononuclear cells (PBMC) to house dust
mite (HDM) allergens in the presence of 10% fresh autologous (IgE-containing) serum may be
greatly reduced by heating serum at 56°C for 30±60 min, conditions that irreversibly denature IgE
(maximum stimulation index [mSI] 36 6 30 and 12 6 17 with fresh unheated vs. heated
autologous serum, respectively; means 6 SD, n = 13, p = 0.003, paired T-test). This suggests a
possible equilibrium between IgE on FceRI and in medium in vitro. Prior lactic acid stripping of
atopic PBMC (pH 3.9 for 5 min) did not enhance the differences between responses in the
presence of unheated autologous serum vs. heated autologous serum (mSI 37 6 26 vs. 11 6 22
without lactic acid stripping; mSI 18 6 6 vs. 8 6 8 with stripping; n = 4). Finally, in preliminary
experiments, proliferative responses to HDM were inhibited by af®nity-puri®ed FceRI antibody
3G6 (10 mg/mL, Upstate Biotech), whether or not the cells were subjected to prior lactic acid
stripping (42% vs. 40% reduction in mSI without vs. with lactic acid stripping, respectively).
Therefore, direct antagonism of FceRI on APC may be a viable therapeutic approach in atopy.
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Functional Characterization of Neurotensin Receptors on Human Cutaneous T Cell
Lymphoma Malignant Lymphocytes
E. Poszepczynska, M. Ramez, L. Boumsell, N. Vita, D. Caput, P. Ferrara, A. Bensussan, and M.
Bagot
CreÂteil and LabeÁge, France
Cutaneous T-cell lymphomas (CTCL) are clonal proliferations of CD4+ T lymphocytes primarily
involving the skin. Mycosis fungoides is an epidermotropic CD4+ CTCL, and a more aggressive
form Sezary syndrome occurs when the malignant cells become nonepidermotropic. The role of
neuropeptides on the growth and chemotaxis capacity of CTCL cells remains unknown. Here, we
report that CTCL cells, similarly to normal resting or activated peripheral lymphocytes, were able
to bind neurotensin. We used an IL-2-dependent CTCL malignant T cell line derived from CTCL
lesions in order to study the role of neurotensin on the proliferation and the migration of these
malignant cells. First, we determined that these malignant cells expressed neurotensin receptors on
their cell membrane. Functional results indicated that neurotensin did not stimulate the growth of
the cell line. In contrast, this neuropeptide inhibited the proliferation of the tumor cells in response
to exogenous IL-2. Furthermore, we found that neurotensin enhanced both spontaneous and
chemoattractant-induced migration of the malignant cells. These results suggest that neurotensin in
skin can play a role in the evolution of the disease by locally limiting the growth of the CTCL
tumor cells in response to cytokines and by enhancing their chemotaxis capacity.
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Acquired CD40-Ligand De®ciency in SeÂzary Syndrome
L.E. French, R. Shane, B. Huard, M. Wysocka, M. Zaki, and A.H. Rook
Department of Dermatology, University of Pennsylvania, Philadelphia, PA, and University of Geneva,
Switzerland
SeÂzary syndrome (SS) is a form of cutaneous T cell lymphoma that is characterized by prominent
immunologic defects including depressed cell-mediated immunity and defective TH1 cytokine
production. The purpose of this study was to determine if CD40L, a cytokine known to be
important for TH1 responses, is involved in the pathogenesis of SS and a possible candidate for
therapeutic intervention. We show by FACS analysis that CD4+ T lymphocytes of SeÂzary patients
(7/7 cases) have a marked defect in CD40L expression upon activation by anti-CD3 in vitro. This
defect is not restricted to the CD4+/CD7- population, and is more pronounced in patients with a
high circulating tumor burden. In these patients, production of IFNg, TNFa and IL-12 by
peripheral blood mononuclear cells (PBMC) after in vitro T cell activation was also strongly
reduced, and most markedly in those with a high tumor burden. As a similar defect was reproduced
in healthy control PBMC by CD40L blockade, and no defect in CD40 expression was detected in
SeÂzary patient's APC, defective CD40L expression and signaling was thought to be a possible
cause. Indeed, incubation of PBMC from SeÂzary patients with recombinant soluble
CD40L+ IFNg, but not IFNg alone, partially restored TNF a and IL-12 production. We thus
propose that acquired de®ciency of CD40L on CD3-activated T cells in SS accounts for some of
the acquired immune defects of patients with SS. As shown here in vitro, recombinant CD40L may
be a rational approach to therapy.
220
TCR aÄaÈ T Cells in Peripheral Blood and Skin in Systemic Lupus Erythematosus Patients
E. Robak, A. Wozniacka, H. Niewiadomska, J. Blonski, J. Bartkowiak, A. Sysa-Jedrzejowska, and
T. Robak
Medical University of Lodz, Lodz, Poland
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the deposition of
autoantibodies and immune complexes leading to tissue damage. Despite signi®cant advances in
our understanding of the etiopathogenesis of lupus till now the mechanisms responsible for the
breakdown of immunological balance is searched. Among multiple functional defects in different
cells of the immune system the role of aÄaÈ T cells in the disease pathogenesis is underlined in many
reports. The purpose of our study was to evaluate the total account of aÄaÈ lymphocytes and their
subpopulations in peripheral blood and skin in patients with active and inactive phase of systemic
lupus erythematosus and in healthy volunteers. The investigations were performed using ¯ow
cytometry and immunohistochemical methods. Statistical analysis showed the signi®cant decrease
of the total number of aÄaÈ T cells in peripheral blood of SLE patients in both active and inactive
stage of the disease comparing to the control group. The similar results were noticed in VaÈ2
TCR+, VaÈ9 TCR+, CD3+, CD4+ and CD8+ subpopulations. On the contrary the number of
VaÈ3 TCR+ lymphocytes was only slightly elevated in SLE patients but not con®rmed with
statistical methods. These values were not dependent on the disease activity. Different results were
obtained in skin. The total number of aÄaÈ T cells and VaÈ2 TCR + subpopulation were higher in
SLE patients than in control group and correlated with disease activity. VaÈ3 TCR+ was higher, in
comparison to control, only in active phase of the disease. VaÈ 9 TCR+ and CD8+ were increased
in all SLE patients and did not differ between active and inactive stage. The number of CD3+
lymphocytes did not differ in patients and control. The total number of CD3+ lymphocytes was
almost equal in SLE patients and healthy individuals. The obtained results may indicate the possible
role of aÄaÈ T cells and their subpopulations in SLE pathogenesis. The differences in number of T
cells between circulation and tissue may suggest their migration from blood to skin in SLE patients
mainly during exacerbation of the disease. Other possible explanation might be the thesis that
antilymphocytic antibodies may play a role in the depletion of this cellular subset in peripheral
blood. The titer of anti-T cell antibodies could correlate with the disease activity.
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In®ltrating Cells and Related Cytokines in Lesional Skin of Patients with Chronic
Idiopatic Urticaria and Positive Autologous Serum Skin Test
W. Volpi, M. Caproni, D. Macchia, M. Manfredi, P. Campi, B. Giomi, C. Cardinali, and P.
Fabbri
Florence, Italy
The term chronic autoimmune urticaria (CAIU) is used to identify a group of patients with
chronic idiopatic urticaria (CIU) and circulating auto-antibodies (IgG, IgM) against the high-
af®nity IgE receptor and/or against IgE. These auto-antibodies have the capability to provoke in
vivo a wheal and ¯are response in this group of patients by intradermal injection of autologous
serum (autologous serum skin test, ASST), and in vitro to evoke mediator release from basophils and
mast cells; therefore it has been suggested that these auto-antibodies might have an important role
in the pathogenesis of the disease. In the present study an immunohistochemical analysis of
in®ltrating cells (CD4, MPO, EG1, EG2, tryptase) was performed on spontaneous wheals of 7
patients (4M, 3F; median age: 45 years; range: 23±50) with CIU and positive ASST in comparison
with their uninvoled skin and with skin from 4 healthy donors. We also evaluated the presence of
cytokines (IL-4, IL-5, IFN-g) and chemokines (IL-8, CCR-3, CXCR-3) correlated to the activity
of the lesional skin in®ltrating cells. In the lesional skin we could observe an increased number of
CD4+ T lymphocytes (29.1 6 11.3) if compared to controls (skin from healty donors) (6.3 6 1.3),
an increased number of neutrophils (MPO: 86.1 6 14.1 vs. 17.6 6 1.7) and eosinophils (EG1:
23 6 9.9 vs. 3.3 6 3.5; EG2: 26.3 6 6.5 vs. 2 6 0.1) whereas mast cells did not show a signi®cant
variation (20,3 6 6 vs. 23.7 6 6.06). We observed an expression of IL-4, IL-5, and IL-8 only in the
lesional skin, while IFN-g showed a slight expression in lesional skin and in uninvolded skin.
CXCR-3 had a marked expression only in the lesional skin (46.6 6 13.2 vs. 20.7 6 7.9) whereas
CCR-3 had a similar expression also in the controls. Our results document a signi®cant role of
CD4+ Th2 lymphocytes and neutrophils in the pathogenesis of both spontaneous and autologous
serum-induced wheals in CIU.
1 Greaves MW. N Engl J Med 32:1767±72, 1995
2 Sabroe RA, Greaves MW. Arch Dermatol 133:1003±1800, 1997
3 Hide M, Francis DM, Grattan CE et al. N Engl J Med 328:1599±1604, 1993
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Mast Cells Promote Wound Healing by Initiating In¯ammation
K. Weller, J. Knop, and M. Maurer
Department of Dermatology, University Mainz, Germany
We have recently demonstrated that murine skin mast cells (MC), key regulators of in¯ammation,
are required for normal early wound healing: Skin wounds in genetically MC-de®cient KitW/KitW±
v-mice are signi®cantly larger during the ®rst four days after wounding as compared to normal+/+
mice or KitW/KitW±v-mice that were reconstituted with bone marrow derived cultured MC.
Speculating, that induction of in¯ammation may be one mechanism by which MC promote
wound healing, we have quanti®ed (1) MC activation in wounded skin of C57BL/6 mice and (2)
early in¯ammatory skin reactions to experimentally induced full-thickness skin wounds in MC-
de®cient KitW/KitW±v-mice and normal+/+ mice. The extent of MC-degranulation in 6 mm
punch biopsy-induced back skin wounds of C57BL/6 mice was assessed by histomorphometric
analysis of plastic embedded, alkaline Giemsa stained 1 mm sections of skin-biopsies obtained 1 h
after wounding. Skin adjacent to wound area showed markedly more extensively degranulated MC
(66 6 8%) as compared to normal control skin (1 6 1%, p < 0001). The extent of MC
degranulation dropped with increasing distance from the wound area. To test whether MC-
degranulation after wounding contributes to the in¯ammatory phase of wound healing, we have
examined the extravasation of Evan's blue (EB) in early wounds of KitW/KitW±v-mice and normal
Kit+/+ mice. Kit+/+ mice exhibit prominent extravasation of EB in skin adjoining wounds as
compared to normal control skin (56 6 5 ng EB/g tissue vs. 11 6 2 ng EB per g tissue, p < 0.001,
30 min after wounding), signi®cantly more (p < 0001) than KitW/KitW±v-mice that showed no
signi®cant in¯ammatory response after wounding (wound area: 16 6 2 ng EB/g tissue vs. Control
skin: 10 6 2 ng EB per g tissue) These data point towards a crucial role of activated MC in the
initial in¯ammatory phase of skin wound healing. Our ®ndings suggest that MC-induced
in¯ammation is required for normal wound healing.
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Altered Regulation of Apoptosis in Cutaneous Mastocytosis
K. Hartmann, M. Artuc, B. Hermes, Ya Mekori, and B.M. Henz
Cologne and Berlin, Germany, and Tel-Aviv, Israel
Mastocytosis is characterized by a focal or generalized increase of mast cells, particularly in the skin,
but also in other organs. In order to investigate whether an altered regulation of mast cell apoptosis
may be involved in the pathogenesis of mastocytosis, the number of apoptotic TUNEL-positive
mast cells, the proliferation marker Ki67, and the expression of the apoptosis-regulating proteins
P53, Bcl-2, and Bcl-XL were studied by immunohistochemistry in cutaneous lesions of 8 infants
with solitary mastocytomas, 5 children with multiple mastocytomas, 11 children with generalized
urticaria pigmentosa, and 7 adults with urticaria pigmentosa and compared to skin from 7 normal
controls. In addition, semiquantitative RT-PCR was used to examine the expression bcl-2 and
bcl-XL mRNA in cutaneous lesions of 6 children and 3 adults with mastocytosis. The number of
toluidine blue-positive mast cells was signi®cantly increased in all patients, particularly in children.
In contrast to other forms of cutaneous mastocytosis, a decreased number of TUNEL-positive mast
cells was observed in solitary mastocytomas. While the expression of Ki67, P53, and Bcl-XL in
mastocytosis lesions was comparable to normal skin, the expression of Bcl-2 was signi®cantly
enhanced in solitary mastocytomas and urticaria pigmentosa, particularly in lesions of less than one
year duration. Accordingly, an increased expression of bcl-2 mRNA, but not bcl-XL mRNA, was
found in mastocytosis lesions. These ®ndings demonstrate that the apoptosis-preventing molecule
bcl-2 is overexpresssed in cutaneous lesions of mastocytosis. Alterations in the mechanisms of
apoptosis may in part account for the accumulation of mast cells in mastocytosis.
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Toll-Like Receptors 2 and 4 are Expressed on Human Keratinocytes and Mediate the
Killing of Pathogens
A. Pivarcsi, B. ReÂthi, M. SzeÂll, A. Kenderessy-SzaboÂ, Z. Beer, Z. Bata-CsoÈrgoÄ, M. Magocsi, EÂ .
RajnavoÈlgyi, A. Dobozy, and L. KemeÂny
Szeged, GoÈd, and Budapest, Hungary
Keratinocytes have the ability to kill pathogenic fungi and bacteria by producing antimicrobial
compounds such as nitric oxide and antimicrobial peptides. Previously we demonstrated that
keratinocytes have a direct candidacial activity, which may be mediated by the keratinocyte
mannose receptor. The present study was designed to explore whether Toll-like receptors (TLRs)
and activation of NF-kB could be responsible for mediating the killing of pathogenic
microorganisms by keratinocytes. RT-PCR analysis was used to examine the expression of the
two main pattern recognition receptors (TLR2 and TLR4) in cultured epidermal keratinocytes in
the third passage and in HaCaT cells. The activation and nuclear translocation of NF-kB in
cultured keratinocytes and HaCaT cells was examined by electrophoretic mobility shift assay
(EMSA). We demonstrated that both unstimulated cultured keratinocytes and HaCaT cells express
TLR2 and TLR4 mRNA, which could be regulated by induction of cells with pathogenic
microorganisms or by cell differentiation. Incubation of cultured keratinocytes and HaCaT cells
with Candida albicans, Staphylococcus aureus, Mycobacterium tuberculosis or the fungal cell wall
component mannan, and the Gram negative cell wall component LPS, resulted in the activation
and nuclear translocation of NF-kB. As the expression of inducible nitric oxide synthase (iNOS) is
known to be regulated by NF-kB we examined the expression of iNOS by RT-PCR. We
demonstrated that pathogenic microorganisms induce iNOS mRNA expression in keratinocytes.
In our work, we give the ®rst evidence that epidermal keratinocytes express toll-like receptor 2 and
4 and microbial compounds activate NF-kB, which may be involved in pathogen-mediated
intracellular signaling.
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The T-Cell Mitogen of Propionibacterium Acnes is a Cell Wall Component
U. Jappe, M.D. Farrar,* E. Ingham,* and K.T. Holland*
Department of Dermatology, University of Heidelberg; *Division of Microbiology, University of Leeds, UK
We have previously reported that whole cells of P. acnes, the microorganism associated with acne,
has mitogenic activity. We are attempting to clarify, chemically characterize and locate the T-cell
mitogen in the cells. This study reports on its' location in P. acnes. The laboratory strain P. acnes P37
was grown and the cells processed to give three fractions: material external to the cell wall and not
covalently bound; cell-wall components; and soluble cytoplasmic components. A lymphocyte
transformation assay (LTA) was used to detect responses of seven cord blood mononuclear cell
(CBMNC) samples to the different fractions before and after incubation with a mouse-antihuman
MHC class II monoclonal antibody (TU39), which inhibits an antigenic response to P. acnes
products. 7/7 CBMNC samples were stimulated by cell-wall components of P. acnes and this
reaction could not be blocked by TU39. All 7 samples were activated by the cytoplasmic cell
fraction and 5 by the external cell wall fraction but with lower stimulation indices compared to the
cell wall components. Furthermore, TU39 totally blocked the stimulation of 5/7 and 3/5
lymphocyte samples when exposed to the cytoplasmic and external cell wall fractions, respectively.
We conclude the T-cell mitogen is located covalently bound to the cell wall of P. acnes and the
activity shown in the other fractions to some of the CBMNC samples was due to minor
distribution of the T-cell mitogen during cell breakage and partial separation combined with
varying sensitivity of CBMNCs.
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Propionibacterium Acnes Reactive T-Cell Lines Established from Early In¯amed Acne
Lesions
P.E. Mouser, B.S. Baker, E. Seaton, and A. Chu
Department of Dermatology, Imperial College of Science, Hammersmith and St Mary's campus, London, UK
Recent studies have indicated that in¯ammatory acne is a T cell mediated disease with
Propionibacterium acnes (P. acnes) being implicated as the major stimulus for acne in¯ammation. To
determine whether P. acnes ±reactive T cells are present in acne skin, T cell lines (TCL) were
cultured from 7 skin biopsies of early in¯amed lesions and tested in a proliferation assay with
sonicated P. acnes. The TCL were stained for CD4, CD8 and TCR-ab expression and analysed by
¯ow cytometry. Skin biopsy fragments were placed in tissue culture medium supplemented with
human AB+ serum and sonicated P. acnes. T lymphocytes and dendritic cells migrated from skin
biopsies and formed clusters. TCL were cultured for 10±14 days, adding Interleukin-2 every 3 days.
Two of the seven TCL died off. The remaining TCL all responded to sonicated P. acnes (at optimal
dilutions) to a varying extent. The mean counts per minute; c.p.m, ranged from 9470 to 17056.
The TCL proliferated to a greater extent (17728±59849 c.p.m) using the positive control,
phytohaemagglutinin (PHA). The skin TCL consisted predominantly of TCR-ab+, CD4+ T cells
(89.2±98.2%) with minimal (0.3±8.9%) CD8+ T cells present. This is compatible with the ®ndings
of previous histological studies of acne lesions. This study shows that T lymphocytes can be
cultured from early in¯amed acne lesions and con®rms that cellular in®ltrates in acne lesions are
predominantly CD4-positive. The TCL are reactive to P. acnes, the natural ¯ora in pilosebaceous
follicles.
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Differences Between Propionibacterium Acnes Strains for T-Cell Stimulation
R. Boit, R. Bojar,* E. Ingham,* K.T. Holland,* and D. Petzoldt, and U. Jappe
Department of Dermatology, Heidelberg, Germany; *Department of Microbiology, Leeds, UK
Preliminary data showed that P. acnes is associated with in¯ammatory acne via antigenic and T-cell
mitogenic mechanisms. To determine whether the stimulating capacity of two clinical isolates, one
from in¯ammatory acne and one from a case of endocarditis, were different to the laboratory strain
P37, a lymphocyte transformation assay (LTA) was performed with 11 peripheral blood
mononuclear cell (PBMNC) samples from patients with different variants of in¯ammatory acne, as
well as with 9 cord blood mononuclear cell (CBMNC) samples. Whereas 9/9 CBMNC samples
were stimulated by all three bacterial isolates and showed maximal stimulation between days 5 and
7, 6/11 of the PBMNC samples were reactive with two peaks of stimulation at day 3 and 7.
Maximal stimulation indices (SI) were higher for the clinical isolates in 8/9 CBMNC samples (4/6
PBMNC samples). Although statistical analysis did not reveal signi®cant differences between the
three bacterial strains in a time course experiment, total SI-values were higher for the clinical
isolates compared to P37. Although mass spectrometry analysis of cells had revealed only minor
differences between clinical isolates and the laboratory strain P. acnes P37 there may be differences
between P. acnes isolates for their immunogenic/mitogenic capacities and/or susceptibility in
patients with in¯ammatory acne.
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Skin Fibroblasts Exert an Inhibitory Effect on Neutrophil Oxidative Stress
A. Zalewska,* P. Lewkowicz, B. Dziankowska-Bartkowiak, A. Sysa-JeÃdrzejowska,* E. Gowacka,
and H. TchoÂrzewski*
Department of Dermatology, Medical University of LoÂdz, *Department of Clinical Immunology, Institute
Polish Mother Memorial Hospital, LoÂdz, Poland
Fairly recently it has been suggested that ®broblasts play an important role in the switch from an
acute in¯ammation to the adaptive immunity and tissue repair. The aim of our study was to
evaluate the in¯uence of ®broblasts on neutrophil (PMNL) by assessing its production of reactive
oxygen intermediates (ROI). The study was performed on two-cell in vitro system, i.e. human
®broblasts of the third passage obtained from the healthy skin with blood neutrophils from healthy
donors. Neutrophils:®broblasts ratio was 10 : 1 and 100 : 1, incubation temperature 37°C, in 5%
CO2, in PBS medium. PMNL ROI production (oxidative stress) was evaluated by luminol-
enhanced chemiluminescence (RLUTotal) immediately after adding PMNL to ®broblast system
[0 min], after 15, 30 and 45 min Some neutrophils were also primed with TNF-alfa (at
concentration 10 ng per mL, for 15 min, at 22°C). The system was subsequently stimulated by N-
formyl-methionyl-leucyl-phenylalanine (N-fMLP) at concentration 2 3 10±6 M or phorbol-
myristate-acetate (PMA) at concentration 200 ng per mL. We observed 1. ®broblasts demonstrated
an inhibitory effect on ROI production by nonprimed neutrophils when comparing to nonprimed
neutrophiles alone when the system was stimulated by N-fMLP (mean 0.12 vs. 0.25 RLUTotal,
respectively; p < 0.05), when stimulated with PMA only slight inhibitory effect was noted 2. TNF-
alfa primed neutrophils to some extent abrogated the above inhibitory effect of ®broblasts after N-
fMLP stimulation (mean 0.24 vs. 0.33 RLVTotal, respectively; p < 0.05); 3. the inhibition effect
depends on the time of cell-cell contact (the most pronounced at time [0] and subsequently it
diminishes, reaching plateau at 30 min) and the number of ®broblasts (the more ®broblasts in the
system, the more pronounced blocking effect). In conclusion, it seems that skin ®broblasts exert an
inhibitory effect on neutrophil oxidative stress reaction.
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Human Sebocytes Express CD14 Molecules and their IL8 Production is Induced by Both
CD14-Dependent and Independent Pathways
H. Seltmann and C. Zouboulis
Berlin, Germany
We have previously reported that lipopolysaccharides (LPS) stimulate IL8 secretion by human
sebocytes but do not in¯uence IL1a expression at the mRNA and protein levels. Moreover, we
have shown that linoleic acid (LA) reduces IL8 secretion. These results implicate the expression of
CD14 molecules in human sebocytes and a competition of the proin¯ammatory activity of LPS
through LA. Although CD14 expression was previously only determined in in¯ammatory cells,
current reports have also postulated CD14 expression in keratinocytes. Therefore, we investigated
the CD14 expression in SZ95 sebocytes by FACS analysis and by ¯uorospectrometry after labeling
the cells with a ¯uorescent conjugated CD14 antibody. HL-60 promyelocytes served as control.
While CD14 was detected on the surface and into the cytoplasm of HL-60 cells, SZ95 sebocytes
only expressed CD14 into their cytoplasm. CD14 expression was enhanced in HL-60 cells by
phorbol myristate acetate (PMA, 2.7-fold), but not by LPS and LA. LPS, PMA and LA did not
alter CD14 expression in SZ95 sebocytes, but LPS and PMA markedly reduced the intracellular
expression of CD14, a ®nding that indicates traslocation of CD14 to the cell surface. Interestingly,
both LPS and PMA enhanced IL8 expression in SZ95 sebocytes, while LA (10±5 M) was unable to
inhibit the stimulatory LPS effect. IL1a expression in SZ95 sebocytes was barely affected by LPS,
PMA or LA. PMA, but not LPS and LA, stimulated total sebaceous lipids. In conclusion, LPS and
PMA are likely to serve as proin¯ammatory signals in human sebocytes, respectively, inducing
CD14-dependent and independent IL8 expression. The latter may be mediated by the PMA
enhanced total sebaceous lipids. LA was unable to antagonize the proin¯ammatory activity of LPS.
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Ageing In¯uences the Function of Human Epidermal Langerhans' Cells
C.E.M. Grif®ths, M. Bhushan, M. Cumberbatch, R.J. Dearman, and I. Kimber
Dermatology Centre, University of Manchester, Manchester, UK and Syngenta, Alderley Park, Maccles®eld,
UK
One clinical consequence of the ageing process is a reduced prevalence of allergic contact
dermatitis in the elderly. Epidermal Langerhans' cells (LC) are key determinants of the skin's
immune response to contact allergens. Following exposure to allergen subsequent migration of LC
from the epidermis to draining lymph nodes is reliant upon receipt of two cytokine signals: one
provided by tumour necrosis factor-a (TNF-a) and the other by interleukin (IL)-1b. We have
investigated the effect of ageing on human epidermal LC numbers and their migration in response
to exogenous TNF-a and IL-1b. Ten elderly (mean age 76 years) and 10 young (mean age
23 years) volunteers received intradermal injections of 200 U human recombinant TNF-a diluted
in sterile saline and control injections of sterile saline at paired sites on photoprotected buttock. In a
second cohort of volunteers 6 elderly (mean age 75 years) and 6 young (mean age 31 years) subjects
received intradermal injections of 100 U IL-1b or sterile saline at paired sites on photoprotected
buttock. Each injection site was subsequently biopsied under local anaesthesia either 2 h (TNF-a
cohort) or 4 h later (IL-1b cohort). The frequency of CD1a+ LC mm±2 of epidermis was assessed
following direct immuno¯ourescence staining of epidermal sheets. The average baseline (saline
treated) values for epidermal LC frequency in elderly subjects (852.6 6 42.9) was signi®cantly
(p < 0.01) reduced as compared with young subjects (1126.7 6 38.7). The response to TNF-a was
signi®cantly (p < 0.05) impaired in the elderly. Thus, the average percent reduction in LC
frequency following injection was 9% as compared with 23% in the young. In contrast the response
to exogenous IL-1b was retained in elderly skin with a 22% reduction in epidermal LC frequency
as compared with a 19% reduction in young volunteers. These experiments indicate that in aged
skin there is a reduction in frequency of epidermal LC coupled with an impaired migratory
response to TNF-a. However, the response to IL-1b is retained with age. We conclude that aged
skin is characterised by a decline in both LC frequency and function perhaps associated with a
relative local de®ciency of IL-1b. These factors may partly explain the reduced prevalence of
allergic contact dermatitis in the elderly.
231
Reduced Susceptibility of Human Immature Dendritic Cells (IDC) to NK Cell Lysis
after Interaction with the Opportunistic Yeast Malassezia Furfur (MF)
E. Buentke, L.C. Hef¯er, J. Wilson,* R.P.A. Wallin,* C. LoÈfman,² B.J. Chambers,* H.G.
Ljunggren,* and A. Scheynius
Unit of Clinical Allergy Research, *Microbiology and Tumor Biology Center, Karolinska Institutet and
Hospital, Stockholm; ²Department of Animal Development and Genetics, Uppsala University, Sweden
The yeast Mf, normally present in the human skin micro¯ora, is nevertheless a factor contributing
to the severity of the chronic in¯ammatory skin disease atopic dermatitis (AD). The aim of this
study was to assess whether coculture of Mf and human iDCs would affect subsequent interactions
of DCs with autologous NK cells. iDCs preincubated with Mf showed a reduced susceptibility to
NK cell killing when compared to untreated iDCs. Moreover, also when iDCs were treated with
Mf-iDC coculture supernatant, a reduced susceptible to killing was observed, indicative of the
presence of soluble factors. The numbers of CD40, CD80, CD83 and CD86+ DCs increased and
HLA-DR expression was up-regulated after supernatant treatment. NK (CD56+/CD3±) cells were
found in the dermis of skin biopsy specimens from healthy individuals and AD patients. However,
in the AD patients CD56+ cells were also found in the epidermis. These data suggest that NK cells
and iDCs can interact, that Mf affects this interaction and that NK cells may play a role in regulating
DCs. Furthermore, the data imply that DCs and NK cells can meet in the skin.
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UVB Irradiation of Human Epidermal and Monocyte-Derived Langerhans Cells
Perturbs the Antigen-Presenting Function: In Vitro Evaluation
M.F. Aries, C. VaissieÁre, F. Dodeller, G. Riffet, M. Charveron, and Y. Gall
Institut de Recherche Pierre FABRE, Laboratoire de Biologie Cellulaire CutaneÂe, FaculteÂ de MeÂdecine de
Rangueil, 133 Route de Narbonne, 31062 Toulouse
Exposure of the human skin to UV radiation causes an imbalance of its homeostasis and a reduced
cutaneous immunity. The immunosuppression brought about by UVB is assumed to result in
particular from the direct effects of UVB on the antigen-presenting function of the Langerhans
cells (LCs), adhesion and costimulatory molecules being of crucial importance for the interaction of
antigen-presenting cells with immune cells, especially T lymphocytes. The aim of the present study
was to determine the differential effects of UVB on Langerhans cells antigen-presenting function
by means of two models: (1) a human skin explant model irradiated with increasing levels of UVB
(312 nm; 0.5±1 J per cm2): after irradiation, LCs freshly isolated were tested for their allostimulating
capacity in mixed lympho-epidermal culture (MLEC). UVB inhibited the lymphocyte
proliferating response which was evaluated in the presence of 3H thymidine: 0.75 J per cm2
caused a 43% inhibition of the response; (2) a human monocyte-derived Langerhans cells (MoLCs)
model: monocytes were cultured for 6 days in supplemented RPMI-1640, containing 50 ng per
mL IL4, 100 ng per mL GM-CSF, 4 ng per mL TGFb. In vitro UVB irradiation of MoLCs to
increasing doses (0.005±0.03 J per cm2) perturbed their allostimulating capacity in MLEC (0.03 J
per cm2 caused a 34% inhibition of the response) and modulated their functional expression of
HLA-DR, CD54, CD86: MoLCs were stained for four-color analysis with the corresponding
different monoclonal antibodies and analyzed on a double laser equipped FACSCalibur ¯ow
cytometer. Better knowledge of mechanisms involved in UV-induced immune suppression is
essential for developing new strategies aimed at photoprotection and cancer prevention. Our
results can be used and expanded to quantify UV-mediated Langerhans cell damage and the degree
of immune photoprotection provided by various agents or sunscreens.
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NaõÈve Human Langerhans Cells Show Phosphotyrosine Activity Without Stimulus
S. Dandapat, H. Mehmet, and A.C. Chu
The signalling pathways in naõÈve human epidermal Langerhans cells are poorly understood. Studies
on murine Langerhans cells have shown that following stimulation with contact sensitizers,
increased tyrosine phosphorylation can be detected. A similar result was observed following the
investigation of human MHC classII positive cells following stimulation with haptens. However, in
these studies Langerhans cells were cultured as an epidermal cell population and keratinocyte
contamination was not taken into account. This may be important as keratinocytes can be induced
to express MHC classII and could have been responsible for the effect observed. To investigate the
intracellular signalling mechanisms involved in human Langerhans cells, we have studied
phosphotyrosine activity in freshly isolated naõÈve Langerhans cells. The techniques used include an
in vitro kinase assay using a phospho-speci®c antibody, in conjunction with Western blot analysis of
these naõÈve cells. We observed the selective phosphorylation of two protein bands with molecular
weights between 60 and 70 kDa. Preliminary results indicate that the protein bands belong to the
src family of protein kinases, as shown using anti phospho-src antibodies. Keratinocyte
contamination was evaluated with decreasing cell number and was found to negligible; enriched
Langerhans cells were consistently 98% pure. These studies suggest that naõÈve Langerhans cells
show phosphotyrosine activity and provide the basis for future work into the signalling pathways of
these cells following their activation.
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Induction of Dendritic Cell Maturation by Different Stimuli
E. Geiger, J. Neumann,* J.P. Allam, N. Koch,* T. Bieber, and S. Koch
Department of Dermatology, *Division of Immunobiology, Institute of Zoophysiology, University of Bonn,
Germany
Human epidermal Langerhans cells (LC) aquire their antigens in the dermal tissue and migrate to
the regional lymph node for presentation of the processed antigens to T-cells. During this
migration the LC mature by changing their surface molecules and up-regulating, i.e. CD80, CD86
and CD83. Culture of CD34+ hematopoietic precursor cells in the presence of GM-CSF, TNF-a,
SCF, FLT-3 L and TGF-b gives rise to immature dendritic cells (DC). A signi®cant amount of
these cells can be characterized as LC by the expression of Lag, intermediate levels of MHC II and
low levels of CD86. We exposed these cells to different maturation stimuli and observed
pronounced differences in phenotype and functional status. After exposure to LPS, poly I/C,
TNF-a or a mix of TNF-a, IL1 and IL-6 a rapid up-regulation of maturation markers such as
CD83, CD86, CD80 and MHCII appeared within two hours. Treatment of the cells with poly I/
C or LPS led to a further increase of these markers until up to 6±12 h after stimulation, CD83
expression was back to prestimulation levels after 24 h. By contrast, monocyte-derived dendritic
cells (MoDC) (generated in the presence of GM-CSF and IL-4) matured under poly I/C
maintained their mature phenotype for at least 72 h. Treatment of immature CD34-derived DC
with cytokines elevated the level of maturation markers for one to two days, then there was a slow
decline. 30 min after TNF-a. Treatment: biosynthesis of MHCII molecules was stimulated as
judged by immunoprecipitation. The in vitro generated LC were potent inducers of an allogeneic
MLR, their potency increased after maturation. In conclusion, different maturation agents
stimulate CD34-derived LC with different kinetics, suggesting different working mechanisms and
possibly different functional implications. This ®nding is in contrast to observations on
conventional monocyte-derived dendritic cells.
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Immunophenotype and Apoptosis of Epidermal Dendritic Cells in Atopic Dermatitis
Lesions Treated with Tacrolimus Oinment
A. Wollenberg, E. Schuller, M. Moderer, and T. Oppel
Munich, Germany
The newer immunomodulatory macrolactam ointments are new therapeutic options in atopic
dermatitis (AD). Lymphocytes are well known target cells, but there is also evidence for an effect
on mast cells, endothelial cells and dendritic cells (DC). Beside Langerhans cells (LC), a second
epidermal dendritic cell population has been described in AD lesions, which is characterised by a
high CD11b and FceRI expression but does not contain Birbek granules ± the in¯ammatory
dendritic epidermal cells (IDEC). Since previous studies with tacrolimus (FK506) ointment had
shown a depletion of IDEC from the epidermis, the effects of FK506 and hydrocortisone on the
immunophenotype and apoptosis rate of LC and IDEC were investigated in vitro and in vivo. In
vitro, time kinetic studies with epidermal cell suspensions were performed in AnnexinV and
TUNEL technique. A signi®cant spontaneous rate of LC apoptosis was seen following LC isolation
from normal human skin. Cell culture with different concentrations of FK506 did not in¯uence
this spontaneous apoptosis rate. All LC constantly expressed low amounts of CD95/Fas molecules.
Ex vivo studies were performed in 15 AD patients treated double blinded with FK506 vs.
hydrocortisone ointment. Epidermal dendritic cell phenotyping was performed from cell
suspensions prepared from AD lesions before and after 1 week of therapy. Epidermal DC numbers
± known to be increased in AD lesions ± decreased during treatment by both FK506 and
hydrocortisone. Thereby, only a slight decrease of LC was seen, in contrast to a 75% reduction in
the cell number of IDEC. Apoptotic DC could be detected in all of our epidermal cell suspensions
in variable percentages, including LC and IDEC. The rate of early apoptotic DC in situ was
increased in hydrocortisone treated AD lesions for both LC and IDEC, whereas FK506 treatment
did not lead to a higher percentage of apoptotic epidermal DC. An increased CD32 expression, but
decreased FceRI, CD36 and CD80 expression was found on IDEC during FK506 treatment,
witnessing the altered cutaneous microenvironment. In conclusion, therapeutic concentrations of
FK506 do not seem to induce apoptosis in epidermal DC, but change the immunophenotype of
epidermal DC during topical treatment of AD.
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Correlation Between Th2 like PBMC Response and Atopy Patch Test Reaction to
M. Furfur in Atopic Dermatitis Patients
C. Johansson, H. Eshaghi, M. Tengvall Linder, E. Jakobson, and A. Scheynius
Stockholm, Sweden
The yeast Malassezia furfur belongs to the normal cutaneous ¯ora but is also considered to be one of
the triggering allergens that can contribute to atopic dermatitis (AD). To illuminate the impact of
circulating allergen speci®c T cells in AD, we have correlated the PBMC response with the in vivo
skin prick test (SPT) and atopy patch test (APT) reactivity to M. furfur in AD patients (n = 40) and
healthy controls (HC). None of the HC (n = 16) showed a positive in vivo reaction. The AD
patients, of whom 18 had serum-IgE reactivity to M. furfur, could be subdivided into: SPT+/
APT+ (n = 12), SPT+/APT± (n = 12), and SPT±/APT± (n = 16). The SPT+/APT+ and the
SPT+/APT± groups but not the STP±/APT± group had a signi®cant higher PBMC stimulation
index (SI) (p < 0.01) than the HC. Interestingly, the SI values in the SPT+/APT+ group were
signi®cantly higher (p < 0.05) than in the SPT+/APT± group. In the M. furfur SPT+ AD patients
(n = 24) a correlation between SI and the M. furfur APT reactions (rs = 0.62, p < 0.01), but not
between SI and M. furfur speci®c serum-IgE levels was found. Furthermore, production of the Th2
related cytokines interleukin(IL)-4, IL-5 and IL-13 (rs = 0.80, p < 0.001; rs = 0.58, p < 0.01;
rs = 0.81, p < 0.001, respectively), but not the Th1 related interferon-g correlated with SI to
M. furfur extract. Our data strongly suggest a relationship between circulating speci®c T cells, with
Th2 like cytokine pro®le, and positive APT reactions.
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Transcriptional Regulation of the Melanoma Cell Adhesion Molecule Gene in T Cells
S. Karlen and L.R. Braathen
Berne, Switzerland
Extravasation and tissue in®ltration of leukocytes and metastatic tumor cells require the regulated
expression and function of adhesive surface molecules. Originally, the melanoma cell adhesion
molecule MCAM/MUC18/CD146 was de®ned as a marker of tumor progression and mestastasis
formation in human melanoma. MCAM in¯uences later stages of the metastatic process, namely
extravasation and establishment of new foci of growth. Recently, MCAM expression on CD3+ T
cells in®ltrating delayed-type hypersensitivity lesions of the skin, on synovial ¯uid T cells of
rheumatoid arthritis patients and on distinct T leukemia cells, suggesting that this molecule might
be involved in the extravasation and/or homing of activated T cells. In this study, we show that the
mechanisms for up-regulation of MCAM in melanoma and in activated T cells are very similar.
Using a combination of CAT reporter assays and semiquantitative RT-PCR, we observed that
cAMP signi®cantly increases transcription of MCAM in Jurkat T cells and in leukemia cell lines
such as HL60 or K562 to levels comparable to those observed in cAMP-treated SB2 melanoma
cells. Interestingly, MCAM transcription was not initiated in cells treated with reagents known to
stimulate T cells, like phytohemagglutinin (PHA), phorbol esters (PMA), aCD28, or calcium
ionophore (CaI) used in various combinations. On the contrary, the cAMP-dependent activation
of the MCAM promoter was impeded upon treatment with PMA or PHA. The pyrimidine-rich
initiator sequence Inr that overlaps the MCAM RNA start site was essential for promoter function
and was shown to mediate the response to the stimulatory signals. DNA mobility shift experiments
showed that in both melanoma and T cells, factors belonging to the basic HLH transcription factor
family was induced upon cAMP treatment, a phenomenon that could be completely reversed upon
addition of PMA. Taken together, these results indicate that transcription of the MCAM gene is
very similar in both melanoma and T cells, con®rming the hypothesis that MCAM could play a
similar role in the migration and extravasation of these two cell types.
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Regulation of Chemokine Gene Expression by IFN-g and IL-4 in Human Dermal
Fibroblasts and Epidermal Keratinocytes
M. Shibata,T. Hariya, and H. Ichikawa
Shiseido Life Science Research Center, Yokohama, Japan
Chemokines are known to play important roles for chemotaxis and activation of in¯ammatory cells
in a phase of acute or allergic in¯ammation, such as atopic dermatitis. We investigated the effects of
interferon-g (IFN-g) and interleukin (IL)-4 on chemokine gene expression in cell culture systems
of normal human dermal ®broblasts (NHDF) and epidermal keratinocytes (NHEK). NHDF and
NHEK were stimulated by tumor necrosis factor-a (TNF-a) or interleukin-1a(IL-1a) in the
presence of IFN-g or IL-4. After incubation, total RNA was extracted and reverse transcribed to
cDNA. Amount of speci®c cDNA for IL-8, eotaxin and RANTES was determined by real-time
quantitative PCR. Gene expression of these chemokines was standardized with expression of an
internal control, GAPDH gene. In NHDF, TNF-a and IL-1a stimulated the gene expression of
IL-8, eotaxin and RANTES with a different manner. IL-8 expression reached maximum at 6 h
after stimulation, and declined thereafter, whereas the expression of eotaxin and RANTES was
increased until 48 h. Interestingly, IL-1a hardly induced RANTES gene compared with TNF-a.
IFN-g and IL-4 inhibited IL-8 expression. Moreover, it was con®rmed by quantitative PCR that
eotaxin gene expression was stimulated by IL-4, and inhibited by IFN-g. In contrast, RANTES
expression was stimulated by IFN-g. In NHDK, the manner of chemokine induction and its
modi®cation with IFN-g and IL-4 is more than a little different from those in NHDF. These results
suggest that the expression of these chemokines is differentially regulated by Th1 and Th2
cytokines.
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Vasoactive Intestinal Peptide Plays a Central Role in Cytokine Network Around
Keratinocytes
M. Kakurai, N. Fujita,* S. Murata, Y. Furukawa,² T. Demitsu,³ and H. Nakagawa
Department of Dermatology, *Division of Endocrinology and Metabolism, Department of Medicine,
²Division of Molecular Hematopoiesis, Center for Molecular Medicine, Jichi Medical School, Tochigi, and
³Department of Dermatology, Omiya Medical Center, Saitama, Japan
VIP has been suggested to play some roles in in¯ammatory dermatoses such as atopic dermatitis and
psoriasis. The aim of this study is to clarify the precise mechanisms of how VIP is implicated in the
pathogenesis of these disorders. We investigated the expression of VIP and its receptors in normal
human epidermal keratinocytes (NHEK), and a human epidermal keratinocyte cell line DJM-1
using reverse transcription-polymerase chain reaction and Northern blotting. Type I VIP receptor
(VIP1R) mRNA was expressed in NHEK and DJM-1 cells, and the latter also expressed type II
receptor (VIP2R) in lesser amounts. VIP transcript was not found in any cells examined. VIP1R
mRNA was up-regulated by Th1 (IFN-g), Th2 cytokines (IL-4) and TNF-a, as well as VIP itself,
suggesting the presence of autoregulatory loop. VIP increased cAMP production and cell
proliferation of DJM-1 cells, and also induced the production of in¯ammatory cytokines such as
IL-6, IL-8, and RANTES. The production of cAMP and cytokines was abrogated by a VIP1R
selective antagonist, indicating that VIP1R mediates these effects. Overall, these results suggest that
up-regulation of VIP receptors by cytokines from in¯ammatory cells in the dermis enhances the
proliferation and cytokine production of keratinocyte in response to VIP from nerve endings. This
cytokine network around keratinocytes may be involved in the pathogenesis of in¯ammatory
dermatoses.
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Human Eosinophil Recruitment by Intradermally Injected Eotaxin: A Lightmicroscopic
Study
J. Grohmann, A. Stein, and G. Wozel
Department of Dermatology, University Hospital Carl Gustav Carus, Dresden University of Technology,
Germany
Eotaxin as a CC-chemokine is a potent eosinophilic chemoattractant in vitro. There is, however,
only little information about the in vivo activity of eotaxin in humans. We therefore investigated
the effect of eotaxin in normal skin as compared with uninvolved skin of patients with
in¯ammatory skin diseases associated with peripheral eosinophilia. 50 ng and 100 ng eotaxin,
respectively, dissolved in 50 ml saline were injected intradermally (control: 50 ml saline). After
designated intervals 4 mm punch biopsies were taken and specimens processed by H&E and
Giemsa staining. Apart from a transient wheal formation no other in¯ammatory signs at injection
sites were seen. Injection of saline in normal skin induced no in¯ammatory changes. Histologically,
challenge with eotaxin resulted in a discrete to moderate super®cial dermatitis with a small number
of eosinophils in a dose-dependent manner. In contrast to normal skin tissue from patients with
blood eosinophilia showed a moderate (50 ng eotaxin) to heavy (100 ng of eotaxin) super®cial
perivascular lymphohistiocytic in®ltrate with neutrophils and additionally numerous (10 per slide)
to signi®cant eosinophil accumulation (> 20 per slide). Moreover, in some cases 100 ng eotaxin
induced histologic signs of vasculitis. Skin from patients with saline control revealed a moderate
in®ltrate but with a reduced number of eosinophils. Based on these observations we conclude that
in human being eotaxin has also the capability to induce eosinophil-recruitment by binding to
CCR3.
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CXCR4 Expression in the Resolution of T Cell Mediated Cutaneous In¯ammation
J. Reed, C. Buckley, L. Poulter, M. Rustin, M. Salmon, and A. Akbar
London and Birmingham, UK
The resolution of acute cutaneous T cell mediated in¯ammation is dependent on the clearance of
the expanded T cell population. This involves apoptosis of the T cells, but additionally emigration
of leucocytes probably plays a signi®cant role. Chemokines and their receptors recruit lymphocytes
to sites of in¯ammation, and regulate the compartmentalisation of the cells between lymphoid and
peripheral nonlymphoid tissues. We have investigated the expression of chemokines and
chemokine receptors during the induction and resolution phases of cutaneous tuberculin puri®ed
protein derivative-induced delayed-type hypersensitivity (Mantoux reaction) in 20 healthy
volunteers. This was undertaken using 4-colour ¯ow cytometric analysis of skin suction blister
¯uid cells and PBMC in conjunction with immunohistochemistry on skin biopsies. The clinical
peak of the response occurred at day 3; however, T cell numbers were maximal at day 7. Non-
speci®c in¯ammation associated with blister induction on control skin showed reduced CXCR4
(6.7%) and CCR7 (27.83%) expression on CD4+ lympocytes compared to those in the peripheral
blood (PB) (12.13% and 87.75%, respectively). In contrast during Mantoux reactions, CXCR4
expression was increased at day 3 (33.31%) and at day 7 (24.26%) compared to PB CD4+
lymphocytes (15.27% and 9.10%, respectively). By day 14, CXCR4 expression was reduced
(16.65%), but was still elevated compared to PB (11.33%). CCR7 expression at day 3 was increased
(54.68%) compared to controls, but was lower than on PB CD4 + lymphocytes (81.27%).
Decreasing CCR7 expression was noted during the course of the response at day 7 (30.29%) and
particularly in the resolution phase at day 14 (11.97%) associated with stable expression within the
PB (89.76% and 90.39%, respectively). Decreasing CCR7 expression during an immune response
may indicate an increasing proportion of terminally differentiated CD4+ lymphocytes, but
additionally represents a population of cells unable to home to peripheral lymphatic vessels during
the resolution phase. Increased expression of CXCR4 during an in¯ammatory response may be
important in retaining activated antigen-speci®c T lymphocytes within the in¯ammatory focus,
while down-regulation may be required in order for these cells to emigrate during resolution of
in¯ammation.
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In Vitro Testing with Keratinocytes for Contact Allergy
B. Bjarnason, E. FlosadoÂttir, H. Xu, and C.A. Elmets
Birmingham, Alabama, USA and Stockholm, Sweden
The aim of this study is to investigate whether secretion of interleukin-8 (IL-8) proteins by
keratinocytes following in vitro exposure to a contact allergen can be used to detect contact allergy.
Suction blisters were made on skin of allergic and anergic subjects to urushiol, the contact allergen
of poison ivy. Keratinocyte cultures were prepared from suction blisters of nontreated skin. They
were then exposed to the allergen in vitro. Controls were the allergen solvent. Variable allergen
concentrations, allergen exposure times and cell culture times were used. At the end of each culture
time, IL-8 proteins of the culture supernatants were analyzed by ELISA. The concentration of IL-8
in the supernatants proved to be a successful way to distinguish between subjects who claimed to
be allergic and who patch tested positive with a nontoxic concentration of urushiol and subjects
who claimed no contact reactivity despite multiple contacts with the plant and who tested
negative. In the allergic subjects, a correlation was established between the dose of the allergen and
the IL-8 protein concentration in the supernatants. In vitro testing of contact allergies in patients
makes possible an objective assessment of their allergic status without risking active sensitizations.
The results indicate that the method may be used as an alternative method to animal models for
testing consumer products before their marketing, thus avoiding ethical problems and problems
related to interpretation of tests because of biological differences between animals and humans.
243
Interleukin-8 in Blister Fluid of Allergic Patch Tests is Chemotactic for T-Lymphocytes
and a Detector of Grade of Contact Allergy
E. FlosadoÂttir, B. Bjarnason, H. Xu, and C.A. Elmets
Birmingham, Alabama, USA and Stockholm, Sweden
The purpose of this study is to investigate interleukin-8 (IL-8) as a chemokine for T-lymphocytes
and as a marker of magnitude of contact allergy. Urushiol, the contact allergen of poison ivy, was
applied to allergic and anergic volunteers. Suction blisters of urushiol exposed and nonexposed skin
were produced 48 h later and the ¯uids were analyzed for chemotactic activity for T-lymphocytes
using modi®ed Boyden chambers. Anti-IL-8-antibodies were added to the ¯uids to investigate
their effect on the chemotactic activity. IL-8 protein concentration of the ¯uids was determined by
ELISA and its correlation with visible test responses was investigated. Signi®cant chemotactic
activity for T-lymphocytes was only present in blister ¯uid from urushiol exposed skin and only
from the allergic subjects. The chemotactic activity could be neutralized with the anti-IL-8
antibodies. There was an excellent correlation between the IL-8 protein concentration in blister
¯uids and the clinical appearance of the in¯ammatory reactions at the skin test sites. The results
support the hypothesis that IL-8 in blister ¯uid is both chemotactic for T-lymphocytes and is a
sensitive marker of an in¯ammatory response. Determination of the concentration of IL-8 proteins
in blister ¯uid of patch tests may be of future use for objective assessment of clinically important
contact allergies.
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The Tole of Histamine in DNFB Induced Contact Hypersensitivity
E. Garaczi, M. SzeÂll, T. JaÂnossy, E. BuzaÂs, A. Falus, L. KemeÂny, and A. Dobozy
Department of Dermatology, University of Szeged, Hungary; Dermatological Research Group of Hungarian
Academy of Sciences, Szeged, Hungary; Institute of Surgical Research, University of Szeged, Hungary;
Department of Genetics, Cell- and Immunobiology, Semmelweis University of Medicine, Budapest, Hungary
The functions of mast cells and histamine in immediate hypersensitivity reactions are well known,
and it is also known that histamine participates in the regulation of various immunological
functions. The aim of this study was to investigate the role of histamine in the regulation of
dinitro¯uorobenzene (DNFB) induced contact hypersensitivity. The abdominal skin of histidine
decarboxylase (HDC) knockout mice was sensitized and ®ve days later the dorsal surface of the ears
were challenged with DNFB in aceton/olive oil. Ear thickness was measured at different time
points, the skin-draining regional lymph nodes (DLN) were excised 48 h following the ®nal
chemical treatment and the cells were prepared for phenotypic analysis by ¯ow cytometry.
Routine histology and immunhistochemistry were also performed on ear specimens. The
expression of IL-2, IL-4 and IFN-g genes were examined by RT-PCR in the ear samles. The
DNFB induced increase of the ear thickness was signi®cantly higher in HDC±/± mice compared
to wild type mice. We observed a signi®cant decrease in the percentage of CD4+ Th and
CD8+ Tc cells, and a signi®cant increase in the percentage of B220+ B cells in the DLN of
HDC±/± mice in contrast to wild type mice. In the ear specimens the majority of the in®ltrating
cells were neutrophils at 24 and 48 h post challenge of both groups, but the number of neutrophils
was higher in HDC±/± mice compared to wild type mice. We observed signi®cantly more
CD45+ leukocytes in HDC±/± mice in contrast to wild type mice in immunhistochemistry. The
rate of CD3+ T lymphocytes was not increased in DNFB sensitized mice, in comparison with the
control (aceton treated) mice. IL-2, IL-4 and IFN-g mRNA expressions were unchanged both in
wild type and in HDC±/± mice irrespective of the DNFB treatment. These results suggest that the
immunregulatory effects of histamine play important role in DNFB induced contact
hypersensitivity.
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Cellular In Vitro Reactivity in Nickel-Allergy: Early Increase of IL-4 Production
Preceeding Speci®c Proliferation and IFN-g Production
B. Summer, S. Barnstorf, K. Ghoreschi, C.A. Sander, B. Przybilla, and P. Thomas
Department of Dermatology, Ludwig-Maximilians-University, D-80337 Munich, Germany
In Nickel contact allergy antigen-speci®c T-cell proliferation can be assessed in vitro. In addition to
speci®c proliferation, we examined the kinetics of mediator production and secretion pattern for
IL-4 and IFN-g after speci®c and mitogen-induced T-cell activation in vitro. Peripheral blood
mononuclear cells (PBMC) of 6 nickel-allergic patients (history and patch test positive) and 4
nonallergic individuals were cultured in the presence of either medium, PHA, NiSO4 or tetanus
toxoid (TT). IFN-g and IL-4 were measured by ELISA after 1 h, 2 h, 4 h, 24 h, 72 h and 144 h. The
mRNA expression for IFN-g and IL-4 was assessed by RT-PCR at the same time points. Actual
cytokine production was also examined by ¯ow cytometry using a surface and intracytoplasmatic
staining. As control PBMC from nonallergic donors or unstimulated cultures were used. Whereas
IFN-g production and speci®c proliferation to Nickel and TT both increased at later time points
(between 72 h and 144 h), there was an early IL-4 production. The latter was detectable both at
RNA and protein level within 24 h. The transient IL-4 peak may contribute to Th1-favouring
conditions, since IL-12 production was subsequently seen at FACS analysis.
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Traf®cking of CLA+ Nickel-Speci®c CD8+ and CD4+ Lymphocytes is Directed by
CXCR3 and CCR4 Chemokine Receptors, Respectively
S. Sebastiani, F. Nasorri, G. Girolomoni, and A. Cavani
Laboratory of Immunology, Istituto Dermopatico dell'Immacolata, IRCCS, Rome, Italy
Allergic contact dermatitis results from a T cell response to haptens applied to the skin, with CD8+
T lymphocytes providing the most relevant mechanisms of tissue damage, and CD4+ cells exerting
both effector and regulatory functions. Thus, a differential recruitment of these two T cell subsets
may have a direct impact either in the ampli®cation or in the resolution of the immune reaction.
Here, we investigate the migratory behavior of CLA+, nickel (Ni)-speci®c T lymphocytes obtained
from the peripheral blood of allergic individuals. In vitro migration assays indicated that IP-10
(CXCL10) and TARC (CCL17) represent the most potent chemoattractants for CD8+ and CD4+
T cells, respectively. MCP-1 (CCL2) induced a signi®cant migration of both the subsets.
Accordingly, CXCR3 (IP-10 receptor) was uniformly expressed on CD8+ T lymphocytes
independently from the cytokine pro®le, whereas Th1, but not Th2 CD4+ lymphocytes expressed
signi®cant levels of CXCR3. Conversely, CCR4 (TARC receptor) was detected on the vast
majority of Ni-speci®c CD4+, but only on a limited percentage of CD8+ cells. CCR2 (MCP-1
receptor) was uniformly expressed by both CD4+ and CD8+ subsets. RT-PCR from skin biopsies,
showed that MCP-1 was already highly present at 16 h, whereas TARC and IP-10 reached a peak
at 48 h after hapten challenge. Supernatants of IFN-g-activated keratinocytes, which represent the
most important source of IP-10 in the skin, induced comparable migration of CD4+ and CD8+
cells. However, neutralization of IP-10 with speci®c Ab determined a much higher inhibition of
CD8+ (80%) compared to CD4+ (40%). Our data indicate that the axis CCR4/TARC, and
CXCR3/IP-10 direct Ni-speci®c CD4+ and CD8+ skin recruitment, respectively.
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Serum Eosinophil Cationic Protein (ECP), Myeloperoxidase (MPO), Tryptase, Eotaxin
and Th-2-Like Cytokines in Dermatitis Herpetiformis
C. Cardinali, M. Caproni, E. Pestelli, A. D'Agata, and P. Fabbri
Florence, Italy
Dermatitis herpetiformis (DH) is a subepidermal bullous disease characterized by a neutrophilic and
eosinophilic in®ltrate, together with activated lymphocytes. So far the role of soluble mediators
such as cytokines and chemokines has not been studied in the peripheral blood of DH, as well as
the serum levels of myeloperoxidase (MPO), eosinophil cationic protein (ECP) and tryptase. We
investigate the presence of possible alterations in interleukin (IL)-4, IL-5, eotaxin, MPO, ECP and
tryptase concentrations in 40 DH patients (19 females, 21 males, median age 22.5 years, range 5±
80) in order to study the potential pathogenetic role of Th2-like cytokines and chemokines and to
con®rm the role of granulocytes and mast cells in determining typical lesions of DH. As controls,
sera from 20 healthy volunteers (11 females, 9 males, median age 24 years, range 25±52) were
collected and tested in parallel. IL-4 and IL-5 and eotaxin serum contents were determined by a
solid phase enzyme-linked immunosorbent assay (ELISA). A double antibody radioimmunoassay
was used for measuring the serum levels of MPO, ECP and tryptase. In DH patients, IL-5 serum
levels were within the normal range (mean 1.53 pg per mL; values ranging from 0.0 to 6.6 pg per
mL) except for a sole patient in which increased values were demonstrated (75.0 pg per mL). IL-4
levels were found in the normal range (mean 2.68 pg per mL; values ranging from 0.0 to 14.0) as
well as eotaxin ones (mean 99.48 pg per mL; values ranging from 30.5 to 248.7 pg per mL) in all
DH patients. IL-5, IL-4 and eotaxin levels were normal in the sera of healthy controls. MPO serum
levels showed a signi®cant increase (1173.74 6 430.36 ng per mL); a moderate increase for ECP
serum values was even documented (19.52 6 14.16 ng per mL) and, interestingly, a signi®cant
correlation between the levels of MPO and ECP was detected (t = 4.3; p < 0.001). Finally our
study did not document the presence of tryptase in the serum of DH patients examined. In healthy
controls, MPO serum levels were within the normal range (180±326 ng per mL) while the mean
ECP values was 7.9 ng per mL (range 2.3±16). Tryptase was not documented in the healthy group
too. The detection of Th2-like cytokines, eotaxin and tryptase levels in serum of DH patients can
not be considered a marker of disease activity while the increased serum levels of MPO and ECP
we obtained con®rm the utility of these mediators as serologic parameters of neutrophil and
eosinophil activation.
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The Chemokine Eotaxin is Elevated in the Serum of Patients with Dermatitis
Herpetiformis Duhring
C. Poppe, G. Richter-Huhn, M. Meurer, G. Wozel, and C. Pfeiffer
Department of Dermatology, Technical University of Dresden, Germany
Dermatitis herpetiformis (DH) Duhring is a papulovesicular eruption mainly involving shoulders,
elbows and back. The disease is characterized by granular papillary IgA deposits of unclear
pathophysiologic signi®cance and a dermal in®ltrate rich in neutrophils and eosinophils. These cells
are implicated in the pathogenesis of the disease through secretion of tissue-destroying enzymes.
Homing of these cells can be attributed to cytokines such as eotaxin, IL-13 and TNFa. To evaluate
the serum cytokine milieu necessary for eosinophil maturation and chemotaxis, we analyzed serum
samples of 8 patients with DH by ELISA for eotaxin, IL-5 and IL-13. Additionally, we examined
lesional cryostat sections for eotaxin deposition and expression of the eotaxin receptor CCR3 on
the in®ltrating cells by immunohistochemistry. Serum analysis revealed an about 3-fold higher
eotaxin concentration in sera of DH patients (median: 0.6 pg per mL, range 0.28±1.09) compared
to healthy controls (median: 0.2 pg per mL, range 0.03±0.43). IL-5 and IL-13 serum levels as
detected by ELISA were below the respective detection limits (32 pg per mL and 3 pg per mL).
Immunohistochemistry of lesional cryostat sections demonstrated eotaxin staining in subepidermal
papillae. The expression of the eotaxin receptor CCR3 could be shown on lesional in¯ammatory
cells. Thus eotaxin is not only present in lesional skin but is also elevated in the serum of DH
patients. Eotaxin exerts its chemotactic effect on eosinophils and TH2 cells by binding to CCR3
expressed on lesional in®ltrating cells. Therefore eotaxin might contribute to the perpetuation of
DH and may be suitable as a serum marker for the in¯ammatory activity of the disease.
249
Estimation of Soluble Receptors of Interleukin 2 and Tumor Necrosis Factor a Levels in
Serum of Systemic Sclerosis Patients
B. Dziankowska-Bartkowiak, A. Choczaj-Kukua, A. Zalewska, and A. Sysa-JeÃdrzejowska
Department of Dermatology, Medical University of LoÂdz, LoÂdz, Poland
Pro-in¯ammatory cytokines are regarded to be involved in autoimmunologically determined
®brosis in the course of systemic sclerosis. Soluble interleukin 2 receptor (sIL-2R) and tumor
necrosis factor alfa (sTNFaRI) as activation markers of lymphocytes are postulated to play some
role in evaluation of disease activity. The aim of our study was to estimate whether serum levels of
sIL-2R and sTNFaRI could be of help in systemic sclerosis (SSc) course monitoring. The study
was performed in the group of 17 SSc patients (12 with limited ± lSSc; and 5 with diffuse form ±
dSSc; 3 male and 14 female, aged 31±70 years). The control group comprised 19 healthy people (1
male and 18 female, aged 16±60 years). Degree of skin ®brosis was estimated on the basis of Total
Skin Score (TSS) according to Kahaleh et al. Measurements of serum cytokines were performed
three times (I, II, III) in one year follow-up period. Serum levels of sIL-2R and sTNFaRI were
performed by ELISA method (Quantikine R&D Systems, INC, USA). The obtained results were
analysed by statistical methods including Friedman test, Wilcoxon test for paired data and both
Mann±Whitney and Kruksal-Wallis tests. It was demonstrated that levels of both soluble receptors
were increased in serum of SSc patients (sIL-2R mean values in I ± 2418.659 pg per mL; in II ±
2142.612 pg per mL, in III ± 1967.447 pg per mL; sTNFaRI mean values in I ± 1402.659 pg per
mL, in II ± 1342.829 pg per mL, in III ± 1292.929 pg per mL) in comparison to healthy people
(mean sIL-2R ± 1258.982 pg per mL and mean sTNFaRI ± 938.491 pg per mL). The above
correlations were statistically signi®cant at p < 0.05. In one-year follow-up period, when treatment
was introduced, clinical improvement was observed and serum levels of the soluble receptors
decreased (not statistically signi®cant difference p > 0.05). Measurements of serum sIL-2R and
sTNFaRI levels could be of help in estimation of disease activity in SSc patients.
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Induction of Interleukin-8 in Keratinocytes by Unique Pseudomonas Aeruginosa-
Derived Pathogen-Associated Molecules
L. Schwichtenberg, J. Harder, M. Sticherling, and J.-M. SchroÈder
Kiel, Germany
Epithelial infections with the gram-negative bacterium Pseudomonas aeruginosa (PA) often show a
massive in¯ux of neutrophils resulting in pustule formation. The mechanism of this neutrophil
accumulation is as yet speculative. Although bacteria-derived neutrophil attractants may play a role
and complement activation is important, we speculated that epithelial Interleukin-8 (IL-8)
induction could also contribute to this phenomenon. Therefore the aim of this study was to analyse
whether PA is capable of stimulating IL-8-production in keratinocytes. We investigated different
PA strains (ATCC strains) for induction of IL-8 mRNA-expression in primary keratinocytes as
well as HaCat cells by RT-PCR and protein release using an in-house IL-8-ELISA. IL-8 mRNA-
induction was found in keratinocytes that were in contact with both, mucoid and nonmucoid
types of heat-inactivated PA. Further analyses revealed that IL-8-inducing activity can also be
found in bacterial culture supernatants indicating that IL-8-inducing activity is released from
bacteria. In order to investigate whether lipopolysaccharide is the IL-8-inducer we stimulated
primary keratinocytes with PA supernatants in the presence of the LPS-inhibitor Polymyxin B.
However, we did not ®nd any in¯uence of IL-8-induction. Biochemical characterization
experiments demonstrated that one part of the IL-8-inducing activity can be extracted with
organic solvents indicating that it is a lipid, whereas another part is most likely a protein. RP-
HPLC of both the lipid-like and hydrophilic IL-8-inducing activities revealed elution in single
fractions indicating separate Pathogen Associated Molecules (PAMs) that induce IL-8 synthesis.
Focussing on the proteinaceous activity we further puri®ed IL-8-inducing factors utilising
additional chromatographic steps. Analysis of the fractions corresponding to this IL-8-inducing
activity by SDS-PAGE reveals a single protein band. A further molecular characterization is
currently in progress. In conclusion, our ®ndings support the hypothesis that human skin
keratinocytes recognise PAMs that are unique for highly pathogenic, bio®lm-forming
microorganisms such as P. aeruginosa bacteria to mount an epithelial defense reaction by inducing
epithelial neutrophil attractants such as IL-8.
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Ela®n ± A Serine-Protease Inhibitor with Antimicrobial Activity, Inducible by
Supernatants of Pseudomonas Aeruginosa
U. Meyer-Hoffert, N. Wichmann, L. Schwichtenberg, E. Christophers, and O. Wiedow
Kiel, Germany
Ela®n is a peptide like serine-protease inhibitor, secreted during differentiation of keratinocytes. It
is believed to be important in the regulation of elastase-mediated tissue damage and might play an
important role in maintaining the stratum corneum integrity of the skin. Recent studies provided
evidences for the antimicrobial activity of ela®n against P. aeruginosa. Therefore, we were
interested, whether supernatants of P. aeruginosa are capable of inducing ela®n expression in
keratinocytes. In our study we could demonstrate using realtime-PCR that ela®n mRNA-
expression was up-regulated during differentiation of cultured keratinocytes. Supernatants of
various P. aeruginosa strains stimulated ela®n mRNA-expression and protein release, which we
analysed by speci®c ELISA. The increase of induction was higher compared to stimulation with
IL-1b and TNF-a in both, differentiated and nondifferentiated keratinocytes. In nondifferentiated
cells the relative increase was much higher (100 fold) than in differentiated cells (6 fold), which
though exhibited higher constitutive mRNA expression (500 fold). Differences in ela®n transcripts
did not correlate to secreted ela®n by keratinocytes. After stimulation secreted ela®n concentrations
were similar in differentiated or nondifferentiated cells. This is explainable by the fact that ela®n is
bound covalently to extra-cellular components by transglutaminase, which is expressed in
differentiated keratinocytes. In this study we could not con®rm bactericide effect against
P. aeruginosa as described previously but bacteriostatic properties as demonstrated for different
strains in liquid cultures. We conclude that the role of ela®n in human skin depends on the level of
keratinocyte-differentiation. Constitutively expressed in differentiated cells it maintains the
integrity of the stratum corneum. In basal keratinocytes it appears to be an in¯ammatory response
factor with serine-protease inhibitory and antimicrobial activity.
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Interleukine-4 Plasma Levels in Patients with Different Types of Psoriasis
A. Zalewska, B. Dziankowska-Bartkowiak,* J. WyczoÂ3kowska,* J. Dastych, K. Kondras, and A.
Sysa-JeÃdrzejowska
Department of Dermatology, Medical University of LoÂdz, *Department of Biogenic Amines, Polish Academy
of Sciences, LoÂdz, Poland
Interleukin 4 (IL-4) is a pleiotropic cytokine produced by T lymphocytes and mast cells. It exerts
its action on many different cells including ®broblasts, endothelial cells, T and B lymphocytes and
many others. Since mast cell±®broblast interactions are postulated to be involved in psoriasis, the
aim of our study was to evaluate IL-4 levels in plasma of psoriatic patients in comparison to healthy
donors. The study comprised 30 patients with active psoriasis (erythrodermic form, psoriasis
arthropatica and eruptive guttatae psoriasis) ± Group 1, 15 patients with stable psoriasis ± Group 2
and 10 healthy donors ± Group 3. Severity of the disease was evaluated in each patients (PASI
score). The patients were off any systemic treatment for at least 4 weeks and off local treatment,
with the exception of emollients, for at least 2 weeks. IL-4 levels were evaluated before the
treatment and 3 weeks after an in-patient intensive treatment (Ingram method or methotrexate
regimen). IL-4 levels were measured by ELISA method (capture ± puri®ed mouse antihuman IL-4,
standard ± rhIL-4, antibody ± biotin rat antihuman IL-4, all Phar Mingen; Labsystem Multiskan
RC at 492 nm). Before the treatment, in Group 1, IL-4 levels ranged from 930.7 to 12.2 pg per mL
(mean 224.6) and after the 4-week treatment it decreased and ranged from 315.0 to 4.7 pg per mL
(mean 87.5) (p < 0.05). Before the treatment, in the Group 2, IL-4 levels ranged from 29.1 to
0.0 pg per mL (mean 8.4) and after the treatment ranged from 15.6 to 0.0 pg per mL (mean 3.8)
(p < 0.05). Whereas in the control group (Group 3) IL-4 levels ranged from 84.2 to 0.0 pg per mL
(mean 9.95). The changes in IL-4 levels were pronounced in the group with active, extensive
psoriasis which well responded to treatment. When exacerbation of the disease or resistance to the
introduced treatment was noted during the hospitalisation period, IL-4 levels showed a tendency to
stay at the same level. The obtained results suggest that IL-4 is the next cytokine, out of the whole
network already, to be involved in the course of psoriasis.
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Histochemical Analysis of Macrophage Migration Inhibitory Factor (MIF) in Psoriasis
Vulgaris
T. Shimizu, J. Nishihira,* Y. Mizue,² H. Nakamura, R. Abe, H. Watanabe, and H. Shimizu
Department of Dermatology and *Central Research Institute, Hokkaido University School of Medicine,
Sapporo 060±8638, ²Sapporo Immunodiagnostic Laboratory, Japan
Psoriasis is a persistent cutaneous disease characterized by skin in¯ammation with in®ltration of
immunocytes, such as lymphocytes and monocytes/macrophages concomitant with abnormal
epidermal hyperproliferation. We previously showed that serum macrophage migration inhibitory
factor (MIF) level and its production by peripheral blood mononuclear cells (PBMCs) of the
patients with psoriasis closely correlated with the severity of clinical symptoms; however, the
precise role of MIF in psoriasis remains to be clari®ed. The current study was carried out in order
to elucidate the possible involvement of MIF in the pathomechanism of psoriasis, using
immunohistochemistry and in situ hybridization. Contrasting to elevated serum MIF in psoriasis,
MIF-positive staining in lesional psoriatic epidermis was signi®cantly decreased examined by
immunohistochemical analysis using an anti-MIF antibody. The intensities of positively stained
MIF bands of psoriatic epidermis were signi®cantly lower than those of normal controls by
Western blot analysis. Consistent with these ®ndings, we found that MIF mRNA concomitantly
decreased in the psoriatic lesions using in situ hybridization. Taken together theses results, it is
considered that the major source of elevated serum MIF in psoriasis could be PBMCs, and that
different MIF levels in psoriatic lesions and circulation may re¯ect the pathology of the chronic
in¯ammatory skin disease with regard to epidermal hyperproliferation and systemic in¯ammation.
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Dimethylfumarate Inhibits TNF-Induced CD62E Expression in a NF-kB-Dependent
Manner
M. Pillinger, R. Loewe, R. de Martin,* U. Mrowietz,² M. GroÈger, W. Holnthoner, K. Wolff, W.
Wiegrebe,³ D. Jirovsky,³ and P. Petzelbauer
Department of Dermatology, Division of General Dermatology and *Institute for Vascular Biology and
Thrombosis Research, University of Vienna Medical School, Vienna, Austria; ²Department of Dermatology,
University of Kiel, Kiel and ³Institute of Pharmacy, University of Regensburg, Regensburg, Germany
Fumaric acid esters (FAE) are thought to improve psoriasis by altering leukocyte, keratinocyte and/
or endothelial functions. To determine speci®city, kinetics and molecular mechanisms of different
FAE in their ability to inhibit endothelial cell activation, we analyzed CD62E and CD54
expression in endothelial cells in vivo and in vitro. In lesional skin of psoriatic patients, oral FAE
treatment resulted in a marked reduction of CD62E but not of CD54 expression on dermal
microvessels. Using human umbilical vein endothelial cells (HUVEC), dimethylfumarate (DMF)
almost completely inhibited TNF-induced CD62E, but not CD54 expression at
concentrations < 70 mM, mimicking the situation in vivo. A 60-min DMF preincubation was
suf®cient to block TNF-induced CD62E expression for up to 24 h. In contrast, equimolar
concentrations of methylhydrogen fumarate (MHF), the hydrolysis product of DMF, did not
suppress TNF-induced CD62E expression. Likewise, all FAE other than DMF were ineffective.
Using CD62E, NF-kB or AP-1-responsive promoter constructs, DMF inhibited TNF-induced
activation of the CD62E and the NF-kB but not of the AP-1 promoter construct. In summary, at a
dose range < 70 mM, DMF appeared to be a speci®c inhibitor of CD62E expression in a NF-kB-
dependent manner.
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Dimethylfumarate Inhibits Tumor Necrosis Factor-Induced Nuclear Entry of NF-kB/
p65 in Human Endothelial Cells
R. Loewe, W. Holnthoner, M. Pillinger, E. Hofer,* M. GroÈger, D. Mechtcheriakova,* K. Wolff,
and P. Petzelbauer
Department of Dermatology, Division of General Dermatology, and *Institute for Vascular Biology and
Thrombosis Research, University of Vienna Medical School, Vienna, Austria
Dimethylfumarate (DMF), a diester of fumaric acid, is known to inhibit TNF-induced activation
of endothelial cells in vivo and in vitro. To characterize the molecular basis of DMF action, we
analyzed TNF- and/or VEGF-induced tissue factor expression in human endothelial cells in
culture. We show that DMF inhibited TNF-induced tissue factor mRNA transcription and
protein expression, as well as TNF-induced DNA binding of NF-kB in endothelial cells. In
contrast, DMF has no effect on VEGF-induced tissue factor protein and mRNA expression as well
as DNA binding of EGR-1 and constitutive SP1. Employing immunoblots of nuclear extracts and
FACS analysis of nuclei isolated from green ¯uorescent protein-NF-kB/p65-transfected
endothelial cells we show that DMF inhibited the TNF-induced nuclear entry of p65. This is
not due to inhibition of TNF-signaling down to IkB, because DMF does not alter TNF-induced
IkBa phosphorylation and IkBa degradation. Also the constitutive shuttling of inactive p65/IeÃB
complexes into and out of the nucleus is not altered by DMF. We conclude that DMF inhibits NF-
kB-induced gene transcription at the level of the nuclear entry of p65, after its release from IkB.
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Evaluation of the Convenience of the Cd7 Marker in the Identi®cation of SeÂzary Cells
A.C. Knol, N. Robillard, F. Accard, N. Chebassier, S. Leroy, M.C. Pandol®no, Y. Guilloux, F.
Jotereau, and B. DreÂno
INSERM U463 et CHU Hotel-Dieu, Nantes, France
Cutaneous T-cell lymphomas (CTCL) are characterized by the in®ltration of the skin by T
lymphocytes of the CD2+ CD3+ CD4+ CD45RO + DR + phenotype. CTCL represent a unique
model in tumoral terms because both tumoral and reactive cells are T lymphocytes. Till now no
speci®cal marker of tumoral cells has been described in the literature. Nevertheless, since the
idiotype of the TCR represents a unique marker for a malignant clone of T lymphocyte, the clonal
origin of tumoral cells allows us to think that the TCR-Vb clone corresponds to the tumoral cell.
Concurrently, loss of expression of CD7 is considered as a diagnostical criterium for CTCL
because of its frequent publication and would be speci®c of Sezary cells. But this hypothesis
remains uncon®rmed. Our goal is to determine whether this CD7- population represents the
SeÂzary cells. Our study turns on one patient, cytologically con®rmed and exhibiting more than
50% circulating Sezary cells. A sorting, by cell sorter, has been realised in order to harvest the
CD4+ CD7+ and CD4+ CD7- populations, which were then submitted to a cytological
evaluation on the basis of the cerebriform nucleus of SeÂzary cells. We found for this ®rst patient
that both CD4+ CD7+ and CD4+ CD7- populations contained SeÂzary cells, so this ®nding
suggests that CD7 is not an appropriate marker to identify SeÂzary cells. Moreover we were able to
note that this cerebriform appearance was lost after a few days of in vitro culture with IL-2, IL-7 or
IL-15, therefore this aspect could be the consequence of the sensitivity of the lymphocytes to the
cutaneous microenvironment.
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In Vitro Expression of Interleukin-15 and its Receptor by Normal Human Keratinocytes
and In Vivo Expression in Cutaneous T-Cell Lymphomas Mycosis Fungoides and SeÂzary
Syndrome
S. Leroy, J. Bernard, N. Chebassier, A.C. Knol, A. Plet, A. Godard, Y. Jacques, and B. DreÂno
INSERM U463, Nantes, France
Interleukin (IL)-15 exerts similar biological activities as IL-2 through common receptor
transducing subunits, IL-2/IL-15Rb and gc chains. The speci®city of the receptor for IL-2 or
IL-15 is obtained after association with a third chain lacking transducing activity (IL-2Ra, IL-
15Ra). Unlike IL-2, IL-15 mRNA are ubiquitously expressed but their translation is tightly
controlled and IL-15 protein is seldom produced under physiological conditions. The aim of this
work was to study IL-15 and IL-15 receptor expression ®rstly by normal human keratinocytes in
vitro and secondly in vivo in cutaneous T-cell lymphomas (mycosis fungoides and SeÂzary syndrome),
psoriasis and atopic dermatitis. We observed that unstimulated normal human keratinocytes
expressed IL-15 and IL-15 receptor mRNA and also IL-15 and IL-15Ra proteins in vitro. Their
expression was increased after stimulation of cells by IFNa or g. Interestingly, it appeared that IL-
15Ra protein was mainly located in the nucleus, whereas IL-15 protein was detected in the
cytoplasm and/or at cell membrane. In vivo, we did not detect IL-15 and IL-15Ra protein
expression both in normal human skin and cutaneous lesions of atopic dermatitis and psoriasis.
However, IL-15 and IL-15Ra protein expression was observed in keratinocytes for IL-15 and in
T-cell in®ltrates for IL-15Ra of cutaneous T-cell lymphoma, strongly suggesting a possible role of
IL-15 in this disease. The stimulus responsible for IL-15 induction in cutaneous T-cell lymphoma
remains however, to be identi®ed.
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High Immunomodulatory Potency of Consensus Interferon Alfacon-1 on Melanoma
Cell Lines
S. Ugurel, G. Rappl, W. Tilgen, and U. Reinhold
Saarland University Hospital, Homburg/Saar, Germany
The interferon(IFN)s are known for their antiproliferative, antiviral and immunoregulatory effects
in vitro and in vivo, though these effects vary in magnitude depending on the cell type targeted. In
regard to melanoma cells, IFN-b and IFN-g have been shown to exert stronger antiproliferative
and immunomodulatory potencies than IFN-a. In the present study we investigated the effects of
the synthetic type I consensus IFN alfacon-1 compared to IFN-a2b, IFN-b and IFN-g in 5
melanoma cell lines. The cell surface expression of HLA class-I/±II molecules and of the apoptosis-
associated proteins FasR/CD95, bcl-2 and bcl-xS was determined by ¯ow cytometry. The
sensitivity towards FasR/CD95-mediated apoptosis was measured using ¯uorescence double-
staining with annexin-V and propidiumiodide. We found a strong dose-dependent up-regulation
of HLA class-I on all 5 cell lines by IFN-b, IFN-g and alfacon-1, instead of a slight increase by
IFN-a. IFN-b and alfacon-1 signi®cantly revealed antiproliferative action in 4 of 5 cell lines, with
highest potencies by IFN-b. IFN-a and IFN-g showed antiproliferative effects in 1 of 5 and 2 of 5
cell lines, respectively. IFN-b, IFN-g and alfacon-1 signi®cantly sensitized 4 of 5 cell lines towards
FasR/CD95-mediated apoptosis, whereas IFN-a showed no response. In conclusion, our data
indicate the consensus IFN alfacon-1 as a potent immunomodulatory agent in malignant
melanoma in vitro, suggesting further studies on the in vivo use of this new type of IFN.
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Fibroblasts Derived from Chronic Diabetic Ulcers Differ in their Response to Growth
Factors Compared to Controls
M.A.M. Loots,* S.B. Kenter, F.L. Au, E. Middelkoop,* J.D. Bos, and J.R. Mekkes
Department of Dermatology, Academic Medical Centre, Amsterdam; *Red Cross Hospital and Dutch Burns
Foundation, Beverwijk, The Netherlands.
Patients with diabetes mellitus experience impaired wound healing, often resulting in chronic foot
ulcers. Healing can be accelerated by application of growth factors like platelet-derived growth
factor (PDGF). We investigated the mitogenic responses, measured by 3[H] Thymidine
incorporation, of ®broblasts cultured from diabetic ulcers, non diabetic ulcers, and non lesional
diabetic and age matched controls to recombinant human PDGF-AB, epidermal growth factor
(EGF), ®broblast growth factor (bFGF) and insulin-like growth factor-I (IGF-I). We determined
the optimal concentration of these factors, and investigated which single factor, or combination of
factors, added simultaneously or sequently, induced the highest mitogenic response. For single
growth factor additions: (1) diabetic ulcer ®broblasts needed more EGF to reach their maximum
mitogenic value compared to non lesional controls (p#0.04) and (2) PDGF-AB induced the
highest mitogenic response in all four categories of ®broblasts, this was a signi®cant ®nding for
diabetic ulcer ®broblasts when compared to IGF-I (p#0.007) and bFGF (p#0.05) and (3) the
optimum stimulation achieved by IGF-I was signi®cantly lower for diabetic ulcer ®broblasts vs.
controls (p#0.003). Simultaneous addition of combinations of growth factors to diabetic ulcer
®broblasts always produced a higher stimulatory response than sequential additions (signi®cant for
PDGF-IGF, FGF-PDGF and FGF-PDGF; p < 0.01). The highest response was obtained by the
simultaneous addition of PDGF-AB and IGF-I (synergistic effect, p < 0.05 vs. all other
combinations), this was not observed in the chronic ulcer and age matched controls. In conclusion,
the combination of PDGF-AB and IGF-I seems more promising than PDGF-AB alone for clinical
application in chronic diabetic wounds.
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Expression of SMAD 7 in Cultured Fibroblasts From Patients with Keloid Scarring
O. Bock, H. Yu, R. GlaÈser, and U. Mrowietz
Kiel, Germany
The SMAD Proteins have been recently described as the intracellular signalling pathway of the
transforming growth factor b (TGFb). SMAD's consist of three groups: receptor regulated
SMAD's (SMAD 1, 2, 3, 5, 8), common SMAD (SMAD 4) and the inhibitory SMAD's (SMAD 6
and 7). Receptor±ligand interaction is leading to phosphorylation of the receptor regulated
SMAD's. Inhibitory SMAD's terminate the TGFb signal in a negative feed-back loop. TGFb plays
an important role in the pathogenesis of keloid scarring. Keloids develop after skin injury and tend
to grow invasively into the surrounding healthy skin. TGFb has been reported to be responsible for
the ongoing, massive over-expression of extracellular matrix components in keloids. Until today it
remains unknown why the TGFb signal in keloids is not terminated. Therefore we investigated the
expression of the inhibitory SMAD 7 in cultures of ®broblasts from keloid tissue biopsies. For
comparison ®broblast cultures from patients not suffering from keloids were established. Semi-
con¯uent ®broblast cultures were stimulated with 20 ng TGFb-1 for 30 min, 1 h, 2 h, 6 and 24 h.
After stimulation mRNA was isolated for real-time RT-PCR. In addition ®broblasts were lysed
after stimulation to investigate protein expression by western-blotting. First results showed that
mRNA expression of SMAD 7 after stimulation with TGFb-1 is reduced in keloid ®broblasts
compared to ®broblasts of normal skin. Expression of SMAD 7 protein in keloid ®broblasts
investigated by western-blotting showed a diminished amount of SMAD 7 protein compared to
normal skin. These results show that the expression of SMAD 7, the major inhibitory SMAD
protein, is reduced on protein and on mRNA level in cultures of keloid ®broblasts. The decreased
SMAD 7 concentration in keloid ®broblasts may shift the balance between activating SMAD's and
inhibitory SMAD's in favour of the activating side leading to an ongoing cellular proliferation.
261
Keratinocytes Downregulate Expression of Connective Tissue Growth Factor in
Fibroblasts
D. Nowinski, P. HoÈijer, T. Engstrand, K. Rubin, B. Gerdin, and M. Ivarsson
Uppsala, Sweden
The role of keratinocytes for regulation of ®brogenic cytokines in ®broblasts was investigated.
Fibroblasts were cultured in multiwell plates together with keratinocytes in semipermeable cell
culture inserts. By this method, the two cell types were physically separated but could exchange
diffusible factors. In presence of keratinocytes, expression of CTGF mRNA in ®broblasts was
suppressed by half 6 h after establishment of cocultures, and inhibition persisted throughout a 48-h
culture period. Keratinocytes suppressed both serum or TGF-b1 stimulated CTGF mRNA in
®broblasts and the effect was also seen with conditioned medium from keratinocytes. Basal or
TGF-b1 stimulated CTGF protein expression was also suppressed by at least half in the presence of
keratinocytes. TGF-b1 mRNA in ®broblasts was less affected by coculturing with keratinocytes
and corresponding protein unchanged. Furthermore, keratinocytes suppressed collagen I
expression at the level of mRNA and protein synthesis while general protein synthesis was
unaffected in our model. TNF-a is a possible candidate for the suppressive effects on CTGF and
collagen I mRNA but was not operative in our model. Taken together, the results provide a
mechanism that may explain, at least partly, the clinical observation that epithelial coverage is
important for down-regulation of connective tissue activity during the end-stage of wound
healing.
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Functional Activation of Calcineurin by Differentiation Promoting Agents in Human
Epidermal Keratinocytes and Inhibition by Cyclosporin A
W.I. Al-Daraji, K.R. Grant, K. Ryan, P. Fearon, and N.J. Reynolds
Department of Dermatology, University of Newcastle upon Tyne, UK
Systemic cyclosporin A (CsA) is an effective treatment for psoriasis but its mechanism of action is
incompletely understood. IL-2 production in T cells depends on activation of the phosphatase
calcineurin and translocation of the transcription factor NFAT accompanied by calcineurin to the
nucleus. CsA blocks T cell activation by inhibiting this pathway. Reverse transcriptase/PCR and
western analysis demonstrated the presence of calcineurin A2 and B in human epidermal
keratinocytes. Cultured human keratinocytes were treated with differentiation- promoting agents
that also induce a rise in intracellular calcium, ®xed, stained sequentially with monoclonal
antibodies to calcineurin A and calcineurin B subunits, Cells were visualized by immuno¯uor-
escence and confocal microscopy and the proportion of cells showing nuclear positivity counted.
Calcineurin A and calcineurin B colocalized and appeared predominantly cytoplasmic in un-
treated keratinocytes. TPA (50 nM), TPA plus ionomycin (1 mM), and increased extracellular
calcium (1.5 mM [Ca2+]o) induced translocation of calcineurin A and calcineurin B subunits to the
nucleus by 2 h that was maximal at 4 h (n = 3, p < 0.0001 compared to control) and sustained to
18 h in response to TPA and TPA plus ionomycin. Pre-treatment of keratinocytes with CsA
(1 mM) reduced the mean percentage (6SD) of cells showing nuclear positivity for calcineurin A
from 94 6 1 to 10 6 2.3 in response to 1.5 mM [Ca2+]o for 4 h and from 65 6 4 to 10 6 5 in
response to TPA for 4 h (n = 3, p < 0.0001). All three agents also induced translocation of
calcineurin A and B to the plasma membrane at 4 h that was inhibited by CsA. These data provide
evidence that differentiation-promoting agents activate calcineurin in human keratinocytes
resulting in nuclear translocation and that CsA inhibits this signaling pathway.
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Cyclosporin A Directs Cyclophilin B to the Constitutive Secretory Pathway in Human
Keratinocytes
P. Fearon and N.J. Reynolds
Department of Dermatology, University of Newcastle upon Tyne, UK
Cyclosporin A (CsA) is effective treatment for in¯ammatory skin diseases. The mechanism of
action of CsA in T-cells is well characterised, however, its effects in skin are less well understood.
Cyclophilin B (CypB) is a 21-kDa protein capable of both binding CsA, and catalysing the
isomerisation of certain peptide bonds. In T-cells, CypB is secreted in response to treatment with
CsA, and is thought to contribute to the effects of CsA. As yet, the physiological role of CypB
remains unclear. The aim of this study was to determine if CypB is expressed in skin, and if CsA
modulates CypB in cultured keratinocytes. CypB was shown to be expressed by human
keratinocytes using RT-PCR and immunoblotting. Human keratinocytes were treated with CsA
(1 mM) for up to 96 h then either (1) ®xed and double labeled with anti-CypB antibody and a
probe for the golgi apparatus or (2) culture medium was collected (either immediately or up to 96 h
after removal of CsA from cells) and analysed by immunoblotting. In untreated cells, CypB was
found in both the nucleus and cytoplasm, but after treatment with CsA, CypB colocalised with the
golgi apparatus and the plasma membrane. CypB accumulated in the medium of treated
keratinocytes in a time dependant manner, and continued to be secreted upon removal of CsA
from the culture medium. Secretion of CypB could be inhibited by pretreatment of cells with
brefeldin A, an inhibitor of constitutive secretion. These data show that CsA promotes secretion of
CypB by keratinocytes and suggest that CypB may play a role in mediating the action of CsA in
in¯ammatory skin disease.
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Vascular Endothelial Growth Factor-C is Involved in Lymph Node Localization of
Human Melanoma Metastases
F. Cianfarani, P.M. Lacal,* C. Schietroma, T. Odorisio, A. Orecchia, J. Kanitakis,² S. D'Atri,*
C.M. Failla, and G. Zambruno
Molecular and Cell Biology Laboratory and *Pharmacology Laboratory, IDI-IRCCS, Rome, Italy;
²Department of Dermatology, Hop. Ed. Herriot, Lyon, France
Melanoma can metastasize through different routes comprising direct invasion of surrounding
tissue and spread via the vascular and/or the lymphatic system. However, little is known about the
molecular mechanisms which guide metastasis spreading and localization in distinct tissues. Among
the cytokines of the vascular endothelial growth factor family (VEGFs), VEGF-C and VEGF-D
have been shown to be involved in tumor-induced lymphangiogenesis and lymphatic metastasis
formation. These cytokines are ligands for VEGFR-3/Flt-4, a tyrosine kinase receptor almost
exclusively localized to lymphatic vessels in the adult. To characterize the role of VEGF-C and
VEGF-D in human melanoma, we have analyzed expression of these cytokines in cultured human
melanoma cell lines derived from cutaneous and lymph node metastases. VEGF-C mRNA and
protein were preferentially expressed in lymph node-derived tumor cell lines. On the other hand,
VEGF-D was detected at extremely low level in all the melanoma cell lines examined.
Immunohistochemistry on melanoma specimens from which the cell lines were derived
demonstrated a correspondence in VEGF-C expression between cultured cell lines and tumor
samples. In addition, immunohistochemical analysis of 46 human melanoma specimens con®rmed
the preferential expression of VEGF-C in lymph node (16/21) vs. cutaneous (6/25) metastases.
Our ®ndings indicate that VEGF-C may be involved in melanoma metastasis spreading via the
lymphatics and open new prospect for therapy.
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Intracellular Signalling of Phytoestrogens in Relation to VEGF Receptors Expression by
Hair Follicle Cells
S. Lachgar, M. CharveÂron, M.E. Balana, and Y. Gall
Pierre Fabre Research Institute, FaculteÂ de MeÂdecine Rangueil, Toulouse, France
Many studies indicate the impact of phytoestrogens (PHO) in normal physiology of humans and
animals. They have demonstrated to possess numerous biological properties such as inhibition of
tyrosine kinase activity. The mechanisms by which these PHO exert their effect are multifactorial
and tissue-speci®c. The impact of PHO on hair growth was less extensively investigated. Published
reports indicate that treatment of keratinocytes with selective PKC inhibitors stimulates their
proliferation and in vivo stimulates murine hair growth (Yokoo et al. 1999). These data led us to
study ®rstly the effect of PHO on PKC and then after to test the hypothesis that the vascular
responses of hair follicle cells in vitro are linked to the effects of PHO on PKC activity and
expression. We evaluated by Western- blot analysis the effect of two total plant extracts: soya and
pueraria in comparison with two free forms (genistein, daidzein) on the expression of PKC a and d
isoforms. We also evaluated their effect on PKC activity in cultured human hair follicle dermal
papilla cells (DPC). In parallel, we evaluated by Western-blot and RT-PCR the effect of PHO on
VEGF receptors (¯t-1 and Flk-1) expression on DPC. The direct effect of PHO on hair growth
was assessed on human hair follicles. Our results showed a dose-dependent inhibition of PKC a
and d expression in the presence of PHO and speci®c inhibitors of PKC isoforms. PKC activity
was also seen to be markedly decreased in the presence of genistein, daidzein and soya extracts
(42%inhibition for 1 mM genistein and 44% for soya extract at 1 mg per mL). The PKC activity was
less reduced in the presence of pueraria extract at 1 mg per mL (10% inhibition). The inhibition
induced by genistein is similar to that of a PKC inhibitor: Calphostin C (45%inhibition). However,
we observed an increase of VEGF receptors expression in the presence of PHO. Speci®c inhibitors
of PKC also promoted Flt-1 expression by DPC. Our results showed that Flt-1 and KDR
expression within hair DPC is mainly mediated through the PKC pathway. This signalization is
modi®ed in the presence of PHO and chemical protein kinase inhibitors: an overexpression of
VEGF receptors is observed in DPC. It will be of interest to examine the functional impact and
signi®cance of protein kinase C modulation on the established vasculature of the hair follicle.
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Disappearance of the Capillary Network in Alopecia Areata is due to Growth Inhibition
of Human Microendothelial Cells by Pro-Apoptotic Molecules Released from
Peripheral Mononuclear Blood Cells (PBMC)
A. Gelber,*² N. Mandt,* C. Sommer,*² C.C. Geilen,* and U. Blume-Peytavi*²
*Department of Dermatology, University Medical Center Benjamin Franklin, The Free University of Berlin,
and ²Department of Dermatology, University Medical Center ChariteÂ, Humboldt University of Berlin,
Berlin, Germany
Alopecia areata (AA) is considered to be a T-cell mediated immunologic disease with genetic
predisposition, however, its etiopathogenesis has not yet been fully elucidated. Histopathologic
examination in the early in¯ammatory phase of AA shows a strong peribulbar in®ltrate with
disappearance of the vascular network surrounding the hair follicle. The aim of the present study is
to investigate signaling molecules previously identi®ed as key mediators in alopecia areata as well as
peripheral mononuclear blood cells (PMBCs) for their signi®cance in regulating endothelial cell
growth. Cultured human microendothelial cells (HMECs) were treated with different signaling
molecules as well as activated and nonactivated PBMCs of both AA patients and nonaffected
individuals. After 3 h incubation HMECs were analyzed for their apoptotic behavior using a
photometric enzyme-immunoassay (cell death detection ELISA). Necrosis was excluded by
measuring lactate dehydrogenase activity released into cell culture supernatants. IL-1a, IL-1b, IL-2
(all 10 ng per mL), TNF-a (20 ng per mL) and TGF-b (4 ng per mL) induced apoptosis in HMECs
without necrosis. In contrast, IL-4 (100 ng per mL), IFN-g (0.5 ng per mL), IL-8, IL-10, and IGF-
1 (all 10 ng per mL) did not lead to apoptosis or necrosis in HMECs. Furthermore, supernatants of
Phythamagglutinin (PHA) stimulated PBMCs induced signi®cant apoptosis without necrosis in a
1 : 8 dilution exclusively in AA patients but not in nonaffected individuals. However, using a lower
concentration (1 : 1) of supernatants from PMBCs apoptosis and also necrosis were detected in both
supernatants from AA and in nonaffected individuals. We suggest that proin¯ammatory cytokines
like IL-1a,-1b and TNF-a as well as proapoptotic molecules released from PMBCs are responsible
in AA for the disappearance of the capillary network surrounding the hair follicle, subsequently
leading to initiation of the catagen phase.
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Sphingosine Kinase is Expressed in the Human Immortalized Keratinocyte Cell Line
HaCaT
H. Kamp, C.C. Geilen,* and U. Blume-Peytavi
Department of Dermatology, University Medical Center ChariteÂ, Humboldt University of Berlin, Germany;
*Department of Dermatology, University Medical Center Benjamin Franklin, The Free University of Berlin,
Germany
Formation and maintenance of the normal epidermis is a balanced tissue formation where
regulation of proliferation and differentation of keratinocytes is highly important. Pathological
reactions of the skin like atrophy or hyperkeratosis may be considered as directly related to
proliferation and programmed cell death, i.e. apoptosis. Sphingosine-1-phosphate (SPP) is a highly
bioactive sphingolipid metabolite exerting both intracellular and extracellular actions in
mammalian cells. Various stimuli, serum and platelet-derived growth factor (PDGF), activate
sphingosine kinase, the enzyme that phosphorylates sphingosine yielding SPP. Intracellular SPP
was shown to in¯uence signaling pathways leading to cellular proliferation and inhibition of
apoptosis in various cell types. On the other side, SPP exerts extracellular functions as the ligand for
the G-protein-coupled receptor EDG-1, which in¯uences cell migration. Previous studies showed
that ceramides are mediators of apoptosis induced via tumor necrosis factor a (TNF a). As the
intracellular balance of SPP and ceramides may determine the fate of the cell, we investigated the
role of SPP in the keratinocyte cell line HaCaT. In the present study, we demonstrate for the ®rst
time the expression of sphingosine kinase in the keratinocyte cell line HaCaT. Sphingosine kinase
experiments using cytosol of HaCaT showed a time and concentration-dependent formation of
SPP. In addition, SPP-formation could be blocked using competetive inhibitors of sphingosine
kinase. Our data indicate that sphingosine kinase may be involved in cellular processes concerning
keratinocyte proliferation and differentiation.
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Augmentation of Perilipin and PPARau Expression is Associated with the
Accumulation of Intracellular Lipids in Hamster Sebocytes In Vitro
N. Akimoto, T. Sato, F. Shibata, M. Sumida,* and A. Ito
Department of Biochemistry, Tokyo University of Pharmacy, and Life Science, Hachioji, Tokyo 192±0392,
and *Department of Second Medical Biochemistry, Ehime University School of Medicine, Shigenobu, Ehime
791±0295, Japan
Sebaceous glands are important skin appendages and sebum excretion is considered to be associated
with the functional maintenance of the cutaneous surface as a biological barrier. Sebocytic
differentiation sequentially occurs with accumulating cytoplasmic lipids. On the other hand, it is
well known that adipocytes are differentiated to accumulate abundant lipids in the cytoplasm.
Perilipin has been located at the periphery of the lipid droplets and associated with lipid metabolism
in adipocytes. In addition, PPAR participates in lipogenesis in the differentiated cells. However, it
remains unclear whether perilipin and PPAR participate in the accumulation of intracellular lipids
in sebocytes. Therefore, we have investigated the expression of perilipin and PPAR in
differentiated hamster sebocytes by Western blot and immunohistochemical analysis. When
hamster sebocytes were treated with insulin, 5ad-dihydrotestosterone (5ad-DHT) and interleukin 6
(IL-6), the expression of perilipin was augmented along with increase in the accumulation of
intracellular lipids. Furthermore, the expression of PPARac was augmented by these factors but
that of PPARgw was negligible. On the other hand, insulin augmented the expression of perilipin
and the lipogenesis in primary hamster adipocytes whereas 5ar-DHT and IL-6 did not in¯uence
them. In addition, neither PPARaD nor PPARgn expression was modulated in these factors-
treated hamster adipocytes. Therefore, these results suggest that the augmentation of perilipin and
PPARae expression may be associated with lipogenesis in differentiated hamster sebocytes, and
further that the regulation of perilipin and PPARs expression in sebocytes may differ from that in
adipocytes.
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Assessment of the Skin Metabolism of Two Stable Antioxidant Precursors to a Free
Tocopherol, Tocopheryl-Glucoside vs. Tocopherol Acetate, in an Epidermal Equivalent
V. Raufast and A. Mavon
Service de PharmacocineÂtique cutaneÂe, Institut de Recherche Pierre Fabre, Toulouse, France
Among the enzymes involved in the epidermal barrier function, two, an esterase and a b-
glucocerebrosidase can serve to release bioactive compounds. The aim of this study was to assessed
the skin penetration and metabolism of two stable antioxidant precursors, the a-tocopherol acetate
and the d-tocopheryl-glucoside. The study was performed with a reconstructed human epidermis
(RHE). After an isotopic dilution of the tritiated molecules, 0.1% of the precursor solubilise in a
cosmetic oil have been deposited both on in®nite and ®nite dose. Radio-HPLC analysis has been
used to determine the amount of precursors which have penetrate and to quantify the conversion
into free tocopherol at 18 H for in®nite dose study, and at 2, 6 and 18 H for ®nite dose study. After
an exposure of 18 h radio-HPLC analysis show penetration of the two precursors in the RHE. In
in®nite dose, about 18 6 7% and 47 6 13% (n = 9) of the total d-tocopheryl-glucoside was
converted into d-tocopherol in the stratum corneum (1 tape stripping) and in the epidermis,
respectively. No conversion of a-tocopherol acetate to a-tocopherol was found in the RHE.
Accordingly, only the kinetic of conversion the d-tocopheryl-glucoside has been studied. The
results show that 45, 76 and 89% (n = 4 for each time) were converted into free tocopherol at 2, 6
and 18 h, respectively. These ®ndings show that epidermal equivalent can be used to assess the
metabolism of topicaly applied molecules. No free a-tocopherol was converted from a-tocopherol
acetate. On the other hand the gluco-conjugated tocopherol is a valuable precursor to deliver into
the skin free tocopherol, ®rstly the glucoconjugation increases the thermal and photochemical
stability of d-tocopherol and secondly the reservoir effect coupled with the enzymatic conversion
constitutes an ef®cient controlled released of free tocopherol in situ.
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Barrier Function of the Axillary Stratum Corneum
R.S. Lee, A. Watkinson, S.E. Paterson, A.E. Moore, P. Pudney, and A.V. Rawlings
Sharnbrook and Port Sunlight, U.K
Axillary stratum corneum has a unique environment, being subjected to hydration stress as a result
of sweat and its enclosed anatomical location. To determine whether this region contains
phenotypically altered axillary skin we have investigated the stratum corneum barrier function.
Both trans-epidermal water loss (TEWL) measurements, in a carefully controlled setting, and
corneosurfametry (CSM) revealed that the axilla had a reduced barrier function compared to the
forearm. HPTLC analysis of stratum corneum lipids demonstrated sign®cantly elevated levels of
fatty acids, ceramide and particularly cholesterol in the axilla compared with forearm. Attenuated
total re¯ectance Fourier transformed infrared (ATR FTIR) spectrometry was used to investigate
lipid lamellae organisation. Preliminary data indicated that the organisation of the axillary barrier
lipids differed from that of the forearm, which may explain the observed barrier effects. To
investigate whether a specially formulated aerosol antiperspirant (AP) product, containing a
moisturising cream, could be used to supplement barrier function, Skin Surface Water Loss
(SSWL) analysis was performed on AP treated skin. AP treatment reduced by approximately 50%
the water loss from the site compared to untreated control. By contrast, repeating the treatment
with the AP in the absence of the moisturising cream gave a similar water loss to that of the
untreated control. Conclusion: (1) axillary stratum corneum has a de®cient barrier; (2) the levels of
axillary stratum corneum lipids are signi®cantly elevated compared to forearm: (3) perturbation of
the stratum corneum lipid ratios may explain barrier de®ciency; (4) a specially formulated aerosol
AP product can signi®cantly improve the water holding capacity of the stratum corneum, and
promote normal barrier function.
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Visual Scaliness of Human Skin Correlates to Decreased Ceramide Levels and Decreased
Stratum Corneum Protease Activity
L. Van Overloop, L. Declercq, and D. Maes*
EsteÂe Lauder Coordination Center, Oevel, Belgium and *EsteÂe Lauder Companies, Melville, New York,
New York
Variations in scaliness of the human skin with age or in conditions of barrier perturbation have
often been attributed to alterations in stratum corneum hydration as well as a disturbed lipid
content. The protein compartment of the epidermal barrier has thereby received relatively little
attention. The stratum corneum proteases SCCE (chymotryptic enzyme) and SCTE (tryptic
enzyme) are believed to play a major role in the regulation of the desquamation process of the
stratum corneum. We have previously shown that barrier disruption by tape stripping leads to a
temporary reduction in the activity of these proteases, suggesting that reducing the degradation rate
of intercellular cohesive structures may contribute to the initial phase of barrier recovery. In the
present study we investigated whether variations in scaliness of the skin on different anatomic sites
(lower leg, the inner forearm and the face) would be associated with changes in protease activity
and ceramide content in the upper stratum corneum. After normalization to total protein a
signi®cant and inverse correlation was observed between skin scaliness and protease activity as well
as ceramide level. This effect was most pronounced for the phytosphingosine based ceramide
subfraction. The data suggest that both a chronical decrease in active proteases and a diminished
activity, caused by a decreased amount of water retaining ceramides, may contribute to the
induction of a scaly dry skin.
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Slow Internal Release of Bioactive Compounds Under the Effect of Skin Enzymes
D. Redoules, C. Viode,² R. Tarroux, C. Casas, A. Lougayre,* D. Fournier,* and J. Perie²
Chimie CutaneÂe, Institut de Recherche Pierre Fabre, Vigoulet Auzil, 31322 Castanet-Tolosan; *Laboratory
d'Entomologie AppliqueÂe et ²Groupe de Chimie Organique Biologique, UniversiteÂ Paul Sabatier, 118 Rte
de Narbonne, 31062 Toulouse, France
Among the enzymes involved in the maintenance of the epidermal barrier function (1), two of
them, a b-glucocerebrosidase and an esterase can be exploited as a route for the delivery of
bioactive compounds. These two enzymatic activities are ®rst evidenced and assayed in a normal
skin, using appropriate substrates. A more detailed analysis of the requierements for hydrolysis by
the ®rst enzyme was obtained after cloning and overexpressing it. Hydrolysis occurs as long as the
leaving group is good enough (pk < 10) and there is no steric hindrance at the glycosidic bond
being broken. This strategy is ®rstly illustrated with an antioxidant d-tocopherol owing to the
general importance of that class of compounds. The corresponding glucoconjugate is hydrolysed
with release of d-tocopherol the antioxidant properties of which are higher than those of the a-
derivative. Moreover this strategy of slow release of the compound prevents a pro oxidant effect.
Release of any compound can obtained by introducing a spacer between the glucose unit and the
molecule to be released. This spacer may also provide an extra bioactivity. This situation is
exampli®ed with the release of retinoic acid, using two different spacers, hydroquinone
(depigmentent) and glycerol (control agent of water loss) the two spacers allowing the control
of the rate of the release. It should be noticed, in relationship with practical applications, that
glucoconjugation increases the thermal and photochemical stabilities of d-tocopherol; it was
checked that for the d-toco-conjugate, the delivery of the compound is actually observed in vivo, at
the stratum corneum level, and this with a reservoir effect. This strategy can be extended to diverse
situations: care and therapy of the skin, delivery of compounds which presently are internalized in
the body from patches and drugs which have shown a hepatic toxicity by oral route.
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Development of New 5-a Reductase Inhibitors
A.P. Piccirilli, N. Piccardi, and P. Msika
R&D Center, Laboratoires PharmascienceTM, Courbevoie, France
5-a reductase, the enzymes system that metabolizes testosterone into dihydrotestosterone (DHT),
occurs in two isoforms, the type A which represents the ``cutaneous type'' and the type 2 which is
located mainly in the epididymis, seminale vesicles, prostate,¼Androgen-dependent skin
disorders, such as seborrhoea, acne, female hirsutism and/or androgenetic alopecia are among
the most common diseases encountered by the dermatologist. Thus the development of new
compounds that effectively inhibit the type 1 isoenzyme of 5-a reductase are of major importance
for dermatological purpose. The aim of this work is to present new compounds which are able to
inhibit signi®cantly 5-a reductase type 1. The ef®ciency of these molecules was tested on human
skin ®broblasts in culture. Cells were cultured with radiolabelled testosterone and the evaluation of
DHT formation by thin-layer chromatography has been applied to evaluate 5-a reductase activity.
Using this protocol, we have demonstrated that butyl avocadate, methyl ricinoleate and Pygeum
Africanum were effective 5-a reductase type 1 inhibitors.
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Cyclosporine a Reduces Retinoic Acid Degradation and Increases The Expression of a
Retinoid-Regulated Gene in Cultured Keratinocytes
H. ToÈrmaÈ, T. Jarhede, and A. Vahlquist
Department of Dermatology, Uppsala, Sweden
Cyclosporine A (CsA) and synthetic retinoids is often used to treat severe psoriasis. Both
endogenous retinoids (e.g. retinoic acid; RA) and CsA are metabolized by cytochrome p450-
dependent enzymes. The aim of this work was to study if cultured keratinocytes exposed to CsA
exhibit altered RA metabolism and signaling. We exposed keratinocytes to 10 mM CsA or
liarozole, a retinoic acid metabolism blocking agent, and studied the metabolism of [3H]retinol and
[3H]RA in the cells by radiochromatography. In parallell experiments we measured the mRNA
expression of a retinoid-regulated gene, CRABPII, by real-time quantitative PCR. It was found
that CsA altered the metabolism of both [3H]retinol and [3H]RA. In the former case, a 10±20-fold
increase of cellular [3H]retinol and [3H]RA, and a 10-fold decrease of 3,4-[3H]didehydroretinol
and 3,4-[3H]dide-hydroretinoic acid was found. In the latter case the cellular content of [3H]RA
was increased 3Ä-fold compared to control cells. Liarozole also increased cellular [3H]RA, but the
effect was less pronounced than with CsA in both cases. Furthermore, in cells exposed to CsA the
mRNA expression of CRABPII increased about 2±3 times, peaking at 8±16 h. A novel mechanism
is proposed by which CsA affects psoriasis: through increased endogenous retinoid-signaling,
mimicing the effect of cytochrome p450-inhibitors, e.g. liarozole.
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Cellular Uptake, Metabolism and Biological Effectiveness of 13-cis Retinoic Acid on
SZ95 Sebocytes are Regulated by Extracellular Binding Protein Levels
M. Tsukada, M. SchroÈder, H. Seltmann, C.E. Orfanos, and C. Zouboulis
Berlin, Germany
13-cis Retinoic acid is rapidly absorbed into human sebocytes, is selectively isomerized to high
levels of all-trans retinoic acid and exerts an antiproliferative effect by binding the retinoic acid
receptors in normal culture conditions in vitro (J Invest Dermatol 115: 321±7, 2000). In this study,
we provide evidence that the levels of extracellular binding protein plays an important role for
cellular uptake, metabolism and biological effectiveness of 13-cis retinoic acid on human sebocytes.
The addition of highly concentrated bovine serum albumin (20-fold), that selectively binds
nonaromatic retinoids, to the serum-free medium resulted in a decreased and controlled uptake of
13-cis retinoic acid into SZ95 sebocytes; almost constant levels of 13-cis retinoic acid for 72 h were
detected after a single treatment. In addition, delayed isomerization of 13-cis retinoic acid into all-
trans retinoic acid was observed. The intracellular concentration of all-trans retinoic acid after 13-cis
retinoic acid treatment was nearly similar to that of 13-cis retinoic acid at 24 h, however, it was 2-
to 8-fold higher at 48±120 h after treatment. In a parallel experiment, the antiproliferative effect of
13-cis retinoic acid (10±7 M) was diminished by adding high levels of bovine serum albumin in the
serum-free medium compared to the effect detected in experiments with normal levels of bovine
serum albumin. These results indicate a critical function of serum albumin, as extracellular retinoid-
binding protein, in reducing the intracellular concentration of active retinoids and in diminishing
the biological effect of retinoic acids on human sebocytes.
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Addition of Pentoxifylline Reduces the Side-Effects of Fumaric Acid Esters in
Treatment of Psoriasis
M. Friedrich, A. Klein,* R. RuÈckert, W.D. DoÈcke, W. Sterry, and K. Asadullah*
Berlin, Germany
The ef®cacy of fumaric acid esters (FAE) for treatment of psoriasis is well proven, however,
patients often discontinue the FAE-treatment due to gastrointestinal side-effects and ¯ush, which
are supposed to be mediated by TNF-a release from monocytes. We speculated that a reduction of
FAE-induced TNF-a secretion should improve the tolerability of the compound. Therefore, we
compared FAE therapy and the combination of FAE plus pentoxifylline (PTX), a potent suppresser
of TNF-a release. 44 patients with moderate to severe psoriasis vulgaris were included in this open-
label prospective trial. In group A (FAE monotherapy), 16 out of 21 patients showed adverse
effects, 4 patients ceased the FAE treatment. The incidence was slightly lower in group B
(combination therapy FAE plus PTX) where 12 patients out of 23 reported adverse effects leading
to withdrawal from the study in 4 cases. Each of the adverse effects, were less frequently reported in
the patients receiving PTX coapplication. Concerning the severity of all side-effects a signi®cant
reduction was found in the patients with combination therapy. Our data supports the hypothesis
that the FAE-associated side-effects are TNF-a mediated and indicates that adding PTX seems to
increase the tolerability of this therapy regime.
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Comparative In Vivo Pharmacokinetic Study of 8-Methoxypsoralen (8-MOP)
Penetration into Human Skin by Microdialysis after Creme, Bath or Oral Delivery
M. Grundmann-Kollmann, I. Tegeder, G. Geiblinger, R. Kaufmann, and M. Podda
Frankfurt, Germany
Photochemotherapy with oral or topical psoralens combined with long wave ultraviolet light
(PUVA) is a standard treatment regimen for various dermatological disorders. However, until now
clinical treatment schedules are based largely on phototoxicity testing and determination of 8-
MOP serum kinetics, while 8-MOP tissue kinetics are still missing. Providing concentration-time
pro®les with a high temporal resolution microdialysis has been shown to be a suitable method for
the characterisation of transdermal drug transport in vivo. We used the microdialysis technique to
compare tissue concentrations in humans after topical (bath and cream) and oral administration of
8-MOP. The microdialysis is based on a diffusion process through a semipermeable membrane
located at the tip of a microdialysis catheter. The catheter is constantly perfused with a physiologic
solution (¯ow rate 0.5±3 mL per min). Substances that enter the catheter through diffusion are
transported to the outlet tube and can be analysed in the dialysate. Because proteins cannot pass the
membrane, it is pharmacodynamically relevant unbound fraction of a substance that can be
determined by microdialysis. 8-MOP was applied topical and systemical in 8 healthy volunteers in
a cross over study. Dialysate sampling was performed up to 6 h in 20 min intervals. Plasma samples
were taken up to 10 h after 8-MOP application. Plasma and tissue concentrations of 8-MOP were
determined by LC with double masspectography. Plasma concentrations after oral 8-MOP
administration were signi®cantly higher than after topical 8-MOP application while tissue
concentrations were signi®cantly lower after oral 8-MOP and showed a large variance. Tissue
concentrations after oral 8-MOP reached a maximum after 1±3 h. There was no signi®cant
difference between bath PUVA and cream PUVA. Tissue concentrations after 8-MOP bath and 8-
MOP cream decreased rapidly within 30 min. We conclude that cream PUVA can be a substitute
for bath PUVA therapy, as the pharmacokinetic pro®les of bath and cream PUVA are very similar.
Our data further indicate that topical 8-MOP application is superior to the oral route as skin
concentrations are higher and more predictable.
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Anti-Angiogenic Properties of Temozolomide
H. Kurzen, S. Schmitt, T. MoÈhler, and H. NaÈher
Heidelberg, Germany
Temozolomide (TMZ) is a methylating agent used in the therapy of malignant melanoma. It is
well established that certain chemotherapeutic agents display potent antiangiogenic properties
which may be part of their antitumor activity. We sought to determine whether TMZ is capable of
inhibiting angiogenesis, which would favour its use in antiangiogenic tumor therapy regimens. We
examined the inhibitory activity of TMZ on angiogenesis in the chicken chorion-allantois
membrane (CAM) assay, in the matrigel assay and a methylene blue- based proliferation assay,
using human umbilical vein endothelial cells (HUVEC) and human dermal microvascular
endothelial cells (HDMEC). In the CAM assay angiogenesis was induced by bFGF or conditioned
medium from NIH3T3 ®broblasts. The vessel count in TMZ treated CAMs was signi®cantly
lower than in the positive control. In the matrigel assay, the alignment of HUVEC and HDMEC
to form capillary-like structures was signi®cantly inhibited by TMZ as evidenced by the count of
``capillary intersections''. Likewise, in the proliferation assay, TMZ showed an inhibitory action
which corresponded to the well known inhibitory potential of vinblastin, which was used in
comparison. The concentration of TMZ in all three assays (5 mg per mL) corresponded to serum
levels obtained after cyclic high dose regimens (200 mg per m2 body surface). The antitumor
activity of TMZ may therefore in part be due to its antiangiogenic properties. Further studies will
have to show whether lower concentrations of TMZ retain their antiangiogenic properties, thus
enabeling the design of orally available antiangiogenic treatment schedules of malignant melanoma.
279
Pharmacological Study of Levocetirizine in IgE-Dependent Hypersensitivity Cutaneous
Reaction in Grass Pollen Allergic Volunteers: Demonstration of Mediator Release and
Eosinophil Recruitment Modulation by Levocetirizine
M. Laurence, J. Francette, L. VeÂronique, and D. Louis
Institut de Recherche sur la Peau, INSERM U532, HoÃpital Saint-Louis, 75010 Paris, France
This study aimed to quantitatively determine the effects of oral administration of levocetirizine
(5 mg per day during 6 days) on the release of mediators (soluble VCAM-1, LTC4, TNFa
histamine, tryptase), the vasopermeability and the cell recruitment induced by antigenic stimulation
in 15 grass pollen allergic subjects during a 25-h- in vivo IgE-mediated hypersensitivity cutaneous
reaction. This was a monocentre, randomized, double-blind, placebo controlled, cross-over study
in 15 subjects allergic to grass pollen (mean age = 27.1 years). The methodology was based on the
skin chamber technique: at the 4th day of oral treatment, skin blisters were created on the forearm
and skin chambers were applied on the dermis. At the morning of the 5th day, pollen vs. control
medium were introduced into skin chambers and renewed hourly during 6 h, left until the 24th
hour and collected at the 25th hour. Rebuck's glasscoverslips were then applied during one hour to
establish cell recruitment during the late phase reaction. For each mediator the AUC of the
difference between control and pollen chamber were used to compare levocetirizine and placebo.
A modulatory effect of levocetirizine as compared with placebo was observed on the activation of
the vascular endothelium: ± the VCAM-1 level as well as the protein level in the ®rst 6 h of pollen-
induced reaction were signi®cantly inhibited under levocetirizine (VCAM-1 mean AUC = 2.3 ng
per h per mL per cm2 and protein mean AUC = 4.3 mg per h per mL per cm2) compared with
placebo (VCAM-1 mean AUC = 10.3 ng per h per mL per cm2 and protein mean AUC = 7.3 mg
per h per mL per cm2), [respectively, p = 0.011 and p < 0.02]. There were no major effects of
levocetirizine on the other measured mediators: histamine, tryptase, TNFa and LTC4. A decrease
in the recruitment of eosinophils was observed under levocetirizine for the 4 subjects with high
migration (eosinophils cell greater than 6%): median eosinophil counts were 11.6% under placebo
and only 1.8% under levocetirizine. Nevertheless, no conclusion can be drawn for subjects
presenting a low eosinophilic migration. These results require further investigation in order to
con®rm this major modulatory property of levocetirizine on eosinophils. In conclusion, our results
shows 3 main inhibitory effects of levocetirizine on VCAM-1 release, vascular permeability and
eosinophil recruitment in response to allergic stimulation.
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Arsenic Trioxide Induces Apoptosis of Sezary Cells In Vitro: Evidence for a Partially
Caspase-Independent Pathway and Potentiation by Ascorbic Acid (Vitamin C)
L. Michel, A. Dupuy, F. Jeanlouis, L. Dubertret, and H. Bachelez
Skin Research Institute, UniteÂ INSERM U532, HoÃpital Saint-Louis, Paris, France
Arsenic trioxide (As2O3) has recently been shown to exhibit antiproliferative and apoptogenic
properties against malignant cells of either myeloid or lymphoid lineage. In this study, we
investigated the effects of As2O3 on the proliferation and the viability of the Sezary cell line HUT-
78 and peripheral blood mononuclear cells (PBMCs) derived from patients with SeÂzary syndrome
(SS) showing a high proportion of tumoral cells in the peripheral blood. Viability/apoptosis were
assessed by using ¯ow cytometric analysis after propidium iodide and annexin-V staining, Terminal
dUTP Nick End Labelling (TUNEL), cell cycle analysis, mitochondrial transmembrane potential
(Dym) alterations, and detection of processed caspase 3 by Western blot and ¯ow cytometry. The
results show that a As2O3 10 mM is needed to induce signi®cant cell death of HUT-78, whereas
PBMCs from patients with SS exhibit a much greater sensitivity to apoptosis induction, in a time-
and dose-dependent manner. Thus, 50% of cells were annexin positive after 72 h incubation with
As2O3 2 mM. Both kinetics and quantitation of As2O3-induced apoptosis of PBMCs from patients
with SS were found in the same range than those of PBMCs from healthy blood donors. Double
staining with anti-TCRBV/anti-CD3 monoclonal antibodies showed that the proportion of
tumoral cells remained stable after As2O3 treatment, suggesting a similar sensitivity of SeÂzary cells
and normal lymphocytes from a given patient to As2O3-induced apoptosis. Ascorbic acid 100 mM
was shown to potentiate As2O3-induced Sezary cell death at a greater extent than PBMCs from
normal individuals, while interferon a showed no synergistic effect. Caspase 3 activity was shown
to be induced by treatment of tumoral cells with As2O3 by Western blot and ¯ow cytometry.
Nevertheless, As2O3-induced apoptosis of SeÂzary cells was not altered by speci®c caspase inhibitors
(ac-DEVD-CHO, ac-LEHD-CHO) and only partially inhibited by the pan-caspase inhibitor Z-
VAD-fmk. These results demonstrate that As2O3 synergizes with vitamin C to induce Sezary cell
death in vitro at clinically achievable concentrations, through a pathway partially independent of
caspase activation. These data warrant clinical studies in order to evaluate in vivo the therapeutic
ef®cacy and the toxicity of arsenic trioxyde in patients affected with cutaneous T-cell lymphoma
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Evaluation of the Avene Spring Water Effect on Oxygen Radicals Generation
C. Baudouin, M-F. Aries, M. Charveron, and Y. Gall
Toulouse, France
During cellular metabolism, cutaneous in¯ammatory process or pathogenesis of human diseases,
oxygen radicals can be generated. The release of reactive oxygen species (ROS) is indicative of cell
stress and their overproduction induces an important cellular alteration especially of the plasmic
membrane components, of the proteins and of the genomic material. Avene spring water (ASW)
has been widely used in the treatment of various in¯ammatory skin diseases (atopic dermatitis and
psoriasis). In order to evaluate the ASW effect (from 0 to 100% in millipore water) on oxygen
radicals generation, we have used different in vivo and in vitro models. We have ®rst analysed the
ASW effect on ROS production by phorbol ester (TPA)-stimulated mouse peritoneal
macrophages, using a chemiluminescence assay. The effect of ASW on macrophage oxidative
metabolism was investigated by measuring the peak of luminol-enhanced chemiluminescence
response. The chemiluminescence inhibition (ROS production inhibition) following ASW
treatment was signi®cant with 50% and 75% of ASW. We have secondly analysed the in vitro ASW
potential protective role against alteration of the main cellular targets (membrane lipids, ADN and
proteins) induced by ROS generated during ultraviolet (UVA) irradiation. So, we used UVA-
irradiated human skin cells in which we measured the lipid peroxidation level by assaying the
TBARS (ThioBarbituric Acid Reactive Substances), the DNA damages using the comet assay, and
the oxidized proteins by immunodetection of carbonyl group. The membrane lipid oxidation assay
(TBARS) clearly showed the protective effect of ASW which is maximal for 50% and 75% ASW.
The qualitative and quantitative evaluation of DNA strand breaks showed the genomic protection
ef®ciency of ASW with a maximal effect at 50% of ASW. Moreover, the ASW also decreased the
protein oxidation in a dose-dependent manner. These studies clearly show a signi®cant antioxidant
activity of the ASW. In conclusion, by its antiradical properties, Avene spring water preserves the
cutaneous tissue from dramatical effect of free radicals during in¯ammation process of the skin.
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Tocopherol Precursor Evaluation: Effect on Oxygen Radicals Generation in Cutaneous
Cells
M.-J. Haure, C. Baudouin, S. Larrue, M. Charveron, and Y. Gall
Toulouse, France
The skin is always in contact with oxygen. In fact, endogenous and exogenous oxygen radicals
could be generated during cellular metabolism, prooxidant stress from environment or during
cutaneous pathogenesis of human diseases. The release of reactive oxygen species (ROS) is
indicative of cell stress and their overproduction induces an important cellular alteration especially
of the plasmic membrane components, proteins and nucleic acids. In order to evaluate the
antioxidant activity of delta tocopheryl glucopyranoside, an a tocopherol precursor, we used in
vitro models. Oxidative stress is investigated by treating cutaneous cells with chemicals agents, like
H2O2 or with physiological proin¯ammatory molecule, the TNFa (Tumor Necrosis Factor).
Firstable, we used the ¯uorescent probe, 2¢-7¢-dichloro¯uorescin-diacetate (H2DCF-DA) to assess
ROS generation in the intracellular partition, constituting a precocious step of the oxidative stress.
In this approach, the d tocopheryl glucopyranoside strongly reduces the intracellular ROS. Then,
we analysed the d tocopheryl glucopyranoside potential protective role against alteration of cellular
targets (membrane lipids and genomic DNA) induced by ROS. So, we measured the lipid
peroxidation level by assaying the TBARS and also the DNA damages using the comet assay.
Starting from the lowest concentration (5 mg per mL), d tocopheryl glucopyranoside ef®ciently
protect DNA and membrane from oxidative attack. In comparison with reference molecules (a
tocopherol), these studies clearly show a signi®cant antiradical activity of the d tocopheryl
glucopyranoside. Like this, by its antioxidant properties, topical application of d tocopheryl
glucopyranoside could constitute a preventive factor of skin aging by supporting physiological
mechanisms to maintain or restore a healthy skin barrier.
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UV-Induced Suppression of Chronic CHS Leads to In Vivo Formation of Suppressor T
Cells that are Capable of Immunosuppression of Acute as well as Chronic CHS
F. Yakazaki, Y. Aragane, A. Maeda, K. Matsushita, A. Kawada, and T. Tezuka
Osaka Japan
Chronic CHS is induced by repeated application of hapten, resulting in site-directed shift to the
immediate onset of CHS, peaked usually at 1±3 h postchallenge. We could currently show that, in
addition to immunosuppression in conventional acute CHS induced by sensitization followed by
challenge only once, ultraviolet (UV) light is also capable of suppression of this type of CHS, when
animals were exposed to low doses of UVB before challenge. However, it still remains unclear if
the suppression of chronic CHS by UV is mediated by in vivo generation of suppressor cells. To
address this issue, C3H/HeJ mice were ®rst UV-exposed or left untreated, were sensitized with
dinitro¯uorobenzene (DNFB). 5 days later, mice were challenged with the right earlobes, followed
by repeated DNFB application at every third day, totally 12 times. Subsequently, the immediate ear
swelling response was observed in non-UV-exposed mice upon ®nal challenge, which was
signi®cantly prevented with UV exposure before sensitization, indicating that UV suppresses
chronic CHS. Interestingly, suppression of chronic CHS is only seen in C3H/HeJ mice, known to
be UV resistant in acute CHS, but not UV-susceptible C3H/HeN mice, indicating that
immunologic pathways involved in chronic CHS is different between acute and chronic CHS.
Adoptive transfer of T cells from UV-exposed, repeatedly challenged animals, but not of T cells
from non-UV-exposed mice, results in successful transfer of the immunosuppressive phenotype to
naõÈve animals, strongly suggesting that UV-mediated suppression of chronic CHS is, at least in part,
mediated by induction of suppressor T cells capable of suppression of acute CHS. To further
elucidate whether already established chronic CHS is prevented by those suppressor T cells, T cells
obtained from UV-tolerised mice in chronic CHS or from non-UV-exposed mice showing
immediate ear swelling were transferred to animals that were already repeatedly DNFB-challenged
and thus were showing the immediate ear swelling response. While transfer of T cells from non-
UV-exposed animals results in no prevention of the immediate ear swelling response, the
immunosuppressive phenotype of chronic CHS is partially, but signi®cantly reproduced in animals
that have shown immediate ear swelling before the transfer. Together, our present study
demonstrates that T cells from UV-tolerized-mice in chronic CHS may act as suppressor T cells
both for acute and for chronic CHS, thereby suggesting the presence of a new class of suppressor T
cells.
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UVA and UVB Differentially Modify the Tyrosine Kinase Pro®le of Normal Human
Keratinocytes and Induce the Expression of the Tyrosine Kinase abl-2
G. Klosner, R. Varecka, and F. Trautinger
Vienna, Austria
Exposure of human skin to UV induces major changes in the genetic program of the exposed cells
leading to immediate and long-term skin changes. Although it can be assumed that UV-induced
modi®cations of signal transduction involving protein tyrosin kinases (PTKs) regulate these
processes, details as to the speci®c changes in PTK expression after UV exposure are unknown. To
investigate PTK expression in normal human keratinocytes (HNK) we employed a reversed
transcriptase-PCR approach using degenerate primers derived from the conserved catalytic domain
of PTKs. PCR products were cloned and PTKs from randomly picked colonies (up to n = 90 per
screen) were identi®ed by sequence analysis. PTK pro®les of sham-irradiated, UVA (®ltered metal
halide lamp, 60 J per cm2), and UVB (®ltered metal halide lamp, 256 mJ per cm2) treated HNK
were analyzed 7 h after exposure. Real time PCR with speci®c primers was used to track the
kinetics of PTKs identi®ed with the initial screen. We identi®ed 14 PTKs including 3 receptor
kinases (axl, cak, fgfr2) and 11 nonreceptor kinases (abl1, abl2, lck, map4k2, fyn, yes, src, cnk, ptk6,
mstr1, jak1). Differential screening revealed a further induction of abl2 expression by UVA. At 7 h
after exposure UVB had no in¯uence on abl2 but predominantly induced the expression of the
receptor kinases of the axl-family. Both treatments lead to a down-regulation of src-family kinases
(src, fyn, yes). Overall evaluation revealed that UVA predominantly stimulates expression of
nonreceptor kinases and inhibits receptor PTKs, while UVB had the opposite effect. The
differences reached statistical signi®cance at p < 0.0001 (c2 test). Real time PCR revealed that abl2
expression peaked at 16 h after exposure to UVA and reached again baseline at 24 h. UVB induced
a late induction at 16 h and 24 h after exposure. We conclude that regulation of PTK expression is
part of genetic program that mediates late effects of UVA and UVB. The observed effects are
wavelength dependent and affect PTKs which are involved in the regulation of gene transcription,
cell death, and proliferation.
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UVA and UVB Irradiation Decreases the Expression of CD44 and Hyaluronate in Mouse
Epidermis
G. Kaya, E. Calikoglu, O. Sorg, P. Carraux, and J.H. Saurat
Geneva, Switzerland
CD44 is a polymorphic transmembrane glycoprotein and the principal cell surface receptor of
hyaluronate (HA). The expression of CD44 in mouse epidermis is con®ned to the basal, spinous
and granular layers. HA, the major component of the extracellular matrix, is a high molecular
weight glycosaminoglycan and present mainly in dermis and also in epidermis. HA is capable of
immobilizing the water in the tissue and therefore of changing the dermal volume and elasticity,
and maintains the extracellular space. The distribution of HA in the skin shows a parallelism to that
of CD44. In a recent study we have shown that two major functions of CD44 in the mouse skin
are the regulation of keratinocyte proliferation in response to extracellular stimuli and the
maintenance of local HA homeostasis. Our previous studies have shown that UVA but not UVB
irradiation generated an oxidative stress in SKH1 hairless mouse skin. In this study we examined,
by anti-CD44 antibody and hyaluronate binding protein (HABP) stainings, the effect of UVA and
UVB irradiation on the expression of CD44 and HA in mouse epidermis. Immunostaining of
vehicle-treated back skin of SKH1 hairless mice revealed the standard membrane localization of
CD44 and HA in basal and suprabasal keratinocytes. CD44 expression was signi®cantly reduced in
the membrane and became cytoplasmic 2 h after UVA (10 J per cm2) or UVB (1 J per cm2)
irradiation and reconstituted within 8 and 24 h for UVA and UVB, respectively. HA showed a
similar pattern of decrease and reconstitution. The importance of the decrease of epidermal CD44
and HA in the mediation of UV-induced deleterious effects and in the generation of oxidative
stress induced by UVA irradiation is yet to be elucidated.
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Mouse Epidermal Vitamin A Reconstitution after UV-Induced Depletion is Oxidative
Stress Dependent
O. Sorg, C. Tran, L. Didierjean, P. Carraux, and J.H. Saurat
Department of Dermatology, University Hospital, Geneva, Switzerland
We previously showed that epidermal vitamin A (retinol and retinyl esters) from hairless mice was
strongly decreased following an acute UVB exposure (Dermatology 199 : 302±307,1999), and that
a pretreatment with topical natural retinoids (retinol, retinal and retinoic acid) prevented a UVB-
unduced epidermal hypovitaminosis A (Photochem. Photobiol. 71:in press, 2001). Here, using the
same mouse model, we studied the effects of UVA on epidermal vitamin A content and lipid
peroxidation (LPO), as well as the the putative prevention of both by topical antioxidants. Vitamin
A was assayed by HPLC, and lipid peroxides were assayed by ferrous oxidation followed by orange
xylenol complexometry. An acute exposure to UVA completely depleted epidermal vitamin A
with ED50s of 0.25 and 0.5 J per cm
2 for retinyl esters and retinol, respectively; these values were
0.1 J per cm2 for both retinoids with UVB. A single UVA exposure induced a dose-dependent
epidermal lipid peroxidation (ED50 = 3.5 J per cm
2) giving rise to 55.4 6 4.2 nmol lipid peroxides
per g at 20 J per cm2, while UVB, up to 2 J per cm2, did not increase the basal concentration of
6.7 6 0.9 nmol lipid peroxides per g. Topical menadione (vitamin K3) also induced a signi®cant
(2.5-fold) increase of LPO, without affecting vitamin A content. A pretreatment with the natural
antioxidant a-tocopherol did not inhibit UV-induced vitamin A depletion, but it prevented the
increased LPO induced by UV or menadione, and accelerated the reconstitution of vitamin A.
Thus (i) acute UVA induced both epidermal vitamin A depletion and LPO (ii) UVB induced only
vitamin A depletion (iii) topical menadione induced only LPO, and (iv) topical antioxidants
prevented UV-induced LPO, without protecting vitamin A, but accelerated vitamin A
reconstitution. This indicates that UV-induced epidermal vitamin A depletion is not mediated
by oxidative stress, but the latter affects vitamin A reconstitution following UV irradiation.
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Effects of Cell Differentiation on the SOD Activity and UVB-Induced Cytotoxicity in
Cultured Human Keratinocytes
T. Itoh, H. Sasaki, H. Akamatsu, H. Okamoto, and T. Horio
Department of Dermatology, Kansai Medical University, Osaka, Japan
We examined the effects of calcium (Ca2+) concentration of culture medium on the SOD activity
and UVB-induced apoptosis in cultured human keratinocytes in order to investigate the
relationship between Ca2+ dependent cellular differentiation and antioxidant capacity. Human
keratinocytes were incubated in high Ca2+ concentration (> 1 mM) or low Ca2+ concentration
(< 0.1 mM) DMEM. Then, we measured SOD activity and both Cu,Zn- and Mn-SOD activities
in keratinocytes. Furthermore, after incubation in high or low Ca2+ DMEM, human keratinocytes
were irradiated with UVB. Total SOD and Cu,Zn-SOD activities in keratinocytes cultured in low
Ca2+ DMEM were signi®cantly lower than in keratinocytes cultured in high Ca2+ DMEM,
whereas Mn-SOD activity was not affected. LDH leakage from keratinocytes cultured in low Ca2+
DMEM and the percentage of apoptotic keratinocytes cultured in low Ca2+ DMEM were
signi®cantly higher than that of keratinocytes cultured in high Ca2+ DMEM following UVB
irradiation. These results indicate that well differentiated epidermal cells have higher Cu,Zn-SOD
activities and resistance to UVB-injury, suggesting that keratinocytes in outer layer have stronger
protective ability to exogenous stresses.
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Phototoxicity of Curcuma Longa Extract in Cultures of Human Keratinocytes
A. Bernd, A. Ramirez-Bosca, S. Kippenberger, S. Simon, J. Miquel, J. Sempere Ortells, E.Q.
Almagro, J. Diaz-Alperi, J. Bereiter-Hahn, and R. Kaufmann
Frankfurt/M., Germany and Alicante, Spain
The use of psoralens and UVA (PUVA) is an effective treatment of severe psoriasis and other skin
diseases. However, PUVA therapy holds some risk of development of skin cancer. Searching for
alternatives we investigated the effect of yellow Curcuma longa extract (ZCL8) combined with both,
UVA or visible light on the human keratinocyte cell line HaCaT and on normal skin derived
human keratinocytes in vitro. Uptake studies were carried out measuring the absorbance of
methanolic extracts of the cells after treatment with 10 mg per mL ZCL8. Growth inhibition was
measured by BrdU incorporation. The intracellular distribution was investigated by confocal laser
scanning microscopy making use of the low ¯uorescence activity of Curcuma longa compounds.
The absorbance maximum of ZCL8 was at approximately 430 nm. The uptake studies revealed a
maximum uptake of ZCL8 by human keratinocytes within about one hour. Afterwards a slow
bleaching of the intracellular colored ZCL8 compounds was observed indicating a metabolic
destruction and/or conversion. The ¯uorescent ZCL8 compounds showed a granular, perinuclear
cytoplasmatic location 40 min after addition to the cell culture medium. There was no detectable
¯uorescence in the cell nuclei even after UVA irradiation and after an incubation time of 4 h.
Using the BrdU incorporation technique no detectable phototoxic effects occurred after treatment
with ZCL8 combined with UVB light. However, ZCL8 showed clear phototoxic properties in
both the human keratinocyte cell line (HaCaT) and in the cultures of normal human epidermal
cells in combination with UVA, UVA1 or visible light. The degree of phototoxicity was
comparable with that of psoralens. All 3 effective light sources caused growth inhibition in the
presence of concentrations as low as 1±2 mg per mL of ZCL8. Investigations of the essential
preincubation time for ZCL8 showed that 1 h of preincubation was suf®cient to obtain optimal
phototoxic effects in the cultures of human keratinocytes. These ®ndings could contribute to a
new photo therapeutic treatment strategy with low risk. Additional investigations with regard to
the effects on the immune system, to the DNA integrity, and to the underlying mechanisms of
growth inhibition are currently carried out.
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Nitric Oxide and PGE2 Mediate UVB-Induced Erythema
L.E. Rhodes, G. Belgi,* R. Parslew,² L. McLouchlin,² G.F. Clough,* and P.S. Friedmann*
Photobiology Unit,Manchester, *Dermatopharmacology Unit, Southampton, ²Dermatology Department,
Liverpool, UK
Prostaglandin E2 (PGE2) and nitric oxide (NO) have been implicated in the generation of UVB-
induced vasodilatation, but their relative contributions are unclear. We explored the effects of
inhibiting synthesis of PGE2 and NO with indomethacin and L-NAME on vasodilatation induced
by 1, 2 and 4xMED of UVB. Single applications of 1% indomethacin gel immediately after
irradiation signi®cantly suppressed strong erythema from 2 and 4xMED but had little or no effect
on weak erythema (1MED). Repeated applications every 12 h did not increase the inhibition. The
slope of the UVB erythema dose±response curve was signi®cantly ¯attened by indomethacin.
Twenty-four hours after irradiation with 4xMED, mean PGE2 levels in suction blisters were
27.2 ng per mL (SE 11) compared with 8.6 ng per mL in unirradiated skin (n = 25; p < 0.01). PGE2
levels in dermal tissues, sampled by microdialysis (depth 0.6 6 0.1 mm), were 310 pg per mL (SE
123) and 237 pg per mL (SE 88) in irradiated and unirradiated skin, respectively (n = 7, NS). Nitric
oxide also made a signi®cant contribution to UVB-induced erythema. UV-erythema was inhibited
by L-NAME in a dose-related fashion with 2 mM L-NAME causing total abolition of the
response. In contrast to indomethacin, L-NAME shifted the UVB erythema dose±response curve
in parallel. L-NAME was effective at all time points up to 48 h suggesting that nitric oxide (NO)
was produced continuously. NO was undetectable in suction blister ¯uid but in dermal
microdialysate NO was present at 44.3 ng per mL (SE 6.2) following UVB compared with 26.0 ng
per mL (SE 8.0) in unirradiated skin (p < 0.05), approximately 1000 times the molar concentration
of PGE2. These ®ndings con®rm PGE2 and NO to be mediators of UV-induced erythema. They
also show that there is prolonged synthesis of both mediators within the erythemal response and
that synthesis of NO is induced by lower doses of UVB compared with that of PGE2. It remains to
be shown whether PGE2 is generated as a consequence of activation of Cyclo-oxygenase by NO.
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UV-Induced TNFa Production is In¯uenced by the Application of Sunscreens
R. Hofmann-Wellenhof, J. Smolle, A. Roschger, D. Strunk, M. Hubmer, C. Hoffmann, M.
Horn, H. Kerl, and P. Wolf
Graz, Austria
Human in vitro methods to test the immunoprotective effect of sunscreen are rare. We used human
skin explants to investigate the effect of two different sunscreens (containing UVB-®lter alone or
UVB and UVA-®lters) on the production of TNFa and interleukin 10 after irradiation with
different doses of solar simulated UV. Skin explants of the thigh were obtained from 12 different
individuals undergoing plastic surgery. First the skin was divided into 2 pieces of equal size, each
half was treated with placebo cream or a sunscreen. Each of the two pieces was again divided into 4
parts which were irradiated with a solar simulator with 0.5, 1, and 2 minimal erythema dose
equivalent (MEDE) multiplied by the sun protection factor (SPF) of the placebo or of the
sunscreens. One quarter of each group was sham irradiated. After irradiation at least three 6-mm
skin biopsies were cut of each part and ¯oated on RMPI medium for 48 h. The concentration of
the soluble mediators in the medium was measured by ELISA. TNFa production increased with
increasing irradiation dose. Both sunscreens signi®cantly prevented the production of TNFa
compared to the placebo treated group. SSC-UVAB showed a signi®cant increase of TNFa
already in 1 MEDE group compared to the sham irradiated group, whereas in the placebo and
SSC-UVB treated groups TNFa signi®cantly differed only between sham irradiated and 2MEDE
groups. Both sunscreens reduced the production of TNFa after irradiation with 2 MEDE about
50% compared to the placebo treated group. The production of interleukin 10 did neither
correspond to the irradiation nor to the treatment groups. Skin explants can be used to measure the
UV induced TNFa and interleucin 10 production. Using this in vitro method sunscreens
containing organic UVB-®lter or UVB and UVA-®lters showed a protective effect on the
production of TNFa comparable to their SPF.
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UV-Induced Cytochrome c Release During Apoptosis is Mediated Primarily via Death
Receptor Activation and Free Radical Formation but Mostly Independent of UV-
Induced DNA Damage
D. Kulms, B. PoÈppelmann, and T. Schwarz
Department of Dermatology, MuÈnster, Germany
During UV induced apoptosis nuclear DNA damage as well as direct activation of death receptors
play a major role, both pathways beeing independent of each other. Additionally release of
cytochrome c (cytoc) from mitochondria into the cytoplasm is observed after UV radiation, another
important event during apoptosis. Cytoplasmic cytoc together with ATP and Apaf-1 activates the
effector cysteine protease caspase-9, resulting in execution of apoptosis. We tried to elucidate
whether cytoc release during UV-induced apoptosis is a consequence of DNA damage, of death
receptor activation or of a third pathway. Western blot analysis revealed cytoc release into the
cytoplasm of UV-irradiated HeLa cells starting 8 h after UV exposure. Inhibition of death receptor
clustering by UV by irradiating cells at 4°C blocked cytoc release partially, whereas removal of
DNA damage by enhancing DNA repair via photoreactivation did not affect cytoc release at all.
This indicates that UV-induced cytoc release seems to be DNA damage independent, but mediated
via cell death receptor activation. During death receptor signaling caspase-8 induces cytoc release
via cleavage of Bid. Consequently, UV-induced Bid cleavage was inhibited in cells exposed either
at 4°C or in the presence of zIETD the speci®c inhibitor of caspase-8. The only partial inhibition
suggested other pathways to be involved as well. Addition of the free radical scavenger
pyrrolidinedithiocarbamate signi®cantly suppressed UV-mediated cytoc release and consequently
apoptosis. Hence, these data indicate that cytoc release during UV-induced apoptosis is primarily
mediated by cell death receptor activation and free radical formation, but mostly independent of
DNA damage.
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DNA Damage Mediates Downregulation of the UV-Repressible Serpin Hurpin (PI13) in
HaCaT Keratinocytes
M. Papoutsaki,*² R. Kosztolanji,³ H. Stege,* J. Krutmann,* T. Welss,* S. Chimenti,² T.
Ruzicka*, and H.F. Abts*
*Department of Dermatology, Heinrich Heine University, Duesseldorf, Germany; ²Department of
Dermatology, University of Rome `Tor Vergata' ³Department of Dermatology, University of Pecs, Hungary
Epidermal keratinocytes are the primary target of midrange ultraviolet part of terrestrial sunlight
(UVB, 290±320 nm). Analysis of the resulting UV response at the transcriptional level by
differential display RT-PCR identi®ed a large group of genes demonstrating a down regulation
following UVB irradiation. Among those UV-repressible genes, a novel, keratinocyte associated
serine protease inhibitor (serpin) termed hurpin (HaCaT UV-repressible serpin) has been
identi®ed.In this study we try to unravel the molecular mechanism underlying the observed down-
regulation of hurpin. Based on the knowledge of UVB-mediated effects the irradiation induced
DNA-damage itself could be one of the mediators of the repression. To analyze the role of UV-
mediated DNA-damage in the repression of hurpin we used two different set-ups. In the ®rst we
enhanced the repair capacity of the irradiated cells by supplying them with the DNA-repair
enzyme Photolyase. In the second we preserved the DNA-damage by blocking the DNA-repair by
treatment with Aphidocolin. Following these treatments we analysed the expression of Hurpin in
both treated and untreated HaCaT cells by RT-PCR analysis. Enhancing DNA-repair through
Photolyase led to a less pronounced hurpin repression compared to the expression pattern
following UVB irradiation alone. On the other hand the preservation of the UV-induced DNA
damage by incubation with the repair inhibitor Aphidocolin resulted in a more prominent and
longer persistent down-regulation of hurpin. These ®ndings suggest that UVB induced DNA
damage plays an important role in the regulation of the expression of hurpin. According to
previous observations hurpin might be involved in proliferation and differentiation of keratinocytes
through a possible antiapoptotic function. Such a function would be in good accordance with the
observed overexpression of hurpin in psoriatic skin lesions compared to healthy skin. Notably
psoriasis is responsive to UV-irradiation. Further investigation of the mechanisms underlying the
regulation of hurpin after UVB irradiation could lead to new therapeutical approaches in diseases
characterized by hyperproliferation of keratinocytes, such as psoriasis.
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Epidermal Response to UV-Induced DNA Damage
H. BaÈckvall, C. Wassberg,* B. Berne,* and F. Ponten
Department of Genetics and Pathology, *Department of Dermatology, University Hospital, Uppsala, Sweden
In order to determine levels of UV-induced DNA damage and p53 expression in epidermis at
different sun-exposed sites, chronically sun-exposed and nonexposed skin were analyzed in the
same set of individuals. Healthy volunteers were irradiated with arti®cial UVA + UVB, with and
without photo-protection. Skin from same individuals were also analyzed after six summer weeks
in Sweden. The total UV-dose received from natural sun was measured. Punch biopsies were
taken 24 h after UV-irradiation and after 6 summer weeks, and immunohistochemically stained for
thymine-dimers and p53 protein. Non-exposed skin showed more DNA damage compared to
chronically sun-exposed skin after UV-irradiation. Photo-protection reduced levels of DNA
damage and p53 protein. A correlation between amount of p53 immunoreactive keratinocytes and
UV-dose received during 6 summer weeks was found. Frequently sun-exposed skin is located in
cosmetic areas, why in vivo experiments are dif®cult to perform. We developed a skin organ culture
model, where UV-responses seen in vivo can be reproduced in vitro. Human skin explants from
chronically sun-exposed and nonexposed skin were irradiated with arti®cial UVA + UVB, with
and without sunscreen (SPF 15). Kinetics of UV-induced DNA damage, p53 response and repair
was analyzed by immunohistochemistry. A large amount of TT-dimers was observed 4 h after UV-
irradiation followed by an accumulation of p53. TT-dimers were gradually repaired during
incubation time. A shown in vivo, sunscreen had the ability to reduce the formation of TT-dimers
and induction of p53 protein normally found in nonprotected skin after UV-irradiation. In
conclusion, data demonstrates inter- and intraindividual variability in responses to UV-induced
DNA damage including a comparison between chronically sun-exposed skin and nonexposed skin.
DNA repair appeared more ef®cient in chronically sun-exposed skin compared to nonexposed
skin. In vitro results suggest that organ cultured skin provides a valuable tool for studies of UV-
induced epidermal responses in chronically sun-exposed skin.
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Analysis of Speci®c DNA Damages Induced by UVA and UVB Radiations on Human
Skin
C. Baudouin, C. Sola, T. Douki, J. Cadet, M. CharveÂron, and Y. Gall
Toulouse and Grenoble, France
In addition to biological effects on human skin such as in¯ammation, immunosuppression and
premature photoaging, ultraviolet (UV) radiations can initiate skin photocarcinogenesis through
induction of DNA damage. Both UVB and UVA radiations have been described as mutagenic.
However, the processes by which they alter DNA are different. UVB light is directly absorbed by
the DNA bases and induces predominantly dipyrimidine photoproducts such as cyclobutane
pyrimidine dimers (CPD) and pyrimidine (6±4) pyrimidone adducts ((6±4)PP). At higher
wavelengths corresponding to UVA, DNA absorption is very weak. However, UVA and to a lesser
extent, UVB may interact with other cellular chromophores giving rise to reactive oxygen species
through photosensitization processes. DNA and particularly guanine could be the target of ROS.
As a result 8-oxo-7,8-dihydro-2¢-deoxyguanosine (8-oxodGuo) has been shown to be mainly
generated. In order to determine the speci®c contribution of the different ranges of UV radiation
to the induction of DNA damages, human skin samples were exposed to broad sources of UVB
(312 nm), UVA (365 nm) and both UVB + UVA. Subsequently DNA was extracted and puri®ed
prior its analysis. Thus, the content of DNA in CPD and (6±4) PP was estimated by immuno-dot-
blot assays using speci®c antibodies. In addition, the formation of the latter adducts and of the 8-
oxodGuo, was singled out using the highly resolutive HPLC-MS/MS method. It was also
established the noncytotoxic dose ranges of UVA (5±12.5 J per cm2) and UVB (0.01±0.1 J per cm2)
that allow the formation of a maximum of photodamage in cutaneous DNA. CPD appear to be the
major lesions induced by both UV radiations, UVB light being however, more ef®cient than UVA
to generate these photoproducts. UVA and UVB radiations are both able to induce the 8-
oxodGuo which is, however, more effective at higher wavelengths. The validation step being
achieved, we have used both the skin system and the above analytical methods to evaluate the
photoprotection ef®ciency of sunscreens and the antioxidant activity of products.
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The Mutagenic Effects of Long-Wave Ultraviolet A in Human Skin; Studied by
Analysing the p53 Gene in Single Cells
D. Wiegleb EdstroÈm, AÊ .E. Persson,* H. BaÈckvall,² J. Lundeberg,* F. PonteÂn,² A.-M. Ros, and C.
Williams*
Department of Dermatology, Karolinska Hospital, Stockholm; *Royal Institute of Technology (KTH),
Department of Biotechnology, Stockholm; ²University Hospital, Department of Pathology and Medical
Genetics, Uppsala, Sweden
Skin cancer is the most common cancer in the western world, and the incidence is increasing.
Ultraviolet B radiation is considered the major cause of skin cancer. However, several ®ndings
indicate that also ultraviolet A radiation may play a role in carcinogenesis of the skin. It has
previously been shown that repetitive suberythemal doses of long-wave ultraviolet A on healthy
human skin induced an increase of p53 positive cells in epidermis. We now examined if long-wave
ultraviolet A had mutational effects on p53 in human skin. Three healthy individuals were
irradiated 6 times with physiological ¯uences (40 J per cm2) of long-wave ultraviolet A on
unexposed skin. Biopsies taken after the last exposure and ®ve days after the last exposure were
analysed. Microdissection of p53 immunopositive single cells were followed by a modi®ed
multiplex ampli®cation and sequence analysis of exon 4±11 of the p53 gene. Three mutations were
found, one in codon 231 of exon 7 and the other two in introns. All were C?A mutations, typical
for UVA. This gives an average of 1 mutation per 8700 bases or 1 per 12 cells. It correlates well
with the earlier ®ndings of ultraviolet A signature mutations in normal human sunexposed skin.
Our ®ndings indicate that this amount of mutations represents the mutation load of long-wave
ultraviolet A resulting from normal sun exposure.
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Adalimumab, a Fully Human Anti-TNF-a Monoclonal antibody (MoAb), Reduces the
UVB Induced Expression of c-jun and Phosphorylated c-jun In Vivo
M. Tjioe, M.J.P. Gerritsen, A.A. den Broeder,* C.A.E.M. van Hooijdonk, E.J.A. Kroot,*
P.L.C.M. van Riel,* P. Barrera,* and P.C.M. van de Kerkhof
Department of Dermatology and *Department of Rheumatology, University Hospital Nijmegen, the
Netherlands
TNF-a is known to play an important role in UV induced immunomodulation and photodamage.
It plays a role in UVB mediated induction of apoptosis and is a strong inducer of the JNK pathway,
which eventually leads to the loss of dermal collagen and elastin content. Recently chimeric anti-
TNF-a has been introduced as a therapy for rheumatoid arthritis. The present study focuses on the
effect of anti-TNF-a on apoptosis and c-Jun/phosphorylated c-Jun induction, aspects which have
been claimed to be TNF-a dependent and which could affect photoaging and carcinogenesis.
Twelve patients with rheumatoid arthritis were included and irradiated with 2 MED broad band
UVB before and after administration of 0.5 mg per kg anti-TNF-a monoclonal antibody. Biopsies
were taken 24 h after each irradiation and frozen sections were stained for p53, c-Jun,
phosphorylated c-Jun and sunburn cells. No signi®cant changes were observed in the expression of
p53 and sunburn cells after treatment with anti-TNF-a, whereas a signi®cant decrease in c-Jun and
phosphorylated c-Jun expression was noted (p = 0.0250 and p = 0.0431, respectively). The
reduction of c-Jun and phosphorylated c-Jun may lead to a decrease in expression of matrix
metalloproteinases and suggests a protective effect on photoaging. Anti-TNF-a at therapeutic
doses decreases c-Jun/phosphorylated c-Jun expression whilst leaving apoptosis and p53 expression
unaffected.
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Effects of UVB Radiation on Migration and Activation of Langerhans Cells in PLE
Patients and Healthy Volunteers
W. KoÈlgen, H. van Weelden, I. Bihari, C.L.H. Guikers, E.F. Knol, C.A.F.M. Bruijnzeel-
Koomen, W.A. van Vloten, and F.R. de Gruijl
Utrecht and Leiden, the Netherlands
UV radiation suppresses cellular immune reactions in healthy individuals. This suppression is
associated with the disappearance of Langerhans cells (LC) from the epidermis, and is thought to
prevent illicit immune reactions in UV -irradiated skin. Failure in this suppressive response may
lead to adverse skin reactions, such as polymorphic light eruption (PLE). In contrast to what is
observed in healthy volunteers, we found that the LC of PLE patients did not disappear after
overexposure (6 MED) of the buttock skin to UVB. Subsequently, we established that the
disappearance of LC in healthy individuals is due to migration. This led us to the hypothesis that
LC in PLE patients are defective in their migratory response. Furthermore, we speculated that the
`UVB-resistant' LC might become activated and present antigens at the wrong location (viz. the
epidermis) thereby contributing to the pathogenesis of PLE. To test these hypotheses, we exposed
buttock skin of PLE patients and healthy volunteers to 6 MED UVB, and suction blisters were
raised 16±18 h later on the exposed and on an unexposed area of the skin. Blister ¯uid and blister
roofs were collected and stained immunohistochemically for CD1a (LC). Skin biopsies were taken
24 and 48 h after the exposure and stained for activation markers (CD86, CD40, ICAM-1, HLA-
DR) and for the dendritic cell maturation marker CD83. Migrating LC were found in the blister
¯uid of healthy volunteers as well as PLE patients. The decline in the number of LC in blister roofs
of PLE patients was, however, only very moderate in comparison to the almost complete depletion
of LC in blister roofs of healthy volunteers. The ``UVB-resistant'' LC in PLE patients, and the few
epidermal LC in UVB-exposed skin of healthy volunteers, did not express CD86, CD40, ICAM-1
or CD83, but did strongly express HLA-DR, in contrast to LC in the unexposed skin. Our data
show that LC in PLE patients are not defective in their migratory response to UV exposure, and
that the remaining epidermal LC do not become fully activated or matured. The enhanced state of
HLA-DR may, however, cause a strong, illicit antigen presentation by LC in UV-irradiated skin of
PLE patients.
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Photodynamic Therapy Induces Neovascularisation in Psoriatic Plaques
J. Fransson and A.-M. Ros
Stockholm, Sweden
The effect of photodynamic therapy (PDT) was evaluated in eight psoriatic patients. One plaque
was selected in each patient and treated once weekly with PDT 10±30 J per cm2 2±5 times. The
result was evaluated clinically by using a modi®ed Psoriasis Area and Severity (PASI) score
(maximal score/patient = 9) and a Visual Analogue Scale (VAS), ranging from 0 to10, to assess pain
during treatment. Skin biopsies were taken before treatment, after two treatments and after
completion of treatment, and evaluated by immunohistochemistry. Median PASI scores were
reduced from 7 (range 5±9) to 2 (range 0±3) following treatment. Pain during PDT was assessed as
7 (range 3±10). The number of dermal vessels, identi®ed by antibodies against Factor VIII,
markedly increased in ®ve of eight patients. Before treatment, there was a moderate in®ltrate of
CD4+ cells and a few CD8+ cells in the dermis. The EGF receptor was displayed throughout
epidermis, keratin 16 suprabasally, involucrin from stratum granulosum to the lower spinous layers
and ®laggrin in stratum granulosum with focal absence. Following treatment the EGF receptor was
displayed throughout the epidermis in most of the specimens, whereas the expression of
cytokeratin 16 was markedly decreased. The expression of involucrin was not seen as deep in the
spinous layers as before PDT. Filaggrin was expressed throughout stratum granulsom and a weak
staining was sometimes present in a few granular layers. The number of CD4+ and CD8+ dermal
cells decreased. PDT improved psoriasis and induced dermal neovascularisation. The mechanism of
the neovascularisation is unknown, but may be a recovery phenomena.
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Antinuclear Antibodies in Patients with Polymorphous Light Eruption (PLE): An 8.5-
Year Follow-Up Study
S. Tzaneva, B. Volc-Platzer, H. HoÈnigsmann, and A. Tanew
Vienna, Austria
Previous studies have shown that elevated titers of antinuclear autoantibodies (ANA) may occur in
4±19% of patients with polymorphous light eruption (PLE). Whereas in some of these patients a
diagnosis of lupus erythematodes (LE) was ®nally established upon further examination, in the
prevailing majority the diagnostic criteria of LE were not met. The present long-term follow-up
study was performed to investigate whether the presence of ANA in PLE patients is associated with
an increased risk of eventual progression into LE. The study cohort comprised 472 PLE patients
who were seen at our phototherapy unit between 1986 and 1999 and had been tested for the
presence of ANA. ANA positivity was de®ned as an ANA titer of = 1 : 80. All ANA positive
patients were asked to attend for follow-up examination that included a complete blood cell count,
serum and urine chemistry, serum protein electrophoresis, total Ig, C3c, C4 and CH50 levels,
ANA, and antibodies to SS-A/Ro, SS-B/La, U1 RNP, Sm, Scl-70, Jo-1, dsDNA, histones and
centromeres. The median age of all 472 patients was 34 years (range, 12±75) and the median disease
duration 8 years (range, 1±60). Out of all patients 55 (11.7%) were found to be ANA positive on
one or several occasions, two of them also had antibodies to SS-A/Ro. 39 (70.9%) of all ANA
positive patients were available for a thourough follow-up examination. Their median age and
disease duration was 41 years (range, 23±73) and 15 years (range, 5±34), the median follow-up
period was 8.5 years (range, 1±14). 25 patients showed persistence of ANA positivity with a median
titer of 160 (range, 80±640), whereas in 14 patients ANA titers had reverted to normal levels.
Clinical and laboratory examination of all 39 patients including the 2 patients with antibodies to
SS-A/Ro did not reveal any ®nding suggestive of LE. In addition, in the latter 2 patients the
eruption was short-lived, histopathology of lesional skin was indicative for PLE, and direct IF as
well as lupus band test were both negative. In conclusion, we found an increased prevalence
(11.7%) of moderately elevated ANA in a cohort 472 PLE patients. Antibodies to SS-A/Ro were
negative in all but two patients who lacked further evidence of LE. None of the ANA positive
patients developed LE within the follow-up period. These ®ndings indicate that PLE has no
tendency to progress to LE.
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The Time Course of UVB-Induced Erythema in Red-Heads
T. Ha, K. Waterston, and J.L. Rees
Edinburgh, UK
The melanocortin 1 receptor gene (chromosome 16q24.3) is currently the only gene identi®ed that
explains substantial phenotypic variance in human pigmentation. In people with MC1R variants
associated with red hair, fair skin and increased sensitivity to burning from UV radiation is
described. To further delineate the red-hair phenotype, we have objectively followed the duration
and intensity of cutaneous erythema induced by UV-B radiation (Oriel Xenon-arc source) for
21 days in 10 red-headed subjects (homozygous loss of function mutations) and 10 nonred controls
using contact laser Doppler ¯ux (LDV) methodology (Moor instruments). Triplicate LDV readings
were made on 7 separate occasions over a 21-day study period. The results were analysed using
Mann±Whitney-U-test and Students' t-test on Arcus Quickstat. Following duplicate serial dosing
of UVB on the lower back (9 doses of 5±112 mJ per cm2 in Ö2 increments), maximal erythema was
seen at 1±2 days depending on the dose of UVB delivered. There was no signi®cant difference in
the intensity of maximal erythema induced in either group (p = 0.771). At the end of the study
period, both groups contained individuals with persistent erythema, but there was no signi®cant
difference between red-heads and nonred controls (p = 0.331). However, when area under the
curves were obtained from serial data and the mean areas calculated, red headed individuals
demonstrated a 2±4 fold increased mean ¯ux in response to 40 and 28 mJ per cm2 of UVB
(p = 0.0026 and p = 0.0175, respectively). Sustained erythema to a single exposure of UVB of 5±
112 mJ per cm2 is not a feature of red-headed-individuals. However, red-heads develop more total
erythema when exposed to 28 and 40 mJ per cm2 of UVB than nonred controls when followed
over time (21 days).
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Reproducibility of Irritant Patch Tests Over Time
L. Naysmith, K. Waterston, T. Ha, and J.L. Rees
Edinburgh, Scotland
Variation in response to in¯ammatory stimuli may be under primarily genetic or environmental
control. In man as compared with model organisms the position is not clear. One way to get a
handle on partitioning the variance between genetic and environmental causes is to look at
variation over time within the same individuals and between individuals. We assessed the response
of increasing concentrations of broadband ultraviolet B radiation (21/3 increments from 119 to 300
mJ cm±2 ± Phillips PLS 9 W/12), doubling doses of anthralin (0.005±0.08%) and sodium dodecyl
sulphate (0.5±8%) in 15 healthy volunteers over time. Patch tests were applied in duplicate to the
upper back for 24 h using 8 mm Finn chambers (Epitest Ltd, Finland). The same irritants and
in¯ammatory stimuli were then applied 2±3 months later, again in duplicate to the adjacent skin.
The in¯ammatory response was measured objectively using a re¯ectance spectrophotometer, a
Lisca scanning laser Doppler and the Moor contact laser Doppler. Statistical analyses of data, using
Excel, produced dose±response curves and the gradient of the curves were then compared. There
was a striking lack of reproducibility over time particularly with the SDS (greater than 50%
variation) compared with ultraviolet B (less than 15% variation). The amount of variation within
individuals on the same day was much less for all irritants compared with variation over time. The
variation amongst test substances could be ranked as UVB (8%) less than anthralin (12%) less than
SDS (33%). Although our results are preliminary, they suggest that there are large temporal
in¯uences on the in¯ammatory system. Such results would suggest limits to genetic determinants of
cutaneous in¯ammation, at least in an experimental system.
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Demonstration of a Clinically Relevant Sensitization to House Dust Mite Allergen in
Prick and RAST Negative Intrinsic Atopic Dermatitis Patients with the Atopy Patch
Test
S. GuÈnther, K. Reiser, U. Darsow, and A. Wollenberg
Munich, Germany
Atopic dermatitis (AD) is a clinically de®ned, highly pruritic skin disease frequently associated with
IgE responses against aero- and food-allergenes. A so-called intrinsic type of AD (IAD) has been
delineated from the more common extrinsic AD (EAD) by normal serum IgE levels, negative
RAST tests and negative immediate-type skin reactions towards environmental allergenes. Since in
IAD, a clinically relevant sensitization against these allergens cannot be determined by standard
prick tests or RAST, there is a need for other test procedures. Here we report 2 key patients in
which the recently standardized atopy patch test (APT) was employed to con®rm the clinically
suspected role of house dust mite allergen for their AD. A 24-year-old optician and a 59-year-old
masseur with clinically characteristic AD lesions both had a negative family history for atopy. The
two female patients both experienced an itch sensation after house dust exposure, which was
followed by a ¯are up of their AD lesions. The allergological workup did not show any positive
prick test or RAST results, and the total serum IgE was 23 kU per liter and 55 kU per liter,
respectively. A diagnosis of IAD was made and an APT was performed in the two patients, which
showed strongly positive results for the house dust mite allergen D. pter. in a test concentration of
200 IR. Epidermal Dendritic Cell Phenotyping (EDCP) is a recently standardized diagnostic
procedure based on the quantitative evaluation of Langerhans cells and in¯ammatory dendritic
epidermal cells (IDEC) of in¯amed skin. The naturally developed lesions of EAD are characterized
by an increased number of IDEC with a high expression of FceRI on their cell surface. The EDCP
of our two patients' APT reactions showed an unusually high number of IDEC, but a low FceRI-
expression ± a pattern previously seen in naturally developed IAD lesions. Our conclusion is that
the APT may become an important diagnostic tool especially in patients with IAD where the
standard prick tests and blood analyses do not identify those allergens relevant to the clinical course
of disease.
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Atopic Dermatitis and Concomitant Disease Patterns in Children Up to 2 Years of Age
M. BoÈhme, E. LanneroÈ, M. Wickman, S.L. Nordvall, and C.F. Wahlgren
Stockholm and Uppsala, Sweden
There are few prospective studies of atopic dermatitis and coexisting diseases such as respiratory
infections, in children up to two years of age. Using annual questionnaires, we studied the two-
year-prevalence of atopic dermatitis and concomitant symptoms of other atopic diseases and
respiratory infections in 0±2-year-old children in a prospective birth cohort of 4089 children.
There was an increased risk of asthma (RR 1.45, 95% CI 1.16±1.80), allergic rhinoconjunctivitis
(RR 2.25, 1.77±2.85), adverse reactions to foods (RR 3.20, 2.83±3.62), and urticaria (RR 2.04,
1.80±2.31) as well as otitis (RR 1.13, 1.05±1.21), more than one pneumonia during the ®rst and/
or second year of life (RR 2.17, 1.14±4.15) and the use of antibiotics at least twice yearly (RR
1.29, 1.07±1.56) in children with AD as compared with those without. The risk of atopic disease
manifestations, but not respiratory infections, was higher with onset of atopic dermatitis during the
®rst year of life than during the second. Already during their ®rst two years of life, children with
AD have a signi®cantly increased risk not only of other atopic disease manifestations, but also of
respiratory infections manifested in an increased rate of otitis, pneumonia and use of antibiotics.
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The Prevalence of Atopic Diseases and the Level of IgE in Patients with Systemic Lupus
Erythematosus
A. Wozniacka, E. Robak, A. Sysa-Jedrzejowska, Z. Samochocki,* and M. Zak-Prelich
Department of Dermatology, Medical University, Lodz, *Department of Dermatology, Military Medical
University Hospital, Warsaw, Poland
The coexistence of atopic diseases (AD) and systemic lupus erythematosus (SLE) as well as the
observations regarding the elevated level of IgE in SLE patients remain controversial. Therefore the
aim of the study was to investigate the prevalence of atopic diseases among patients with SLE and
the serum level of total IgE. The group of patients consisted of 39 patients (36 female, 3 male) aged
30±50 years (mean = 38.5). All the patients were in inactive phase of SLE. The activity was
evaluated according to Liang score. The diagnosis of atopic diseases was based on interview,
physical examination and additional tests. Total IgE concentration was determined in the sera by
ELISA using commercially available kits. The control group consisted of 31 healthy persons, age
and sex-matched. Atopic diseases were present in 26% of patients. The most frequent diagnosis
was: allergic rhinitis (9/39), atopic dermatitis (2/39), and allergic conjunctivitis (1/39). More than
1 atopic disease was diagnosed in 2 patients. The mean IgE concentration in SLE patients was
204 IU per mL (Me = 49 IU per mL) and 37 IU per mL (Me = 24 IU per mL) in the controls. The
difference was statistically signi®cant (p = 0.02). In SLE patients with concomitant atopic diseases
IgE concentration was 496 IU per mL (Me = 169 IU per mL) and in the patients without
AD 104 IU per mL (Me = 38 IU per mL). There were no statistically signi®cant differences
(p > 0.05) between the IgE concentration in SLE patients without AD and the controls. The higher
level of IgE in SLE patients was connected with the coexistence of atopic diseases. In conclusion, it
seems that the prevalence of atopic diseases in SLE patients and the IgE level in inactive phase of
the disease is not different from the general population.
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Treatment of Chronic Plaque Psoriasis by Targeting CD45RO+ Memory-Effector T
Lymphocytes: A Randomized Phase II Trial of Alefacept (AmeviveTM)
R. Langley, and D. Shrager
Halifax, Nova Scotia and Cambridge, Massachusetts
Chronic plaque psoriasis is characterized by in®ltration of CD45RO+ memory-effector T-
lymphocytes in the skin. Alefacept (human LFA-3/IgG1 fusion protein, currently being developed
under the trade name, AMEVIVETM) selectively binds to CD2 receptors expressed on these T
cells. It blocks the LFA-3/CD2 interaction, reduces T-cell activation, and modi®es the
in¯ammatory process. A multicenter, randomized, placebo-controlled, double-blind study was
conducted to evaluate the ef®cacy, safety, and quality-of-life (QoL) impact of alefacept in patients
with psoriasis. 229 subjects were randomized to receive placebo or alefacept (0.025, 0.075, or
0.150 mg per kg) administered as a 30-second IV injection once weekly for 12 weeks. Ef®cacy
endpoints were assessed at 2- and 12-weeks after dosing and included changes from baseline in
PASI and PGA. Alefacept was effective in the majority of patients, with 76% achieving > 50%
improvement in PASI scores at anytime after receiving the ®rst dose. A signi®cantly greater percent
of patients who received alefacept 0.075 mg per kg IV demonstrated >75% reduction in PASI
from baseline at 2- and 12-weeks after dosing compared with placebo (33% vs. 10%; p = 0.02 and
31% vs. 11%; p = 0.02, respectively). Based on PGA, a signi®cantly greater percent of patients in
the alefacept group were clear or almost clear of psoriasis at 2 and 12 weeks after completion of
therapy (p < 0.05 vs. placebo). Alefacept therapy was well tolerated, with no reports of disease
rebound after treatment was completed. There was no evidence of an increased risk of infection
with alefacept therapy. Of the 229 patients enrolled, 205 completed baseline and follow-up QoL
questionnaires. Signi®cant treatment effects were observed; patients receiving alefacept reported
greater improvements in the dermatology-speci®c instruments, DLQI and DQOLS, compared
with those who received placebo (p < 0.05). In this phase II trial, alefacept produced clinically
meaningful and statistically signifcant responses with a favorable safety pro®le in patients with
chronic plaque psoriasis. There are no reports of rapid ¯ares or rebound following discontinuation
of therapy. Additionally, when compared with placebo, alefacept was associated with greater
improvements in patients' QoL.
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PUVA Maintenance Treatment for Psoriasis
A. Tanew, S. Radakovic-Fijan, A. Seeber, and H. HoÈnigsmann
Vienna, Austria
Photochemotherapy (PUVA) is a highly effective and widely performed treatment option for
patients with severe psoriasis. Like other currently available antipsoriatic agents PUVA is only
remittive and most patients relapse within one year after cessation of treatment. One approach
aimed at prolonging the disease free interval is maintenance treatment which denotes continuation
of PUVA treatment beyond the clearing phase at a lower frequency. Studies performed so far on
the ef®cacy of maintenance treament for preventing early relapse of psoriasis are scarce and have
provided inconsistent results. We therefore sought to reinvestigate this important issue by means of
a prospective, intrapatient, left-right comparison study. 34 patients with chronic relapsing plaque
type psoriasis were included in the study. PUVA treatment for clearing was given 4 times weekly
according to the European standard protocol. Thereafter all patients were placed on a halfside
maintenance schedule that consisted of two weekly irradiations over 4 weeks followed by one
weekly irradiation for another 4 weeks. In all patients complete or near complete clearing was
achieved after a mean of 19.7 6 7.0 exposures, 41.2 6 16.9 days and a total UVA dose of
55.3 6 43.2 J per cm2. The respective values for maintenance treatment were 10.4 6 2.1 exposures,
47.8 6 14.1 days and 50.4 6 48.3 J per cm2. The mean number of maintenance exposures was less
than 12 because 9 patients already relapsed on both half-sides while still under maintenance
treatment. Overall, maintenance treatment was disappointingly ineffective in stabilizing the
therapeutic outcome of the clearing phase. In only 3 patients (8.8%) a delay in the onset of
recurrence of 1.5±2 months was observed. No half-side difference with respect to the time until
appearance of new lesions was detectable in the remaining 31 patients (91.2%). The mean time
interval until relapse without and with maintenance irradiation was 4.5 6 3.4 months and
4.6 6 3.4 months, respectively. Our data demonstrate that short-term maintenance treatment while
considerably adding up to the patients' cumulative UVA exposure load is ineffective in preventing
early relapse in the great majority of patients and should be avoided.
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A Three-Month Multiple-Dose Toxicity Study of Alefacept (AmeviveTM) in Baboons
C.N. Tenhoor
Cambridge, Massachusetts
The toxicity of alefacept (human LFA-3/IgG1 fusion protein, currently being developed under the
trade name AMEVIVETM) was evaluated following repeat IV administration to baboons. Twenty-
four baboons were divided into 4 dose groups, with 3 males and 3 females in each group, and
randomized to receive sterile saline or alefacept 0.1, 2, or 40 mg per kg administered once weekly
for 13 weeks. The 40-mg per kg per week dose is approximately 500 times higher than the clinical
dose used in human subjects. On Day 93, one preselected male and female baboon from each
group were sacri®ced. The remaining animals were evaluated for an additional 7 months and
sacri®ced on Day 316. Overall, alefacept was well tolerated and no clinical signs of toxicity,
infectious compromise, or neoplastic changes were observed during treatment or throughout the
224-day observation period. Alefacept-related changes were limited to dose-dependent reductions
in peripheral and tissue-associated T-cell subsets in all 4 dose groups. However, these effects
appeared to be saturable, with CD2+ and CD4+ T-cell reductions plateauing at approximately
80% below baseline. Despite the use of doses up to 500 times higher than the clinical dose, T-cell
subsets could not be depressed below this threshold. Additionally, T-cell reductions were not
signi®cantly different in animals treated with the 40-mg per kg per week dose compared with the
2-mg per kg per week group. By Day 316, peripheral lymphocyte counts had returned to predose
baseline levels in the 0.1-mg per kg per week group and continued to recover toward baseline
levels in the 2- and 40-mg per kg per week groups. There were no gross abnormalities observed in
any animals. Alefacept therapy led to subtle yet distinct reductions in cellularity of T-cell-speci®c
regions of the spleen and the lymph nodes. Tissue changes remained evident in the spleens of the
recovery sacri®ced animals that had received alefacept 40-mg per kg per week. However, the
extent of these changes was less evident than in those animals evaluated on Day 93. Weekly
alefacept administration was well tolerated with no signs of toxicity, infectious compromise, or
neoplastic changes observed during treatment. The effects of alefacept on peripheral T cells were
saturable at 80% below baseline. Additionally, animals receiving the 0.1-mg per kg per week dose,
which is representative of the clinical dose, demonstrated complete recovery from reductions in
peripheral and tissue-related lymphocyte counts following treatment cessation.
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Alefacept (AmeviveTM) Therapy Targets Key Mediators of Psoriasis and Produces Long-
Lasting Clinical Response
R. Langley and D. Shrager
Halifax, Nova Scotia and Cambridge, Massachusetts
The presence of memory-effector T cells (CD4+ CD45RO+ and CD8+ CD45RO+) in the skin
stimulates hyperproliferation of keratinocytes, leading to the development of psoriatic plaques.
Memory-effector T cells are generated when antigen-presenting cells process antigen, migrate to
regional lymph nodes, and interact with naõÈve T-cells. CD2 is a cell-surface protein that is
expressed on all T-cell subsets, but is up-regulated on the surface of memory-effector T cells. LFA-
3, expressed on antigen-presenting cells, is the natural ligand of CD2. Interaction of CD2 with
LFA-3 costimulates T-cell activation and proliferation and increases cytotoxic T-cell effector
function. Alefacept, a fully human fusion protein of LFA-3/IgG1 (currently being developed under
the trade name AMEVIVETM) inhibits memory-effector T-cell activation by blocking the
costimulatory interaction between CD2 and LFA-3. It also interacts with FcgRIII receptors on
natural killer cells and facilitates T-cell apoptosis. Alefacept has a selective immunomodulatory
effect that does not interfere with the activity of naõÈve T-cells or other immune cells, such as B
cells. The effect of this targeted action of alefacept on duration of clinical response was evaluated.
Patients with chronic plaque psoriasis (n = 229) were randomized to receive placebo or alefacept
(0.025, 0.075, and 0.150 mg per kg) administered as a 30-second IV injection once weekly for
12 weeks. Ef®cacy endpoints included Physician Global Assessment (PGA) and changes in PASI
from baseline. Upon completion of the study, patients had the option to receive subsequent doses
of alefacept in an open-label study, where the time to retreatment was recorded. During the phase
II trial, 19 patients were clear or almost clear of disease by PGA 2 weeks after dosing was complete,
with 84% maintaining this response during the 12-week follow-up period. An additional 12
patients continued to improve and became clear or almost clear of disease over the 12-week
postdosing period. Of these 28 patients, 26 were followed in the open-label study and did not
require subsequent doses of alefacept for a median of 10 months (range, 6±18 months). The
selective immunomodulatory effect of alefacept on key mediators of psoriasis may contribute to the
lasting remission, lack of disease rebound, and favorable safety pro®le observed in phase II studies.
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Subcutaneous Injection of MEDI-507, an Anti-T-Cell Monoclonal Antibody, for the
Treatment of Psoriasis: Phase I Results
R. Matheson, K. Beutner, C. McCall, and C. Dingivan
Portland, Oregon; Vallejo, California; Atlanta, Georgia; Gaithersburg, Maryland
MEDI-507 is a humanized IgG1 monoclonal antibody that binds to the CD2 receptor of T-cells
and natural killer cells. Abnormal T-cell activity has been shown to be important in the
development of psoriasis. It has been observed in vitro that MEDI-507 has the potential to
selectively suppress the function of the immune system. Dosing by subcutaneous (SQ) injection is
considered preferable to intravenous (IV) infusion for chronic treatment of psoriasis. MEDI-507 in
the range of 0.1±7 mg has been evaluated in a Phase I/II, open-label, dose-escalation study
involving 12 weekly SQ injections (n = 39). Entry criteria required 10% body surface area psoriasis
involvement and a prior treatment washout period. Clinical response is assessed using the Psoriasis
Area and Severity Index (PASI). The majority of adverse events reported to date have been
transient and judged mild in severity with the most common adverse events including headache,
injection site reaction (mild erythema), decreased lymphocyte count, and asymptomatic changes in
vital signs during the postdose observation period. Following multiple injections, reductions in
PASI are observed at all dose levels although more clinically signi®cant disease improvement is seen
at the higher dose levels. Changes in absolute lymphocyte counts are less pronounced following
weekly SQ dosing when compared to comparable doses of MEDI-507 given by weekly IV
infusion. Preliminary data indicate that SQ MEDI-507 suppresses disease activity and is well
tolerated with minimal site of injection reactions. A Phase II program has been initiated in Europe.
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Phase I Results of Intravenous MEDI-507, an Anti-T-Cell Monoclonal Antibody, for the
Treatment of Psoriasis
R. Langley, H. Roenigk, C. McCall, G. Stricklin, and C. Dingivan
Halifax, NS Canada; Phoenix, Arizona; Atlanta, Georgia; Nashville, Tenneessee, and Gaithersburg,
Maryland
MEDI-507 is a humanized IgG1 monoclonal antibody that binds to the CD2 receptor found on
the surface of T-cells and natural killer cells. It has been observed through in vitro model systems
that MEDI-507 has the potential to selectively suppress the function of the immune system.
Abnormal T-cell activity has been shown to be important in the development of psoriasis,
therefore modulation of T-cell activities may provide an effective treatment for psoriasis.
Intravenous (IV) administration of MEDI-507 has been evaluated in a Phase I, open-label, single-
dose IV safety study (n = 14) and a Phase I/II, open-label, dose-escalation study involving 8 weekly
IV infusions (n = 26). Entry criteria required 10% body surface area psoriasis involvement and a
prior treatment washout period. MEDI-507 doses in the range of 0.4±40 mg per kg were evaluated.
Clinical response was assessed using the Psoriasis Area and Severity Index (PASI). The majority of
adverse events reported were transient and judged mild to moderate in severity. The most
common related adverse events include chills, headache, and decreased lymphocyte count. Dose-
dependent reductions in target lymphocyte populations were observed. Clinically signi®cant
disease response was observed at dose levels at or above 1.2 mg per kg MEDI-507. The 40 mg per kg
dose resulted in the highest peak serum levels and the highest disease activity. Of the 6 volunteers
treated at this dose level, 50% experienced a greater than 75% improvement in PASI as compared
to entry baseline. Preliminary data indicate that multiple IV infusions of MEDI-507 are well
tolerated and that clinically meaningful improvements in psoriasis have been observed. A Phase II
program has begun in North America.
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A Multiparameter Flow Cytometric Analysis of the Effect of Bexarotene on the
Epidermis of the Psoriatic Lesion
M.E.J. Franssen, J.V. Smit, P.E.J. van Erp, and P.C.M. van de Kerkhof
Nijmegen, the Netherlands
Recently, a new drug bexarotene (Targretinq) was investigated in a large multicentre trial for its
possibility as an antipsoriatic treatment. Bexarotene is a novel synthetic retinoid X receptor
(RXR)-selective retinoid. Retinoids are known to act as modulators of epidermal growth and
differentiation. In psoriatic keratinocytes, they induce normal differentiation and suppress
proliferation. Therefore, the aim of the present study was to analyse these processes in epidermal
single cell suspensions derived from lesions of psoriatic patients treated with various doses of
bexarotene. 34 patients with moderate to severe plaque psoriasis participated in this study and were
assigned in sequence to four different dose panels: 0.5, 1, 2, and 3 mg per kg once daily for a period
of 12 weeks. Before and after 12 weeks of treatment, punch biopsies were taken from lesional skin
and epidermal single cell suspensions were prepared using an optimised thermolysin-protocol. To
establish a comparison of clinical and ¯ow cytometric data, a sum of scores was determined for each
biopsy-site, based on a four-point scale for erythema, induration and desquamation. An improved
multiparameter ¯ow cytometric assay was used which enabled simultaneous assessment of
epidermal proliferation, various aspects of differentiation and epidermal in¯ammation. The
following parameters were measured simultaneously: DNA-distribution (DAPI), cell size, keratin
10 (RKSE 60), keratin 6 (LHK6B), and vimentin expression (V9). Isotype speci®c secondary
antibodies conjugated with phycoerythrin and ¯uorescein isothiocyanate were used as the second
step in the staining procedure. Differences in cell size and intermediate ®lament expression enabled
us to distinguish in¯ammation cells from keratinocytes. After 12 weeks of treatment, the
subpopulation of keratin 10 only expressing cells showed an average increase of 89.9% of the value
before treatment. Additionally, the subpopulation of keratin 6 only expressing cells showed an
average decrease of 32,8%. The subpopulation of keratin 6 and 10 coexpressing cells showed a
slight increase of 17,8%. In conclusion, treatment with bexarotene results in a marked decrease of
epidermal hyperproliferation and normalisation of keratinisation in moderate to severe plaque
psoriasis.
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Evaluation of a New X-Ray Fluorescent Analysis Technique for the Creation of a Nordic
Hair Database. Elemental Distributions within the Root and the Virgin Segment of Hair
Fibres
B. Forslind, M. Stocklassa, G. Aransay-Vitores,² C. Nilsson,² D. Karlsson,² B. and Wiegleb³
*EDRG, Department of Medical Biophysics, Karolinska Institute, Stockholm, Sweden Cox Analytical
Systems AB, Gothenburg, Sweden; ²National Laboratory of Forensic Science, LinkoÈping, Sweden;
³Department of Dermalology, Karolinska Hospital, Stockholm
A new, non destructive X-ray ¯uorescence technique for quantitative estimation of elemental
content in biological tissues has been developed. Technical and instrumental characteristics of the
ITRAX X-ray spectrometer have been evaluated in relation to the properties of biological samples,
i.e. human hair ®bres. Thus, attenuation variations of the ¯uorescent X-rays in the hair bulk mass
was demonstrated at analysis of sulfur, calcium and zinc in a part near the root of one hair ®ber with
elliptical cross section. By rotation of the hair ®ber and successive analyzes made of the same part of
the hair ®ber the results showed that concentrations of elements varied as functions of the diameter
of the analyzed hair volume. Other sources of errors are also discussed. The ITRAX instrument
allows for precise, fast, nondestructive, simultaneous, quantitative recording of the detected
elements and trace elements down to levels of 1 p.p.m. (mg per g). The instrument was used for
assessment of normal values of physiologically important elements present in hair in a cohort of
normal, healthy Swedish, Caucasian individuals. The database erected from data retrieved from a
conceivably homogenous ethnic set of individuals represents to our knowledge the ®rst of its kind.
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Spectral Anlysis of Malignant Melanoma
C. Gauger,* R. Sold,* R. Gemperlein, J. Remling, R. Ring, and A. Hein
Department of Dermatology and Allergology, Technical University, *Department of Biology, Ludwig-
Maximilian-University; Munich, Germany
Noninvasive dignostic methods to determine the diagnosis of malignant melanoma become more
and more important. Recent studies report on spectral differences between normal skin, naevocytic
naevi and malignant melanoma (Marcchesini et al. 1991, 1992, 1995; Wallace et al. 2000). The
method of re¯ection-spectroscopy and image analysis by Fourier interferometer (FIRS and FIBA,
respectively) are two methods to measure and put into image the spectrum of optic re¯ection of
the skin. The intention of the study was to investigate spectral differences between normal skin,
benign pigmented lesions (BPL) and malignant melanoma (MM) to aim for a possible new method
for early diagnosis of MM. Until now, 13 patients with MM have been investigated. Due to
technical reasons, only 9 patients could be evaluated. 5 (2f/3m) presented with super®cial spreading
melanoma (SSM), 3 (1f/2m) with nodular malignant melanoma (NMM) and one with lentiga
maligna melanoma (LMM). Normal surrounding skin of the patients and several BPL served as a
control group. A Xenon lamp with the light spectrum of 230±1300 nm was used as the light source
for FIRS. Re¯ection images were taken by an attached CCD camera, clculation and imaging was
done with FIBA computer program analysis (Mosenheuer, 1993). The outcome was presented by
diagrams showing the re¯ection spectrum (amplitudes) and relative re¯ection spectrum over the
wavelength of 400±1200 nm. Re¯ection spectrums of BPL and MM demonstrated characteristic
curves. Up to 600 nm, BPL showed less re¯ection than the surrounding skin. Concerning the
wavelength of hemoglobin absorption, the re¯ection of BPL was similar to normal skin, i.e. no
enhanced blood supply could be seen. At 600 nm, re¯ection of BPL was even higher than the
surrounding skin, resulting in a characteristic bend of the curves. Re¯ection curves of MM differed
signi®cantly from BPL. Within the absorption spectrum of hemoglobin, MM showed a higher
re¯ection due to higher vascularisation. At 600 nm MM didn't demonstrate the characteristic bend
as seen in BPL. In summary, MM demonstrate chracteristic re¯ection curves in FIRS and FIBA
due to structural and vasculary alterations resulting in changed optical qualities of the tissue. FIRS
together with FIBA seems to be a promising noninvasive method for diagnosis of malignant
melanoma. Since it is still innovative and experimental, further investigations with a higher number
of patients are needed.
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Detection of Circulating Malignant Melanoma Cells in Periphral Blood by Quantitative
RT-PCR Assay
N. Hayre, T. Nigra, G. Peck, K. Burman, K. Bixby, and M. Ringel
Washington Hospital Center, Washington, DC
Early identi®cation of metastases in patients with melanoma is critical. We developed a nested RT-
PCR assay for detection of tyrosinase (tyr) mRNA by real-time ¯uorescent RT-PCR. Consistent
detection of tyr negative RNA spiked with tyr positive RNA from malignant melanoma cells was
achieved. Total RNA was extracted from blood of 17 patients with stage IB-IV melanoma. All 4
stage IV patients tested positive while both stage IB patients tested negative. One of 9 patients with
lymph node metastases identi®ed only by tyr RT-PCR on node tissue was positive, consistent with
rates of disease progression. One stage IV patient with a positive assay prior to and during treatment
converted to a negative result at the time of radiographical remission. We next developed a novel
quantitative RT-PCR assay to detect tyr mRNA in blood using our primer pair and ¯ourescent
probe. Using spiked RNA, a sensitivity of 100 cells per ml of blood was achieved. We are currently
applying this quantitative assay clinically. In summary, we developed a nested PCR assay with
potential clinical utility, and a novel quantitative tyr mRNA assay for further testing. Our goal is to
develop a blood test that will improve the initial staging of melanoma, allow for better monitoring
of disease progression, and ultimately result in more timely and effective therapy.
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Human Papillomavirus (HPV)-DNA Sequences in Melanoma Specimens
M. La Placa, S. Venturoli, F. Bonvicini, M. Cricca, T. Bianchi, C. Varotti, M. Musiani, and M.
Zerbini
Department of Clinical and Experimental Medicine, University of Bologna, Bologna, Italy
Although the etiology of melanoma is still unknown, UV radiation from sun exposure, in
particular in people with light hair and skin and with mumerous nevi, seem to play an important
role. Viruses, especially Human Papillomavirus (HPV), have been implicated in the pathogenesis of
cancer, including nonmelanoma skin cancers. In our study, we investigated the possible presence of
HPV-DNA sequences in melanoma biopsy specimens. Two polymerase chain reactions (PCR)
were used for the detection of different genotypes of HPV on 4 melanoma biopsy specimens,
paraf®n included, obtained from 4 patients with melanoma. We used two sets of consensus primers
located within the L1 region of HPV genome, MY11/MY09 and GP5+/GP6+. The GP primers
can be used in the nested PCR following ampli®cation with the MY primers. The ampli®cation
products of both PCRs were hybridized with two sets of type-speci®c biotinylated probes for HPV
types 16, 18, 31, 33, 35, 39, 45, 52 and 58. The hybrids were captured on streptavidin-coated
microtitre plates and detected by ELISA. No typeable specimens were evaluated by DNA
electrophoresis. The best results were obtained when the GP primer sets were used. In fact any
samples were positive only with GP primers. The possible reasons for that are smaller size of the
PCR product (»140 bp GP product against »450 bp MY product) and that the GP primers do not
contain degenerated bases. Furthermore the use of MY/GP nested PCR increased signi®cantly the
positivity rate of HPV-DNA detection and should be used for samples with a low copy number of
HPV-DNA. The use of the two sets of primers individually in PCR or together in a nested PCR
has permitted to detect DNA sequences of HPV 18 and 31 in one patient and HPV-16 in an other
melanoma patient. These HPV-genotypes are considered at high risk for cancer development in
nonmelanoma skin cancer. The possible pathogenetic role of HPV in melanoma is now under
discussion and needs further investigations.
316
Clinical Ef®ciency of Cytotoxic T Cells as Adjuvant Treatment in Melanoma
B. Dreno,² N. Labarriere,² A. Khammari, M.C. Pandol®no,* S. Gervais,² M.H. Tessier,* and F.
Jotereau²
Department of Skin Oncology, *Unit of Cellular and Gene Therapy, ² INSERM U 463
Speci®c cytotoxic T lymphocytes of melanoma antigens (TIL) are considered as crucial in the
antitumor response. However, until now a direct correlation between speci®c T cytotoxic activity
against tumor cells and clinical response has never been demonstrated in melanoma. This is the aim
of our study. 88 patients in stage III (ASLL) with clinical lymph node have been included in an
adjuvant randomized open study after positive lymph node resection. One arm (n = 44) received
IL2 alone during 2 months, 6 weeks after the lymph node resection and the other arm (n = 44)
received TIL and IL2 in the same condition. Moreover, among the TIL arm, the percentage of
speci®c cytotoxic T lymphocytes has been determined in 26 patients by studying the
intracytoplasmic production of g interferon by the TIL incubated with autologous melanoma
cell line. With a median follow up of 3 years, this study shows a signi®cant decrease of relapse (73%
without relapse in TIL arm vs. 44% in IL2 arm p = 0.019) and an increase of survival in patients
treated with TIL with only one invaded lymph node (p = 0.026). The percentage of speci®c TIL
injected varied between 0.3% and 10%. The injection of speci®c TIL was signi®cantly associated
with a decrease of relapse and an increase of survival (p = 0.02) compared with patients injected
with non speci®c TIL. In conclusion, this study demonstrates a clinical bene®t of TIL used as
adjuvant therapy in melanoma stage III and for the ®rst time a correlation between relapse and
overall survival and the injection of speci®c cytotoxic T cells. At the moment, we begin another
study injecting only clonal cytotoxic T cells against MELAN-A/MART-1 antigen in patients stage
IV.
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An Oral 5-Lipoxygenase Inhibitor Reduces In¯ammatory Lesions, and Total and Pro-
In¯ammatory Sebum Lipids in Acne Vulgaris
Ch.C. Zouboulis, S. Nestoris, Y.D. Adler, M. Picardo, E. Camera, M. Orth, and C.E. Orfanos
Berlin, Germany and Rome, Italy
Despite the wide consent that P. acnes is a major causative factor for acne, there is evidence which
calls in question bacterial involvement in the initiation of acne lesions. In addition, antibiotics that
are successfully used in the treatment of in¯ammatory acne, also exhibit an anti-in¯ammatory
activity. However, anti-in¯ammatory compounds have been barely used in acne treatment.
Therefore, a clinical proof of principle (1C) study was conducted to treat in¯ammatory acne
vulgaris with an oral selective 5-lipoxygenase inhibitor, aiming to control molecular steps of
in¯ammation. Ten patients with acne papulopustulosa (m:f 6 : 4, aged 19 6 5 years) were treated
with (6)-1-(1-benzo[b]thien-2-ylethyl)-1-hydroxyurea 4 3 600 mg per day p.o. for 3 months.
Documentation was performed at baseline, and weeks 2, 4, 8, 12, and 14. The acne severity index
continuously decreased in a time-dependent manner to 41 6 28% of the initial score at week 12.
This was due to a 71 6 24% decrease of in¯ammatory lesions, while comedones did not respond.
No adverse events were registered during and after treatment. Interestingly, total sebum lipids
signi®cantly decreased and the squalene/cholesterol ratio, free fatty acids and lipoperoxides were
markedly diminished in patients' sebum under treatment, whereas the magnitude of clinical
improvement strongly correlated with the reduction of total sebum lipids and free fatty acids. In
contrast, the levels of leukotriene B4 in blood and of the casual skin surface lipids were not affected.
All parameters studied remained practically unchanged during the 2-week post-treatment
observation period. In conclusion, in¯ammatory acne signi®cantly responded to an oral 5-
lipoxygenase inhibitor. Moreover, systemic inhibition of arachidonic acid metabolism reduced
total and pro-in¯ammatory sebum lipids; the latter probably being responsible for the development
of in¯ammatory acne lesions.
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Testosteron Level in Female Acne Patients
A. Petrov and N. Petrova
Skopje, Macedonia
Pathological process in acne is in sebaceous follicle. Sebaceous glands are target organ for human
androgens. In female, the role of androgens is weak, but if these in¯uences are stronger, side-effects
are more obvious. Testosterone is the most important regulator of sebaceous function. Reports
from literature are contradictory, notifying testosterone level in acne patient in compare with
healthy individuals. We have compared examining group of acne patient (105) with healthy
control (30). Female acne patient has been classi®ed according two main criteria: age and clinical
®ndings. Testosterone was detected by RIA method twice in interval of two months, with J125
(Farmos Diagnostic Oulunsalo Finland). According to our investigation total testosterone level
(arithmetical medium) is greater in experimental group of patients. Total testosterone level is in
correlation with severity of clinical picture in all age groups. Total testosterone level is signi®cantly
higher in patients with acne then in healthy controls. This is especially case in more dif®cult clinical
pictures as acne nodulo-cystica and acne conglobata.
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Cutaneous Sensory Nerve Fibers are Decreased in Number Following Peripheral and
Central Nerve Damage
J. Wallengren, E. Tegner, and F. Sundler
Lund, Sweden
Two dermatological patients, dysplaying peripheral and central nerve damage, respectively, are
described. Cutaneous nerve ®bers in both patients were studied in skin biopsies taken from
neuropathic areas and from the contra-lateral side, immunocytochemistry being applied to a pan-
neuronal marker, a protein gene-product (PGP 9.5). One of the patients, suffering from
compression of the ulnar nerve, had dishidrotic eczema of the hands that was absent on areas of skin
that were neuropathic. The cutaneous innervation (most of which being sensory) was reduced by
50% in the neuropathic area as compared with the contra-lateral side. The other patient had
unilateral pruritus on the parethic side following a stroke. The cutaneous innervation of that side
was reduced by 80% as compared with the other side. It seems that peripheral sensory innervation
is a prerequisite for in¯ammation while spontaneous itching may emanate from a central nervous
system disorder such as a stroke and continue on in partly denervated skin.
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Pemphigus Sebaceous Assosiated with Scleroderma Diffusa
N.P. Kuznetsova, A.Y. Chaschin, and I.G. Afanasyeva
Department of Dermatology, Medical University of Irkutsk, Russia
We observed a woman of 50 with pemphigus sebaceous and scleroderma diffusa. During 10 years
the patient was treated by glucocorticosteroids and metotrexate in Reumatological Center.
Dermatological manifestations appeared after contact with toxic chemical products. The patient
was hospitalized in dermatological clinic. Clinical signs were revealed through multiplied blisters
on the skin of the trunk, face, hands and legs. On the legs were sclerotic and atrophic changes. The
acantholytic cells of Tsank were found out. The state of the patients was hard. The patient received
glucocorticosteroids and her state turned out to be better. This case demonstrated the rare
association of two autoimmune diseases in the patient, who was treated for a long time by
immunesupresivetherapy.
321
Induction of Partial Tumor Regression in Cutaneous T Cell Lymphoma by Anti-
Idiotype Vaccination
J.M. Muche, T. Sherev, R. Demine, A. Lukowsky, S. Gellrich, H.G. HolzhuÈtter, W. Sterry, and
P. Walden
Berlin, Germany
Peptides derived from the complementarity determining region (CDR)-3 of the tumor-speci®c T
cell receptor (TCR) are known to be recognized by autologous HLA class-I restricted CD8+ T
cells. The present study aimed the determination of immunogenic idiotype sequences and their
capacities to induce clinical and immunological responses in CTCL patients. After sequencing the
tumor-speci®c TCRb of four patients with different HLA types, epitopes were predicted that
match both, the proteasome cleavage speci®city and the binding requirements of the respective
HLA molecules using an own algorithm for the former and the SYFPEITHI database for the latter.
CD8+ T cells speci®c for the nonapeptides with the highest predictive scores were demonstrated
in all patients by intracellular IFNg staining of peptide activated cells. In one patient with tumor
stage Mycosis fungoides, vaccination with these nonapeptides together with helper T cells inducing
antigens led to partial remission of the tumor nodules. Each vaccination boostered enhanced
frequencies of peptide-speci®c CD8+ T cells in the peripheral blood. Since tumor-speci®c TCRb
DNA but not mRNA was detected in the remaining tumors, resistance of the neoplastic cells in
this case might be mediated by down-regulation or loss of expression of the tumor-speci®c TCR.
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Patients with Chronic Graft vs. Host Disease have Ampli®ed Circulating Clonal T Cell
Populations: Evidence for a Possible Correlation with Response to Photopheresis
L.E. French, T. Alcindor, M. Shapiro, D.J. Margolis, D. Porter, D.G.B. Leonard, F. Foss, and
A.H. Rook
Departments of Dermatology and Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, and
Department of Medicine, Tufts-New England Medical Center, Boston, Massachusetts
Chronic graft vs. host disease (cGVHD) is a major complication of bone marrow transplantation
(BMT) and is responsive to photopheresis, a treatment that induces an anticlonotypic immune
response and has proven to be effective in cutaneous T cell lymphomas with circulating clonal T
cells. We screened blood samples of 23 patients after HLA-matched allogeneic bone marrow
transplantation (allo-BMT), 10 without cGVHD and 13 with extensive cGVHD, for clonal T-cell
receptor g (TCRg) gene rearrangements using ¯uorescent-based polymerase chain reaction (PCR)
and automated high-resolution capillary electrophoresis. Ampli®ed clonal populations of T cells
with unique TCRg gene rearrangements were found in 6 of 10 (60%) allo-BMT patients without
cGVHD and 11 of 13 (84.6%) allo-BMT patients with cGVHD, as compared to 0 of 10 (0%)
healthy controls. Eight patients with cGVHD were treated by photopheresis, and the presence of
ampli®ed clonal populations of T cells was found to be associated with a cutaneous response to
photopheresis, as 6 of 6 (100%) clone positive vs. 0 of 2 (0%) clone negative patients experienced a
clinically signi®cant cutaneous response to treatment. Our ®ndings suggest that a high proportion
of patients with cGVHD have detectable expanded clonal T cell populations in their peripheral
blood, and such patients may be more likely to respond to treatment by photopheresis.
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Induction of Granulation Tissue Formation in Chronic Wounds by Hyalo®ll-Fq (a
Derivative of Hyaluronan)
M. Nahuys and J.R. Mekkes
Department of Dermatology, Academic Medical Center, University of Amsterdam, the Netherlands
Background Hyalo®ll-Fq is a nonwoven benzyl esteri®ed hyaluronic acid derivative. When
applied to a wound, it hydrolyses and provides a hyaluronan-rich environment. Hyaluronan, a
linear polymer of glucuronic acid N-acetylglucosamine disaccharide, has been shown to be
associated with multiple biological events in wound healing and promotes tissue repair and
angiogenesis in experimental models. Several case reports and descriptive studies on the clinical use
of hyaluronan have been published, but controlled clinical trials are scarce. The purpose of this
study was to ®nd clinical evidence for the hypothesis that hyaluronan derivatives induce
granulation tissue formation. Because hyaluronic acid gauzes form a gel after contact with wound
¯uid, another gel (IntraSite gel) was used as control treatment.
Methods In 10 consecutive patients with large nonhealing ulcers, caused by venous
insuf®ciency (8) or vasculitis (2), part of the ulcers was treated with hyaluronic acid (Hyalo®ll-
F), while the other part was treated with IntraSite gel. Wound size, time until a red granulating
wound bed was achieved, total wound healing time, and number of required grafting procedures
were recorded.
Results Compared to control, time until grafting was reduced with 7 days (29%, p = 0.004),
total wound healing time was reduced with 19 days (31%, p = 0.0003). The hyaluronic acid-treated
ulcers required 6 grafting procedures, vs. 11 in the control group.
Conclusion The advantage of this intrapatient or intraindividual comparative study design is that
important confounding variables, such as ulcer duration, etiology, age, nutritional state, glucose
levels, general condition, smoking, hypertension, and compliance can be eliminated. By using this
special study design, we were able to conclude that Hyalo®ll-Fq, a hyaluronan derivative, is able to
stimulate granulation tissue formation and wound healing. Based on this study, we recommend
that hyaluronan should be tried in yellow necrotic ulcers that fail to respond to conventional
treatment.
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Image Analysis Techniques in Evaluation of the Healing Process in the Course of
Chronic Leg Ulcers
A. Zalewska, M. Strzelecki, and A. KwiecienÄ
Dermatology Department, Medical University of LoÂdz, Institute of Electronics Technical University of LoÂdz,
LoÂdz, Poland
Image analysis techniques have a long-standing tradition in medicine. They are regarded to be of
considerable help in precise, quick, objective and automated characteristics of different objects.
Nowadays, computed image analysis techniques are used in a vast majority of morphometric
studies (e.g. for individual cell description). They are also introduced in evaluation of some skin
lesion extensiveness. The aim of our study was to estimate healing process progress in the course of
chronic leg ulcers on the basis of computed image analysis technique measurements of ulcer area.
The study was performed on series of photographs obtained from 22 patients with chronic leg
ulcers in the course of intensive inpatient and outpatient treatment. This material was subsequently
analysed by image analysis procedures performed using a number of subroutines written in Delphi
developed at the Institute of Electronics, Technical University of LoÂdz. The analysed images were
scanned using HP 3c-colour scanner in true-colour (24 bits per pixel) format, with size 512 3 512
pixels each. Next, image histogram stretching procedure was performed to improve image
contrast. Subsequently, thresholding was performed to visualize leg ulcer lesions. Then,
geometrical features of the objects such as edge and area of the leg ulcers were calculated.
However, at the beginning of the study we had some problems with estimation the edge and
subsequently area of the ulcers which were tightly covered with purulent exudates. Overall, the
employed method allowed for evaluation of leg ulcer healing process on the basis of their area
decrease in an objective and precise way. Demonstration of such objective results was also
appreciated by the patients, who were predominantly above 60 years of age. This method exerted a
surprisingly good impact on psychological approach of the patients to therapy.
VOL. 117, NO. 3 SEPTEMBER 2001 ABSTRACTS 819
325
Psoriasis is Highly Associated with Increased Risk for Fatal Cardiovascular Disease
L. Mallbris, L. Yin,* A. Ekbom,* and M. StaÊhle-BaÈckdahl
Unit of Dermatology and *Unit of Clinical Epidemiology, Department of Medicine, Karolinska Institute,
Stockholm, Sweden
Con¯icting data exist regarding the risk for cardiovascular disease in psoriasis patients.
Methods To assess the risk for fatal cardiovascular disease such as myocardial infarction and
stroke in psoriasis patients, we have performed a nation-wide large-scale epidemiological study
using population based national registries, the Swedish Causes of Death registry and the Swedish
Discharge registry. The latter started in 1964 and is built up on a county-based basis encompassing
an increasing number of counties over time, in 1964±20% and in 1987±100%. The registry
comprises all episodes of in-patient care in Sweden identifying in this study a total of 10.667
patients, 5.638 males and 5.029 females, who were followed for 15 years or more. All patients had
psoriasis as ®rst diagnosis. Patients with psoriasis as secondary diagnosis or who reported an episode
of cardiovascular event prior to being diagnosed with psoriasis were excluded (appr 10.000). Risks
are presented as standard mortality ratio (SMR), i.e. the ratio between the observed and the
expected number of deaths, and 95% con®dence intervals (95%CI).
Results Overall, 2255 deaths caused by cardiovascular events, were observed in psoriasis
patients compared to the expected 1257. The risk for cardiovascular death increased with
increasing number of admissions to the hospital. The youngest age group, 20±40 years, had the
highest risk, SMR 2.85; (95% CI 3.75±4.95, the latter patients being admitted at least three times
for in-patient care. At age 40±60 the corresponding risk was 1.91; (95% CI 2.13±2.31).
Conclusion Psoriasis patients who are hospitilized with psoriasis as ®rst diagnosis have overall a
two-fold increased risk for fatal cardiovascular disease compared to the general population. The risk
increases with decreasing age and increasing number of hospitalizations suggesting a correlation
between severity of psoriasis and risk for cardiovascular death. Whether cardiovascular morbidity is
a consequence of systemic in¯ammation or re¯ects deranged blood lipids,smoking habits or other
remains to be elucidated.
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Relevance of Immunosuppressive Load and Other Risk Factors in the Development of
Squamous Cell Carcinoma (SCC) and Basal Cell Carcinoma (BCC) in Heart Transplant
(HT) Recipients
A.B. Fortina, S. Piaserico, A.L.P. Caforio, M. Alaibac, F. Tona, and A. Peserico
Padua, Italy
HT recipients show an increased incidence of cutaneous malignancies, with a reversal in SCC/
BCC ratio compared with the general population. What induces such reversal has not yet been
fully clari®ed. We studied 360 HT recipients (302 male, mean age at HT 49 6 16 years); mean
post-HT follow-up was 5.5 years (range: 1 month ± 14 years). Each patient underwent regular
dermatological follow-up. Multivariate analysis (Cox regression) included: age at HT, sex, warts
and solar keratosis, skin type, occupational sunlight exposure, number of treated acute rejection
episodes during the 1st post-HT year, 1st year post-HT cumulative dosage of i.v. boluses of
methylprednisolone and cumulative azathioprine, cyclosporine A and prednisone dosage at
3 months, 6 months, 1 years, 2 years, 3 years post-HT. In order to evaluate the global
immunosuppressive load, we also included the weighted linear combination (WLC) of the
cumulative azathioprine, cyclosporine A and prednisone dosage for each patient at 3 months,
6 months, 1 years, 2 years and 3 years post-HT. Fifty-seven HT patients (15.8%) developed a total
of 131 nonmelanoma skin cancers after HT (90 SCC; 41 BCC; SCC/BCC ratio 2.19 : 1). The
cumulative incidence was 9% (95% CI, 5%-13%) and 20% (95% CI, 10%-30%) for SCCs and 8%
(95% CI, 4%-12%) and 14% (95% CI, 6%-22%) for BCCs after 5 and 10 years, respectively. Age at
HT > 49 years (p = 0.02; RR = 4.4), occupational sunlight exposure > 30000 h (p = 0.01;
RR = 2.7), solar keratosis (p < 0.0001; RR = 6.1), WLC of the cumulative azathioprine,
cyclosporine A and prednisone dosage at 3 years post HT (p = 0.05; RR = 2.4) were risk factors
for SCC. Age at HT > 49 years (p = 0.02; RR = 4.4) and skin type 2 (p = 0.0003; RR = 6.4) were
risk factors for BCC. Our study con®rms the well known importance of cumulative sunlight
exposure for the development of SCC and the association between skin type and BCC; it
furthermore suggests that the risk of SCC, but not of BCC, in HT recipients is related to a higher
level of immunosuppression. This could tentatively explain the reversal of the SCC/BCC ratio on
the basis of an escape from the immunosurveillance mechanism more relevant for the highly
immunogenic SCC than for the less immunogenic BCC.
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Transforming and Biochemical Properties of the HPV77 E7 Protein, a Novel
Papillomavirus Isolated from a Renal Transplant Recipient
J. Freed, J. Pennington, and A. Storey
ICRF Skin Tumour Laboratory, Centre for Cutaneous Research, 2, Newark Street, London E1 2AT, U.K
Renal transplant recipients (RTRs) suffer from a 50±100 fold increased risk of developing
squamous cell carcinomas (SCCs) which may be linked to infection with speci®c human
papillomavirus (HPV) types. A broad spectrum of HPV types have been found in these lesions
including many novel types. We have investigated the transforming potential of one of these,
HPV77. Structure-function analysis was used to investigate the HPV77 E7 protein in terms of its
ability to transform immortalised rodent ®broblasts and bind the Rb tumour supressor protein in
vitro, and compared this to the known transforming ability and binding capacity of HPV16 E7. We
show that the HPV77 E7 protein transforms immortalised rodent ®broblasts, although at slightly
reduced levels to HPV16 E7 and in contrast to the E7 proteins of two other cutaneous HPV types,
HPV5 and HPV10. Motifs in HPV77 E7 revealed the presence of pRb binding and casein kinase II
(CKII) phosphorylation sites. Using recombinant HPV GST fusion proteins produced in bacteria,
we show that HPV77 E7 is capable of binding pRb in vitro produced in a transcription/translation
coupled reaction. Furthermore we demonstrate that the HPV77 E7 protein is a good substrate for
CKII phosphorylation. In contrast to HPV16 E7, site-directed mutagenesis of the two serine
residues of the HPV77 E7 CKII phosphorylation site to either alanine or aspartate, to mimic the
unphosphorylated or phosphorylated forms of HPV77 E7, respectively, abolished its transforming
ability. These results demonstrate that HPV77 E7 is a transforming protein that shares homology
with HPV16 E7 in speci®c regions known to be important for its transformation function.
However, important differences in the regulation of this transforming ability are in evidence
between HPV16 E7 and HPV77 E7 in terms of the effects of CKII phosphorylation.
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Factors Affecting the Expression of Lipases by the Skin Commensal, Staphylococcus
Epidermidis
C.M. Longshaw and K.T. Holland
Leeds, UK
Staphylococcus epidermidis is the dominant staphylococcal strain isolated from human skin and
although historically considered to be a nonpathogenic commensal, has emerged as an important
cause of nosocomial infections. Staphylococcus epidermidis predominantly inhabits regions of the skin
which are rich in sebaceous lipid, such as the face, upper chest and back. Therefore, as part of
research to identify factors important for colonisation of normal human skin, the lipolytic activity
of S. epidermidis was examined. Staphylococcus epidermidis produces two different lipolytic enzymes,
GehC and GehD. To study the differences between these enzymes, in vitro reporter gene fusions
for each of the lipases were constructed and the effects of a number of factors on gene expression
were tested. As is common for many staphylococcal exoproteins, both lipases were found to be
produced at the postexponential phase of growth. Furthermore, induction of exponential phase
expression upon addition of stationary phase cell-free supernatant suggested they may be regulated
by a cell density-sensing system. Lipase expression was increased upon addition of ethanol or the
sebaceous triglyceride, triolein to cultures while being reduced in the presence of oleic acid.
Expression of both lipases was also strongly repressed by addition of glucose. Although the genes
are not located together as an operon, these results indicate a co-ordinated method of regulation for
S. epidermidis lipases and suggest that they may be important for colonisation of staphylococci on
human skin.
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Absence of Anti-Human Herpesvirus 8 (HHV-8) Antibody in 32 Japanese Hemophiliacs
with the Advanced HIV Infection
S. Shimizu, C. Yasui, K. Tsuchiya, H. Katano, T. Sata, K.R. Chen, H. Tagami, H. Hanabusa, and
H. Shimizu
Sapporo and Tokyo, Japan
It is well known that the incidence of Kaposi's sarcoma (KS) is high, 20±45%, among HIV-positive
homosexual men infected through sexual contact. Their seroprevalence of HHV-8 has been
reported as 90%. In contrast, no KS were seen in any of the 53 Japanese HIV-positive hemophiliacs
during more than the 13-year follow-up period after seroconversion to HIV. To clarify the
seroprevalence of HHV-8 in this group, we used a sensitive mixed-antigen ELISA test using 4
recombinant proteins encoded by ORF 59, 65, 73 and K8.1. Sera were available from 32 out of 53
patients. The examination demonstrated that none of the serum samples from the 32 HIV-positive
hemophiliacs contained anti-HHV-8 antibodies. The seropositivity rate of HHV-8 was no more
than that in the general Japanese population (1.4%). This study showed that the prevalence of KS
and seroprevalence of HHV-8 were no higher in Japanese HIV-positive hemophiliacs exposed to
HIV through blood product. Our data supports the previous notion that HHV-8 infection is
strongly related to the development of KS in HIV infected individuals.
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Association Between Seasonal UV Exposure and the Incidence of Chickenpox and
Shingles
M. Zak-Prelich, J.L. Borkowski,* F. Alexander,² and M. Norval³
Dermatology, Medical University, Lodz, Poland, Institute of Geophysics, Polish Academy of Sciences,
Warsaw, Poland; *Public Health Sciences and ²Medical Microbiology, ³University of Edinburgh Medical
School, Edinburgh, UK
UV radiation is recognised to suppress immune responses, and cell-mediated immunity is
important in the control of zoster virus during chickenpox and shingles and in the latent period in-
between. The aim of the present study was to determine whether the incidence of chickenpox and
shingles occurring in a de®ned area of Lodz correlated with solar UV irradiance. The irradiance
was measured daily in Warsaw, about 120 km north-east of Lodz, for the years 1999 and 2000 and
was expressed as minimum erythemal dose (MED) where one MED was de®ned as 21 mJ per cm2
effective radiation. The monthly irradiance ranged from about 10 in December to about 400
MEDs in June/July. The number of cases of chickenpox and shingles occurring in each month
over the same two year period was also recorded. For chickenpox, they totalled 14 865 (range 120±
1123 per month) and, for shingles, 585 (349 female and 236 male, range 13±46 per month).
Seasonal variation was assessed by `cosina' analysis in which the ®rst terms in the Fourier series were
®tted in a Poisson regression model for numbers of cases of chickenpox/shingles and a linear
regression model for UV irradiance. Rank correlations between the monthly UV and the clinical
cases were computed. The seasonality of UV was highly statistically signi®cant (p < 0.001).
Signi®cant evidence of seasonal variation was found for total shingles (p = 0.04) and for shingles in
males (p = 0.02) with the lowest number of cases in the winter. For chickenpox, there was highly
statistically signi®cant evidence of seasonality with the maximum number of cases in March and the
minimum in August/September. There were quite large, although nonsigni®cant, negative
correlations of solar UV/day and shingles cases per day with chickenpox cases per day. Thus the
pattern of seasonality with regard to the incidence of these two infections was quite different. The
change in chickenpox numbers with season is probably due to the ease of spread of the virus by
indoor living in the winter months. For shingles, it is tempting to speculate that the increase in
solar UV in the summer could down-regulate immunity, hence contributing to the reactivation of
the virus and the increased incidence.
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